Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3003396	ab-be	mmol/l (mmol/l)	37616	326893	0.00%
3003396	ab-be	— (—)	18112	59551	100.00%	Distribution not available
3003396	ab-emäsylimäärä	mmol/l (mmol/l)	3447	9017	0.00%
3003396	ab-be	mmol/L (mmol/l)	673	1611	0.00%
3003396	ab-be	mmol/l____ (mmol/l)	592	1165	0.00%
3003396	emäsylimäärä,valtimoveri	mmol/l (mmol/l)	522	1062	0.00%
3003396	ab-be	MMOL/L (mmol/l)	298	915	0.00%
3003396	ab-emäsylimäärä	mmol/l____ (mmol/l)	90	138	0.00%
3003396	emäsylimäärä,valtimoveri	mmol/l____ (mmol/l)	14	16	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Alcohol dependence

2911

14157

2.35

322.83

9.7

8.3

1.17

0.80

mmol/l

4.25

2417

11660

Constipation

8388

36704

1.65

322.19

7.8

7.9

1.15

0.85

mmol/l

8.96

7057

30261

Schizophrenia or delusion, excluding more controls

2697

12439

2.36

320.36

8.1

7.9

1.84

0.76

mmol/l

31.97

2257

10238

Nerve, nerve root and plexus disorders

9694

38621

1.59

320.25

7.5

7.9

1.10

0.86

mmol/l

7.42

7967

31912

Acute bronchitis

4149

22236

2.01

319.84

8.2

7.3

1.44

0.82

mmol/l

17.31

3501

18094

Other special examinations and investigations of persons without complaint or reported diagnosis

5702

16560

1.85

319.56

8.2

7.7

1.09

0.80

mmol/l

5.60

4536

13748

Volume depletion

1316

4483

3.70

319.10

9.7

6.7

1.02

1.04

mmol/l

0.03

1083

3621

Infections of the skin and subcutaneous tissue

5489

31972

1.82

318.56

9.9

8.0

0.85

mmol/l

0.02

4641

26330

Sciatica+with lumbago

4856

24482

1.90

318.09

6.8

8.3

1.13

0.82

mmol/l

7.04

4020

20331

Other functional intestinal disorders

4446

22462

1.95

317.24

7.4

7.2

1.23

0.95

mmol/l

4.65

3699

18423

Certain infectious and parasitic diseases, including avohilmo

6050

17687

1.81

317.04

8.5

7.0

0.88

0.90

mmol/l

0.09

4948

14375

Other and unspecified iron deficiency

3607

18957

2.12

316.64

9.5

6.9

0.77

0.96

mmol/l

1.76

3009

15533

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2174

9536

2.70

315.61

7.6

0.99

1.15

mmol/l

1.12

1856

7856

Focal epilepsy, strict definition

2234

9890

2.64

314.82

8.2

7.9

1.02

0.88

mmol/l

0.97

1811

8093

Benign neoplasm of colon, rectum, anus and anal canal

6524

34306

1.74

312.41

7.8

7.6

0.79

0.99

mmol/l

3.48

5454

28505

Brain meningioma

769

1897

5.87

310.89

5.6

7.4

1.11

1.22

mmol/l

0.33

576

1555

ILD, hospital admissions 1, main diag only

1839

7641

3.04

310.80

9.6

7.3

1.30

0.96

mmol/l

2.88

1590

6240

Abnormal findings on examination of blood, without diagnosis

4991

26356

1.89

310.05

8.5

8.0

0.76

0.87

mmol/l

1.01

4123

21774

Anxiety disorders, excluding more controls

6896

27231

1.71

310.04

8.5

7.9

1.05

0.81

mmol/l

5.03

5787

22568

Brain meningioma, including Hilmo

784

1972

5.71

308.61

5.6

7.3

1.13

1.24

mmol/l

0.31

590

1616

Explicit bacterial Sepsis

1343

4702

3.52

307.81

11.8

6.3

0.88

0.84

mmol/l

0.11

1134

3824

Other septicaemia

5937

19459

3.62

307.65

12.7

6.6

0.85

0.92

mmol/l

0.49

4923

16024

Non-rheumatic valve diseases

5691

15607

3.05

307.65

10.4

6.7

0.91

0.81

mmol/l

1.00

4872

12894

Non-invasive ventilation

6205

4847

18.67

307.65

9.0

5.4

2.31

0.44

mmol/l

179.03

4985

4078

Fall on same level

10300

34325

1.69

307.65

8.9

7.8

0.95

0.82

mmol/l

2.44

8610

28117

Non-allergic asthma (mode), excluding more controls

1838

6229

3.34

307.65

7.8

5.9

1.42

0.32

mmol/l

26.07

1552

5061

Hernia

8509

36066

1.66

307.65

8.4

7.7

0.89

0.94

mmol/l

0.61

7160

29738

Angina pectoris

6249

19535

2.41

307.65

8.5

7.0

1.15

0.96

mmol/l

3.00

5193

16355

Acute renal failure

3725

12749

3.91

307.65

17.0

6.6

-0.27

1.13

mmol/l

39.61

3058

10511

Spinal stenosis

5593

22529

2.03

307.65

6.8

7.9

1.04

0.86

mmol/l

2.60

4639

18702

Renal failure

7199

25113

3.00

307.65

13.3

6.7

-0.20

1.14

mmol/l

81.06

5812

20866

Disorders of gallbladder, biliary tract and pancreas

9325

36858

1.68

307.65

9.1

7.5

0.84

0.93

mmol/l

1.40

7790

30425

Asthma-related infections

7206

31052

2.58

307.65

8.6

7.6

1.58

0.77

mmol/l

49.86

6073

25425

Sequelae of external causes of morbidity and mortality

3109

13892

2.63

307.65

11.0

7.5

1.07

0.92

mmol/l

1.27

2696

11427

Heart failure and coronary heart disease

6415

15988

3.56

307.65

11.0

6.8

1.07

0.97

mmol/l

0.90

5353

13315

Hypothyroidism, drug reimbursement

904

987

7.06

307.65

9.2

4.7

0.90

0.73

mmol/l

0.49

751

762

Cerebrovascular diseases (FINNGEN)

4104

5471

6.55

307.65

11.4

6.0

0.98

0.82

mmol/l

1.45

3460

4484

Condition for Implicit Sepsis (Organ dysfunction codes)

11614

29616

3.19

307.65

11.7

6.4

1.01

0.86

mmol/l

2.64

9743

24420

Bacterial Sepsis

8162

21226

4.13

307.65

12.6

6.2

1.14

0.86

mmol/l

5.51

6804

17494

Other interstitial pulmonary diseases

2082

8750

2.97

307.65

9.6

7.3

1.33

0.94

mmol/l

3.78

1792

7147

Certain infectious and parasitic diseases

8877

23880

1.99

307.65

9.3

6.8

0.87

0.84

mmol/l

0.27

7360

19528

Cardiac arrest

882

1373

7.08

307.65

16.1

6.2

0.73

0.75

mmol/l

0.03

736

1110

Provisional assignment of new diseases of uncertain etiology

6489

28710

2.57

307.65

11.0

7.1

1.09

0.83

mmol/l

5.39

5555

23413

Diverticular disease of intestine

7063

26310

1.80

307.65

7.9

7.5

0.81

1.00

mmol/l

3.38

5894

21774

Ischemic heart diseases

9605

24796

2.63

307.65

10.8

7.1

0.96

mmol/l

0.02

8092

20745

Erysipelas

6821

26636

2.53

307.65

9.0

6.9

1.17

0.92

mmol/l

4.65

5742

22065

Diabetes mellitus

9800

31265

1.95

307.65

10.1

7.1

0.76

0.97

mmol/l

4.21

8056

25909

Later onset COPD

3522

14302

2.31

307.65

7.3

6.5

1.83

0.72

mmol/l

39.64

2954

11560

Mental and behavioural disorders due to alcohol

5609

27134

2.20

307.65

10.2

8.1

1.00

0.78

mmol/l

2.99

4640

22349

Septicaemia

6666

21054

3.62

307.65

12.4

6.7

0.87

0.91

mmol/l

0.29

5534

17342

Type 2 diabetes

9437

30524

1.93

307.65

9.9

7.0

0.83

0.98

mmol/l

2.39

7769

25333

Anaemias

2397

1516

12.03

307.65

12.4

4.8

0.47

0.60

mmol/l

0.52

2002

1140

Heart failure, not strict

11238

24790

3.80

307.65

11.7

6.9

1.12

0.77

mmol/l

12.12

9610

20599

Codes for special purposes

6497

28730

2.58

307.65

11.0

7.1

1.10

0.83

mmol/l

5.55

5561

23426

Transplanted organ and tissue status

1464

4061

4.96

307.65

25.5

7.7

-0.74

0.94

mmol/l

39.22

1300

3355

10446

32923

1.70

307.65

8.0

7.4

1.23

0.72

mmol/l

29.77

8748

26958

Use of hypnotics and sedatives

9859

35757

1.67

307.65

8.2

8.0

0.99

0.86

mmol/l

2.50

8240

29457

Later onset COPD, excluding more controls

3142

7396

4.20

307.65

7.7

6.0

1.83

0.34

mmol/l

56.26

2669

6063

Explicit Sepsis, including avohilmo

6955

21149

3.71

307.65

12.5

6.2

0.87

0.84

mmol/l

0.19

5780

17363

Viral Sepsis

3301

10050

4.29

307.65

12.0

6.2

1.30

0.88

mmol/l

5.37

2776

8190

Implicit viral Sepsis, including avohilmo

4446

15087

3.67

307.65

11.4

6.1

1.16

0.86

mmol/l

3.98

3765

12341

Asthma, hospital admissions 3, pneumonia

5390

20003

3.30

307.65

9.3

7.1

1.75

0.80

mmol/l

47.43

4598

16302

Any event in cancer register

9102

26517

2.19

307.65

8.2

0.67

1.03

mmol/l

14.87

7629

21711

Implicit fungal Sepsis, including avohilmo

1037

2995

4.67

307.65

13.3

6.3

1.19

0.90

mmol/l

1.14

904

2446

Early onset COPD, excluding more controls

2921

8048

4.66

307.65

10.1

7.0

2.00

0.33

mmol/l

75.58

2574

6625

Biguanides

8760

33606

1.67

307.65

8.5

7.5

0.93

0.95

mmol/l

0.15

7145

27980

Excluding asthma or asthma-COPD overlap

7171

16582

2.35

307.65

9.0

6.8

1.16

0.33

mmol/l

48.10

5954

13501

Poisoning by medicine

2407

8391

3.39

307.65

9.2

8.4

1.07

0.76

mmol/l

2.80

2004

6869

Obesity

6034

31023

1.99

307.65

9.4

8.0

1.30

0.80

mmol/l

15.71

5112

25582

Asthma, hospital admissions , main diagnosis only

7833

39978

1.83

307.65

7.4

7.9

1.37

0.81

mmol/l

29.93

6576

32796

Type 2 diabetes, definitions combined, including avohilmo

8715

29767

1.81

307.65

9.4

7.1

0.90

0.98

mmol/l

1.01

7178

24733

Mental and behavioural disorders due to alcohol, excluding acute intoxication

4977

24656

2.26

307.65

10.4

8.3

1.01

0.81

mmol/l

2.24

4134

20401

COPD, hospital admissions

6332

23125

2.80

307.65

8.6

7.4

1.92

0.73

mmol/l

83.78

5440

19017

Statin medication

5211

16352

1.90

307.65

9.5

7.2

0.72

1.06

mmol/l

6.71

4307

13397

Asthma, hospital admission 2, infections

7206

31052

2.58

307.65

8.6

7.6

1.58

0.77

mmol/l

49.86

6073

25425

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

9974

33745

2.03

307.65

11.3

7.0

0.68

0.93

mmol/l

7.76

8398

27696

Asthma

8103

16445

2.83

307.65

8.0

6.8

1.34

0.34

mmol/l

77.73

6783

13396

Metabolic disorders

10921

29258

2.51

307.65

9.6

7.3

0.86

0.95

mmol/l

1.29

9142

24066

Intracranial trauma

5499

16392

2.48

307.65

8.6

7.7

1.10

0.59

mmol/l

15.10

4559

13484

Substance use, excluding alcohol

2133

8165

3.04

307.65

9.7

8.4

1.21

0.80

mmol/l

4.09

1854

6707

Any reimbursement code in KELA

4459

7587

3.19

307.65

9.5

6.8

0.83

0.68

mmol/l

1.41

3642

6081

Other respiratory diseases principally affecting the interstitium

2465

10308

2.97

307.65

10.6

7.3

1.40

0.94

mmol/l

5.92

2107

8407

Any mental disorder

9903

30671

1.71

307.65

8.3

7.8

1.08

0.80

mmol/l

8.77

8210

25348

Malignant neoplasm, including Hilmo

8739

25567

2.18

307.65

8.3

8.2

0.67

1.06

mmol/l

16.12

7390

20923

Asthma, unspecified (mode), excluding more controls

6077

13732

3.65

307.65

8.2

6.4

1.40

0.34

mmol/l

64.17

5121

11195

Other disorders of urethra and urinary system

6537

27031

1.80

307.65

7.6

7.4

1.00

0.88

mmol/l

1.45

5412

22060

Low back pain

7290

28221

1.87

307.65

7.4

8.2

1.19

0.78

mmol/l

15.68

6099

23211

Colorectal cancer

2811

12656

2.47

307.65

7.9

7.3

0.46

1.14

mmol/l

16.83

2417

10362

Solid cancers

8403

24978

2.16

307.65

8.0

8.2

0.69

1.08

mmol/l

15.78

7143

20476

Other chronic obstructive pulmonary disease

6336

20607

3.10

307.65

8.7

7.5

1.92

0.68

mmol/l

88.49

5449

16981

Malignant neoplasm of digestive organs, including Hilmo

5228

17675

2.51

307.65

9.0

7.8

0.56

1.14

mmol/l

21.18

4550

14571

Neoplasms

6184

17057

2.02

307.65

8.7

0.67

0.95

mmol/l

6.10

5083

13777

6643

29884

2.15

307.65

10.5

7.9

0.89

0.82

mmol/l

0.63

5515

24631

First line medication for Crohn's disease

11442

31050

2.16

307.65

8.8

7.6

0.94

0.79

mmol/l

3.09

9548

25330

Suicide or other Intentional self-harm

2494

10252

2.79

307.65

9.4

8.3

1.11

0.80

mmol/l

2.96

2083

8406

Implicit Sepsis, including avohilmo

11604

29805

3.31

307.65

11.7

6.5

1.02

0.86

mmol/l

2.99

9749

24566

Asthma-related pneumonia or sepsis

5390

20003

3.30

307.65

9.3

7.1

1.75

0.80

mmol/l

47.43

4598

16302

Other respiratory disorders and diseases

3438

11314

4.11

307.65

12.2

6.9

2.92

0.77

mmol/l

129.67

3070

9111

Interstitial lung disease

2082

8766

2.97

307.65

9.6

7.3

1.33

0.94

mmol/l

3.75

1792

7152

Asthma (only as main-diagnosis)

7251

16445

2.73

307.65

7.5

6.8

1.36

0.34

mmol/l

75.59

6104

13396

Ischaemic heart disease, wide definition

8648

25945

2.31

307.65

9.6

7.5

0.96

0.98

mmol/l

0.19

7268

21829

Complications of medical and surgical care

9182

37033

2.55

307.65

10.1

7.2

1.01

0.90

mmol/l

1.78

7723

30504

Pain in limb

8135

28903

1.93

307.65

7.9

8.1

0.92

0.85

mmol/l

0.78

6880

23652

Malaise and fatigue

6457

20663

2.82

307.65

8.1

7.5

1.16

0.80

mmol/l

8.21

5415

17020

All kidney diseases

11543

34309

2.54

307.65

10.9

7.0

0.47

1.06

mmol/l

33.29

9623

28334

Poisoning by drugs, medicaments and biological substances

2647

9440

3.30

307.65

9.1

8.3

1.08

0.79

mmol/l

2.61

2195

7735

Codeine or tramadol medication

11136

34510

1.89

307.65

7.8

0.88

0.91

mmol/l

0.29

9288

28264

Continuous positive airway pressure

1725

3783

4.38

307.65

11.3

5.7

0.95

0.46

mmol/l

3.85

1499

3209

COPD related to multimorbidity

5673

20406

2.88

307.65

8.8

7.3

1.87

0.72

mmol/l

67.55

4854

16709

COPD/asthma related infections

9789

24636

2.16

307.65

9.1

6.8

1.26

0.54

mmol/l

49.28

8167

20182

Iron deficiency anaemia

4622

24387

2.07

307.65

9.7

6.9

0.78

0.94

mmol/l

1.60

3836

20012

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3551

6912

3.58

307.65

9.5

5.9

0.97

0.75

mmol/l

2.26

2971

5581

Other and unspecified anaemias

5071

25129

2.14

307.65

9.1

7.0

0.58

0.97

mmol/l

7.08

4145

20745

Hypertensive Heart Disease

2958

8515

3.13

307.65

8.6

6.7

1.07

0.99

mmol/l

0.38

2525

7023

Bleeding

10003

33777

2.35

307.65

10.2

7.3

1.00

0.91

mmol/l

1.37

8344

28032

Malignant neoplasm

8519

25285

2.16

307.65

8.2

0.70

1.07

mmol/l

13.94

7211

20720

Other disorders of fluid, electrolyte and acid-base balance

4682

15687

3.51

307.65

10.8

6.7

1.05

1.03

mmol/l

0.12

3891

12889

Pure hypercholesterolaemia

8579

26298

2.32

307.65

8.3

7.2

0.83

1.00

mmol/l

3.22

7220

21769

COPD (mode)

5013

10685

4.81

307.65

8.9

6.7

1.98

0.36

mmol/l

106.96

4333

8784

Symptoms and signs involving the digestive system and abdomen

8941

28127

1.68

307.65

8.6

7.9

0.93

0.85

mmol/l

0.95

7358

23093

Hypothyroidism and >3 levothyroxin purchases

1592

1559

6.22

307.65

10.0

4.8

0.59

0.65

mmol/l

0.18

1292

1173

All pneumoniae

13467

32116

3.17

307.65

10.8

7.0

1.43

0.58

mmol/l

88.75

11420

26317

Complications of procedures, not elsewhere classified

9655

35979

2.44

307.65

10.2

7.1

1.00

0.89

mmol/l

1.90

8157

29542

Injuries to the head

10266

38958

1.65

307.65

8.5

7.8

0.95

0.86

mmol/l

1.31

8530

32049

COPD differential diagnosis

7119

16612

2.32

307.65

9.0

6.8

1.16

0.33

mmol/l

48.10

5909

13531

11774

24636

3.25

307.65

10.5

6.8

1.42

0.54

mmol/l

79.55

9956

20182

General symptoms and signs

10816

26309

2.24

307.65

8.6

7.6

0.99

0.79

mmol/l

4.84

8934

21610

Other dorsopathies, not elsewhere classified

8684

28689

1.66

307.65

7.4

8.3

1.04

0.77

mmol/l

7.75

7144

23576

Any death

8345

25716

2.70

307.65

10.7

7.3

1.22

0.83

mmol/l

10.04

6919

21759

Non-ischemic cardiomyopathy

4220

11800

3.50

307.65

10.3

6.7

1.58

0.78

mmol/l

21.52

3648

9811

Valvular heart disease excluding rheumatic fever

5754

15679

3.08

307.65

10.8

6.8

0.90

0.81

mmol/l

0.86

4931

12951

Aneurysms, operations, SAH

1987

8063

2.98

307.65

9.4

7.3

1.03

0.99

mmol/l

0.18

1630

6621

Dorsalgia

8750

28671

1.71

307.65

7.2

8.2

1.02

0.77

mmol/l

6.67

7240

23559

ILD differential diagnosis

7113

16608

2.32

307.65

9.0

6.8

1.16

0.33

mmol/l

47.97

5903

13529

Persons encountering health services for specific procedures and health care

12186

32791

2.44

307.65

9.9

7.4

0.89

0.85

mmol/l

0.55

10155

26928

Other diseases of pleura

6578

23834

2.93

307.65

10.6

7.1

2.06

0.71

mmol/l

106.76

5731

19494

Hypertensive diseases

7708

18788

2.56

307.65

9.9

7.4

0.86

0.92

mmol/l

0.51

6451

15478

Polyarthropathies

6413

23377

1.90

307.65

8.7

8.3

0.73

0.92

mmol/l

2.73

5354

19138

4729

21699

2.42

307.65

8.2

7.9

1.54

0.75

mmol/l

34.44

4002

17794

Lower back pain or/and sciatica

10013

39683

1.66

307.65

7.2

8.0

1.13

0.84

mmol/l

10.69

8343

32640

Bronchitis

10128

38717

1.66

307.65

8.2

7.6

1.27

0.79

mmol/l

24.98

8459

31751

Abnormalities of breathing

10354

23447

2.84

307.65

8.0

8.1

1.27

0.68

mmol/l

35.04

8574

19179

Early onset COPD

2921

11386

3.18

307.65

10.1

8.2

2.00

0.71

mmol/l

48.54

2574

9391

COPD, hospital admissions 3, with asthma pneumonia sepsis

4163

13891

3.25

307.65

9.0

7.0

2.16

0.70

mmol/l

77.36

3584

11224

COPD-related respiratory insufficiency

2245

6206

5.56

307.65

11.3

7.1

2.70

0.69

mmol/l

74.45

2003

5009

Care involving dialysis

1184

3475

4.69

307.65

16.5

7.7

-1.25

0.86

mmol/l

40.49

999

2875

Hypertension, essential

7822

18521

2.66

307.65

9.2

7.3

0.88

0.93

mmol/l

0.46

6546

15258

Bacterial pneumoniae

6020

17766

3.67

307.65

10.9

6.7

1.78

0.55

mmol/l

83.24

4994

14597

COPD, hospital admissions 1, only main diagnosis

4794

17964

2.78

307.65

8.5

7.2

2.05

0.74

mmol/l

74.70

4141

14634

COPD, hospital admission 2, with asthma infections

4769

16499

3.10

307.65

9.0

7.1

2.04

0.70

mmol/l

76.07

4104

13383

Other neurological diseases

7526

34309

1.85

307.65

7.6

7.7

1.06

0.92

mmol/l

2.27

6189

28459

Secondary hypertension

816

1699

5.75

307.65

12.0

6.4

-0.23

0.72

mmol/l

6.11

697

1380

Dialysis, with operation codes

2015

6086

4.63

307.65

20.2

7.3

-0.91

1.10

mmol/l

56.75

1704

5046

Aplastic and other anaemias

5510

26400

2.16

307.65

9.2

7.1

0.58

0.97

mmol/l

7.38

4501

21807

Diabetes medication

9816

33798

1.81

307.65

9.4

7.3

0.83

0.95

mmol/l

1.83

8032

28061

Heart failure, strict

8984

23481

3.33

307.65

10.6

7.1

1.30

0.80

mmol/l

18.31

7601

19491

Syncope and collapse

4629

19435

2.19

307.65

7.5

0.89

0.82

mmol/l

0.47

3808

15997

Other acute lower respiratory infections

5515

28954

1.98

307.65

8.6

7.6

1.44

0.80

mmol/l

24.28

4674

23599

Dipeptidyl peptidase 4 (DPP-4) inhibitors

6038

26454

1.99

307.65

8.6

7.3

0.71

1.01

mmol/l

4.96

4815

22174

Cerebrovascular diseases

8772

30989

2.22

307.65

9.2

7.5

0.94

0.95

mmol/l

0.08

7343

25758

STROKE

6327

15292

3.23

307.65

10.2

6.4

1.01

0.98

mmol/l

0.19

5324

12834

Diabetes, varying definitions

9763

31275

1.95

307.65

10.1

7.1

0.76

0.97

mmol/l

4.45

8029

25917

Implicit bacterial Sepsis

7381

19515

4.28

307.65

12.9

6.2

1.18

0.86

mmol/l

6.11

6152

16088

Other nutritional deficiencies

6426

32176

1.98

307.65

9.4

8.0

1.27

0.80

mmol/l

14.40

5432

26539

AV-block

2126

6939

3.08

307.65

9.5

6.2

0.75

0.82

mmol/l

0.33

1741

5659

Other bacterial diseases, including avohilmo

12826

31885

2.88

307.65

10.4

7.0

0.98

0.87

mmol/l

1.98

10751

26208

Other anaemias

5106

25281

2.14

307.65

9.1

7.0

0.58

0.97

mmol/l

6.87

4176

20871

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

7785

34914

2.18

307.65

8.4

7.5

1.28

0.88

mmol/l

15.53

6644

28791

Other (not insulin) diabetes medications

9019

32671

1.72

307.65

8.6

7.3

0.94

0.97

mmol/l

0.26

7373

27179

Pain in throat and chest

8696

23199

2.44

307.65

7.6

8.1

0.93

0.69

mmol/l

6.52

7202

19012

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2749

5004

2.96

307.65

8.5

7.9

0.94

0.59

mmol/l

3.85

2245

4039

Endocrine, nutritional and metabolic diseases

6589

16562

2.14

307.65

9.8

6.8

0.75

0.88

mmol/l

1.50

5427

13515

Respiratory insufficiency

1845

3046

10.52

307.65

11.2

6.4

3.58

0.30

mmol/l

140.64

1694

2451

Other soft tissue disorders, not elsewhere classified

8807

29287

1.83

307.65

8.0

8.1

0.90

0.85

mmol/l

0.47

7390

23962

Hypokalaemia

1525

5455

3.44

307.65

10.6

6.8

2.05

1.08

mmol/l

10.04

1319

4468

Hypertensive heart and/or renal disease

3277

8977

3.17

307.65

8.7

6.8

0.94

1.00

mmol/l

0.30

2772

7410

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1755

5996

3.46

307.65

9.6

8.6

0.97

0.76

mmol/l

1.21

1461

4923

Headache

5766

23717

2.01

307.65

7.4

7.6

1.00

0.78

mmol/l

4.07

4735

19512

Any gastric operation

7059

15006

2.55

307.65

9.5

5.9

0.76

0.97

mmol/l

3.58

5829

11994

Diseases of arteries, arterioles and capillaries

8319

29658

2.36

307.65

10.3

7.1

0.71

1.00

mmol/l

7.45

7019

24561

All influenza

3185

11782

3.20

307.65

8.4

6.9

1.46

0.52

mmol/l

29.45

2640

9647

Neurological diseases

6926

20552

1.78

307.65

8.3

8.1

0.97

0.60

mmol/l

10.86

5623

16871

Atherosclerosis, excluding cerebral and coronary sclerosis

5056

20036

2.28

307.65

9.2

6.7

0.69

0.99

mmol/l

4.81

4147

16431

Pulmonary embolism

3865

16672

2.78

307.65

9.1

7.3

1.25

0.90

mmol/l

6.17

3236

13711

Venous thromboembolism

6160

31230

2.13

307.65

8.5

7.3

1.16

0.92

mmol/l

5.17

5170

25785

Atrial fibrillation and flutter with reimbursement

3124

4199

5.76

307.65

11.7

6.1

1.06

0.85

mmol/l

1.67

2698

3476

Abnormal findings on diagnostic imaging of lung

5819

28225

2.23

307.65

8.4

7.4

1.40

0.87

mmol/l

19.66

5007

23313

Obesity and other hyperalimentation

6051

31157

1.98

307.65

9.4

8.0

1.30

0.80

mmol/l

15.91

5127

25693

Symptoms and signs involving the circulatory and respiratory systems

9242

23482

2.12

307.65

8.0

8.1

1.03

0.68

mmol/l

12.40

7557

19208

Antihypertensive medication - note that there are other indications

4368

9331

2.62

307.65

10.1

6.7

0.63

0.76

mmol/l

1.13

3561

7439

Other CVD (FINNGEN)

1450

2139

6.57

307.65

9.3

6.0

1.15

0.79

mmol/l

1.93

1215

1763

Heart failure and bmi 25plus

4953

12706

3.24

307.65

10.3

6.9

1.41

0.88

mmol/l

12.15

4183

10368

Haemorrhage from respiratory passages

4011

15450

2.63

307.65

9.3

7.7

1.08

0.74

mmol/l

5.42

3340

12739

Paroxysmal tachycardia

2029

4459

4.32

307.65

11.2

5.9

0.75

0.72

mmol/l

0.14

1672

3653

Major coronary heart disease event

9954

26216

2.59

307.65

10.7

7.1

0.96

0.98

mmol/l

0.11

8363

21925

Symptoms and signs involving cognition, perception, emotional state and behaviour

9613

37030

1.87

307.65

7.6

8.1

1.08

0.85

mmol/l

6.40

7920

30631

Pain, not elsewhere classified

2781

12247

2.54

307.65

8.4

7.3

1.14

0.78

mmol/l

5.01

2337

10074

Other heart diseases, wide

9767

24392

2.70

307.65

10.8

7.1

0.99

0.77

mmol/l

5.38

8262

19954

Renal tubulo-interstitial diseases

11132

33982

2.77

307.65

11.2

6.9

0.38

1.05

mmol/l

39.63

9220

28132

Myocardial infarction

5824

17832

2.65

307.65

9.8

7.0

0.70

0.96

mmol/l

4.30

4805

14908

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2740

11495

2.68

307.65

9.1

8.2

1.02

0.74

mmol/l

2.77

2263

9321

Pulmonary heart disease

3865

16815

2.75

307.65

9.1

7.3

1.25

0.92

mmol/l

5.65

3236

13836

Mental and behavioural disorders due to psychoactive substance use

6666

30394

2.24

307.65

10.0

8.0

1.02

0.80

mmol/l

3.65

5577

25022

Nausea and vomiting

3029

12974

2.59

307.65

9.2

7.1

0.86

0.89

mmol/l

0.15

2525

10617

Chronic kidney disease

4336

18538

2.69

307.65

11.4

6.5

-0.51

1.14

mmol/l

80.59

3434

15236

Abdominal and pelvic pain

8819

28123

1.66

307.65

8.4

7.9

0.95

0.85

mmol/l

1.42

7285

23091

6401

29376

2.17

307.65

10.5

7.9

0.88

0.81

mmol/l

0.53

5304

24222

Fever of other and unknown origin

6690

23596

2.79

307.65

9.4

7.6

0.94

0.79

mmol/l

2.31

5608

19392

Episodal and paroxysmal disorders

9556

30473

1.68

307.65

8.0

7.9

1.02

0.76

mmol/l

7.51

7824

24977

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

13153

32560

3.13

307.65

10.5

7.1

1.44

0.59

mmol/l

86.55

11138

26722

Percutaneous Coronary Intervention

9631

24271

2.79

307.65

10.8

7.1

0.96

mmol/l

0.07

8092

20330

Malignant neoplasm of digestive organs

4655

16885

2.42

307.65

8.9

7.7

0.57

1.14

mmol/l

18.43

4024

13908

L04AD Calcineurin inhibitors

1485

4572

4.28

307.65

22.3

8.7

-0.70

0.93

mmol/l

39.19

1308

3786

Other heart diseases

5314

7575

5.36

307.65

12.9

6.1

0.96

0.72

mmol/l

3.32

4526

6121

GASTRO-related operations

7059

15006

2.55

307.65

9.5

5.9

0.76

0.97

mmol/l

3.58

5829

11994

Alcohol abuse, main dg, excluding more controls

1698

6225

3.24

307.65

9.9

8.3

1.10

0.68

mmol/l

3.15

1392

5134

Ischaemic Stroke, excluding all haemorrhages

5942

26130

1.84

307.65

8.5

7.5

0.99

0.97

mmol/l

0.13

4935

21659

Coronary artery bypass grafting

3120

9957

2.76

307.65

11.4

6.7

0.76

0.88

mmol/l

0.89

2637

8251

Other diseases of the digestive system

3803

19312

2.25

307.65

10.0

7.1

0.85

0.90

mmol/l

0.27

3135

15787

Oxycodone

5450

17555

3.18

307.65

8.1

7.3

1.45

0.92

mmol/l

17.37

4668

14322

Cardiac arrhythmias

5598

11775

3.40

307.65

10.6

6.2

0.96

0.82

mmol/l

1.69

4667

9695

Hard cardiovascular diseases

9920

23467

2.88

307.65

11.2

6.9

0.99

0.95

mmol/l

0.34

8371

19611

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6693

32666

2.32

307.65

10.3

7.2

0.99

0.92

mmol/l

0.65

5646

26977

Concussion

4408

16306

2.26

307.65

7.6

7.7

1.14

0.59

mmol/l

14.65

3633

13425

COPD/asthma/ILD related infections

9789

24636

2.16

307.65

9.1

6.8

1.26

0.54

mmol/l

49.28

8167

20182

Symptoms and signs involving the urinary system

7399

34914

1.71

307.65

8.1

7.7

0.82

0.96

mmol/l

2.03

6190

28896

Acute tubulo-interstitial nephritis

7058

28248

2.36

307.65

8.4

6.7

0.86

1.06

mmol/l

3.56

5832

23357

Other bacterial diseases

12772

32661

3.03

307.65

10.6

7.0

0.95

0.90

mmol/l

0.64

10699

26986

COPD, early/later onset

6400

23276

2.80

307.65

8.6

7.4

1.91

0.73

mmol/l

82.90

5503

19145

Other diseases of intestines

9572

31724

1.79

307.65

8.7

7.8

0.77

0.90

mmol/l

2.08

7967

25926

Implicit Sepsis

11256

28911

3.47

307.65

11.8

6.5

1.08

0.85

mmol/l

5.48

9455

23870

All chronic kidney diseases

7192

24126

2.78

307.65

10.4

6.8

-0.05

1.10

mmol/l

68.44

5789

20052

Influenza and pneumonia

13571

31307

3.09

307.65

10.6

7.0

1.40

0.57

mmol/l

86.80

11474

25644

Sequelae with surgical and medical care as external cause

2480

10856

2.73

307.65

10.9

7.5

1.13

0.95

mmol/l

1.59

2163

8937

Viral pneumonia

1875

5402

4.50

307.65

13.2

7.0

1.45

0.58

mmol/l

13.69

1588

4379

Erysipelas, including avohilmo

8690

29024

2.51

307.65

8.8

6.9

1.13

0.91

mmol/l

4.59

7323

24004

Pulmonary heart disease, diseases of pulmonary circulation

4363

18385

2.87

307.65

9.3

7.2

1.34

0.92

mmol/l

9.40

3663

15117

Insulin, fast-acting or short human

3858

20130

2.14

307.65

10.7

7.8

0.64

0.86

mmol/l

2.07

3136

16586

Insulin, intermediate and long-acting

6242

31576

2.14

307.65

10.1

7.5

0.66

0.92

mmol/l

3.94

5057

26169

Other diseases of the respiratory system

3438

11314

4.11

307.65

12.2

6.9

2.92

0.77

mmol/l

129.67

3070

9111

Myocardial infarction, without ST-elevation

4980

23276

2.22

307.65

9.0

7.2

0.74

0.98

mmol/l

3.22

4029

19216

Hypothyroidism (congenital or acquired)

1617

1563

6.30

307.65

10.2

4.8

0.58

0.64

mmol/l

0.19

1306

1174

Dyspnoea

12213

35043

2.94

307.65

7.9

7.8

1.34

0.73

mmol/l

46.04

10196

28815

Malignant neoplasm, wide definition

8754

25614

2.18

307.65

8.3

8.2

0.68

1.06

mmol/l

15.57

7406

20965

Hypertensive diseases (excluding secondary)

4989

7453

4.43

307.65

10.9

6.2

0.79

0.75

mmol/l

0.21

4182

6026

Chronic lower respiratory diseases

12163

34915

1.98

307.65

8.1

8.0

1.36

0.65

mmol/l

62.06

10155

28610

Asthma/COPD (KELA code 203)

9585

34888

1.98

307.65

7.4

8.0

1.46

0.65

mmol/l

67.06

8018

28587

Interstitial lung disease endpoints

2082

8766

2.97

307.65

9.6

7.3

1.33

0.94

mmol/l

3.75

1792

7152

Stroke, including SAH

7068

27864

2.03

307.65

9.4

7.4

1.01

0.95

mmol/l

0.51

5904

23131

Stroke, excluding SAH

6544

26999

1.94

307.65

9.1

7.5

1.00

0.96

mmol/l

0.39

5457

22387

Unstable angina pectoris

4077

15342

2.39

307.65

8.0

6.7

1.12

0.97

mmol/l

1.54

3323

12744

Coronary revascularization (ANGIO or CABG)

9587

24279

2.77

307.65

10.8

7.1

0.95

0.96

mmol/l

0.13

8079

20336

Other arrhythmias

5573

21396

2.10

307.65

8.1

6.9

0.95

0.80

mmol/l

2.16

4610

17568

Myocardial infarction, strict

5320

16974

2.56

307.65

9.4

7.0

0.66

0.94

mmol/l

4.71

4382

14179

Parasetamol

6511

14356

2.48

307.65

8.5

8.2

0.88

0.68

mmol/l

2.98

5300

11679

Heart failure,strict

8233

18772

3.92

307.65

11.1

6.8

1.31

0.75

mmol/l

21.06

6998

15579

Bacterial infection, other or unspecified

7640

24771

3.13

307.65

10.4

6.7

0.92

mmol/l

0.01

6384

20472

Mood disorders, excluding more controls

8453

29934

1.77

307.65

8.5

7.8

1.06

0.80

mmol/l

6.73

7077

24768

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

11097

36756

2.26

307.65

9.6

7.4

0.74

0.95

mmol/l

4.76

9206

30320

Diseases of oesophagus, stomach and duodenum

10050

36340

1.74

307.65

9.1

7.6

0.86

0.92

mmol/l

0.57

8354

29930

Tramadol

9342

22567

2.82

307.65

9.1

7.5

0.78

0.91

mmol/l

2.09

8023

18314

Calcific aortic valvular stenosis

3817

18120

2.39

307.65

8.6

6.7

0.89

0.97

mmol/l

0.61

3242

14687

Cardiovascular diseases (excluding rheumatic etc)

5708

9038

4.03

307.65

10.7

6.2

0.75

0.60

mmol/l

1.53

4742

7146

Non-allergic asthma (mode)

1838

6854

3.02

307.65

7.8

6.4

1.42

0.33

mmol/l

25.88

1552

5572

Hypothyroidism, levothyroxine purchases

1592

1559

6.22

307.65

10.0

4.8

0.59

0.65

mmol/l

0.18

1292

1173

Codeine

9082

23506

2.27

307.65

7.9

7.5

0.85

0.88

mmol/l

0.19

7574

18979

Oral corticosteroids

11377

34698

2.10

307.65

8.2

7.7

1.26

0.77

mmol/l

29.65

9436

28505

Emergency coronary revascularization (for ACS)

10495

27651

2.63

307.65

10.4

7.1

0.97

0.98

mmol/l

0.08

8769

23058

Ulcer of lower limb, not elsewhere classified

2090

8229

3.23

307.65

11.1

7.4

0.61

0.95

mmol/l

2.47

1793

6746

Osteopathies and chondropathies

5610

29485

1.89

307.65

8.2

7.5

1.13

0.93

mmol/l

2.94

4755

24403

Asthma (only as main-diagnosis), excluding more controls

6926

14300

2.98

307.65

7.6

6.4

1.36

0.33

mmol/l

73.15

5835

11644

ILD medications: immunosuppressive drugs

5824

29801

1.90

307.65

11.6

7.8

0.58

0.83

mmol/l

4.63

4955

24621

Infections, IBD-co-morbidities

1827

2967

5.15

307.65

11.9

7.5

0.71

0.68

mmol/l

0.09

1547

2475

Presence of cardiac and vascular implants and grafts

5867

20535

2.46

307.65

10.7

6.9

0.85

0.97

mmol/l

1.47

4904

16997

Cardiovascular diseases

4832

7785

3.60

307.65

10.6

6.2

0.71

0.53

mmol/l

1.93

3980

6112

All-cause Heart Failure

8840

23147

3.32

307.65

10.4

7.1

1.32

0.80

mmol/l

19.56

7481

19203

Asthma, including avohilmo

11168

38081

1.72

307.65

7.6

8.0

1.29

0.75

mmol/l

35.23

9309

31269

Insulin, combination of fast acting with intermediate-acting or long-acting

6779

33451

2.03

307.65

10.3

7.4

0.67

0.92

mmol/l

3.96

5485

27688

Asthma, excluding more controls

7685

14300

3.08

307.65

8.1

6.4

1.34

0.33

mmol/l

74.37

6435

11644

Calcific aortic valvular stenosis, diagnosis (helper)

3811

18108

2.38

307.65

8.5

6.7

0.89

0.97

mmol/l

0.59

3236

14677

DVT of lower extremities and pulmonary embolism

5017

24727

2.32

307.65

8.6

7.2

1.21

0.92

mmol/l

5.77

4198

20358

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2740

9630

3.19

307.65

9.1

7.9

1.02

0.64

mmol/l

4.69

2263

7853

Inflammatory bowel disease treatment related agents

11469

35250

1.95

307.65

8.4

7.8

1.14

0.76

mmol/l

18.56

9501

28923

Heart failure and antihypertensive medication

3938

5002

6.88

307.65

13.9

6.6

1.24

1.09

mmol/l

1.03

3391

4165

ILD, hospital admission 2, with pulmonary infections

1558

4401

4.88

307.65

10.7

6.4

1.48

0.58

mmol/l

13.06

1355

3554

Operations 2 for CAVS

3811

18108

2.38

307.65

8.5

6.7

0.89

0.97

mmol/l

0.59

3236

14677

Calcific aortic valvular stenosis, including rheumatic fever

3816

18161

2.37

307.65

8.5

6.7

0.89

0.97

mmol/l

0.58

3240

14717

ILD medications: prednisolone, methylprednisolone, prednisone

11333

32939

2.08

307.65

8.9

7.5

1.01

0.81

mmol/l

5.16

9446

26945

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

9208

30234

1.95

307.65

9.5

7.1

0.83

1.00

mmol/l

2.85

7544

25161

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1645

2285

6.70

307.65

10.7

7.6

1.31

0.80

mmol/l

3.94

1407

1907

Pneumonia, organism unspecified

12096

30434

3.18

307.65

10.2

7.0

1.44

0.57

mmol/l

82.96

10277

24999

Valvular operations

2081

6031

4.54

307.65

14.7

6.6

0.79

0.76

mmol/l

0.11

1831

4914

GI-bleeding

3822

19345

2.26

307.65

9.9

7.1

0.87

0.89

mmol/l

0.09

3137

15803

Dental caries

3213

12088

2.96

307.65

12.7

8.0

0.45

0.91

mmol/l

7.01

2774

9909

Insulin, fast-acting

3841

19140

2.26

307.65

10.7

7.6

0.64

0.88

mmol/l

2.29

3121

15834

Asthma (diagnoses ohter than nonallergic)

9297

39807

2.06

307.65

7.8

1.38

0.79

mmol/l

36.06

7805

32649

Insulin medication

6766

28013

2.24

307.65

10.3

7.3

0.67

0.97

mmol/l

5.33

5478

23328

Caries of dentine

2856

10857

3.01

307.65

12.9

8.0

0.52

0.89

mmol/l

4.32

2458

8900

Peripheral artery disease

5393

21260

2.31

307.65

9.4

6.7

0.73

0.98

mmol/l

3.72

4448

17486

ILD medications

11309

33217

1.98

307.65

9.1

7.5

0.95

0.81

mmol/l

2.97

9425

27162

Oedema, not elsewhere classified

3659

15978

2.55

307.65

8.6

7.2

1.26

0.84

mmol/l

6.71

3145

13179

Bacterial pneumonia, not elsewhere classified

5773

16890

3.72

307.65

10.9

6.7

1.79

0.54

mmol/l

82.29

4799

13861

Other chronic obstructive pulmonary disease, including avohilmo

7256

27001

2.62

307.65

8.6

7.5

1.82

0.75

mmol/l

78.28

6222

22271

Convulsions, not elsewhere classified

2689

9565

3.22

307.65

9.2

7.9

0.84

0.67

mmol/l

1.13

2216

7816

Diarrhoea and gastroenteritis of presumed infectious origin

6736

35014

1.84

307.65

9.3

7.5

0.81

0.87

mmol/l

0.61

5556

28754

Diseases of the digestive system

5055

27136

2.06

307.65

9.9

7.2

0.89

0.91

mmol/l

0.11

4166

22319

Paralytic ileus and intestinal obstruction

3274

14056

2.74

307.65

10.1

7.0

1.04

0.99

mmol/l

0.28

2782

11555

Intestinal infectious diseases

8903

40958

1.72

307.65

9.1

7.6

0.84

0.90

mmol/l

0.57

7344

33749

ILD, hospital admissions 3, with pneumonia sepsis

1387

3877

5.06

307.65

10.7

6.6

1.61

0.58

mmol/l

14.20

1206

3136

Substance abuse, excluding more controls

6521

24260

2.54

307.65

10.1

8.1

1.03

0.72

mmol/l

6.04

5456

19999

Other or unspecified ileus, impaction or obstruction

2276

9755

2.75

307.65

9.5

7.1

1.06

1.02

mmol/l

0.18

1942

7985

Intestinal stricture

3830

17927

2.50

307.65

10.6

7.2

0.93

0.96

mmol/l

0.15

3271

14760

Diseases of the respiratory system

5377

13841

2.08

307.65

8.6

6.8

1.13

0.32

mmol/l

36.66

4423

11286

Benzodiazepine use

9240

40354

1.63

307.65

7.9

7.8

1.17

0.83

mmol/l

12.12

7783

33104

ILD, hospital admissions

2051

8598

2.99

307.65

9.7

7.4

1.34

0.94

mmol/l

4.08

1765

7019

Other septicaemia, including avohilmo

6076

19800

3.62

307.65

12.6

6.6

0.85

0.92

mmol/l

0.45

5045

16311

Diabetes, insulin treatment (Kela reimbursement)

9845

34472

1.83

307.65

9.5

7.4

0.83

0.97

mmol/l

2.32

8072

28734

Hypertension

7695

18785

2.55

307.65

9.9

7.4

0.86

0.92

mmol/l

0.52

6441

15475

Coronary atherosclerosis

7582

21085

2.61

307.65

9.5

7.0

0.87

0.96

mmol/l

0.96

6344

17682

Implicit bacterial Sepsis, including avohilmo

7968

20769

4.17

307.65

12.6

6.2

1.15

0.86

mmol/l

5.49

6659

17129

Type 2 diabetes, strict (exclude DM1)

8883

30170

1.83

307.65

9.4

7.1

0.90

0.99

mmol/l

1.11

7319

25061

Dizziness and giddiness

7047

33754

1.74

307.65

7.1

7.9

1.04

0.87

mmol/l

3.00

5770

27952

Spondylopathies

7681

26461

1.85

307.65

6.9

8.2

1.02

0.83

mmol/l

3.84

6416

21906

Type 2 diabetes, definitions combined

8851

29938

1.84

307.65

9.4

7.0

0.90

0.99

mmol/l

1.13

7295

24858

Personality disorders, excluding more controls

2271

8775

2.88

307.65

8.7

8.2

1.24

0.65

mmol/l

8.94

1898

7147

Covid-19 confirmed case

5508

21000

3.24

307.65

11.7

7.0

1.17

0.86

mmol/l

6.31

4772

17050

Other intervertebral disc disorders

7713

27510

1.79

307.65

7.3

8.2

1.13

0.80

mmol/l

10.48

6290

22691

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7365

33526

2.46

307.65

10.3

7.1

0.99

0.90

mmol/l

1.21

6213

27684

Examination and observation for other reasons

6178

16368

2.34

307.65

9.1

7.8

0.78

0.80

mmol/l

0.18

5199

13611

COPD

6603

21240

3.11

307.65

8.7

7.5

1.87

0.69

mmol/l

83.39

5655

17518

Atrial fibrillation and flutter

3644

5151

5.49

307.65

12.5

6.1

0.99

0.83

mmol/l

1.26

3099

4261

Asthma (mode)

7457

16608

2.59

307.65

7.8

6.8

1.22

0.33

mmol/l

59.94

6225

13529

Care involving use of rehabilitation procedures

7050

30168

2.35

307.65

9.2

7.4

1.35

0.88

mmol/l

18.22

5706

24919

Lung cancer and mesothelioma

2254

7198

3.14

307.65

7.4

6.5

1.43

0.27

mmol/l

38.06

1954

5902

Substance abuse

6521

29926

2.27

307.65

10.1

8.0

1.03

0.79

mmol/l

3.78

5456

24645

Bacterial infection, other or unspecified, including avohilmo

8250

25942

3.12

307.65

10.2

6.7

0.92

0.90

mmol/l

0.15

6892

21419

Major coronary heart disease event excluding revascularizations

7116

21315

2.53

307.65

9.5

7.0

0.87

0.98

mmol/l

1.17

5888

17822

Cardiomyopathy

1956

7391

3.14

307.65

13.7

6.6

0.54

0.75

mmol/l

1.15

1639

6037

Implicit viral Sepsis

3297

10035

4.29

307.65

12.0

6.2

1.29

0.88

mmol/l

5.28

2772

8178

Pneumonias (Asthma/COPD co-morbidities)

13421

32155

3.18

307.65

10.8

7.0

1.43

0.59

mmol/l

85.64

11379

26344

Obesity due to excess calories

4381

23483

2.03

307.65

9.3

7.9

1.27

0.77

mmol/l

12.21

3710

19367

Disorders of lipoprotein metabolism and other lipidaemias

9028

27263

2.23

307.65

8.7

7.2

0.82

1.00

mmol/l

3.81

7582

22540

Hypo-osmolality and hyponatraemia

2426

8757

3.42

307.65

11.2

6.6

1.02

1.12

mmol/l

0.47

2024

7172

Solid cancers, including Hilmo

8606

25343

2.17

307.65

8.1

8.2

0.67

1.07

mmol/l

16.76

7320

20767

Other pulmonary diagnosis

7183

16582

2.35

307.65

9.0

6.8

1.19

0.33

mmol/l

51.34

5968

13501

Depression medications

1855

1634

6.19

307.65

8.8

4.6

0.85

0.68

mmol/l

0.70

1533

1232

Calcific aortic valvular stenosis, operated

3817

18120

2.39

307.65

8.6

6.7

0.89

0.97

mmol/l

0.61

3242

14687

Other medical care

6378

23095

2.71

307.65

7.5

7.0

1.28

0.89

mmol/l

11.07

5370

19112

Complications of surgical and medical care, not elsewhere classified

12059

36874

2.46

307.65

9.9

7.1

0.95

0.89

mmol/l

0.83

10170

30224

Vocal cord dysfunction

1176

2973

3.93

307.65

10.6

5.5

1.26

0.77

mmol/l

4.38

1001

2470

Type 2 diabetes, wide definition

8896

27573

2.27

307.65

9.4

7.1

0.85

1.02

mmol/l

2.70

7309

23024

Nutritional anaemias

5298

28092

1.98

307.65

9.4

6.9

0.78

0.95

mmol/l

2.13

4366

23083

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

11774

24636

3.25

307.65

10.5

6.8

1.42

0.54

mmol/l

79.55

9956

20182

Pacemaker

4499

21525

2.25

307.65

10.7

6.9

1.04

0.95

mmol/l

0.73

3704

17687

Malignant neoplasm

8552

25315

2.17

307.65

8.2

0.70

1.07

mmol/l

14.23

7244

20743

Peripheral arterial reconstruction

2391

10030

2.99

307.65

10.6

6.9

0.64

0.92

mmol/l

2.53

1966

8131

Colorectal cancer, including Hilmo

3157

13738

2.49

307.65

7.9

7.4

0.43

1.15

mmol/l

20.89

2725

11275

Explicit Sepsis

6804

20866

3.70

307.65

12.5

6.2

0.87

0.84

mmol/l

0.16

5650

17137

Gout

3340

14470

2.27

307.65

9.5

7.8

0.39

0.98

mmol/l

10.35

2764

11882

Other disorders of skin and subcutaneous tissue

7088

37091

1.73

307.65

8.6

7.5

0.94

0.93

mmol/l

0.11

5897

30669

Epilepsy

3460

15412

2.55

307.65

8.3

7.8

1.03

0.75

mmol/l

3.62

2832

12620

Diseases of arteries, arterioles and capillaries (FINNGEN)

3326

4223

6.96

307.65

12.1

6.1

0.64

0.82

mmol/l

1.28

2878

3502

Focal epilepsy

2391

10542

2.64

307.65

8.1

7.9

1.01

0.86

mmol/l

1.13

1933

8618

Alcohol use disorder, ICD-based

4585

22970

2.25

307.65

10.4

8.3

1.02

0.81

mmol/l

2.24

3802

18990

Asthma-related pneumonia

5382

19966

3.30

307.65

9.3

7.1

1.76

0.80

mmol/l

47.73

4590

16270

Asthma, unspecified (mode)

6320

15814

3.31

307.65

8.1

6.7

1.39

0.34

mmol/l

65.79

5310

12895

Obesity related asthma

3794

17489

2.48

307.65

8.7

7.9

1.66

0.79

mmol/l

33.54

3257

14513

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

11481

29489

3.04

307.65

11.7

6.5

1.01

0.84

mmol/l

3.27

9631

24262

Alcohol use disorder, Swedish definition

6138

28377

2.20

307.65

10.7

8.0

0.90

0.82

mmol/l

0.66

5119

23400

Other antidepressants

9502

30136

1.71

307.65

8.1

7.8

1.09

0.78

mmol/l

10.72

7879

24653

Nephropathy related operations

1966

6042

4.61

307.65

20.2

8.0

-0.85

0.98

mmol/l

48.00

1663

4987

Hernia of abdominal wall, postoperative

2281

7080

3.85

307.65

10.4

6.1

0.83

1.07

mmol/l

1.85

1962

5787

Bacterial pneumonia (organism specified)

6341

22517

3.07

307.65

10.7

6.9

1.74

0.71

mmol/l

65.23

5256

18414

Conduction disorders

3102

10832

2.60

307.65

9.1

6.4

0.82

0.79

mmol/l

0.15

2585

8914

Opioids

9336

23701

2.20

307.65

8.7

7.5

0.83

0.87

mmol/l

0.38

7788

19116

Neurological diseases, wide definition

2174

3837

3.06

307.65

9.4

8.3

0.90

0.56

mmol/l

3.20

1762

3149

Explicit bacterial Sepsis, including avohilmo

1388

4804

3.57

307.65

12.1

6.3

0.84

0.83

mmol/l

0.04

1174

3903

L04AA Selective immunosuppressants

2297

10351

2.55

307.51

15.8

8.2

-0.08

0.93

mmol/l

23.84

1997

8603

Kidney transplant status

810

2110

5.60

306.27

15.6

10.1

-1.60

0.91

mmol/l

44.69

711

1764

Obesity, other/unspecified

3042

15185

2.20

305.24

9.4

7.9

1.18

0.78

mmol/l

5.67

2593

12460

malignant neoplasm of female genital organs, including Hilmo

1795

6921

2.89

303.17

5.7

6.3

0.83

1.40

mmol/l

8.34

1514

5719

Focal epilepsy, mode (most common among epilepsy diagnosis)

2103

9243

2.66

301.10

8.2

7.9

1.03

0.88

mmol/l

1.03

1703

7568

Colorectal adenocarcinoma

2388

10953

2.52

300.71

7.7

7.2

0.47

1.13

mmol/l

13.90

2053

8941

Abnormalities of heart beat

3176

15621

2.14

300.52

7.5

0.92

0.70

mmol/l

2.37

2593

12824

Other symptoms and signs involving cognitive functions and awareness

4918

25476

1.87

300.48

6.9

7.6

1.19

0.91

mmol/l

4.89

4033

21128

Streptococcal septicaemia, including avohilmo

1236

4241

3.71

297.66

12.1

6.8

0.82

0.89

mmol/l

0.22

1047

3480

Intestinal infectious diseases, including avohilmo, including avohilmo

10250

38734

1.55

297.64

8.8

7.6

0.85

0.92

mmol/l

0.82

8522

31881

General examination and investigation of persons without complaint and reported diagnosis

5478

16510

1.83

296.30

8.6

7.7

1.29

0.80

mmol/l

15.28

4538

13713

Viral hepatitis, IBD co-morbidity

566

1073

6.36

295.44

11.4

7.6

0.81

0.49

mmol/l

0.83

488

886

Psychiatric diseases

8423

27359

1.62

294.34

8.3

7.9

0.99

0.80

mmol/l

3.83

6960

22604

Mood disorders

8902

37941

1.58

289.51

8.6

7.8

1.04

0.88

mmol/l

3.16

7435

31319

Mood [affective] disorders

8878

37908

1.58

288.70

8.6

7.8

1.04

0.88

mmol/l

3.02

7419

31288

Extreme obesity with alveolar hypoventilation

708

1773

6.27

286.96

10.3

8.3

3.76

0.88

mmol/l

46.12

650

1466

Unspecified kidney failure

1452

5585

3.28

285.06

10.8

6.4

-0.39

1.16

mmol/l

20.88

1168

4575

Gastrointestinal diseases

4398

12028

1.93

284.11

8.8

6.8

0.75

0.90

mmol/l

1.47

3583

9743

Exposure to unspecified factor

9012

41236

1.56

283.97

9.5

7.6

0.72

0.93

mmol/l

5.14

7730

33718

Autoimmune diseases excluding thyroid diseases

9208

33400

1.57

283.73

9.0

7.7

0.79

0.89

mmol/l

1.39

7603

27498

Other diseases of urinary system

8667

32226

1.59

283.26

7.9

0.84

0.86

mmol/l

0.22

7179

26436

Streptococcal septicaemia

1194

4140

3.66

282.10

11.7

6.8

0.85

0.88

mmol/l

0.08

1008

3395

Malignant neoplasm of brain, including Hilmo

744

1924

5.40

280.52

7.8

8.4

1.10

1.07

mmol/l

0.09

589

1586

Emphysema

1073

3538

4.02

280.40

8.8

7.8

1.42

0.57

mmol/l

8.14

916

2902

Falls/tendency to fall

8861

29404

1.58

279.71

8.6

7.8

0.93

0.81

mmol/l

1.84

7340

24059

Lumbar disc prolapse

5745

26064

1.74

278.24

7.6

8.4

1.04

0.81

mmol/l

4.71

4682

21639

Autoimmune diseases excluding thyroid diseases, strict definition

8900

32331

1.57

276.92

8.9

7.7

0.78

0.89

mmol/l

1.50

7345

26619

Malignant neoplasm of urinary organs, including Hilmo

1473

5776

3.17

276.45

7.7

7.6

-0.36

1.13

mmol/l

36.85

1236

4726

Malignant neoplasm of brain

593

1315

6.90

275.94

7.8

8.4

1.09

1.07

mmol/l

0.05

467

1091

Depression

8117

36045

1.58

270.37

8.7

7.9

1.01

0.87

mmol/l

2.28

6794

29795

Personality disorders

2271

10626

2.35

269.35

8.7

8.5

1.24

0.74

mmol/l

6.59

1898

8678

Problems related to lifestyle

1192

4185

3.39

267.82

9.7

8.1

1.18

0.88

mmol/l

1.43

985

3362

Disorders of adult personality and behaviour

2347

11162

2.30

266.30

8.6

8.5

1.27

0.74

mmol/l

8.15

1974

9071

Invasive ventilation

1017

3362

4.01

264.78

18.6

8.1

1.26

0.82

mmol/l

2.05

875

2762

ILD-related respiratory insufficiency

657

1701

6.82

262.79

12.3

7.9

2.11

0.86

mmol/l

10.20

574

1383

Persons encountering health services for specific procedures, not carried out

1004

3238

3.77

262.38

11.4

7.3

0.06

0.86

mmol/l

7.49

905

2635

Intracranial injury

5466

31608

1.72

261.87

8.4

7.7

1.12

0.86

mmol/l

4.58

4500

25977

Alcohol abuse, main dg

1698

7219

2.75

261.60

9.9

8.9

1.10

0.81

mmol/l

1.76

1392

5945

malignant neoplasm of female genital organs

1576

6315

2.86

261.20

5.6

6.3

0.85

1.37

mmol/l

6.41

1330

5217

Injuries to the abdomen, lower back, lumbar spine and pelvis

4036

22934

1.89

261.18

8.6

7.3

1.11

0.89

mmol/l

2.65

3374

18792

Idiopathic pulmonary fibrosis

1152

4167

3.74

260.64

9.1

7.1

1.71

0.91

mmol/l

9.05

986

3376

Cerebral aneurysm, nonruptured

1102

3830

3.66

259.90

7.4

7.6

0.82

1.04

mmol/l

1.06

905

3146

Misadventures to patients during surgical and medical care

1627

6829

2.82

259.55

11.9

7.1

1.06

0.90

mmol/l

0.85

1366

5602

Malignant neoplasm of eye, brain and central nervous system

676

1734

5.53

258.75

7.5

8.4

1.09

1.05

mmol/l

0.10

538

1422

Colectomy operation

1984

9158

2.58

257.81

11.0

7.4

0.22

0.99

mmol/l

13.55

1697

7499

Medical observation and evaluation for suspected diseases and conditions

5398

16557

1.76

257.37

8.5

7.7

0.85

0.80

mmol/l

0.37

4399

13746

Malignant neoplasm of urinary organs

1275

4845

3.30

255.35

7.9

7.6

-0.39

1.12

mmol/l

32.81

1071

3960

Injuries to the hip and thigh

4906

26846

1.77

253.78

7.7

7.2

1.04

0.91

mmol/l

1.38

4163

21983

Type 1 diabetes

2245

10711

2.31

253.43

11.1

7.3

0.27

0.92

mmol/l

8.13

1827

8804

Injuries to the thorax

4624

27928

1.80

253.24

9.2

7.7

1.02

0.90

mmol/l

1.22

3867

23017

Benign neoplasm: Colon

5498

32619

1.72

251.27

7.9

7.6

0.76

0.99

mmol/l

3.76

4604

27128

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

910

2878

4.06

250.75

7.8

8.3

1.11

mmol/l

0.01

727

2360

Hyperkalaemia

865

2674

4.33

250.75

11.1

6.7

0.22

1.08

mmol/l

3.79

671

2157

Acute alcohol intoxication

2600

13278

2.19

249.58

9.4

8.0

1.11

0.79

mmol/l

3.11

2130

10849

Cardiomyopathies, Primary/intrinsic

1304

5001

3.09

249.10

15.3

6.9

0.51

0.74

mmol/l

0.95

1071

4067

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1277

4915

3.24

248.96

7.7

-0.29

1.13

mmol/l

29.59

1078

4025

Peripheral artery operations in Hilmo

1582

6712

2.83

248.85

11.5

6.7

0.50

0.94

mmol/l

3.40

1318

5419

Other reaction to severe stress, and adjustment disorders

2845

14809

2.06

248.62

9.4

8.0

0.84

0.81

mmol/l

0.19

2403

12095

Undetermined asthma, excluding more controls

1164

4164

3.16

246.01

7.6

6.0

1.23

0.31

mmol/l

11.45

972

3388

Allergic asthma (mode), excluding more controls

1620

6577

2.59

245.96

7.5

6.4

1.14

0.25

mmol/l

17.04

1333

5267

Cardiomyopathy (excluding other)

1343

5271

3.01

244.93

15.2

6.8

0.53

0.76

mmol/l

1.02

1104

4289

Gout, FINNGEN

3340

18649

2.01

244.39

9.5

7.4

0.39

0.92

mmol/l

8.89

2764

15316

Benign neoplasms

8214

30111

1.55

244.28

8.0

8.2

0.75

0.88

mmol/l

2.12

6715

24699

Unspecified mental disorder

3436

19210

1.93

243.79

8.1

8.3

1.69

0.78

mmol/l

31.00

2857

15824

Pain (limb, back, neck, head abdominally)

6030

18911

1.68

243.03

8.1

8.2

0.93

0.81

mmol/l

1.32

4901

15405

Specific personality disorders

1944

8909

2.41

242.78

8.7

8.5

1.34

0.74

mmol/l

8.42

1635

7234

Type 1 diabetes, wide definition, subgroup 1

1836

8255

2.47

240.70

10.8

7.3

0.32

0.93

mmol/l

6.21

1478

6778

Glomerular diseases

1970

9279

2.47

240.31

12.0

7.9

-0.42

0.93

mmol/l

30.20

1631

7601

Malignant neoplasm of kidney, except renal pelvis

1165

4365

3.37

240.13

7.7

-0.29

1.12

mmol/l

27.43

985

3561

Fungal Sepsis

647

1709

5.39

238.67

16.8

6.5

1.22

0.84

mmol/l

1.20

557

1410

Disorders of thyroid, IBD co-morbidities

1275

3135

3.02

238.12

9.4

7.0

0.88

0.58

mmol/l

1.67

1045

2578

Artificial opening status

807

2495

4.47

236.68

15.9

7.6

0.60

0.92

mmol/l

1.16

706

2056

Retention of urine

3721

17388

1.91

235.64

7.8

7.6

0.76

0.92

mmol/l

1.36

3050

14191

Diseases of liver

3401

19325

1.94

234.43

11.7

7.8

0.31

0.96

mmol/l

12.79

2836

16083

Sequelae of cerebrovascular disease

3803

18988

1.89

233.32

8.8

7.0

0.94

0.96

mmol/l

0.10

3137

15548

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

744

2129

4.24

233.04

9.9

9.4

1.08

0.70

mmol/l

1.50

647

1748

Hyperlipidaemia, other/unspecified

3748

19598

1.88

232.61

8.2

6.9

0.77

1.03

mmol/l

3.48

3109

16198

Anxiety (asthma-related co-morbidities)

4553

20871

1.75

230.92

8.9

8.0

0.96

0.79

mmol/l

2.14

3803

17204

Extracorporeal dialysis

870

2882

4.15

229.08

17.9

8.9

-0.73

0.84

mmol/l

19.05

722

2396

Dorsopathies

8325

28768

1.53

228.01

7.7

8.3

0.94

0.77

mmol/l

3.36

6817

23641

Osteoporosis

2774

13714

2.09

227.64

7.7

6.7

1.47

1.05

mmol/l

5.34

2346

11381

Cutaneous abscess, furuncle and carbuncle

2465

12719

2.14

227.56

11.1

8.2

0.92

0.84

mmol/l

0.47

2096

10429

1348

5449

2.82

226.81

11.7

7.5

0.82

0.91

mmol/l

0.32

1158

4396

Gout, idiopatic and unspecified

2865

15773

2.08

226.69

9.6

7.5

0.34

0.92

mmol/l

8.74

2379

12928

Implicit fungal Sepsis

603

1574

5.50

226.55

15.8

6.4

1.21

0.86

mmol/l

1.01

520

1291

External causes of morbidity and mortality

5003

15222

1.73

225.72

8.5

7.2

0.92

0.75

mmol/l

2.07

4093

12398

Fracture of femur

3007

14991

2.01

224.75

7.6

6.6

1.05

1.02

mmol/l

0.15

2565

12137

Acute alcohol intoxication, ICD10

2024

9833

2.33

223.64

9.8

8.7

1.01

0.82

mmol/l

1.09

1641

8125

Other headache syndromes

3398

19310

1.88

223.52

7.2

7.7

1.16

0.81

mmol/l

6.60

2811

15950

Liquid cancers, including Hilmo

3349

16806

1.92

222.91

8.5

7.7

1.09

1.12

mmol/l

0.19

2768

13820

Glomerular disorders in diseases classified elsewhere

1380

5808

2.88

222.52

13.4

8.1

-0.82

0.91

mmol/l

33.19

1160

4756

Spondylosis

4977

24443

1.70

221.50

6.9

8.2

1.02

0.85

mmol/l

2.21

4234

20335

Finngen Rheumatological endpoints

7768

30033

1.53

220.34

7.8

8.1

0.90

0.86

mmol/l

0.32

6390

24594

Kela-code for severe mental illness

3098

17334

1.94

220.09

7.8

8.3

1.80

0.79

mmol/l

34.09

2568

14317

Diaphragmatic hernia

3501

20446

1.88

219.67

8.3

7.2

0.76

1.02

mmol/l

3.29

2965

16894

Other CVD

2340

12160

2.21

219.64

8.3

6.8

1.08

0.96

mmol/l

0.66

1923

9885

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

2534

10945

2.15

219.61

7.8

7.4

1.43

1.09

mmol/l

4.37

2193

8956

Schizophrenia or delusion

2697

14505

2.02

217.70

8.1

8.4

1.84

0.80

mmol/l

30.09

2257

11965

Emotionally unstable personality disorder

1018

3629

3.17

216.79

8.0

8.6

1.09

0.59

mmol/l

3.44

839

2914

Other postsurgical states

837

2754

3.90

216.68

9.6

7.3

1.27

1.00

mmol/l

1.35

690

2269

Persons encountering health services in other circumstances, wide

9808

35908

1.46

216.16

9.2

7.4

0.69

0.98

mmol/l

9.21

8359

29212

Factors influencing health status and contact with health services

2438

5986

2.18

215.91

8.9

6.8

0.98

0.87

mmol/l

0.57

1996

4916

Amputation

1288

5344

2.96

215.23

12.2

7.3

0.61

0.92

mmol/l

1.55

1081

4355

Unspecified acute lower respiratory infection

1638

7469

2.52

213.65

10.6

7.9

1.67

0.85

mmol/l

12.76

1411

6076

Schizophrenia, schizotypal and delusional disorders

2699

14608

2.01

213.57

8.1

8.4

1.85

0.81

mmol/l

30.16

2258

12053

Gastroduodenal ulcer

2776

15264

2.02

212.81

9.6

6.9

0.77

0.94

mmol/l

1.18

2249

12496

Unspecified fall

4753

29533

1.69

212.77

9.1

7.6

1.02

0.89

mmol/l

1.28

4023

24283

Disorders of lens

6030

24567

1.62

212.68

9.2

8.1

0.90

0.92

mmol/l

0.09

5019

20591

Chronic pancreatitis

1456

6402

2.73

212.42

13.6

8.0

0.54

0.88

mmol/l

2.06

1263

5298

Hernia of abdominal wall

4344

27063

1.74

211.54

9.4

7.9

1.00

0.89

mmol/l

1.07

3664

22451

Endovascular or surgical operations to intracerebral aneurysms

807

2654

4.00

211.37

8.7

7.8

1.12

1.03

mmol/l

0.32

662

2192

Cough

3303

17656

1.86

211.28

7.4

7.9

1.09

0.71

mmol/l

6.67

2778

14554

Allergic asthma (mode)

1620

7036

2.41

211.26

7.5

6.7

1.14

0.27

mmol/l

16.25

1333

5652

Traumatic subdural haemorrhage

1537

6405

2.60

210.08

9.3

6.8

1.00

0.72

mmol/l

1.64

1253

5200

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2435

12528

2.12

209.82

6.3

7.8

1.09

1.11

mmol/l

0.08

2015

10344

Type 1 diabetes, wide definition

1879

9007

2.29

209.38

10.8

7.2

0.32

0.95

mmol/l

6.61

1511

7368

Neurotic, stress-related and somatoform disorders

7150

33633

1.53

208.50

8.6

8.0

1.03

0.89

mmol/l

2.34

5983

27824

Anxiety disorders

7237

33983

1.53

208.38

8.6

8.0

1.03

0.89

mmol/l

2.25

6057

28123

Other bacterial intestinal infections

1893

9246

2.32

207.10

10.2

7.2

0.94

0.97

mmol/l

0.14

1552

7551

Complications of internal orthopaedic prosthetic devices, implants and grafts

2330

12284

2.14

206.62

7.9

6.5

1.09

0.99

mmol/l

0.54

1973

10116

Malignant neoplasm of colon, including Hilmo

1987

9875

2.29

206.56

7.9

7.1

0.29

1.13

mmol/l

17.52

1675

8035

Transient ischemic attack

5039

25848

1.67

206.28

7.1

7.3

0.99

0.98

mmol/l

0.07

4129

21413

Undetermined asthma

1164

4572

2.86

205.64

7.6

6.4

1.23

0.31

mmol/l

11.50

972

3724

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

8590

38972

1.47

205.28

8.9

7.6

0.80

0.92

mmol/l

1.61

7126

32083

Viral pneumonia (unknown virus, not influenza)

835

2834

3.69

203.67

18.2

8.5

1.03

0.74

mmol/l

1.13

719

2311

Ventral hernia

2406

12853

2.09

203.59

9.9

7.4

0.97

0.96

mmol/l

0.04

2026

10570

Deforming dorsopathies

2478

13284

2.03

202.29

7.1

7.9

1.26

0.85

mmol/l

5.87

2063

11006

Soft tissue disorders

8247

29469

1.49

201.97

7.7

8.2

0.84

0.85

mmol/l

0.11

6791

24096

Status post-ami

2520

10222

2.08

201.82

7.6

6.6

0.71

0.91

mmol/l

1.33

2012

8467

Nontraumatic intracranial haemmorrhage

2144

11076

2.19

201.78

10.7

6.8

1.23

0.96

mmol/l

2.59

1772

9000

Any operation in hilmo

238

24.63

201.28

11.1

5.4

0.96

0.98

mmol/l

0.01

190

Other pulmonary heart/vessel disease

690

2150

4.49

201.09

13.5

7.7

1.90

0.94

mmol/l

6.01

587

1750

Pleural effusion

1747

8439

2.41

200.72

9.8

7.0

1.49

0.70

mmol/l

11.77

1506

6799

Depression or dysthymia

5521

19479

1.63

200.22

8.2

8.1

0.89

0.75

mmol/l

1.73

4641

16069

Fracture of rib(s), sternum and thoracic spine

3148

18419

1.88

197.12

9.5

7.7

1.05

0.90

mmol/l

1.19

2651

15179

Intestinal adhesions without obstruction

1051

4111

3.13

197.07

10.2

7.0

1.02

1.08

mmol/l

0.15

908

3358

Used for control exclusion in common control thyroid runs

8700

31051

1.47

196.86

8.6

7.7

0.75

0.89

mmol/l

2.08

7121

25543

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

755

2447

3.78

196.57

8.5

8.8

1.00

0.87

mmol/l

0.33

624

1984

Other external causes of accidental injury

6362

21207

1.57

196.16

8.2

7.5

0.86

0.84

mmol/l

0.17

5249

17276

Enterocolitis due to Clostridium difficile

1275

5481

2.78

194.91

10.9

7.2

0.97

1.03

mmol/l

0.17

1052

4459

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1157

4772

2.95

194.79

10.5

8.1

1.27

0.90

mmol/l

2.46

972

3920

Other/unspecified dorsalgia

3217

18593

1.83

194.10

7.2

7.9

1.07

0.83

mmol/l

2.94

2726

15326

Diseases of the skin and subcutaneous tissue

8129

28608

1.48

193.06

8.4

7.6

0.87

0.89

mmol/l

0.12

6724

23410

Secondary right heart disease

638

1951

4.65

192.35

13.4

7.2

1.96

0.89

mmol/l

6.62

545

1591

Persons encountering health services for examination and investigation

5169

16561

1.64

190.99

8.3

7.7

0.97

0.80

mmol/l

2.14

4164

13748

Malignant neoplasm of rectum, including Hilmo

1355

6033

2.65

190.46

8.1

7.7

0.52

1.11

mmol/l

6.91

1211

4940

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

984

3763

3.13

190.06

9.1

7.3

1.26

0.90

mmol/l

1.76

826

3067

Gout, unspecified

2321

12658

2.10

189.64

9.6

7.5

0.26

0.94

mmol/l

9.23

1928

10387

Other anxiety disorders

3413

17199

1.78

188.95

9.2

8.0

0.94

0.79

mmol/l

1.35

2862

14054

Aortic aneurysm

2484

13490

2.03

188.91

11.4

7.1

0.70

0.88

mmol/l

1.49

2154

10985

Accidents

6320

21207

1.56

188.81

8.2

7.5

0.87

0.84

mmol/l

0.26

5209

17276

Clear cell adenocarcinoma of kidney

675

2157

4.33

188.70

7.7

8.2

-0.25

1.09

mmol/l

14.92

572

1788

Other complications of surgical and medical care, not elsewhere classified

1022

3998

3.01

187.53

10.7

7.0

0.85

0.91

mmol/l

0.17

868

3276

Congenital malformations, deformations and chromosomal abnormalities

4445

26890

1.65

186.88

9.4

8.0

0.74

0.85

mmol/l

1.16

3707

22087

Cholelithiasis, broad definition with cholecystitis

7391

34571

1.49

185.97

7.9

7.4

0.94

0.95

mmol/l

0.07

6112

28507

Pain in joint

4640

18099

1.65

184.61

7.7

8.3

0.76

0.82

mmol/l

0.38

3907

14841

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1651

8088

2.39

184.09

12.6

8.4

-0.03

0.94

mmol/l

12.03

1396

6679

Missing teeth due to accident, extraction or parodontitis

5728

34798

1.56

183.47

7.9

7.8

1.14

0.93

mmol/l

4.12

4772

29036

Dialysis

559

1605

4.84

183.04

14.6

8.5

-1.53

1.07

mmol/l

28.75

470

1335

Gout, strict definition

2101

11252

2.16

182.68

9.6

7.6

0.31

0.93

mmol/l

7.32

1740

9220

Unspecified haematuria

4156

21468

1.70

182.31

8.6

7.8

0.57

0.94

mmol/l

6.82

3449

17681

Adjustment and management of implanted device

1968

10248

2.18

182.16

12.6

6.6

0.05

0.92

mmol/l

15.89

1737

8360

Hypotension

2015

10621

2.18

181.74

8.1

6.7

1.10

0.96

mmol/l

0.79

1649

8610

Diagnoses used for exclusion with ILD

2528

14218

1.97

181.49

10.7

7.5

1.42

0.92

mmol/l

7.59

2108

11607

Shoulder lesions

6510

26804

1.53

181.29

6.9

8.1

1.06

0.92

mmol/l

2.32

5411

22109

Other and unspecified nonorganic psychotic disorders

1564

7388

2.33

181.28

9.0

8.8

1.52

0.70

mmol/l

11.01

1307

6038

All anxiety disorders

4603

22956

1.63

180.97

8.9

8.2

0.94

0.84

mmol/l

0.99

3842

18899

Other bacterial intestinal infections, including avohilmo

2232

12045

2.04

180.92

9.9

7.3

0.81

0.93

mmol/l

0.67

1834

9906

Cardiodefibrillation

3624

22560

1.77

179.98

10.5

7.4

0.77

0.93

mmol/l

1.54

3056

18641

Benign neoplasm of meninges

1159

4963

2.81

179.54

6.2

7.2

0.91

1.07

mmol/l

0.72

892

4107

Disorders of other endocrine glands

3705

22640

1.72

178.70

8.6

7.6

0.74

0.93

mmol/l

1.93

3090

18628

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

8205

37328

1.45

178.38

8.2

7.8

1.00

0.88

mmol/l

1.84

6872

30781

Diabetic nephropathy, excluding more controls

1698

6853

2.37

177.97

11.9

9.2

-0.24

0.78

mmol/l

13.25

1402

5622

Delirium, not induced by alcohol and other psychoactive substances

1502

7180

2.46

177.51

11.3

6.9

1.27

0.96

mmol/l

1.84

1259

5833

Malignant neoplasm of bronchus and lung, including Hilmo

2208

9922

2.08

177.41

7.4

7.3

1.42

1.12

mmol/l

3.22

1909

8090

Sleep apnoea

8003

36217

1.46

177.00

8.2

7.9

1.25

0.84

mmol/l

16.91

6791

29937

Visual disturbances

4273

27585

1.65

176.52

8.1

7.6

0.93

0.92

mmol/l

0.06

3536

22824

Symptoms and signs involving the nervous and musculoskeletal systems

5085

34070

1.58

176.08

7.7

7.6

1.20

0.87

mmol/l

7.44

4259

28103

All influenza (not pneumonia)

1308

5842

2.50

175.52

9.3

7.4

1.28

0.59

mmol/l

8.00

1087

4759

Senile cataract

5552

22723

1.58

174.58

9.0

8.1

0.92

mmol/l

0.01

4621

19021

Autoimmune diseases

9069

33515

1.42

174.43

8.8

7.7

0.78

0.89

mmol/l

1.57

7439

27588

Bacterial intestinal infections, IBD co-morbidities

1867

9691

2.17

172.71

10.2

7.3

0.91

0.95

mmol/l

0.13

1532

7903

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1158

5048

2.74

171.67

8.1

7.8

0.56

1.13

mmol/l

5.76

1031

4138

Persons encountering health services for other counselling and medical advice, not elsewhere classified

9165

35691

1.42

171.53

9.7

7.4

0.52

0.98

mmol/l

21.58

7912

29072

Brain glioblastoma and astrocytoma

330

675

8.21

171.49

5.4

7.9

0.99

1.15

mmol/l

0.43

263

568

Vascular disorders of the intestines

890

3451

3.21

171.17

12.7

6.7

0.57

1.07

mmol/l

2.27

722

2797

Visual disturbances and blindness

4579

30206

1.61

170.31

8.1

7.5

0.91

0.94

mmol/l

0.17

3788

24951

Cardiomyopathy, other and unspecified

810

2962

3.28

170.20

13.4

6.9

0.41

0.86

mmol/l

1.84

701

2410

Malignant neoplasm of respiratory system and intrathoracic organs

2190

9895

2.05

169.66

7.7

7.4

1.46

1.09

mmol/l

4.42

1899

8072

Malignant neoplasm of colon

1628

8126

2.29

169.58

7.7

7.2

0.37

1.15

mmol/l

12.63

1364

6614

Myocarditis

415

967

5.04

169.53

14.3

6.5

0.89

0.68

mmol/l

0.45

339

776

Ascites

901

3521

3.14

169.42

11.4

7.5

-0.09

0.89

mmol/l

7.06

775

2925

Fracture of lumbar spine and pelvis

2309

12899

1.99

168.76

8.3

6.9

1.17

1.00

mmol/l

1.05

1932

10510

Injury, poisoning and certain other consequences of external causes

3921

12082

1.70

168.33

8.3

7.0

0.93

0.72

mmol/l

2.34

3189

9818

Gastric ulcer

1874

9855

2.15

167.57

9.8

7.0

0.94

0.97

mmol/l

0.10

1548

8068

Genitourinary diseases

4546

14584

1.64

167.54

9.8

8.0

0.70

0.97

mmol/l

4.04

3727

12055

Mental and behavioural disorders due to sedatives or hypnotics

729

2541

3.47

167.36

10.2

8.7

1.32

0.90

mmol/l

1.77

625

2097

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1452

6698

2.36

167.17

14.2

8.5

0.36

0.85

mmol/l

5.03

1265

5485

Benign neoplasm: Cerebral meninges

1059

4504

2.84

166.86

6.3

7.2

0.93

1.06

mmol/l

0.52

814

3717

Other diseases of pericardium

547

1620

4.32

166.60

14.5

7.5

1.18

0.72

mmol/l

1.78

476

1320

Cystitis

6787

28350

1.48

166.52

7.6

0.81

0.87

mmol/l

0.63

5692

23171

Selective serotonin reuptake inhibitors

8065

30201

1.44

166.25

8.0

7.9

1.05

0.78

mmol/l

7.22

6716

24710

Adenocarcinoma and papilloma adenocarcinoma of rectum

1112

4834

2.75

165.89

8.0

7.7

0.53

1.14

mmol/l

6.21

993

3953

Other diseases of intestine

1607

8037

2.27

165.61

12.9

7.7

0.46

1.02

mmol/l

6.20

1389

6645

Endocarditis

473

1283

4.91

165.28

19.3

7.3

0.89

0.78

mmol/l

0.21

410

1045

Mental and behavioural disorders due to opioids

429

1068

5.07

165.01

11.2

9.4

1.52

0.69

mmol/l

3.74

384

878

Other and unspecified drugs and medicaments

938

3790

2.97

163.39

9.1

7.9

1.29

0.89

mmol/l

2.04

787

3101

Lung diseases due to external agents

1542

7683

2.31

162.51

11.2

7.1

1.63

0.92

mmol/l

8.48

1286

6192

Malignant neoplasm of ovary, including Hilmo

662

2238

3.63

161.18

6.5

6.9

0.61

1.41

mmol/l

6.39

572

1849

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1517

7246

2.26

159.82

14.0

8.6

0.37

0.84

mmol/l

4.81

1320

5934

Non-small cell lung cancer, including Hilmo

1609

7635

2.24

159.43

7.7

7.1

1.38

1.08

mmol/l

2.69

1418

6200

Other cataract

4012

19244

1.66

159.31

8.2

7.9

0.95

0.92

mmol/l

0.23

3332

16080

Open wound of head

4886

31065

1.56

159.08

8.3

7.8

0.94

0.87

mmol/l

0.54

4070

25629

Cholelithiasis

6965

34025

1.46

158.67

7.7

7.3

0.93

0.95

mmol/l

0.10

5751

28059

Dysphagia

2360

13485

1.91

158.54

8.6

7.2

1.41

0.89

mmol/l

7.65

1958

11114

Need for other prophylactic measures

693

2470

3.53

156.21

13.5

8.9

0.26

0.90

mmol/l

4.03

648

2033

Bipolar affective disorders

1425

6879

2.26

155.31

7.9

8.2

1.05

0.74

mmol/l

1.87

1181

5610

Glucagon-like peptide-1 (GLP-1) analogues

2632

15613

1.82

153.89

8.6

8.3

1.00

0.93

mmol/l

0.35

2177

13149

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

2632

15613

1.82

153.89

8.6

8.3

1.00

0.93

mmol/l

0.35

2177

13149

Periodontitis

8274

38968

1.41

153.30

8.9

7.7

0.81

0.95

mmol/l

2.39

6936

32215

Chronic periodontitis, including avohilmo

8263

38964

1.41

153.05

8.9

7.7

0.81

0.95

mmol/l

2.31

6926

32210

Non-selective monoamine reuptake inhibitors

3146

18713

1.73

152.92

7.5

7.4

1.38

0.87

mmol/l

9.70

2639

15433

Urinary track infection

3793

11871

1.67

152.57

7.8

6.9

0.88

0.95

mmol/l

0.48

3160

9661

Injuries to the shoulder and upper arm

7276

40879

1.43

152.47

7.8

7.9

1.02

0.90

mmol/l

1.65

6102

33753

Acute upper respiratory infections of multiple and unspecified sites

6147

31632

1.48

152.30

8.6

7.8

1.09

0.83

mmol/l

5.60

5114

26009

Cellulitis

2050

11387

1.98

151.75

9.6

8.0

0.88

0.87

mmol/l

0.03

1733

9328

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

4794

29597

1.54

151.46

9.4

8.0

0.73

0.88

mmol/l

1.84

4007

24338

Amiodarone users

1179

5514

2.59

151.18

16.5

7.6

0.59

0.91

mmol/l

1.80

1011

4533

Congenital malformations of the circulatory system

1263

5757

2.39

150.82

15.3

8.6

0.75

0.82

mmol/l

0.27

1099

4715

Malignant neoplasm of rectum

1086

4864

2.63

150.68

7.9

7.8

0.63

1.13

mmol/l

4.46

968

3983

Disorders of choroid and retina

7106

36133

1.44

150.51

8.3

7.7

0.72

0.97

mmol/l

5.60

5895

29997

Nonischemic cardiomyopathy

1020

4435

2.68

149.66

14.1

7.2

0.86

0.90

mmol/l

0.10

860

3674

Mycoses

2501

14781

1.84

149.02

9.7

7.8

1.04

0.87

mmol/l

1.18

2115

12183

Exclusions for E4_PCOS_BROAD

1510

7634

2.19

147.90

9.1

8.6

0.86

0.87

mmol/l

0.03

1248

6290

Decubitus ulcer and pressure area

807

3222

3.13

147.30

12.8

7.2

1.48

1.04

mmol/l

1.98

685

2629

ILD medications: azathioprine

1228

5754

2.36

146.37

12.7

8.0

0.60

0.81

mmol/l

0.90

1026

4682

Other retinal disorders

5819

31330

1.49

145.38

8.3

7.5

0.78

0.98

mmol/l

3.14

4806

25957

Fracture of lower leg, including ankle

4595

30778

1.54

144.07

9.3

7.7

1.03

0.90

mmol/l

1.22

3877

25429

Rotator cuff syndrome

5322

25491

1.51

143.46

6.9

8.1

1.04

0.93

mmol/l

1.22

4432

21115

Superficial injury of head

2185

12533

1.89

143.42

7.7

7.5

1.12

0.91

mmol/l

1.55

1829

10241

Other arthrosis

4584

20746

1.56

143.11

7.5

8.4

0.95

0.99

mmol/l

0.26

3839

17168

Acute pancreatitis

1878

10384

2.00

142.53

11.7

7.7

0.69

0.89

mmol/l

1.03

1592

8537

Other pleural conditions

1143

5365

2.50

142.06

9.2

6.9

1.63

0.69

mmol/l

10.70

964

4305

Other gastritis (incl. Duodenitis)

2111

12093

1.92

141.90

9.0

7.2

0.76

0.94

mmol/l

1.10

1766

9995

Chronic ulcer of skin, not elsewhere classified

830

3416

2.98

141.29

9.5

7.6

1.58

0.97

mmol/l

3.19

679

2817

Colon adenocarcinoma

1302

6415

2.33

141.24

7.5

7.2

0.38

1.17

mmol/l

10.28

1085

5233

Candidiasis, including avohilmo

2464

14674

1.80

140.73

9.5

7.4

0.94

0.91

mmol/l

0.14

2095

12068

Suppurative and necrotic conditions of lower respiratory tract

712

2745

3.30

140.19

14.2

8.3

1.76

0.89

mmol/l

5.57

635

2259

Other specific joint derangements/joint disorders

5555

24198

1.49

140.12

7.7

8.5

0.79

0.87

mmol/l

0.80

4650

19775

Coxarthrosis [arthrosis of hip](FG)

4922

23342

1.53

140.07

6.9

7.9

0.97

mmol/l

0.04

4096

19331

Liquid cancers

2577

14757

1.79

139.07

8.9

7.6

0.98

1.12

mmol/l

0.85

2119

12130

Subarachnoid haemorrhage

1087

5031

2.52

138.74

11.6

7.0

1.25

1.02

mmol/l

1.29

898

4106

Nonorganic sleeping disorders, excluding more controls

1495

7637

2.10

138.58

8.3

7.7

1.03

0.69

mmol/l

2.80

1276

6227

Coxarthrosis

4516

19745

1.56

138.44

6.9

8.1

0.95

1.00

mmol/l

0.30

3749

16304

Autoimmune diseases related-to ILD

6748

41205

1.42

138.40

8.4

7.7

0.92

0.88

mmol/l

0.45

5603

33934

Malignant neoplasm of bronchus and lung

1891

8777

2.00

138.07

7.2

7.1

1.45

1.11

mmol/l

3.55

1638

7143

Sleep apnoea, including avohilmo

8097

36613

1.39

137.22

7.9

1.25

0.82

mmol/l

18.19

6852

30210

Azathioprine

1228

5903

2.30

137.19

12.7

8.2

0.60

0.73

mmol/l

0.49

1026

4831

Postprocedural musculoskeletal disorders, not elsewhere classified

846

3579

2.91

136.62

8.1

7.8

1.36

0.95

mmol/l

2.52

710

2952

Viral and other specified intestinal infections

1511

7581

2.08

136.25

9.2

7.8

0.95

0.77

mmol/l

0.92

1234

6084

Left ventricular outflow tract obstruction (LVOTO), broad definition

994

4466

2.59

135.79

15.6

9.7

0.81

0.82

mmol/l

0.03

882

3715

Sub-endpoint used in defining T1D endpoints

2425

14280

1.79

135.33

10.7

7.7

0.34

0.89

mmol/l

6.49

1958

11607

Other disorders of the musculoskeletal system and connective tissue

1455

7560

2.18

135.33

8.3

7.7

1.05

0.97

mmol/l

0.34

1223

6210

Sleep disorders (combined)

8860

34983

1.37

134.92

7.8

1.02

0.84

mmol/l

4.20

7425

28600

Injuries to the knee and lower leg

9534

39406

1.35

134.68

8.4

7.7

1.00

0.86

mmol/l

2.97

8024

32312

Abnormal serum enzyme levels

2991

18404

1.71

134.38

8.0

8.4

0.69

0.84

mmol/l

1.35

2459

15197

Gonarthrosis [arthrosis of knee](FG)

6290

26103

1.45

133.19

6.6

8.0

1.00

0.95

mmol/l

0.43

5207

21607

Unspecified privation

1056

4947

2.45

129.68

11.3

7.8

0.37

0.90

mmol/l

4.03

927

4049

Elevated blood glucose level

885

3864

2.69

129.66

10.6

8.2

0.76

0.91

mmol/l

0.45

728

3179

Amputation of toe

863

3776

2.80

129.51

11.0

7.8

0.37

0.93

mmol/l

2.88

717

3073

Viral and other specified intestinal infections, including avohilmo

1961

10713

1.86

128.81

8.8

7.8

0.87

0.76

mmol/l

0.54

1617

8606

severe traumatic brain injury, does not include concussion

2222

13304

1.84

128.61

10.0

7.3

1.09

0.93

mmol/l

1.03

1842

10824

Iron deficiency anaemia secondary to blood loss (chronic)

1576

8533

2.06

128.50

10.9

6.8

0.89

1.01

mmol/l

0.48

1287

6972

Pneumonitis due to solids and liquids

955

4341

2.60

128.47

13.6

7.3

1.78

0.89

mmol/l

7.53

795

3495

Diseases of the eye and adnexa

5686

20160

1.46

127.38

8.6

8.2

0.73

0.85

mmol/l

1.40

4633

16567

Transport accidents

3497

19108

1.59

126.66

8.6

7.6

1.08

0.83

mmol/l

3.30

2876

15579

Assault

1053

4932

2.35

125.10

10.4

9.2

0.71

0.76

mmol/l

0.13

851

4043

Symptoms and signs concerning food and fluid intake

997

4599

2.43

124.44

9.0

7.3

1.14

0.77

mmol/l

1.68

850

3777

Symptoms and signs involving the skin and subcutaneous tissue

5830

40183

1.43

124.00

7.6

7.8

0.92

0.90

mmol/l

0.10

4875

33176

Diabetic maculopathy, excluding more controls

1012

4732

2.42

123.63

10.7

6.8

0.38

1.07

mmol/l

4.99

824

3885

Panic disorder

1019

4708

2.34

123.30

10.2

7.6

0.98

0.69

mmol/l

1.54

837

3772

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

360

1002

4.99

123.27

6.3

5.8

-0.05

1.39

mmol/l

10.25

332

828

Disorders of eyelid, lacrimal system and orbit

7114

39064

1.38

122.91

7.1

7.9

1.11

0.88

mmol/l

5.52

5926

32222

Viral pneumonia (known virus, not influenza)

398

1190

4.60

122.88

12.8

8.6

1.81

0.81

mmol/l

4.19

346

985

Fentanyl

1021

4787

2.40

122.86

9.0

6.6

2.00

0.94

mmol/l

12.72

853

3811

Chronic viral hepatitis

501

1676

3.56

122.61

11.1

9.9

0.79

0.73

mmol/l

0.11

432

1387

Aortic valve malfunction, age under 60 years

923

4203

2.56

122.43

14.6

9.6

0.85

0.83

mmol/l

0.06

817

3490

Gonarthrosis

5338

21445

1.47

122.28

6.5

8.2

0.96

0.98

mmol/l

0.13

4403

17684

Other metabolic disorders

1035

4867

2.34

121.78

9.7

7.1

0.89

0.97

mmol/l

0.27

875

4008

Enlarged lymph nodes

1275

6482

2.15

121.61

8.5

7.9

1.06

0.78

mmol/l

1.82

1048

5336

Spondylolisthesis/Spondylolysis

1585

8706

2.00

121.46

6.6

7.9

1.14

0.88

mmol/l

1.82

1300

7249

Gastro-oesophageal reflux disease

5489

33552

1.44

120.10

8.2

7.6

0.97

0.94

mmol/l

0.19

4599

27779

Acute pancreatitis (for exclusion)

1878

10934

1.89

120.01

11.7

7.8

0.69

0.91

mmol/l

1.26

1592

8957

Acidosis

324

862

5.49

119.70

13.9

7.4

-1.25

0.97

mmol/l

5.42

245

696

Polyneuropathies and other disorders of the peripheral nervous system

2099

12643

1.83

119.34

9.7

7.7

1.04

0.90

mmol/l

0.75

1767

10376

Diseases of the musculoskeletal system and connective tissue

3782

12552

1.57

118.43

8.1

8.8

0.84

0.73

mmol/l

0.81

3071

10176

Pneumonia due to other infectious organisms, not elsewhere classified

397

1195

4.27

118.42

10.7

7.7

1.38

0.58

mmol/l

4.37

335

968

Acute upper respiratory infections

8367

38436

1.35

118.42

8.2

7.6

1.11

0.85

mmol/l

7.45

6966

31611

Arthrosis

5694

22548

1.44

117.21

7.2

8.3

0.96

0.97

mmol/l

0.04

4658

18554

Other dialysis

413

1312

4.34

116.63

14.4

10.2

-1.50

0.86

mmol/l

20.13

350

1090

Acute peritonitis

717

3015

2.88

116.07

14.7

8.5

0.30

0.93

mmol/l

2.99

599

2473

Fracture of shoulder and upper arm

3091

20406

1.61

114.84

8.8

7.6

0.99

0.95

mmol/l

0.21

2603

16843

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2667

17066

1.66

114.42

8.7

7.6

0.91

0.96

mmol/l

0.23

2189

14180

Schizophrenia

1295

6783

2.09

114.34

8.3

8.9

2.31

0.78

mmol/l

29.95

1099

5580

Disorders of mineral metabolism

815

3609

2.60

114.18

9.0

7.3

0.87

0.99

mmol/l

0.27

690

2955

Diseases of peritoneum

999

4838

2.37

113.30

12.3

7.8

0.52

1.00

mmol/l

2.65

817

3956

Other degenerative diseases of the nervous system

2302

10240

1.74

113.26

6.2

6.9

1.11

0.70

mmol/l

4.25

1851

8448

Dermatitis

5109

36347

1.43

111.88

8.2

7.8

0.96

0.90

mmol/l

0.41

4203

30055

Vascular diseases of the intestine

502

1813

3.55

111.63

15.4

6.7

0.27

1.03

mmol/l

2.42

416

1473

Other diseases of anus and rectum

2584

16454

1.67

111.52

7.8

7.1

0.97

0.98

mmol/l

0.04

2155

13509

Cholecystectomy

5733

36024

1.41

110.83

8.1

7.4

0.85

0.96

mmol/l

1.40

4780

29737

Use of disulfiram, acamprosate or naltrexone

836

3806

2.53

110.26

10.1

9.5

1.02

0.85

mmol/l

0.51

716

3155

Poisoning by narcotics and psychodysleptics [hallucinogens]

211

413

7.00

110.23

10.9

11.3

1.28

0.84

mmol/l

0.73

172

349

Other symptoms and signs involving the circulatory and respiratory systems

624

2477

2.90

110.05

7.8

7.7

1.63

0.69

mmol/l

7.81

492

2034

Haemorrhage, not elsewhere classified

474

1662

3.57

109.84

13.8

7.6

0.71

0.84

mmol/l

0.24

397

1369

Malignant neoplasm of corpus uteri, including Hilmo

837

3816

2.52

109.80

4.8

6.1

1.12

1.45

mmol/l

1.73

685

3151

Other viral hepatitis, including avohilmo

586

2259

2.99

109.71

11.4

9.9

0.91

0.77

mmol/l

0.32

505

1866

Mental and behavioural disorders due to use of other stimulants, including caffeine

286

710

4.94

109.62

10.9

10.8

0.99

0.69

mmol/l

0.51

246

574

Abdominal aortic aneurysm (AAA)

1061

5275

2.27

109.22

10.9

6.2

0.65

0.81

mmol/l

0.70

909

4191

Other disorders of glucose regulation and pancreatic internal secretion

817

3695

2.54

109.18

11.5

8.1

0.74

0.86

mmol/l

0.28

668

3025

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2573

16512

1.66

109.17

7.9

7.8

1.48

0.86

mmol/l

12.41

2071

13598

Preparatory care for dialysis

537

2046

3.39

109.04

14.3

8.7

-1.97

0.94

mmol/l

35.82

482

1699

Other and unspecified polyneuropathies, also in other diseases

1846

11019

1.85

108.96

9.5

7.7

0.98

0.91

mmol/l

0.29

1554

9031

Abnormalities of gait and mobility

1242

6609

2.14

108.92

8.6

7.5

0.51

0.86

mmol/l

2.17

1075

5422

Post-traumatic stress disorder

567

2121

2.92

108.85

8.5

7.8

0.63

0.50

mmol/l

0.34

454

1680

Congenital malformations of heart and great arteries

1046

5016

2.25

108.79

16.2

8.7

0.73

0.80

mmol/l

0.25

929

4100

Other viral hepatitis

561

2129

3.06

108.54

11.6

9.9

0.89

0.81

mmol/l

0.15

484

1758

Other disorders of kidney and ureter

1282

6892

2.11

108.43

11.4

7.8

0.14

0.95

mmol/l

9.48

1083

5660

Status epilepticus

435

1464

3.74

108.16

14.3

8.6

1.40

0.78

mmol/l

1.94

361

1198

Fibrosis and cirrhosis of liver

835

3866

2.56

108.05

11.9

8.0

-0.11

1.01

mmol/l

9.35

689

3212

Brain glioblastoma

243

568

6.87

108.01

5.3

7.9

1.12

1.27

mmol/l

0.31

194

472

Disorders resulting from impaired renal tubular function

460

1624

3.70

107.45

15.1

9.3

-1.02

0.92

mmol/l

16.47

382

1347

Neuromuscular dysfunction of bladder

900

4277

2.42

106.97

8.8

7.8

1.25

0.96

mmol/l

1.28

750

3492

Migraine with aura

1548

8665

1.88

106.83

7.1

7.4

0.88

0.66

mmol/l

1.68

1249

7063

Benign neoplasm of other and unspecified endocrine glands

1224

6492

2.12

106.80

7.4

7.9

1.03

0.92

mmol/l

0.45

1003

5353

Toxic effects of substances chiefly nonmedicinal as to source

988

4837

2.28

106.53

8.3

8.4

0.74

0.87

mmol/l

0.44

807

3970

Follow-up examination after treatment for conditions other than malignant neoplasms

3157

13904

1.58

106.42

8.6

7.6

0.54

0.81

mmol/l

3.19

2672

11562

Arterial embolism and thrombosis

645

2680

2.88

106.25

12.0

6.4

0.49

0.88

mmol/l

1.45

531

2165

Mycoses, including avohilmo

7218

42151

1.35

105.81

8.6

7.8

0.90

0.89

mmol/l

0.04

6117

34673

Migraine

3180

16482

1.56

105.43

7.0

7.9

0.89

0.74

mmol/l

1.62

2593

13566

Pyothorax

541

2100

3.28

105.42

14.1

8.3

1.90

0.89

mmol/l

5.98

482

1732

Alcoholic liver disease

1033

5230

2.28

104.93

12.7

8.6

-0.13

0.97

mmol/l

8.74

882

4314

Alcohol withdrawal state with delirium

747

3354

2.67

104.55

13.1

9.3

0.88

0.86

mmol/l

0.03

640

2773

Mental and behavioural disorders due to tobacco

837

3898

2.47

104.53

9.1

8.8

1.23

0.84

mmol/l

1.73

741

3201

Smoking dependency

837

3901

2.47

104.34

9.1

8.8

1.23

0.86

mmol/l

1.57

741

3205

Abnormal findings on diagnostic imaging of other body structures

1291

7007

2.04

104.00

7.5

0.87

0.90

mmol/l

0.09

1078

5790

Alcohol-induced chronic pancreatitis

690

3005

2.77

103.62

15.8

8.9

0.56

0.83

mmol/l

0.73

584

2489

Other specified and unspecified personality disorders

729

3185

2.57

103.59

9.4

8.6

1.36

0.79

mmol/l

3.04

633

2589

Malignant neoplasm of ovary

471

1688

3.36

103.25

7.2

6.6

0.57

1.41

mmol/l

5.22

404

1394

Postprocedural endocrine and metabolic disorders, not elsewhere classified

925

4441

2.28

103.09

9.2

7.1

0.83

0.97

mmol/l

0.51

779

3662

Disorder of lipoprotein metabolism, unspecified

1214

6487

2.09

103.09

9.2

7.1

0.40

1.04

mmol/l

5.62

1037

5305

Open wound of lower leg

1357

7487

1.99

102.94

10.0

7.7

1.10

0.96

mmol/l

0.62

1153

6081

Cervicobrachial syndrome

1704

9990

1.83

102.86

5.9

8.1

1.15

0.82

mmol/l

3.37

1412

8279

Pneumothorax

726

3223

2.64

102.73

11.8

7.7

1.32

0.73

mmol/l

3.47

647

2606

Benign neoplasm of other and ill-defined parts of digestive system

1615

9432

1.89

102.56

8.4

7.4

0.90

0.99

mmol/l

0.43

1386

7806

Soft tissue disorders related to use, overuse and pressure

2324

14794

1.68

102.50

7.9

0.96

0.93

mmol/l

0.13

1972

12317

Phobic anxiety disorders

855

3951

2.32

102.32

9.6

8.1

0.96

0.62

mmol/l

1.59

705

3163

Diabetic retinopathy, excluding more controls

2378

8388

1.73

101.85

11.1

9.0

0.49

0.83

mmol/l

2.78

1991

6905

Chronic periodontitis, complicated

4725

33685

1.43

101.52

9.6

7.9

0.68

0.96

mmol/l

5.01

4026

28145

Cirrhosis of liver, NAS

644

2763

2.88

101.46

12.4

8.5

-0.22

0.91

mmol/l

7.31

534

2293

Lung transplantation

163

290

11.95

101.40

46.2

9.4

1.26

0.81

mmol/l

0.64

153

248

Acute sinusitis

3776

24009

1.49

101.20

8.0

1.07

0.82

mmol/l

3.54

3103

19766

Sequelae of injuries, of poisoning and of other consequences of external causes

1905

11608

1.76

100.58

10.8

8.3

1.16

0.87

mmol/l

2.51

1583

9616

Unspecified misadventure during surgical and medical care

631

2676

2.86

100.53

12.8

8.3

1.21

0.95

mmol/l

0.80

535

2198

Malignant neoplasm of corpus uteri

763

3475

2.53

100.52

4.4

6.1

1.17

1.46

mmol/l

1.33

624

2876

Idiopathic gout

1027

5299

2.26

100.23

9.4

7.8

0.44

0.94

mmol/l

2.88

844

4359

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1716

9982

1.79

99.74

9.4

8.0

0.95

0.67

mmol/l

2.15

1417

7985

Thoracic aortic aneurysm

1394

7898

1.98

99.63

12.3

7.5

0.66

0.89

mmol/l

1.38

1229

6496

Diseases of the myoneural junction and muscle

1187

6389

2.09

99.55

9.2

7.8

1.40

0.92

mmol/l

3.00

1003

5217

Disorders of calcium metabolism

634

2680

2.76

99.38

8.5

6.8

0.78

1.06

mmol/l

0.71

534

2188

Pain in thoracic spine

1227

6599

2.02

99.33

6.7

8.0

1.30

0.83

mmol/l

5.18

1016

5472

Schizoaffective disorder

649

2757

2.68

99.03

7.4

8.7

2.45

0.81

mmol/l

16.70

538

2268

Lung transplant status

161

290

11.71

98.89

46.3

9.4

1.13

0.81

mmol/l

0.43

151

248

Insulin, fast-acting (human)

1072

5518

2.11

98.72

11.7

7.6

0.13

0.91

mmol/l

6.23

889

4510

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

761

3501

2.53

98.69

12.1

7.2

1.14

0.99

mmol/l

0.52

631

2867

Cerebral palsy and other paralytic syndromes

1001

5075

2.21

98.66

9.1

8.1

1.11

0.92

mmol/l

0.70

836

4148

Organic, including symptomatic, mental disorders

4714

24241

1.44

98.58

7.5

7.3

1.29

0.92

mmol/l

7.59

3845

20175

Exclusions for E4_PCOS_CONSORTIUM

4812

21827

1.42

97.11

7.6

7.5

0.90

0.97

mmol/l

0.58

4021

17914

Chronic apical periodontitis

8645

38228

1.30

97.08

8.6

7.6

0.73

0.94

mmol/l

4.58

7264

31360

Asthma and allergy, excluding more controls

717

3106

2.42

96.49

7.1

6.2

0.99

0.13

mmol/l

7.37

594

2468

Other disorders of adrenal gland

470

1754

3.23

95.92

11.1

8.6

0.91

0.94

mmol/l

0.05

401

1448

Other systemic involvement of connective tissue (FG)

2037

12506

1.70

95.86

7.2

7.3

1.14

1.00

mmol/l

0.98

1726

10270

Dilated cardiomyopathy

1177

6429

2.09

95.77

15.2

8.0

0.58

0.86

mmol/l

1.29

959

5286

Coagulation defects, purpura and other haemorrhagic conditions

1623

9623

1.83

95.72

10.3

7.7

0.59

0.89

mmol/l

2.00

1364

7874

Pneumocystosis, including avohilmo

300

902

5.07

95.12

12.3

8.5

1.23

1.00

mmol/l

0.48

252

749

Pneumocystosis

300

902

5.07

95.12

12.3

8.5

1.23

1.00

mmol/l

0.48

252

749

Hydronephrosis

1037

5396

2.14

94.90

8.3

6.7

-0.12

1.12

mmol/l

14.39

837

4456

Candidiasis

1185

6433

2.02

94.39

12.3

7.8

0.96

0.90

mmol/l

0.19

1001

5266

Other aneurysm

603

2575

2.81

94.28

11.1

7.6

0.86

0.93

mmol/l

0.17

502

2083

Colon adenocarcinoma, helper endpoint

1302

7370

1.99

94.02

7.5

7.1

0.38

0.99

mmol/l

6.72

1085

6016

Other and unspecified effects of external causes

1957

12164

1.70

93.71

9.0

8.2

0.77

0.80

mmol/l

0.11

1626

9927

Intracerebral haemorrhage

1246

6936

2.00

93.42

10.6

6.7

1.23

0.96

mmol/l

1.50

1023

5630

L04AX Other immunosuppressants

4240

30819

1.43

93.30

9.5

7.9

0.91

0.90

mmol/l

0.06

3571

25613

Recurrent or chronic depression

2641

12017

1.59

92.82

8.6

8.4

0.83

0.75

mmol/l

0.47

2212

9960

Pneumonia due to Streptococcus pneumoniae

421

1501

3.35

92.74

9.9

8.2

1.37

0.49

mmol/l

3.74

351

1224

Systemic connective tissue disorders

2808

19034

1.56

92.67

7.8

7.1

1.05

0.99

mmol/l

0.35

2369

15692

Arthropathies

6506

25032

1.35

92.57

7.6

8.4

0.74

0.87

mmol/l

1.64

5298

20408

Hypoglycaemia, other or unspecified

661

2939

2.60

92.34

12.1

8.3

0.61

0.86

mmol/l

0.62

539

2398

Fracture of skull and facial bones

1732

10522

1.76

92.15

10.7

8.1

0.94

0.85

mmol/l

0.42

1438

8650

Other noninfective gastroenteritis and colitis

1966

12327

1.70

91.84

9.0

7.6

0.66

0.91

mmol/l

1.78

1622

10128

Certain disorders involving the immune mechanism

1550

9194

1.83

91.64

11.5

8.2

0.82

0.94

mmol/l

0.53

1286

7595

Disturbances of skin sensation

2014

12686

1.68

91.62

7.1

8.1

0.85

0.87

mmol/l

0.09

1675

10455

Noninfective enteritis and colitis

3528

24908

1.48

91.62

8.8

7.9

0.70

0.88

mmol/l

1.89

2890

20521

Diabetic nephropathy

1714

10470

1.83

91.49

11.9

9.0

-0.25

0.81

mmol/l

14.86

1413

8525

Postprocedural disorders of digestive system, not elsewhere classified

395

1394

3.61

91.30

11.1

8.3

1.14

1.01

mmol/l

0.22

343

1158

Carpal tunnel syndrome

4747

30467

1.40

91.25

6.7

7.9

1.15

0.90

mmol/l

4.56

3930

25423

Second line medication for Crohn's disease

4330

31676

1.42

91.16

9.4

7.9

0.90

mmol/l

0.00

3647

26308

Other embolism and thrombosis

1155

6324

2.03

90.72

9.7

7.7

0.85

0.98

mmol/l

0.54

970

5166

Attention to artificial openings

472

1832

3.17

90.47

10.1

7.4

0.79

0.92

mmol/l

0.26

403

1505

Chronic gastritis

2340

15410

1.63

89.81

8.5

6.8

0.67

1.00

mmol/l

3.55

1973

12711

Non-small cell lung cancer

1033

5416

2.11

89.75

7.1

6.8

1.42

1.11

mmol/l

1.99

890

4380

Adrenocortical insufficiency

401

1433

3.47

89.66

11.1

8.5

0.95

mmol/l

0.01

338

1179

Other diseases of blood and blood-forming organs, wide

1831

11406

1.73

89.62

10.2

7.9

1.11

0.91

mmol/l

1.18

1542

9448

Total colectomy

440

1651

3.25

89.47

13.2

9.3

0.08

0.97

mmol/l

3.39

377

1380

Total colectomy operation

440

1651

3.25

89.47

13.2

9.3

0.08

0.97

mmol/l

3.39

377

1380

Cervical disc disorders

2830

19323

1.54

89.43

7.3

8.2

1.21

0.84

mmol/l

6.77

2335

16111

Brain glioblastoma, helper endpoint

243

662

5.78

89.05

5.3

9.5

1.12

1.07

mmol/l

0.09

194

558

Other and unspecified injuries of head

734

3462

2.43

88.83

8.0

7.7

0.82

0.94

mmol/l

0.30

626

2817

Sequelae of other external causes

571

2427

2.75

88.74

11.3

8.4

0.46

0.90

mmol/l

1.48

496

1993

Other joint disorders

6281

24987

1.35

88.72

7.2

8.4

0.80

0.87

mmol/l

0.67

5145

20370

Speech and linguistic disorders, excluding more controls

515

1896

2.76

88.58

10.1

8.7

0.90

0.51

mmol/l

1.21

404

1531

Rheumatoid arthritis

2524

14883

1.59

88.41

7.6

7.8

1.16

1.01

mmol/l

1.06

2116

12248

Viral hepatitis, including avohilmo

633

2796

2.56

88.26

11.2

9.4

0.81

0.85

mmol/l

0.08

544

2305

Intentional self-harm by unspecified means

168

327

6.96

88.15

11.5

11.4

0.14

0.55

mmol/l

0.58

139

265

Persistent mood disorders

1451

8540

1.82

86.62

8.1

7.6

1.10

0.89

mmol/l

1.11

1222

7019

Familial hypercholesterolemia

1326

7670

1.90

86.57

7.8

6.9

1.05

1.03

mmol/l

0.08

1076

6274

Oesophageal varices

482

1946

3.09

86.38

12.3

8.6

-0.37

0.83

mmol/l

6.20

411

1617

Other and unspecified dermatitis

4115

30171

1.42

86.27

8.1

7.7

0.91

mmol/l

0.03

3394

24974

Viral hepatitis

608

2669

2.58

86.20

11.3

9.4

0.79

0.85

mmol/l

0.12

523

2203

Asthma and allergy

716

3253

2.30

85.95

7.1

6.6

0.99

0.14

mmol/l

7.26

593

2581

Tobacco use

529

2207

2.82

85.70

8.7

9.2

1.36

0.79

mmol/l

1.88

443

1838

Mixed and other personality disorders

611

2683

2.54

85.62

7.8

9.0

1.22

0.84

mmol/l

1.24

510

2198

Other diseases of biliary tract

857

4381

2.22

84.00

13.0

7.2

0.44

0.99

mmol/l

3.58

746

3595

Osteomyelitis

663

3089

2.51

83.98

10.7

8.5

0.80

0.83

mmol/l

0.06

575

2549

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1302

7554

1.88

83.78

7.3

7.8

1.31

1.09

mmol/l

1.32

1093

6194

Serous carcinoma of ovary, including Hilmo

348

1195

3.63

83.55

6.5

6.4

0.61

1.44

mmol/l

4.06

309

984

Exposure to other specified factors

6038

40233

1.33

82.33

8.8

8.1

0.80

0.88

mmol/l

0.87

5178

33142

Cholecystitis

1280

7446

1.88

81.88

8.6

7.0

1.14

0.95

mmol/l

0.93

1073

6035

Osteoporosis with pathological fracture (FG)

706

3402

2.38

81.34

8.0

6.1

1.86

1.26

mmol/l

2.88

602

2825

Other arthritis (FG)

2358

15810

1.57

81.27

8.4

8.0

0.84

0.91

mmol/l

0.37

1994

13091

ILD medications: pirfenidone

201

522

7.07

81.24

11.5

8.2

1.51

0.79

mmol/l

2.29

179

434

Abnormal involuntary movements

1160

6580

1.94

80.81

6.9

8.1

0.91

0.90

mmol/l

0.03

979

5385

Pericarditis

350

1217

3.44

80.69

10.7

7.7

1.08

0.68

mmol/l

1.03

295

989

Disorders of parathyroid gland

1757

10986

1.70

80.68

7.9

6.7

0.75

1.13

mmol/l

3.28

1472

9096

Malignant neoplasm of other and unspecified female genital organs

220

588

5.34

80.47

5.5

5.7

0.12

1.36

mmol/l

4.95

204

495

Type of accident

2293

15345

1.58

80.29

7.8

7.9

1.49

0.86

mmol/l

11.60

1845

12659

Gonarthrosis,primary

7362

35297

1.30

79.83

6.7

8.0

1.03

0.94

mmol/l

1.01

6119

29356

Other and unspecified local infections of skin and subcutaneous tissue

871

4536

2.14

79.75

10.9

8.0

0.60

0.91

mmol/l

1.39

736

3713

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

657

3110

2.44

79.47

11.1

6.9

0.37

1.12

mmol/l

5.14

556

2533

Anosmia

138

222

6.68

79.13

7.3

4.2

0.99

1.15

mmol/l

0.16

110

169

Other and unspecified mood [affective] disorders

500

2067

2.65

79.03

9.1

8.0

0.54

0.69

mmol/l

0.35

413

1683

Other mental disorders due to brain damage and dysfunction and to physical disease

1161

6675

1.94

79.01

6.7

7.1

1.40

0.96

mmol/l

3.35

938

5470

Myocardial infarction, with ST-elevation

1647

10362

1.74

78.93

8.8

7.3

0.46

0.93

mmol/l

4.31

1354

8380

Umbilical hernia

2200

14682

1.59

78.78

9.1

8.3

1.01

0.85

mmol/l

1.09

1867

12096

Cytomegalovirus infection, IBD co-morbidity

278

873

4.18

78.74

15.9

10.3

-0.37

0.89

mmol/l

5.14

232

735

Bronchiectasis

737

3655

2.31

78.70

7.9

7.1

1.85

0.72

mmol/l

9.51

625

2974

Cervicalgia

1603

9937

1.72

78.55

6.6

7.8

1.14

0.87

mmol/l

2.15

1357

8203

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

627

2923

2.47

78.51

8.4

7.7

0.57

1.17

mmol/l

3.23

543

2391

KRA_PSY_EATING, excluding more controls

407

1496

2.87

78.20

8.7

7.3

0.69

0.10

mmol/l

1.69

336

1138

Abnormal spermatozoa

290

7870

0.33

78.05

4.8

8.6

1.35

0.77

mmol/l

2.36

225

6455

Other viral diseases

1950

12608

1.62

77.32

10.7

8.5

0.86

0.77

mmol/l

0.46

1629

10283

Polyarthrosis

1714

9752

1.70

77.29

5.5

7.6

1.39

1.12

mmol/l

2.25

1460

8082

Combinations of oral blood glucose lowering drugs

2362

16106

1.57

77.03

9.3

7.8

0.78

0.97

mmol/l

1.25

1892

13502

Diseases of pulp and periapical tissues, including avohilmo

7913

32782

1.28

76.59

8.1

7.6

0.72

0.93

mmol/l

4.15

6574

26859

Seropositive rheumatoid arthritis

1919

12429

1.63

76.34

7.6

7.5

1.15

1.04

mmol/l

0.56

1616

10266

Injury of other and unspecified intrathoracic organs

636

3026

2.43

76.05

13.3

8.3

1.30

0.89

mmol/l

1.70

517

2481

Familial hypercholesterolemia, with ischemic heart disease

855

4523

2.14

75.97

8.6

6.7

0.93

0.89

mmol/l

0.10

694

3716

Other local infections of skin and subcutaneous tissue

907

4875

2.06

75.42

10.8

8.0

0.62

0.91

mmol/l

1.32

766

3994

Appendectomy

4531

32658

1.36

75.07

8.4

8.0

0.71

0.91

mmol/l

2.95

3798

26992

Nonorganic sleeping disorders

1495

9196

1.72

74.84

8.3

8.2

1.03

0.80

mmol/l

1.52

1276

7479

Glomerulonephritis

863

4589

2.11

74.81

10.6

8.5

0.17

0.89

mmol/l

4.91

701

3767

Cytomegaloviral disease

279

905

3.98

74.69

15.8

9.9

-0.36

0.94

mmol/l

5.59

233

763

Benign neoplasm: Colon, unspecified

2233

15186

1.58

74.60

7.9

7.6

0.82

0.93

mmol/l

0.65

1856

12588

Charcot foot

203

530

4.98

74.47

13.3

7.8

0.75

0.92

mmol/l

0.18

178

446

Cytomegaloviral disease, including avohilmo

280

917

3.93

73.69

15.8

9.8

-0.36

0.96

mmol/l

5.74

233

775

Other diseases of liver

1436

8830

1.75

73.63

10.8

8.1

0.43

1.00

mmol/l

5.40

1231

7327

Failure and rejection of transplanted organs and tissues

187

472

5.60

73.48

19.4

9.6

-0.73

0.76

mmol/l

4.37

168

399

Fall on and from stairs and steps

2081

13923

1.59

73.40

8.6

7.7

0.89

0.94

mmol/l

0.22

1745

11475

Migraine without aura

1076

6039

1.86

73.32

7.6

0.79

0.60

mmol/l

0.99

881

4861

Malignant neoplasm of skin, including Hilmo

3937

19519

1.40

73.26

7.0

7.8

0.66

1.14

mmol/l

11.38

3254

16084

Focal brain injury

573

2630

2.44

72.92

11.2

7.4

1.39

0.66

mmol/l

4.13

474

2122

Mental and behavioural disorders due to cannabinoids

239

693

3.98

72.55

11.0

10.9

1.34

0.56

mmol/l

1.59

200

563

Protozoal diseases

349

1312

3.39

72.46

11.9

9.1

1.10

0.97

mmol/l

0.25

291

1087

Other diseases of pancreas

799

4205

2.16

72.30

12.8

7.6

0.59

0.88

mmol/l

1.12

677

3464

Assault by bodily force

576

2645

2.40

72.18

10.1

9.3

0.66

0.78

mmol/l

0.27

480

2182

Other diseases of arteries and capillaries

799

4185

2.13

72.13

11.1

7.1

0.34

0.95

mmol/l

3.56

677

3411

Reimbursement for rheumatic diseases

4212

31640

1.37

72.05

8.3

7.6

1.03

0.95

mmol/l

0.66

3541

26224

Paralytic ileus

416

1696

2.96

71.93

13.7

7.2

1.13

1.09

mmol/l

0.07

357

1375

Hypertensive Renal Disease

378

1459

3.06

71.88

9.1

6.4

-0.08

0.86

mmol/l

3.28

299

1163

Asthma and opportunity respiratory infection

478

2081

2.76

71.88

8.2

7.2

1.93

0.82

mmol/l

7.35

410

1693

Other and unspecified nerve root and plexus disorders, also in other diseases

1604

10177

1.68

71.84

6.6

8.5

1.53

0.86

mmol/l

12.55

1280

8501

Myalgia

1693

10833

1.65

71.83

8.4

7.8

0.91

0.88

mmol/l

0.13

1433

8892

Non-small cell lung cancer, adenocarcinoma

621

2997

2.39

71.67

6.9

1.17

1.15

mmol/l

0.05

539

2450

Traumatic subarachnoid haemorrhage

389

1528

3.02

71.65

14.2

7.3

1.12

0.71

mmol/l

1.07

341

1235

DVT of lower extremities

1598

10190

1.69

71.15

7.6

1.06

0.93

mmol/l

0.62

1327

8372

Pneumonia derived septicemia

361

1377

3.17

71.08

12.5

8.5

1.22

0.70

mmol/l

1.19

307

1127

Other/unspecified cytomegaloviral diseases

240

734

4.34

71.05

16.7

11.3

-0.48

0.79

mmol/l

4.50

204

618

Brain astrocytoma, including Hilmo

112

15.22

70.70

5.9

14.8

0.60

1.48

mmol/l

1.53

Brain astrocytoma

112

15.22

70.70

5.9

14.8

0.60

1.48

mmol/l

1.53

Left ventricular outflow tract obstruction, narrow definition

463

1986

2.73

70.68

19.6

10.0

0.66

0.79

mmol/l

0.32

417

1672

Somnolence, stupor and coma

433

1804

2.82

70.45

9.4

8.0

1.41

0.82

mmol/l

1.90

352

1466

Injury of intra-abdominal organs

271

886

3.79

70.43

16.0

9.8

1.15

0.94

mmol/l

0.36

216

741

Superficial injury of lower leg

1912

12639

1.59

70.33

7.7

7.6

1.08

0.86

mmol/l

1.65

1613

10341

Malignant neoplasm of oral cavity, including Hilmo

448

1906

2.79

70.22

11.4

7.7

1.32

1.19

mmol/l

0.34

398

1582

Protozoal diseases, including avohilmo

353

1357

3.27

69.91

11.8

9.0

1.08

0.98

mmol/l

0.21

295

1120

Other and unspecified myopathies

843

4567

2.08

69.81

9.6

7.7

1.52

0.97

mmol/l

2.56

707

3735

Right hemicolectomy

597

2886

2.43

69.51

13.2

7.0

0.49

1.01

mmol/l

2.11

496

2357

Viral infections characterized by skin and mucous membrane lesions

3179

23152

1.43

69.42

8.7

8.0

0.99

0.89

mmol/l

0.67

2622

19143

Other viral diseases, not elsewhere classified

1306

7904

1.75

69.21

10.4

8.5

1.12

0.83

mmol/l

1.97

1091

6445

Paracetamol or NSAID medication

1093

3033

1.89

69.04

8.8

9.4

0.76

0.75

mmol/l

0.02

889

2425

Morphin

277

936

3.74

68.89

6.2

6.9

2.63

0.91

mmol/l

11.23

245

766

Malignant neoplasm of bladder, including Hilmo

1096

6338

1.88

68.84

8.3

7.1

-0.19

1.04

mmol/l

17.29

910

5111

Disorders of continuity of bone

785

4132

2.08

68.68

8.4

8.3

1.15

0.91

mmol/l

1.04

670

3416

Malignant neoplasm of head and neck, including Hilmo

864

4724

2.03

68.35

10.3

7.7

1.28

1.09

mmol/l

0.77

737

3838

Other specified/unspecified arthritis

2025

13645

1.56

68.22

8.4

8.2

0.89

0.95

mmol/l

0.25

1708

11273

Benign neoplasm of brain and other parts of central nervous system

598

2897

2.37

68.16

7.3

8.3

0.97

0.94

mmol/l

0.06

475

2405

Subjective visual disturbances

1934

12940

1.58

68.00

7.9

7.6

0.92

0.96

mmol/l

0.19

1624

10684

Somatoform disorder

1142

6726

1.81

67.94

7.3

7.7

1.48

0.82

mmol/l

7.09

930

5522

Cerebral cysts

491

2184

2.55

67.78

11.9

8.8

0.84

0.87

mmol/l

0.05

395

1779

Gingivitis and periodontal diseases

7683

32136

1.27

67.73

8.3

7.5

0.76

0.96

mmol/l

4.05

6395

26369

Previous suicide attempt

140

295

6.50

67.66

9.2

11.1

0.55

0.70

mmol/l

0.19

112

247

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1197

7199

1.81

67.56

8.8

7.4

1.42

0.96

mmol/l

2.96

997

5898

Phlebitis and thrombophlebitis (not including DVT)

1777

11758

1.61

66.38

8.2

7.7

0.91

0.89

mmol/l

0.09

1497

9705

Benign neoplasm: Sigmoid colon

1659

10880

1.65

66.26

8.0

7.8

0.61

0.97

mmol/l

2.97

1386

8973

Intentional self-harm by sharp object

218

636

4.02

66.07

9.4

11.1

0.62

0.55

mmol/l

0.08

167

523

Diseases of oral cavity, salivary glands and jaws

4625

18201

1.35

65.95

7.5

7.3

0.84

0.99

mmol/l

1.57

3791

14807

Malignant neoplasm of bladder

683

3509

2.20

65.81

9.2

6.7

-0.29

1.06

mmol/l

12.42

579

2812

Other blood glucose lowering drugs, excl. Insulins

1346

8418

1.74

65.64

8.6

7.1

1.19

1.06

mmol/l

0.54

1092

6966

Scoliosis

620

3041

2.22

65.56

7.9

7.4

1.14

0.81

mmol/l

1.27

534

2482

Injuries to the elbow and forearm

5227

35158

1.31

65.49

8.0

7.8

0.96

0.92

mmol/l

0.30

4354

29054

Disorders of synovium and tendon

3854

24647

1.37

65.03

7.3

8.2

1.00

0.89

mmol/l

0.95

3173

20323

Malignant neoplasm of skin

3728

18886

1.39

64.74

7.0

7.7

0.70

1.14

mmol/l

9.49

3084

15569

Diplopia

1099

6543

1.83

64.67

8.5

7.7

1.07

0.97

mmol/l

0.36

917

5355

Ulcer of oesophagus

673

3487

2.21

64.26

8.4

7.8

1.34

0.90

mmol/l

1.85

561

2865

Psychotic depression

463

2040

2.51

64.22

8.7

7.6

1.21

0.80

mmol/l

1.38

385

1642

Stomatitis and related lesions

1466

9345

1.67

64.21

9.1

7.8

0.79

0.89

mmol/l

0.44

1226

7686

Hydrocephalus

709

3731

2.15

64.17

8.6

7.2

1.31

0.96

mmol/l

1.74

569

3050

Malignant neoplasm of breast, HER2-negative, including Hilmo

2428

10796

1.49

64.11

6.0

6.9

0.98

1.32

mmol/l

4.23

2109

8871

Malignant neoplasm of breast, including Hilmo

2428

10795

1.49

64.10

6.0

6.9

0.98

1.32

mmol/l

4.23

2109

8871

Acute and transient psychotic disorders

844

4645

1.97

63.96

8.1

8.5

1.91

0.80

mmol/l

12.21

716

3821

Shock, not elsewhere classified

149

354

6.21

63.87

33.3

6.7

0.95

0.63

mmol/l

0.27

111

287

Injuries to the neck

1645

10756

1.61

63.85

9.1

8.1

1.21

0.82

mmol/l

3.65

1371

8766

Dermatitis and eczema

8491

41485

1.24

63.65

8.3

7.9

0.93

0.88

mmol/l

0.48

7054

34185

Injuries to unspecified part of trunk, limb or body region

867

4849

1.97

63.50

10.6

7.9

0.75

0.91

mmol/l

0.54

753

3972

Brain astrocytoma, helper endpoint

128

13.18

63.42

5.9

13.4

0.60

1.62

mmol/l

2.16

104

Amputation of foot

331

1309

3.28

63.20

11.9

8.3

0.17

0.86

mmol/l

1.71

277

1073

Parkinson's disease, excluding more controls

1100

6028

1.81

62.84

5.4

6.8

1.68

0.62

mmol/l

15.59

934

4934

Dissociative [conversion] disorders

291

1036

3.18

62.77

6.5

7.8

1.01

0.73

mmol/l

0.58

236

843

Noninfectious colitis NAS

1068

6339

1.82

62.70

8.8

7.6

0.75

0.96

mmol/l

0.90

891

5188

Hyperparathyroidism

1506

9645

1.66

62.62

7.8

6.7

0.59

1.13

mmol/l

5.50

1252

7949

Procreative management

2112

11912

1.52

62.61

10.2

9.1

0.78

0.88

mmol/l

0.55

1767

9894

Hypertension, Pulmonary Arterial

123

251

7.18

62.61

19.2

7.4

1.16

0.88

mmol/l

0.26

100

211

Hepatic failure, not elsewhere classified

396

1692

2.82

62.26

21.0

8.9

-0.24

0.97

mmol/l

4.21

322

1406

Duodenal ulcer

997

5855

1.87

62.21

9.6

7.1

0.69

0.91

mmol/l

0.75

786

4765

Malignant neoplasm of breast, HER2-negative

2384

10702

1.49

62.16

6.1

6.9

1.01

1.32

mmol/l

3.61

2066

8801

Malignant neoplasm of breast

2385

10712

1.49

61.94

6.1

6.9

1.01

1.32

mmol/l

3.59

2066

8809

Other disorders of ear

7066

37176

1.26

61.84

7.2

8.1

1.06

0.88

mmol/l

3.67

5765

30929

Other or ill-defined heart diseases

425

1837

2.58

61.83

12.7

7.1

1.21

0.69

mmol/l

1.76

353

1493

Tubulo-interstitial nephritis, not specified as acute or chronic

566

2762

2.28

61.72

8.0

6.4

0.99

1.18

mmol/l

0.43

463

2250

Cholangitis (primary sclerosing, PSC)

581

2884

2.29

61.70

12.3

7.5

0.26

0.89

mmol/l

3.07

492

2381

Artrosis, including avohilmo

6165

26988

1.28

61.57

7.1

8.6

0.93

0.88

mmol/l

0.41

5045

22180

Short Achilles tendon (acquired)

276

982

3.37

61.44

6.5

8.8

2.18

1.08

mmol/l

7.60

218

820

Arterial embolism and thrombosis of lower extremity artery

380

1600

2.85

61.40

11.3

6.3

0.28

0.94

mmol/l

2.09

309

1298

Extrapyramidal and movement disorders

3148

23433

1.41

61.34

6.2

7.4

1.37

0.92

mmol/l

8.36

2656

19352

Primary_lymphoid and hematopoietic malignant neoplasms

2022

14001

1.54

61.25

9.1

7.5

1.01

0.91

mmol/l

0.51

1658

11536

Caries of dentine, including avohilmo

6124

25006

1.29

61.19

7.7

7.5

0.87

0.95

mmol/l

0.79

5040

20492

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

3569

18074

1.38

61.03

6.9

7.7

0.71

1.14

mmol/l

8.55

2936

14891

Malignant neoplasm of head and neck

717

3834

2.08

61.00

10.8

7.5

1.31

1.10

mmol/l

0.80

621

3131

Other disorders of lacrimal gland

2716

19740

1.44

60.70

7.2

7.5

1.19

0.97

mmol/l

2.41

2277

16388

Disorders of lacrimal system

3276

24093

1.39

60.66

7.0

7.4

1.17

0.96

mmol/l

2.67

2725

19970

Personal history of risk-factors, not elsewhere classified

155

384

5.15

60.59

8.9

8.7

0.59

0.87

mmol/l

0.41

125

316

Laparoscopic right hemicolectomy

596

3052

2.30

60.21

7.0

7.3

0.31

0.96

mmol/l

4.46

503

2525

Blood alcohol or alcohol intoxication level

235

773

3.68

59.96

9.2

1.10

0.75

mmol/l

0.69

195

650

291

1105

3.38

59.66

7.4

7.7

2.20

0.74

mmol/l

6.48

249

906

Osteonecrosis

581

2928

2.27

59.66

9.6

8.1

0.86

0.99

mmol/l

0.32

509

2433

Alzheimer disease, excluding more controls

1467

6065

1.67

59.49

5.1

6.6

1.20

0.68

mmol/l

4.53

1173

4973

Other viral diseases, including avohilmo

2376

16706

1.46

59.33

10.4

8.4

0.82

0.79

mmol/l

0.12

1976

13641

Congenital malformations of aortic and mitral valves

389

1671

2.72

59.31

20.0

9.7

0.77

0.79

mmol/l

0.05

351

1404

Toxic effect of carbon monoxide

221

720

4.03

59.29

4.8

8.9

1.03

0.87

mmol/l

0.25

173

598

Diseases of pulp and periapical tissues and dental caries

5217

21059

1.31

59.14

7.5

7.4

0.82

0.98

mmol/l

1.95

4276

17177

Coxarthrosis, primary

5002

32945

1.31

59.06

6.7

7.5

0.97

mmol/l

0.00

4162

27382

Hyperkinetic disorders, excluding more controls

522

2278

2.22

59.04

8.9

8.3

0.64

0.15

mmol/l

1.96

398

1756

Amputation of thigh

354

1479

2.94

58.94

13.0

6.2

0.84

0.93

mmol/l

0.14

303

1186

Other systemic involvement of connective tissue

2074

14482

1.51

58.85

7.2

7.1

1.13

0.99

mmol/l

0.96

1756

11934

Dental caries, including avohilmo

5767

23543

1.29

58.68

7.8

7.5

0.86

0.97

mmol/l

1.26

4752

19250

Other symptoms and signs involving the nervous and musculoskeletal systems

3033

22534

1.40

58.61

7.5

7.7

1.64

0.86

mmol/l

28.91

2506

18563

Superficial injury of hip and thigh

1254

7903

1.70

58.26

6.9

7.0

1.32

0.95

mmol/l

2.64

1054

6389

Benign neoplasm: Adrenal gland

704

3829

2.08

57.83

7.6

8.0

1.16

0.97

mmol/l

0.63

606

3162

Malignant neoplasm of oesophagus, including Hilmo

383

1667

2.76

57.81

17.4

8.2

0.93

0.98

mmol/l

0.08

348

1363

Pneumococcal septicemia

342

1410

2.91

57.76

12.5

8.8

1.19

0.92

mmol/l

0.45

289

1163

Other symptoms and signs involving general sensations and perceptions

402

1776

2.63

57.43

6.8

8.0

1.24

0.94

mmol/l

0.77

344

1456

Visual field defects

744

4122

2.01

57.00

8.8

7.8

0.73

1.05

mmol/l

1.33

616

3363

Malignant neoplasm of oral cavity

352

1482

2.85

56.89

11.8

7.2

1.21

1.13

mmol/l

0.20

316

1225

Hypopituitarism

575

2912

2.19

56.70

9.1

9.4

0.84

0.77

mmol/l

0.18

474

2404

Benign neoplasm: Rectum, anus and anal canal

1708

11636

1.57

56.67

7.5

7.7

0.86

0.99

mmol/l

0.66

1427

9605

Toxic effect of other and unspecified substances

145

361

5.16

56.51

12.8

12.1

0.38

0.98

mmol/l

0.86

125

306

Dental operations

4878

19706

1.31

56.43

7.4

7.5

0.96

0.86

mmol/l

0.90

3977

16222

Benign neoplasm: Rectum

1546

10341

1.61

56.43

7.6

7.8

0.87

0.98

mmol/l

0.48

1287

8529

Benign neoplasm: Transverse colon

991

5997

1.83

56.39

7.7

7.8

0.86

0.96

mmol/l

0.32

837

4949

Generalized anxiety disorder

898

5168

1.82

56.27

8.2

7.6

0.70

0.66

mmol/l

0.10

763

4125

Purpura and other haemorrhagic conditions

1078

6621

1.76

56.10

9.5

7.8

0.67

0.90

mmol/l

0.99

892

5423

Pulmonary oedema

232

804

3.74

56.04

14.4

6.5

1.76

1.18

mmol/l

0.96

183

644

Acute posthaemorrhagic anaemia

362

1554

2.76

55.80

9.7

7.3

0.51

1.09

mmol/l

1.41

299

1260

Congenital malformations of the urinary system

470

2232

2.37

55.51

9.7

9.3

-0.53

0.84

mmol/l

9.92

387

1842

Superficial injury of thorax

1197

7551

1.70

55.41

8.7

7.7

0.95

0.92

mmol/l

0.10

1011

6155

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

496

2424

2.35

55.34

10.4

6.8

0.36

1.07

mmol/l

3.65

411

1966

Benign neoplasm: Pituitary gland, craniopharyngeal duct

456

2152

2.42

55.28

7.3

8.5

0.74

0.87

mmol/l

0.37

337

1753

Other malignant neoplasms of skin (=non-melanoma skin cancer)

3414

17548

1.37

55.03

6.9

7.6

0.70

1.15

mmol/l

8.96

2806

14457

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

620

3272

2.12

54.84

7.2

6.9

1.19

1.05

mmol/l

0.38

492

2646

Inguinal hernia

4573

23927

1.31

54.53

8.0

8.2

0.88

0.87

mmol/l

0.05

3797

19684

Lesion of ulnar nerve

1077

6677

1.73

53.68

9.1

8.6

1.25

0.85

mmol/l

2.74

906

5541

Trochanteric bursitis

1108

6911

1.71

53.55

6.8

7.2

1.03

1.01

mmol/l

0.05

941

5762

Congenital malformations of the urinary system, including avohilmo

493

2421

2.28

53.27

9.9

9.0

-0.49

0.82

mmol/l

9.58

405

1996

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

478

2340

2.35

53.24

12.0

6.9

0.27

1.03

mmol/l

3.96

401

1906

Disorders of psychological development

656

3232

1.99

53.18

10.7

9.5

0.90

0.53

mmol/l

1.38

510

2574

Other condition

1074

6661

1.73

53.16

8.4

8.1

1.54

0.89

mmol/l

6.21

864

5464

Acute gastritis

639

3442

2.06

53.16

6.8

7.5

1.20

1.00

mmol/l

0.57

532

2833

Parkinson's disease, strict definition, excluding more controls

1007

5720

1.76

53.13

5.3

6.8

1.70

0.61

mmol/l

14.99

858

4676

Dependence on enabling machines and devices, not elsewhere classified

150

407

5.02

52.92

22.6

7.8

-0.20

0.65

mmol/l

1.43

129

334

ILD medications: nintedanib

111

256

8.80

52.73

10.9

7.9

2.01

0.70

mmol/l

3.48

101

210

Strabismus

1785

12307

1.51

52.70

9.7

8.1

1.09

0.84

mmol/l

1.94

1468

10101

Other disorders of nervous system

592

3132

2.13

52.60

7.3

8.3

1.11

0.98

mmol/l

0.37

512

2600

Mental disorders, not otherwise specified

543

2750

2.14

52.52

10.0

8.7

0.86

0.74

mmol/l

0.30

467

2239

Sulfonylureas

2827

16779

1.40

52.48

8.3

6.7

0.67

1.02

mmol/l

3.26

2233

13902

Social phobias

479

2299

2.22

52.46

10.4

8.0

0.73

0.55

mmol/l

0.42

396

1833

Congenital malformations of cardiac septa

477

2240

2.27

52.30

17.0

9.4

0.70

0.71

mmol/l

0.02

424

1844

Symptoms and signs involving speech and voice

2502

18413

1.42

52.20

8.2

7.4

1.05

0.93

mmol/l

0.88

2137

15191

Necrotizing fasciitis

104

224

8.32

52.09

15.8

10.7

0.97

0.83

mmol/l

0.08

184

Non-Hodgkin lymphoma, all, including Hilmo

1033

6405

1.74

51.90

8.8

7.6

1.03

1.12

mmol/l

0.28

849

5238

Drug-induced adrenocortical insufficiency

209

710

3.75

51.87

8.5

10.1

1.47

0.92

mmol/l

1.21

180

601

Radiculopathy

1234

7958

1.65

51.84

6.1

7.6

1.11

0.89

mmol/l

1.24

1003

6573

Follow-up examination after treatment for malignant neoplasms

841

4940

1.85

51.72

7.5

6.8

0.79

0.87

mmol/l

0.23

692

4149

Fall on same level involving ice and snow

4278

33837

1.30

51.70

8.0

7.7

0.97

0.92

mmol/l

0.31

3578

28040

Sulfasalazine

1916

13461

1.48

51.67

7.6

1.12

0.79

mmol/l

3.06

1597

11077

Malignant neoplasm of pancreas, including Hilmo

742

4228

1.93

51.49

8.6

6.9

0.90

1.15

mmol/l

1.02

650

3434

Type 1 diabetes, definitions combined

535

2694

2.11

51.23

11.4

8.1

-0.61

0.73

mmol/l

6.88

424

2214

Basal cell carcinoma, including Hilmo

3408

17650

1.35

51.18

6.8

7.6

0.71

1.15

mmol/l

8.59

2814

14539

Zoster [herpes zoster]

1504

10176

1.57

51.05

8.2

7.3

1.13

1.00

mmol/l

0.57

1270

8381

Speech and linguistic disorders

527

2539

2.13

51.00

11.3

9.9

0.79

0.52

mmol/l

0.76

414

2053

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

6645

42795

1.24

50.80

7.8

8.0

0.85

0.89

mmol/l

0.34

5532

35301

Fall involving bed

372

1698

2.63

50.72

7.7

6.7

2.12

0.99

mmol/l

6.31

310

1390

Dermatophytosis

1127

7187

1.69

50.56

7.2

8.1

1.13

0.88

mmol/l

1.16

953

5899

Other viral diseases, not elsewhere classified, including avohilmo

1685

11519

1.51

50.42

10.2

8.4

0.98

0.78

mmol/l

1.44

1401

9379

Other problems related to primary support group, including family circumstances

636

3330

1.97

50.32

12.4

9.0

0.62

0.64

mmol/l

0.05

541

2702

Disorders of skin appendages

3308

25257

1.34

50.27

8.3

8.0

0.80

0.84

mmol/l

0.22

2716

20804

Other sleep disorders

836

4928

1.82

50.16

7.0

8.0

1.40

0.78

mmol/l

4.87

697

4034

Other disorders of eyelid

3566

26198

1.33

49.77

7.0

7.3

1.15

0.96

mmol/l

2.37

3029

21685

Volvulus

292

1199

2.91

49.76

10.4

7.3

1.19

1.11

mmol/l

0.12

250

988

Kyphosis

167

510

4.33

49.68

8.5

7.3

2.87

1.14

mmol/l

6.40

136

434

Type 1 diabetes, strict (exclude DM2)

528

2677

2.09

49.62

11.5

8.5

-0.65

0.73

mmol/l

7.13

417

2201

Malignant neoplasm of mesothelium and soft tissue

382

1763

2.52

49.59

8.8

8.0

0.65

1.08

mmol/l

1.28

325

1456

Benign neoplasm: Ascending colon

1221

8004

1.66

49.38

7.4

7.6

0.75

0.99

mmol/l

1.16

1015

6616

Inflammatory diseases of the central nervous system

655

3633

1.98

49.33

10.7

8.4

1.07

0.91

mmol/l

0.45

547

2972

Fracture of foot, except ankle

1659

11452

1.51

49.26

8.5

8.2

1.08

0.85

mmol/l

1.60

1380

9417

Functional dyspepsia

1894

13415

1.48

49.18

8.4

7.2

1.27

0.96

mmol/l

3.09

1578

11091

Other arterial embolism and thrombosis

292

1207

2.89

49.11

13.6

6.4

0.64

1.05

mmol/l

0.91

246

984

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

195

661

3.81

48.89

9.1

7.3

0.31

1.29

mmol/l

3.07

174

557

Other congenital malformations of circulatory system

257

1002

3.10

48.73

9.5

0.95

0.92

mmol/l

0.04

204

844

Vitreous haemorrhage

862

5208

1.81

48.64

10.5

7.9

0.43

0.92

mmol/l

2.91

728

4262

Disorders of muscles

775

4531

1.84

48.07

9.9

8.3

1.07

0.92

mmol/l

0.44

648

3699

Event of undetermined intent

496

2527

2.16

48.06

9.9

9.4

0.78

0.83

mmol/l

0.10

427

2068

Adverse effects, not elsewhere classified

1261

8282

1.60

47.89

9.0

8.0

0.77

0.81

mmol/l

0.11

1067

6759

Alzheimer’s disease (Atypical or mixed), excluding more controls

809

3553

1.85

47.46

4.1

6.1

1.37

0.70

mmol/l

4.60

608

2843

Neuralgia and neuritis, unspecified

436

2140

2.28

47.31

7.9

8.6

1.54

0.97

mmol/l

2.50

343

1766

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

1322

8836

1.59

47.31

8.8

8.0

0.62

0.90

mmol/l

2.01

1126

7249

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

1177

7678

1.64

47.24

9.1

8.0

0.56

0.93

mmol/l

2.75

1007

6300

Use of biperiden

450

2247

2.27

47.16

6.8

8.9

2.35

0.96

mmol/l

10.39

379

1855

Recurrent aphthous stomatitis , including avohilmo

1049

6667

1.68

46.96

8.4

7.8

0.92

0.90

mmol/l

0.06

875

5461

Immunodeficiencies

388

1832

2.40

46.84

13.8

9.0

1.04

0.95

mmol/l

0.16

321

1490

Basal cell carcinoma

3272

17183

1.34

46.82

6.7

7.5

0.72

1.16

mmol/l

8.13

2697

14149

Superficial injury of abdomen, lower back and pelvis

1122

7236

1.64

46.71

8.0

7.7

1.02

0.81

mmol/l

0.93

935

5847

Disorders of ocular muscles, binocular movement, accommodation and refraction

3166

24190

1.34

46.63

9.7

7.9

1.01

0.82

mmol/l

1.89

2617

19905

Open wound of ankle and foot

791

4701

1.81

46.45

10.2

8.2

0.74

0.86

mmol/l

0.38

690

3821

Fibromyalgia

582

3140

1.98

46.42

7.4

1.59

0.88

mmol/l

5.89

478

2568

Vascular syndromes of brain in cerebrovascular disorders

443

2233

2.30

46.31

6.9

7.3

1.62

0.88

mmol/l

3.25

347

1830

Other and unspecified abdominal hernia

383

1825

2.43

45.94

8.5

7.9

1.32

1.05

mmol/l

0.56

327

1490

Agranulocytosis

858

5241

1.77

45.93

10.0

8.1

1.33

0.95

mmol/l

2.25

726

4321

Malignant neoplasm of stomach, including Hilmo

526

2793

2.10

45.89

9.9

7.0

0.68

1.09

mmol/l

1.60

453

2264

Mental retardation, excluding more controls

262

1000

2.82

45.82

10.1

9.6

2.18

0.55

mmol/l

6.19

218

845

Heartburn

805

4809

1.79

45.80

9.2

7.6

0.99

0.85

mmol/l

0.57

695

3998

Motor neuron disease (with DMD)

208

749

3.35

45.68

5.7

7.0

4.12

0.59

mmol/l

23.85

184

607

Malignant neoplasm of other connective and soft tissue, including Hilmo

369

1732

2.44

45.63

8.8

7.9

0.43

1.06

mmol/l

2.23

316

1431

Toxic effect of ethanol

319

1400

2.58

45.59

10.1

0.67

0.80

mmol/l

0.20

261

1163

Cystic kidney disease

297

1278

2.73

45.50

10.0

9.3

-0.90

0.91

mmol/l

10.62

250

1063

Bicuspidal aortic valve syndrome

340

1549

2.55

45.48

16.3

9.8

0.86

0.85

mmol/l

0.01

307

1302

Cystic kidney disease, including avohilmo

317

1403

2.64

45.46

10.3

9.4

-0.84

0.95

mmol/l

10.82

266

1166

Family history of malignant neoplasm

696

3996

1.85

45.24

7.5

6.7

0.77

0.96

mmol/l

0.85

600

3278

Abscess of anal and rectal regions

627

3511

1.93

45.13

9.3

8.3

0.43

0.93

mmol/l

2.12

520

2873

Injuries to the ankle and foot

4874

33813

1.26

45.05

8.7

8.3

0.89

0.85

mmol/l

0.30

4078

27904

Injury of unspecified body region

627

3534

1.95

45.05

10.6

8.1

0.76

0.89

mmol/l

0.34

547

2895

Dissocial personality disorder

163

516

3.92

44.84

10.3

11.5

1.57

0.78

mmol/l

1.48

147

430

Artificial joint re-operation

631

3600

1.97

44.82

7.1

1.18

1.00

mmol/l

0.58

531

2979

Alcohol-induced acute pancreatitis

354

1659

2.51

44.78

17.5

9.2

0.13

0.84

mmol/l

1.62

300

1394

Other extrapyramidal and movement disorders in other diseases

1885

13607

1.46

44.77

6.5

7.6

1.12

0.94

mmol/l

1.23

1597

11236

Other maltreatment syndromes

248

977

2.90

44.76

10.3

9.9

0.45

0.95

mmol/l

0.92

203

819

Use of pramipexole

1697

12048

1.49

44.72

7.1

7.4

1.27

0.99

mmol/l

2.26

1426

9972

Conotruncal defects

123

321

4.75

44.65

24.0

13.0

0.69

0.27

mmol/l

0.56

115

271

Non-small cell lung cancer, adenocarcinoma, helper endpoint

621

3533

1.98

44.63

6.9

7.3

1.17

0.95

mmol/l

0.87

539

2878

Degeneration of macula and posterior pole

4033

24877

1.30

44.54

6.7

7.1

0.86

1.02

mmol/l

1.76

3324

20576

Left bundle-branch block

541

2908

2.03

44.53

7.4

6.5

0.10

0.81

mmol/l

3.14

481

2385

Fracture of neck

559

3075

2.05

44.45

12.7

7.6

1.50

0.86

mmol/l

2.94

479

2526

Other diseases of oesophagus

784

4724

1.80

44.32

8.2

7.3

1.27

0.93

mmol/l

1.32

667

3850

Motor neuron disease ALS

203

735

3.34

44.23

5.7

7.0

4.19

0.59

mmol/l

24.05

179

595

Open wound of abdomen, lower back and pelvis

273

1139

2.76

44.06

11.6

9.6

0.72

0.89

mmol/l

0.23

224

939

Polycystic kidney disease

253

1030

2.94

43.97

10.4

9.6

-1.05

0.93

mmol/l

10.09

213

855

Complications of cardiac and vascular prosthetic devices, implants and grafts

234

925

3.14

43.96

15.1

6.8

0.38

0.96

mmol/l

1.19

187

760

Amputation of ankle bones

250

1022

3.03

43.91

14.0

8.1

0.64

0.99

mmol/l

0.67

211

833

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

953

5153

1.66

43.85

10.3

9.0

0.55

0.37

mmol/l

0.71

743

4052

Malignant neoplasm of stomach

464

2413

2.15

43.16

10.4

6.8

0.62

1.08

mmol/l

1.72

403

1969

Abscess of lung

185

654

3.62

43.14

10.2

7.8

1.39

0.97

mmol/l

0.52

167

551

Disorders of the thyroid gland

6863

37422

1.21

43.08

8.0

7.7

0.90

0.87

mmol/l

0.27

5643

30772

Migraine with aura and triptan purchases

841

5127

1.71

43.06

6.4

8.2

0.88

0.70

mmol/l

0.79

660

4153

Oxicams

1875

7591

1.46

43.01

6.3

8.6

0.97

0.98

mmol/l

0.03

1516

6145

Malignant neoplasm of endocrine gland, including Hilmo

556

3045

1.98

42.99

7.2

8.2

0.97

1.10

mmol/l

0.35

468

2485

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

277

1171

2.66

42.81

14.3

9.8

0.29

0.98

mmol/l

1.60

235

972

Allergic bronchopulmonary aspergillosis (ABPA)

10.94

42.56

9.7

5.2

1.82

0.96

mmol/l

0.72

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

660

3849

1.89

42.55

7.6

6.9

1.07

1.02

mmol/l

0.11

535

3142

Polyuria

1779

12845

1.46

42.45

7.5

7.7

0.82

0.93

mmol/l

0.52

1510

10491

Cardiac murmurs and other cardiac sounds

566

3075

1.93

42.22

7.8

8.2

0.95

0.60

mmol/l

1.09

466

2486

Hepatocellular carcinoma, including Hilmo

302

1360

2.63

42.18

14.0

7.0

0.05

1.15

mmol/l

5.41

259

1119

Methotrexate

946

6008

1.67

42.18

8.9

7.4

1.09

0.81

mmol/l

1.35

798

4966

Other other unspecified disorders of the circulatory system

343

1624

2.46

42.06

9.7

8.1

0.95

mmol/l

0.00

288

1320

Presence of other functional implants

4503

25002

1.27

41.98

6.8

6.9

1.02

1.00

mmol/l

0.13

3710

20775

Benign neoplasm: Stomach

790

4855

1.78

41.93

7.9

7.4

1.13

0.99

mmol/l

0.51

681

3999

Oesophagitis

472

2497

2.12

41.92

12.2

7.8

0.48

0.91

mmol/l

1.33

397

2073

Nonalcoholic fatty liver disease

735

4406

1.80

41.92

11.3

8.7

0.51

0.90

mmol/l

1.76

636

3652

Cervicocranial syndrome

755

4544

1.77

41.87

5.8

7.5

1.12

0.85

mmol/l

1.26

616

3765

Meniscus derangement

4011

21289

1.28

41.84

7.0

8.4

0.93

0.98

mmol/l

0.35

3359

17590

Seropositive rheumatoid arthritis, wide

1918

14036

1.43

41.79

7.6

7.3

1.15

0.99

mmol/l

0.89

1615

11632

Rheumatoid arthritis, including avohilmo

2716

20892

1.35

41.78

7.4

7.3

1.16

1.00

mmol/l

1.24

2277

17324

Disorders of oesophagus in diseases classified elsewhere

231

929

3.05

41.76

11.0

8.5

1.18

1.14

mmol/l

0.05

194

770

Progressive vascular leukoencephalopathy

415

2128

2.28

41.72

6.2

5.7

0.10

1.14

mmol/l

4.97

375

1709

Other infectious diseases, including avohilmo

729

4381

1.81

41.69

10.0

7.6

0.93

0.94

mmol/l

0.03

588

3568

Benign neoplasm: Caecum

925

5932

1.70

41.54

8.4

7.5

0.69

0.99

mmol/l

1.48

784

4880

Secondary uncertain malignant neoplasm

1017

6614

1.64

41.52

6.8

7.4

1.28

1.15

mmol/l

0.46

827

5387

Other/unspecified seropositive rheumatoid arthritis

1897

13874

1.43

41.50

7.7

7.3

1.15

1.00

mmol/l

0.84

1595

11493

Congenital malformations and deformations of the musculoskeletal system

519

2782

1.98

41.46

9.7

9.6

0.91

0.68

mmol/l

0.72

436

2263

Hypocalcemia

236

960

2.97

41.36

9.8

8.1

0.42

1.05

mmol/l

0.97

199

797

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3726

28702

1.29

41.31

9.3

8.3

1.11

0.85

mmol/l

4.50

3125

23861

Pyogenic arthritis

550

3058

1.98

41.30

10.0

8.3

0.84

0.99

mmol/l

0.36

461

2505

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1864

13609

1.44

41.24

7.7

7.3

1.16

1.00

mmol/l

0.94

1570

11292

Other disorders involving the immune mechanism, not elsewhere classified

282

1237

2.65

41.18

12.6

10.4

-0.50

0.86

mmol/l

6.01

236

1033

Malignant neoplasm of endocrine gland

490

2615

2.04

41.18

7.4

8.3

0.98

1.13

mmol/l

0.38

416

2141

Postmenopausal osteoporosis with pathological fracture

572

3245

1.97

41.18

7.1

5.7

1.95

1.25

mmol/l

3.17

486

2689

Assault by sharp object

166

557

3.59

41.12

9.8

11.7

0.94

1.05

mmol/l

0.10

124

473

Zoster [herpes zoster], including avohilmo

3927

30519

1.28

41.09

7.5

7.4

0.92

0.96

mmol/l

0.21

3305

25318

Congenital malformations of great arteries

168

552

3.50

41.07

28.5

10.7

0.29

0.28

mmol/l

0.01

150

457

Explicit fungal Sepsis

242

5.92

40.97

36.9

5.7

0.69

0.99

mmol/l

0.26

205

Other coagulation defects

555

3094

1.95

40.95

11.1

8.0

0.47

0.87

mmol/l

1.32

479

2523

Primary gonarthrosis, bilateral

4124

27946

1.28

40.93

6.4

7.7

1.09

0.96

mmol/l

1.37

3440

23241

Benign neoplasm: Brain, supratentorial

167

570

3.65

40.87

7.1

9.2

1.09

0.99

mmol/l

0.15

128

483

Behavioural disorders, excluding more controls

133

380

3.91

40.80

9.7

9.0

0.95

0.22

mmol/l

1.26

109

313

Operations for atrial fibrillation

189

709

3.60

40.80

15.1

8.6

0.36

0.79

mmol/l

0.84

166

592

Eating disorder

410

2034

2.12

40.77

8.7

8.6

0.71

0.31

mmol/l

0.94

339

1566

Childhood asthma (age<16), excluding more controls

491

1987

1.99

40.72

9.6

6.9

0.40

-0.21

mmol/l

2.86

397

1516

Other diseases of upper respiratory tract

8198

36510

1.19

40.70

8.1

7.9

0.96

0.86

mmol/l

1.32

6789

30036

Lesion of lateral popliteal nerve

426

2201

2.18

40.64

10.9

9.0

1.38

0.88

mmol/l

1.54

347

1808

Explicit fungal Sepsis, including avohilmo

244

5.84

40.50

36.9

5.6

0.69

0.99

mmol/l

0.26

205

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

134

399

4.16

40.47

10.0

11.6

1.42

0.86

mmol/l

0.88

110

327

Early complications of trauma

387

1935

2.26

40.44

10.2

9.2

0.92

0.94

mmol/l

0.03

320

1601

!Aliquae complicationes praecoces traumatis

387

1935

2.26

40.44

10.2

9.2

0.92

0.94

mmol/l

0.03

320

1601

Other symptoms and signs involving the urinary system

844

5314

1.72

40.16

7.3

8.0

0.88

0.94

mmol/l

0.18

705

4323

Immunodeficiency with predominantly antibody defects

224

892

2.93

40.13

16.3

9.7

0.89

0.95

mmol/l

0.07

184

746

Adenocarcinoma and Papillary adenocarcinoma of kidney

156

531

4.05

39.99

9.4

8.5

-1.13

1.07

mmol/l

11.02

140

429

Type 1 diabetes, strict definition, subgroup 1

353

1669

2.23

39.95

12.0

7.9

-1.00

0.56

mmol/l

5.44

274

1343

Conductive and sensorineural hearing loss

6100

33984

1.22

39.83

6.8

7.9

1.15

0.90

mmol/l

5.43

4927

28374

Dissection of aorta

316

1484

2.49

39.72

19.4

6.7

1.23

0.98

mmol/l

0.59

276

1213

Other eating disorders

256

1063

2.58

39.71

9.1

8.6

0.59

0.23

mmol/l

0.59

214

815

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

263

1139

2.69

39.57

12.6

10.6

-0.52

0.88

mmol/l

5.92

221

954

Surgical ablation of atrial fibrillation

239

6.75

39.48

13.6

10.2

0.43

0.67

mmol/l

0.23

205

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

426

2234

2.16

39.24

8.0

6.8

1.08

1.13

mmol/l

0.08

369

1834

Open wound of forearm

736

4493

1.76

39.18

7.8

7.9

0.95

0.89

mmol/l

0.15

603

3645

Other diseases of stomach and duodenum

536

3012

1.96

39.14

10.5

7.3

0.62

0.99

mmol/l

1.18

447

2502

Hypothyroidism, strict autoimmune

5026

27180

1.24

39.02

7.6

7.3

0.97

0.89

mmol/l

0.64

4128

22331

Orchitis and epididymitis

781

4865

1.74

38.92

9.8

9.0

0.89

0.73

mmol/l

0.48

634

4008

Thiazolidinediones

907

5864

1.67

38.88

9.9

7.5

0.92

1.06

mmol/l

0.44

750

4859

Emotional disorders starting during childhood or adolecense, excluding more controls

182

619

3.01

38.75

10.7

8.9

0.17

-0.15

mmol/l

0.45

146

469

Other necrotizing vasculopathies (FG)

495

2727

2.01

38.69

8.7

8.0

0.75

0.92

mmol/l

0.43

413

2238

Diseases of the ear and mastoid process

8140

34957

1.19

38.68

7.5

8.2

0.88

0.85

mmol/l

0.23

6623

28940

Other symptoms and signs involving the digestive system and abdomen

1117

7490

1.56

38.62

7.1

1.12

0.98

mmol/l

0.62

899

6222

Hypothyroidism, other/unspecified

6274

34747

1.21

38.58

7.8

7.6

0.92

0.87

mmol/l

0.41

5146

28565

Prophylactic surgery

175

6.01

38.58

9.0

6.3

-0.11

0.65

mmol/l

1.35

147

Pleural plaque

830

5286

1.72

38.51

6.1

6.7

1.61

0.59

mmol/l

9.68

691

4208

Malignant neoplasm of small intestine, including Hilmo

286

1305

2.56

38.47

7.5

7.2

-0.16

1.09

mmol/l

4.45

239

1082

Sequelae of injuries of neck and trunk

268

1185

2.62

38.45

12.8

9.4

1.84

0.91

mmol/l

3.48

225

992

Intestinal malabsorption

379

1912

2.22

38.41

11.9

8.6

0.01

0.90

mmol/l

2.64

318

1585

Adenocarcinoma and ductal carcinoma of pancreas

335

1627

2.37

38.32

9.6

7.1

0.81

1.09

mmol/l

0.78

305

1336

Infection of intervertebral disc (pyogenic)

166

593

3.63

38.31

10.6

8.4

1.09

1.05

mmol/l

0.03

144

499

Childhood asthma (age<16)

491

2035

1.94

38.00

9.6

7.6

0.40

-0.17

mmol/l

2.56

397

1561

Diseases of salivary glands

2229

16892

1.37

37.99

8.4

7.7

1.10

0.91

mmol/l

1.48

1859

13988

Chronic sinusitis

2895

22654

1.31

37.99

7.9

0.96

0.86

mmol/l

0.67

2405

18767

Exposure to other and unspecified inanimate mechanical forces

565

3239

1.89

37.91

11.0

8.8

0.90

0.83

mmol/l

0.16

483

2666

Overexertion and strenuous or repetitive movements

709

4325

1.76

37.85

11.0

8.4

0.45

0.88

mmol/l

2.16

620

3554

Malignant neoplasm of rectosigmoid junction, including Hilmo

282

1291

2.57

37.83

8.8

6.8

0.21

1.08

mmol/l

3.13

237

1062

Haemorrhoids and perianal venous thrombosis

2454

18717

1.35

37.75

6.3

7.2

0.93

0.99

mmol/l

0.32

2027

15417

Artificial joint operation, meniscal resection

6981

38061

1.20

37.71

6.9

8.0

1.00

0.94

mmol/l

0.70

5844

31599

Laparoscopic left hemicolectomy

201

802

3.19

37.68

10.5

8.5

-0.49

0.97

mmol/l

5.76

187

671

Malignant neoplasm of tongue, including Hilmo

251

1096

2.71

37.52

11.3

7.2

1.46

1.20

mmol/l

0.50

218

909

Obsessive-compulsive disorder

354

1724

2.17

37.42

9.2

7.9

1.02

0.56

mmol/l

1.36

296

1366

Hypothyreosis and Thyroxine purchase for inclusion criteria

6497

36052

1.20

37.41

7.7

0.93

0.88

mmol/l

0.40

5337

29671

Ductal carcinoma of pancreas

115

339

4.96

37.39

12.9

7.6

1.24

1.20

mmol/l

0.04

108

285

Leisure time condition

1287

8955

1.51

37.38

7.1

7.8

1.49

0.90

mmol/l

5.83

1033

7330

Abnormal results of function studies

638

3798

1.81

37.32

9.3

7.9

1.18

0.83

mmol/l

1.31

531

3128

Asthma mixed form (mode), excluding more controls

296

1358

2.34

36.80

5.5

6.1

1.81

0.26

mmol/l

10.32

251

1108

Carcinoma in situ of other and unspecified digestive organs

417

2234

2.14

36.71

9.3

8.0

0.24

0.88

mmol/l

2.84

364

1851

Anaemia in chronic diseases classified elsewhere

248

1094

2.71

36.57

10.9

8.7

-0.11

1.07

mmol/l

3.71

181

906

Arthropathies in other diseases classified elsewhere

309

1477

2.38

36.46

11.2

9.8

0.68

0.88

mmol/l

0.33

275

1228

Other necrotizing vasculopathies

588

3472

1.86

36.46

8.8

7.5

0.66

0.96

mmol/l

1.05

491

2853

Type 1 diabetes, strict definition

371

1857

2.10

36.08

12.0

8.1

-0.88

0.60

mmol/l

5.30

291

1506

Atrial septal defect

275

1244

2.46

35.99

17.9

9.7

0.86

0.73

mmol/l

0.24

251

1036

Other inflammatory liver diseases

510

2894

1.93

35.97

10.2

8.2

0.69

0.98

mmol/l

0.66

416

2409

Primary Sclerosing Cholangitis, IBD and UDCA required

184

701

3.05

35.86

18.8

9.3

-0.49

0.85

mmol/l

4.06

162

589

Embolic stroke

421

2260

2.08

35.85

9.3

6.6

1.11

1.02

mmol/l

0.19

344

1811

Sequelae of injuries of head

421

2256

2.06

35.71

13.8

9.1

1.04

0.89

mmol/l

0.27

336

1877

Sequelae of injuries of lower limb

660

4014

1.76

35.63

9.9

8.2

1.05

0.95

mmol/l

0.29

561

3306

Other diseases of hard tissues of teeth

4250

17963

1.26

35.46

7.7

7.4

0.76

0.99

mmol/l

3.18

3534

14652

Other noninfective disorders of lymphatic vessels and lymph nodes

309

1493

2.34

35.41

9.2

8.4

1.26

1.04

mmol/l

0.40

265

1228

Budesonide

907

5931

1.61

35.38

7.9

7.7

0.42

0.77

mmol/l

1.63

736

4838

Septal defects

412

2137

2.05

35.35

16.5

9.9

0.76

0.69

mmol/l

0.14

363

1768

Other and unspecified visual disturbances

781

4966

1.68

35.33

7.4

7.7

0.86

0.94

mmol/l

0.24

635

4085

Sensorineural hearing loss

5844

32940

1.21

35.21

6.6

7.9

1.16

0.91

mmol/l

5.30

4707

27517

Embolic stroke with flimmer

247

1095

2.61

35.20

7.4

6.2

1.28

0.94

mmol/l

0.61

202

877

Malignant neoplasm of oesophagus

266

1226

2.56

35.20

18.5

8.1

1.00

0.98

mmol/l

0.03

242

997

Rheumatism, unspecified

881

5743

1.62

35.19

5.6

7.3

1.48

1.01

mmol/l

3.64

740

4802

Secondary parkinsonism, excluding more controls

224

948

2.72

35.19

5.8

7.0

2.02

0.75

mmol/l

3.51

185

775

Hypercalcemia

392

2080

2.14

35.17

7.5

7.4

1.07

1.03

mmol/l

0.06

327

1698

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

632

3764

1.76

35.14

9.7

9.1

0.92

0.76

mmol/l

0.48

538

3067

Congenital malformations of cardiac chambers and connections

131

6.81

35.06

38.3

18.0

-0.13

0.13

mmol/l

0.18

115

Communicating hydrocephalus

216

914

2.85

34.99

10.4

8.4

1.43

1.06

mmol/l

0.92

174

763

Periapical abscess

3234

25956

1.28

34.98

8.4

0.89

mmol/l

0.02

2695

21601

Olecranon bursitis

528

3061

1.90

34.92

10.8

9.2

0.98

0.89

mmol/l

0.20

449

2522

Hypothermia

199

814

2.99

34.83

9.6

8.8

1.16

0.84

mmol/l

0.37

151

675

Nephrotic syndrome

271

1257

2.49

34.80

11.7

9.5

-0.56

0.89

mmol/l

5.39

222

1054

Diabetic retinopathy

3029

14985

1.32

34.71

10.3

9.0

0.59

0.84

mmol/l

2.20

2497

12295

Cramp and spasm

372

1932

2.14

34.69

6.4

9.6

0.44

0.88

mmol/l

1.32

315

1582

Benign neoplasm: Descending colon

611

3712

1.82

34.50

8.4

7.7

0.77

0.92

mmol/l

0.37

488

3073

Malignant neoplasm of pancreas

575

3418

1.84

34.48

8.6

6.8

0.96

1.13

mmol/l

0.57

503

2785

Mixed disorders of conduct and emotions, excluding more controls

107

295

3.93

34.34

10.3

6.9

0.18

-0.33

mmol/l

0.59

224

Complications of other internal prosthetic devices, implants and grafts

348

1778

2.19

34.22

10.9

6.5

0.82

0.93

mmol/l

0.18

294

1445

Hyperosmolality and hypernatraemia

152

545

3.46

34.22

11.7

6.2

1.61

1.30

mmol/l

0.42

132

430

Car occupant injured in other and unspecified transport accidents

1170

8108

1.50

34.21

8.7

8.1

1.14

0.82

mmol/l

1.81

939

6592

Other disorders of veins

2833

22087

1.30

34.21

7.6

7.4

1.16

0.94

mmol/l

2.14

2460

18318

Obstructive hydrocephalus

153

549

3.41

34.20

12.3

9.4

1.47

0.95

mmol/l

0.89

124

461

Malignant neoplasm of bone and articular cartilage, including Hilmo

182

714

3.05

34.17

10.5

8.6

1.21

1.13

mmol/l

0.10

151

590

Oter anti-inflammatory and antirheumatic agents, non-steroids

1786

7216

1.42

34.17

7.3

8.5

1.07

1.01

mmol/l

0.27

1469

5858

Other diseases of lip and oral mucosa

2895

23015

1.30

34.09

8.2

7.7

0.91

0.94

mmol/l

0.21

2399

19189

Infective dermatitis

837

5453

1.64

34.04

8.3

7.9

1.24

0.92

mmol/l

1.56

659

4476

Primary coxarthrosis, bilateral

2286

17730

1.35

33.97

6.6

7.3

1.00

0.99

mmol/l

0.03

1918

14703

Disorders of magnesium metabolism

103

298

4.75

33.75

12.0

8.1

1.56

1.00

mmol/l

0.52

256

Other congenital malformations of the digestive system

311

1511

2.25

33.73

11.6

9.6

0.51

0.74

mmol/l

0.50

258

1256

Sarcoidosis

943

6318

1.59

33.72

10.2

8.1

1.11

0.97

mmol/l

0.53

781

5200

Malignant neoplasm of breast, HER-positive

1786

9847

1.39

33.60

5.8

6.7

1.09

1.34

mmol/l

2.01

1553

8136

Irritable bowel syndrome

1652

12170

1.40

33.53

6.9

7.2

0.86

0.98

mmol/l

0.62

1402

9986

Malignant neoplasm of breast, ER-positive, including Hilmo

1788

9855

1.39

33.43

5.8

6.7

1.08

1.34

mmol/l

2.03

1554

8142

Urticaria and erythema

2256

17399

1.33

33.40

8.4

7.9

1.00

0.86

mmol/l

1.06

1872

14336

Other strabismus

1318

9337

1.46

33.32

10.1

8.2

1.12

0.83

mmol/l

1.95

1076

7645

Gangrene, not elsewhere classified

102

296

4.72

33.24

9.8

7.3

0.18

0.98

mmol/l

0.93

243

Persons encountering health services in other circumstances

2721

21269

1.30

33.23

7.5

7.3

1.06

0.96

mmol/l

0.61

2245

17326

Maltreatment syndromes

311

1521

2.20

33.15

9.3

10.0

0.62

0.63

mmol/l

0.02

252

1229

Eating disorders

515

2950

1.82

33.12

8.1

8.5

0.96

0.56

mmol/l

1.18

427

2324

Other fall from one level to another

1522

11117

1.42

33.12

9.9

8.4

1.04

0.80

mmol/l

1.56

1267

9087

Other diseases of spinal cord

258

1195

2.47

33.11

10.3

9.2

1.92

1.05

mmol/l

2.74

219

988

Evidence of alcohol involvement determined by blood alcohol level

144

507

3.44

33.09

9.0

9.6

1.04

0.95

mmol/l

0.11

122

425

Inflammatory bowel disease

2041

15569

1.35

33.06

8.8

8.3

0.64

0.86

mmol/l

1.59

1663

12838

Other and unspecified coagulation defects

359

1865

2.11

33.05

11.2

8.5

0.17

0.92

mmol/l

2.64

312

1526

Corns and callosities

527

3096

1.86

33.05

8.1

8.2

1.22

0.96

mmol/l

0.79

429

2568

Other congenital malformations of heart

180

5.64

32.85

25.4

11.3

0.07

0.33

mmol/l

0.27

151

Dermatophytosis, including avohilmo

4632

37969

1.22

32.77

8.1

7.9

0.88

0.89

mmol/l

0.02

3934

31384

Disorders of sclera, cornea, iris and ciliary body

3813

31347

1.25

32.76

7.7

7.9

0.92

0.91

mmol/l

0.04

3133

25980

Retinal vascular occlusion

995

6809

1.57

32.70

7.6

7.0

0.69

1.03

mmol/l

1.49

820

5545

D07AA Corticosteroids, weak (group I)

913

6069

1.57

32.57

7.5

8.5

1.21

0.75

mmol/l

2.58

744

4909

Other obstructive and reflux uropathy

300

1468

2.24

32.46

8.0

7.2

0.53

1.00

mmol/l

1.12

226

1187

In situ neoplasms

2916

23361

1.29

32.45

7.2

7.0

0.56

0.98

mmol/l

7.43

2457

19152

Ptosis of eyelid

892

5981

1.60

32.33

8.1

7.7

0.97

1.00

mmol/l

0.07

757

4935

Specific development disorders of scholastic skills

218

907

2.52

32.25

15.2

11.2

0.75

0.26

mmol/l

0.87

174

740

Coxarthrosis, primary, with hip surgery

3706

28282

1.25

32.14

6.4

7.4

0.90

0.99

mmol/l

0.68

3099

23486

Non-allergic asthma

622

3830

1.75

32.12

7.5

8.5

1.27

0.92

mmol/l

1.49

527

3136

Discitis, unspecified

181

736

3.00

32.05

10.0

8.5

1.29

1.07

mmol/l

0.33

156

617

Thrombocytopenia, unspecified

569

3442

1.80

32.05

10.1

8.3

0.66

0.90

mmol/l

0.67

465

2825

Memory loss

744

4819

1.68

31.97

6.5

7.2

0.88

1.00

mmol/l

0.29

627

3949

Other bursopathies

956

6487

1.56

31.95

7.8

8.1

1.08

0.98

mmol/l

0.32

803

5356

Ovarian cyst

1974

8491

1.37

31.93

6.9

7.2

1.03

0.96

mmol/l

0.35

1613

6977

Evidence of alcohol involvement determined by level of intoxication

102

297

4.21

31.82

10.8

12.3

1.18

0.82

mmol/l

0.37

246

Benign neoplasm: Small intestine

358

1914

2.14

31.67

8.3

7.7

1.02

0.92

mmol/l

0.19

305

1576

L01XE Protein kinase inhibitors

445

2541

1.97

31.66

7.3

7.7

1.16

0.92

mmol/l

0.61

352

2100

Diabetic neuropathy

1044

7272

1.56

31.65

10.1

9.5

0.47

0.73

mmol/l

0.94

865

5940

Retinal vascular disorders

1003

6916

1.55

31.64

7.7

7.0

0.71

1.03

mmol/l

1.35

827

5627

Heart failure and hypertrophic cardiomyopathy

201

870

2.85

31.59

17.8

7.8

0.27

0.96

mmol/l

1.48

165

720

Other infectious diseases

592

3630

1.77

31.53

10.3

7.7

0.71

0.94

mmol/l

0.60

480

2965

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

204

882

2.75

31.37

10.7

7.0

1.31

1.23

mmol/l

0.13

177

731

Polycystic ovarian syndrome, consortium definition

4049

19094

1.24

31.36

7.1

6.8

1.16

0.96

mmol/l

2.66

3358

15680

Fracture of forearm

3756

27760

1.24

31.34

8.0

7.5

1.03

0.97

mmol/l

0.39

3139

22969

Diseases of spleen

183

755

2.93

31.33

13.0

9.4

0.99

0.90

mmol/l

0.10

155

626

Malignant neoplasm of thyroid gland, including Hilmo

466

2666

1.88

31.26

7.3

8.0

1.01

1.15

mmol/l

0.33

390

2186

5-aminosalicylic acid

1266

9039

1.45

31.23

8.8

8.1

0.66

0.74

mmol/l

0.30

1039

7394

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1014

6938

1.54

31.12

6.9

6.2

0.70

1.16

mmol/l

2.98

818

5585

Right ventricular outflow tract obstruction

173

5.33

31.09

30.0

16.0

0.07

0.34

mmol/l

0.26

148

Speech therapy

1860

14180

1.37

31.01

8.0

7.7

0.97

mmol/l

0.02

1527

11748

Other misadventures during surgical and medical care

227

1033

2.58

30.92

14.0

8.0

1.00

1.04

mmol/l

0.05

196

854

Agoraphobia

184

742

2.69

30.86

16.8

9.3

1.29

0.51

mmol/l

1.66

155

605

Carcinoma in situ of colon

284

1421

2.35

30.81

10.0

8.4

0.20

0.93

mmol/l

2.60

250

1186

2519

17168

1.31

30.64

6.2

6.5

0.98

1.00

mmol/l

0.08

2047

14086

Malignant neoplasm of small intestine

217

974

2.63

30.61

6.7

7.5

-0.21

1.03

mmol/l

3.33

183

821

Cluster headache, wide

262

1244

2.31

30.60

8.3

9.0

1.16

0.85

mmol/l

0.70

218

1021

Renal cell carcinoma of kidney

290

1452

2.27

30.58

6.7

6.6

0.16

1.14

mmol/l

3.97

241

1172

Post-traumatic wound infection, not elsewhere classified

241

1123

2.46

30.53

8.8

9.2

0.45

0.91

mmol/l

0.75

201

935

Multiple myeloma, including Hilmo

375

2049

2.04

30.44

7.8

7.0

0.69

1.14

mmol/l

1.08

300

1679

Ulcerative colitis

1570

11681

1.39

30.34

8.6

8.2

0.67

0.86

mmol/l

1.09

1265

9628

Voice disturbances

1819

13853

1.36

30.31

8.0

7.6

0.95

mmol/l

0.02

1570

11462

Diffuse brain injury

252

1183

2.33

30.26

14.6

8.1

1.38

0.68

mmol/l

1.85

210

956

Fracture at wrist and hand level

2318

18140

1.31

30.13

8.6

8.4

0.91

0.86

mmol/l

0.26

1936

15002

Other enthesopathies

1930

14791

1.35

30.12

6.7

8.2

0.83

0.90

mmol/l

0.37

1602

12277

Other disorders of eye and adnexa

923

6279

1.54

30.09

8.5

8.0

0.65

0.90

mmol/l

1.03

765

5137

Diseases of male genital organs

3863

15999

1.25

30.08

8.9

9.6

0.86

0.74

mmol/l

0.97

3161

13327

Monoamine oxidase A inhibitors

772

5068

1.61

30.05

7.9

1.10

0.87

mmol/l

0.89

686

4165

Any dementia, excluding more controls

2921

16155

1.28

29.90

5.2

6.8

1.30

0.91

mmol/l

5.32

2322

13340

Malignant neoplasm of thyroid gland

428

2424

1.90

29.80

7.2

8.1

1.04

1.19

mmol/l

0.33

359

1985

Vitamin deficiency

363

1964

2.03

29.78

9.6

7.9

0.86

0.93

mmol/l

0.10

302

1586

Vitamin deficiency, wide

363

1964

2.03

29.78

9.6

7.9

0.86

0.93

mmol/l

0.10

302

1586

Varicose veins

4429

28061

1.22

29.78

6.8

7.3

1.30

0.94

mmol/l

8.08

3680

23131

Cluster headache, strict

241

1120

2.36

29.71

8.7

9.4

1.01

0.85

mmol/l

0.30

203

924

Migraine without aura and triptan purchases

790

5185

1.58

29.62

7.1

8.2

0.74

0.72

mmol/l

0.05

639

4199

Unspecified jaundice

397

2217

1.96

29.58

10.3

7.8

0.28

0.89

mmol/l

1.89

326

1847

Cardiomyopathy, Hypertrophic obstructive

158

618

2.99

29.52

16.2

7.0

-0.22

0.71

mmol/l

1.66

138

507

Mental retardation

264

1266

2.27

29.48

10.2

11.8

2.16

0.51

mmol/l

6.45

220

1063

Other congenital malformations of the digestive system, including avohilmo

345

1825

2.04

29.31

12.0

9.6

0.54

0.71

mmol/l

0.36

286

1507

Corticotropin deficiency

101

315

4.21

29.25

11.8

9.1

1.24

0.86

mmol/l

0.49

266

Spondyloarthritis

1180

8443

1.46

29.14

7.5

7.7

0.99

0.90

mmol/l

0.34

975

6875

Malignant neoplasm of liver and intrahepatic bile ducts

286

1453

2.24

29.07

11.5

7.2

0.17

1.12

mmol/l

3.54

236

1195

Benign neoplasm: Spinal cord

146

560

3.20

29.05

7.9

10.6

1.26

1.00

mmol/l

0.37

122

473

Drug-induced neutropenia

532

3252

1.78

28.86

9.4

8.2

1.53

0.96

mmol/l

2.80

439

2700

Poisoning by medicine, drug-induced

124

435

3.46

28.79

7.6

9.9

1.83

0.78

mmol/l

1.67

107

366

Other intracranial haemorrhages

300

1559

2.20

28.79

8.9

6.8

0.72

1.04

mmol/l

0.65

246

1261

Manic episode

218

989

2.45

28.78

8.0

9.6

1.88

0.78

mmol/l

3.65

179

838

Ulcerative colitis, NAS

883

6007

1.54

28.76

9.2

8.1

0.63

0.87

mmol/l

0.93

712

4933

Other/unspecified rheumatoid arthritis

894

6132

1.55

28.67

7.7

6.9

1.28

1.05

mmol/l

0.91

729

5035

Examination and encounter for administrative purposes

625

3969

1.69

28.63

7.9

7.6

0.99

0.69

mmol/l

1.25

517

3320

Weight loss

771

5140

1.60

28.57

8.4

7.8

1.09

0.91

mmol/l

0.47

658

4218

Alzheimer’s disease (Late onset), excluding more controls

1130

5186

1.48

28.48

4.6

6.5

1.06

0.70

mmol/l

1.86

902

4232

Speech disturbances, not elsewhere classified

711

4667

1.64

28.47

8.6

7.4

1.33

0.97

mmol/l

1.85

592

3804

Primary adrenocortical insufficiency

113

380

3.69

28.46

11.0

9.0

0.79

1.01

mmol/l

0.21

319

Other disorders of optic [2nd] nerve and visual pathways

467

2764

1.83

28.40

9.1

8.7

0.69

0.87

mmol/l

0.40

366

2273

Amenorrhoea

322

1675

2.02

28.38

9.1

8.2

0.48

0.54

mmol/l

0.09

272

1332

Covid-19 suspected case

1204

8664

1.44

28.32

8.4

7.6

0.71

0.77

mmol/l

0.20

955

7012

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

208

949

2.58

28.31

9.9

7.1

0.41

1.11

mmol/l

1.87

182

781

Collagenous colitis

662

4273

1.66

28.26

8.9

7.4

0.42

0.96

mmol/l

2.38

548

3528

Adult respiratory distress syndrome

139

529

3.26

28.26

25.3

9.5

2.01

0.82

mmol/l

2.38

126

440

Cauda equina syndrome

133

493

3.29

28.12

10.0

9.4

1.98

1.01

mmol/l

2.67

111

413

Acute alcohol intoxication ICD-9

291

1505

2.19

28.04

7.4

8.2

1.55

0.87

mmol/l

1.83

247

1246

Paralytic strabismus

546

3387

1.75

28.00

8.6

7.8

1.06

0.94

mmol/l

0.27

454

2781

Other disorders of bone

1210

8752

1.44

27.99

7.7

8.1

0.73

0.86

mmol/l

0.55

1018

7191

Other shoulder lesions

626

3980

1.66

27.98

6.3

8.2

1.05

0.90

mmol/l

0.47

522

3269

Malignant neoplasm of rectosigmoid junction

173

735

2.84

27.95

8.6

6.9

0.21

1.12

mmol/l

2.14

148

601

Suggestive for eosinophilic asthma

647

4168

1.66

27.84

6.7

8.2

1.23

0.80

mmol/l

2.18

516

3416

Crohn disease

800

5369

1.56

27.82

8.9

8.3

0.47

0.85

mmol/l

1.79

660

4411

Malignant neoplasm of tongue

191

847

2.67

27.81

10.6

7.2

1.30

1.25

mmol/l

0.07

165

704

Conduct disorder

136

499

3.02

27.81

9.7

10.4

0.90

0.52

mmol/l

0.53

111

426

Problems related to social environment

231

1092

2.36

27.80

6.1

7.8

2.24

1.03

mmol/l

3.55

180

889

Mental retardation, wide definition

278

1392

2.17

27.70

9.9

11.6

2.19

0.64

mmol/l

5.91

231

1172

Disorders of speech understanding and production

282

1401

2.15

27.64

9.8

8.8

0.91

0.66

mmol/l

0.45

218

1163

Dronedarone medication

231

1102

2.39

27.61

8.2

6.5

0.86

0.77

mmol/l

0.13

194

909

Specific development disorders of speech and language

346

1802

1.97

27.54

9.2

9.3

0.82

0.61

mmol/l

0.41

271

1467

Asthma mixed form (mode)

296

1519

2.08

27.54

5.5

6.6

1.81

0.32

mmol/l

9.72

251

1232

Gout due to impairment of renal function

134

514

3.40

27.52

8.4

7.9

-0.32

0.74

mmol/l

1.40

109

432

Hypoparathyroidism

293

1528

2.16

27.46

8.3

7.1

1.73

1.04

mmol/l

1.75

254

1270

Localized swelling, mass and lump of skin and subcutaneous tissue

2209

17468

1.30

27.45

7.6

7.9

0.90

0.91

mmol/l

0.05

1853

14408

Other specified/unspecified systemic involvement of connective tissue

398

2271

1.90

27.44

8.2

7.6

1.11

0.95

mmol/l

0.32

335

1860

Open wound of hip and thigh

246

1197

2.28

27.35

10.5

9.6

0.56

0.78

mmol/l

0.36

217

1005

Right bundle-branch block

274

1387

2.17

27.31

11.6

7.0

1.33

0.67

mmol/l

1.53

229

1132

Malignant neoplasm of bone and articular cartilage

108

365

3.76

27.27

11.8

9.1

0.82

1.12

mmol/l

0.35

306

Complex cardiac defects

150

5.58

27.24

39.8

12.6

-0.00

0.81

mmol/l

0.90

126

Bulimia nervosa (incl. atypical)

166

677

2.63

27.05

8.1

8.6

0.63

0.33

mmol/l

0.33

135

519

Follicular cysts of skin and subcutaneous tissue

1257

9232

1.42

26.89

8.1

8.3

0.88

0.89

mmol/l

0.01

1063

7614

Hyperplasia of prostate

2961

13566

1.27

26.86

8.1

9.2

0.90

0.74

mmol/l

1.34

2417

11290

IgA nephropathy (IgA glomerulonephritis)

204

939

2.51

26.83

10.9

10.0

-0.99

0.82

mmol/l

7.08

176

782

Hepatocellular carcinoma

221

1059

2.43

26.63

12.7

7.2

0.15

1.07

mmol/l

3.02

185

867

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2431

23504

0.79

26.52

6.6

7.8

0.89

mmol/l

0.04

1966

19315

Behavioural disorders

133

495

2.97

26.49

9.7

11.0

0.95

0.42

mmol/l

0.85

109

421

Malignant neoplasm of retroperitoneum and peritoneum

300

4.16

26.46

9.9

5.8

0.17

1.54

mmol/l

3.25

253

Exposure to smoke, fire and flames

213

1002

2.43

26.44

9.3

10.5

1.39

0.87

mmol/l

1.04

171

845

Barrett oesophagus

418

2465

1.87

26.38

9.7

8.4

0.70

0.86

mmol/l

0.34

364

2051

Causalgia

134

510

3.06

26.36

7.2

10.3

2.21

0.89

mmol/l

3.60

113

423

Gonarthrosis, primary, with knee surgery

4494

29757

1.20

26.30

6.3

7.8

1.01

0.96

mmol/l

0.42

3744

24752

Disorders of optic nerve and visual pathways

608

3903

1.65

26.28

8.6

8.4

0.59

0.86

mmol/l

0.85

472

3205

Primary biliary cholangitis, wide definition

191

861

2.54

26.23

13.3

7.1

-0.66

0.95

mmol/l

4.64

158

728

Alcoholic gastritis

148

602

2.98

26.21

12.0

8.5

0.64

0.74

mmol/l

0.10

130

507

malignant neoplasm of male genital organs, including Hilmo

2244

10664

1.31

26.20

7.0

8.8

0.42

0.95

mmol/l

7.89

1839

8764

Carbimazole or st.post thyroidectomy, condition for graves disease

1278

9438

1.41

26.09

8.9

7.6

0.85

0.95

mmol/l

0.35

1061

7840

Abnormal findings on examination of urine, without diagnosis

346

1933

1.98

26.07

9.7

8.3

0.18

0.86

mmol/l

1.75

267

1584

Behavioural syndromes associated with physiological disturbances and physical factors

6467

38128

1.16

26.06

7.6

8.1

0.81

0.92

mmol/l

1.42

5452

31477

Other skin changes

1468

11108

1.38

26.04

7.6

7.5

1.26

0.98

mmol/l

2.16

1213

9096

Vitamin B12 deficiency anaemia

779

5302

1.56

25.97

7.5

6.6

0.82

1.00

mmol/l

0.49

615

4312

Injury of urinary and pelvic organs

184

822

2.59

25.97

11.7

10.6

1.07

0.90

mmol/l

0.22

151

682

Exposure to unspecified smoke, fire and flames

105

359

3.67

25.91

6.1

11.3

1.18

0.76

mmol/l

0.53

304

Other disorders of central nervous system

116

416

3.34

25.82

7.8

9.2

0.45

1.07

mmol/l

0.76

343

Congenital malformations of pulmonary and tricuspid valves

159

5.02

25.77

25.3

14.6

0.32

0.77

mmol/l

0.44

137

Spondylopathies in diseases classified elsewhere

132

514

3.16

25.67

7.4

7.7

0.90

1.02

mmol/l

0.11

105

429

Secondary and unspecified malignant neoplasm of lymph nodes

586

3760

1.66

25.67

7.5

7.7

1.13

1.09

mmol/l

0.10

486

3086

Squamous cell neoplasms and carcinomas of the skin

808

5557

1.55

25.67

6.9

6.1

0.53

1.17

mmol/l

4.49

657

4478

Conjunctivitis (acute, non atopic)

1768

13632

1.33

25.65

7.9

8.2

1.04

0.85

mmol/l

1.27

1476

11215

Drug-induced hypoglycaemia without coma

158

667

2.81

25.64

11.1

7.9

0.72

1.03

mmol/l

0.31

136

550

Myocardial infarction, unclassifiable

1782

12376

1.34

25.63

8.3

6.6

0.83

0.94

mmol/l

0.46

1370

9989

Other disorders starting during childhood or adolecense, excluding more controls

183

755

2.42

25.60

19.3

10.0

0.12

0.01

mmol/l

0.14

152

597

Faecal incontinence

634

4139

1.63

25.56

7.0

6.4

0.94

1.05

mmol/l

0.31

526

3446

Hemiplegia

370

2112

1.91

25.55

9.4

7.9

0.98

1.02

mmol/l

0.05

312

1715

Hallux valgus (acquired)

2139

12076

1.30

25.46

6.3

7.8

1.02

1.06

mmol/l

0.20

1804

9962

Persons with potential health hazards related to communicable diseases

1947

15103

1.31

25.40

10.9

8.4

0.45

0.70

mmol/l

2.19

1664

12235

Panhypopituitarism

167

729

2.71

25.22

11.7

9.8

0.58

0.80

mmol/l

0.38

130

600

Congenital malformations of the nervous system

150

612

2.73

25.12

11.9

10.9

0.29

0.54

mmol/l

0.25

111

506

Cyst of kidney

580

3759

1.68

25.06

9.3

7.9

0.65

0.97

mmol/l

1.04

494

3109

Unspecified event, undetermined intent

193

887

2.44

25.03

9.3

10.4

0.71

0.79

mmol/l

0.09

169

739

Other hammer toe(s) (acquired)

1184

7918

1.42

24.89

6.7

7.4

1.08

1.16

mmol/l

0.30

1003

6559

Other and unspecified tonsillitis

1776

11419

1.32

24.77

9.1

9.3

0.69

0.63

mmol/l

0.25

1458

9349

Hypertrophic cardiomyopathy

349

1996

1.95

24.71

14.4

8.4

0.16

0.88

mmol/l

2.29

293

1647

Molar incisor enamel hypoplasia, with caries

144

4.97

24.67

36.7

17.4

-1.53

-0.34

mmol/l

1.46

120

malignant neoplasm of male genital organs

2195

10510

1.30

24.64

6.9

8.8

0.43

0.95

mmol/l

7.44

1799

8631

Urticaria

1728

13415

1.32

24.46

8.6

8.0

0.93

0.86

mmol/l

0.34

1434

11037

Fibroblastic disorders

1675

12999

1.33

24.44

8.1

7.8

0.79

0.89

mmol/l

0.50

1392

10712

Car occupant injured in noncollision transport accident

251

1282

2.15

24.42

10.3

9.7

1.24

0.92

mmol/l

0.56

198

1057

Papulosquamous disorders

2710

22217

1.25

24.39

8.4

7.9

1.06

0.91

mmol/l

1.08

2281

18468

Other congenital malformations

481

2962

1.71

24.34

11.6

9.3

0.39

0.77

mmol/l

1.15

404

2420

Brachial plexus disorders

525

3306

1.67

24.28

6.0

8.9

1.33

0.81

mmol/l

3.37

410

2721

Personal history of other diseases and conditions

518

3220

1.66

24.26

11.5

6.9

0.36

0.70

mmol/l

1.04

440

2565

Drug-induced cataract

199

946

2.42

24.24

13.6

9.4

0.67

0.85

mmol/l

0.25

168

802

Benign neoplasm: Duodenum

239

1226

2.27

24.22

8.8

7.8

1.02

0.95

mmol/l

0.11

205

1008

Small fibre neuropathy

264

1396

2.15

24.19

12.4

8.5

1.11

0.86

mmol/l

0.39

224

1159

Type1 diabetes, definitions combined, early onset

286

1507

1.98

24.07

12.8

10.6

-0.66

0.57

mmol/l

3.69

229

1222

Other orthopaedic follow-up care

386

2264

1.83

24.04

7.7

7.3

0.77

0.92

mmol/l

0.26

338

1861

Pruritus

754

5160

1.53

24.03

8.2

7.2

0.93

0.96

mmol/l

0.07

613

4207

Assault by unspecified means

147

608

2.71

24.02

12.9

11.6

0.28

0.96

mmol/l

0.90

123

508

Intracranial and intraspinal abscess and granuloma

127

504

3.13

23.97

13.4

9.1

0.75

0.88

mmol/l

0.12

103

430

Non-follicular lymphoma

740

5090

1.56

23.93

9.4

7.6

1.16

0.97

mmol/l

0.62

604

4183

Malignant neoplasm of other connective and soft tissue

216

1065

2.31

23.91

8.9

7.9

0.61

1.02

mmol/l

0.70

180

870

Biomechanical lesions, not elsewhere classified

390

2313

1.84

23.89

7.3

7.8

0.14

0.99

mmol/l

4.66

334

1900

Impingement syndrome of shoulder

1607

12442

1.34

23.88

7.4

8.5

1.07

0.87

mmol/l

1.40

1321

10423

Endometroid carcinoma of ovary, including Hilmo

323

3.76

23.87

9.1

5.5

0.87

1.33

mmol/l

0.54

273

Abnormal weight loss

704

4794

1.57

23.69

8.7

7.8

1.01

0.93

mmol/l

0.17

599

3941

Dermatitis due to substances taken internally

380

2231

1.84

23.67

9.5

7.9

1.28

0.95

mmol/l

0.83

307

1827

Secondary thrombocytopenia

128

512

3.06

23.62

13.0

8.1

1.18

0.82

mmol/l

0.40

110

433

Vitamin D deficiency

143

591

2.74

23.58

8.4

9.3

1.05

0.74

mmol/l

0.30

113

485

Malignant neoplasm of other and unspecified parts of tongue

145

615

2.83

23.51

10.3

7.0

1.28

1.34

mmol/l

0.09

126

509

Congenital malformations of trachea and bronchus

104

376

3.49

23.44

14.1

9.8

1.92

0.89

mmol/l

2.51

326

Respiratory disorders in diseases classified elsewhere

137

568

2.92

23.40

11.6

8.8

1.11

1.06

mmol/l

0.04

122

485

Left hemicolectomy

215

1076

2.33

23.34

12.2

7.7

0.29

1.08

mmol/l

2.08

191

897

Portal vein thrombosis

151

652

2.73

23.34

12.7

8.6

0.59

0.87

mmol/l

0.38

130

546

127

493

2.81

23.21

9.0

6.9

0.96

0.62

mmol/l

0.54

106

383

Drug-induced osteoporosis with pathological fracture

160

715

2.67

23.15

13.1

6.7

1.72

1.09

mmol/l

1.00

138

601

Erythema intertrigo

220

1106

2.26

23.12

7.0

7.3

1.79

1.08

mmol/l

1.51

177

912

Other disorders of bladder

890

6356

1.48

23.08

7.6

7.8

1.08

0.92

mmol/l

0.51

724

5153

Acute suppurative otitis media

1272

8860

1.37

23.06

9.2

8.9

0.39

0.67

mmol/l

1.52

1015

7118

Cushing syndrome

109

404

3.26

23.04

10.5

7.7

1.22

0.93

mmol/l

0.26

339

Malignant neoplasm of renal pelvis, including Hilmo

126

508

3.05

22.95

9.8

6.5

-0.97

1.09

mmol/l

6.16

101

413

Enthesopathies of lower limb, excluding foot

1384

10532

1.35

22.92

7.4

8.3

1.02

0.81

mmol/l

1.30

1155

8777

Epidural haemorrhage

304

3.59

22.91

11.4

8.7

2.09

0.63

mmol/l

2.58

247

Viral warts

610

4036

1.59

22.91

8.9

8.4

0.77

0.88

mmol/l

0.28

496

3322

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2100

16585

1.28

22.89

8.6

8.5

0.83

0.77

mmol/l

0.35

1770

13553

Ventricular septal defect, a heart condition

144

601

2.66

22.86

27.3

11.5

0.22

0.31

mmol/l

0.11

130

500

Respiratory conditions due to other external agents

188

899

2.43

22.85

8.2

7.2

1.61

1.03

mmol/l

1.10

165

746

Acute appendicitis

4571

36516

1.18

22.84

8.2

0.84

0.87

mmol/l

0.23

3809

30171

Paraplegia, diplegia of upper limbs

189

902

2.41

22.83

10.1

8.6

1.60

0.86

mmol/l

1.52

154

743

ILD and respiratory illness in diseases classified elsewhere

226

4.64

22.83

13.2

8.4

1.25

1.04

mmol/l

0.16

197

Sequelae of intentional self-harm, assault and events of undetermined intent

185

4.50

22.77

14.0

11.0

1.22

1.00

mmol/l

0.16

151

Malnutrition

189

903

2.40

22.77

14.6

8.5

1.64

1.09

mmol/l

0.86

148

736

Encephalitis

226

1147

2.20

22.76

11.2

9.4

1.08

0.92

mmol/l

0.21

186

954

Need for immunization against other single viral diseases

167

760

2.55

22.76

12.6

10.0

-0.98

0.88

mmol/l

5.57

146

639

Dislocation, sprain and strain of joint and ligaments of hip

298

1661

1.98

22.70

7.2

7.8

1.41

0.91

mmol/l

1.53

244

1365

Papillary adenocarcinoma of thyroid gland

318

1793

1.91

22.66

8.2

8.0

1.04

1.23

mmol/l

0.37

268

1472

Other and unspecified injuries of lower leg

485

3055

1.68

22.64

8.3

1.06

0.85

mmol/l

0.71

415

2480

Exclusion endpoint for clefts

134

545

2.75

22.60

18.4

11.4

0.38

0.66

mmol/l

0.29

118

457

Abnormal blood-pressure reading, without diagnosis

288

1573

1.96

22.60

6.7

7.5

0.73

0.88

mmol/l

0.28

243

1306

Hidradenitis suppurativa

220

1096

2.16

22.59

9.1

9.9

1.10

0.76

mmol/l

0.59

183

904

Primary hyperparathyroidism

776

5431

1.51

22.58

5.7

7.3

0.73

1.06

mmol/l

1.66

645

4515

Postprocedural disorders of nervous system

371

2176

1.80

22.56

5.9

8.8

1.18

0.78

mmol/l

1.53

309

1764

Haemolytic anaemias

273

1485

2.04

22.53

11.4

8.9

0.75

0.97

mmol/l

0.40

223

1224

Other and unspecified paralytic syndromes

131

538

2.88

22.51

7.0

8.0

0.47

0.87

mmol/l

0.44

114

455

Adhesive capsulitis of shoulder

1110

8224

1.41

22.50

7.7

8.1

1.12

0.94

mmol/l

0.86

924

6828

Other follicular disorders

462

2882

1.70

22.49

8.6

8.9

0.95

0.80

mmol/l

0.33

379

2357

Trigger finger

941

6789

1.44

22.39

7.8

8.2

0.93

mmol/l

0.02

781

5649

Early lumbar disc prolapse, operated

473

2951

1.67

22.38

7.5

9.8

1.11

0.59

mmol/l

2.44

387

2448

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

239

1237

2.11

22.37

9.6

9.8

0.47

0.83

mmol/l

0.80

218

1025

Symptoms and signs involving emotional state

205

1003

2.24

22.37

8.4

8.8

0.66

0.90

mmol/l

0.38

174

822

Other secondary coxarthrosis

268

1453

2.05

22.37

7.5

8.6

1.38

0.96

mmol/l

1.08

227

1204

Cholangitis (primary sclerosing, PSC), with reimbursement 202

146

627

2.66

22.36

15.7

10.9

0.00

0.90

mmol/l

1.68

124

532

Other (seronegative) rheumatoid arthritis, wide

1279

9707

1.37

22.22

7.9

7.3

1.19

1.00

mmol/l

1.00

1074

8034

Diffuse large B-cell lymphoma, helper endpoint

370

2209

1.83

22.19

10.3

7.2

1.11

1.19

mmol/l

0.12

296

1818

Diffuse large B-cell lymphoma, including Hilmo

370

2209

1.83

22.19

10.3

7.2

1.11

1.19

mmol/l

0.12

296

1818

Diffuse large B-cell lymphoma

370

2209

1.83

22.19

10.3

7.2

1.11

1.19

mmol/l

0.12

296

1818

Malignant neoplasm of breast, ER-negative, including Hilmo

1174

8189

1.38

22.18

6.4

0.95

1.34

mmol/l

2.96

1023

6773

Lack of expected normal physiological development

248

3.35

22.18

21.9

12.5

-0.45

mmol/l

0.00

204

Gingival hyperplasia

275

1506

2.02

22.11

11.3

9.7

0.09

0.88

mmol/l

2.25

235

1254

Acute appendicitis, no complications

3455

29009

1.21

22.04

7.9

8.4

0.84

0.85

mmol/l

0.02

2875

23943

Malignant neoplasm of other and unspecified parts of biliary tract

152

678

2.65

21.98

10.5

7.0

0.51

1.16

mmol/l

1.38

129

556

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

109

413

3.13

21.94

9.1

7.7

1.07

0.96

mmol/l

0.12

350

207

4.78

21.94

13.9

8.4

1.16

0.94

mmol/l

0.16

182

Atrial septal defect, secundum type

186

883

2.32

21.90

18.7

10.4

0.94

0.51

mmol/l

0.85

171

733

Irregular menses

2366

14410

1.25

21.90

7.3

7.1

0.87

0.88

mmol/l

0.03

1938

11787

Trigeminal neuralgia

402

2448

1.76

21.88

6.4

8.2

1.01

1.06

mmol/l

0.10

338

2012

Thyrotoxicosis

1577

12309

1.32

21.84

8.7

7.3

1.06

0.97

mmol/l

0.37

1303

10185

Other secondary gonarthrosis

403

2471

1.77

21.81

7.7

8.7

1.06

0.97

mmol/l

0.18

343

2052

Redundant prepuce, phimosis and paraphimosis

1437

10913

1.34

21.78

9.1

9.5

0.95

0.74

mmol/l

1.24

1202

9112

Osteopathy in diseases classified elsewhere

298

3.78

21.78

6.3

7.8

0.47

0.89

mmol/l

0.43

253

Abnormal findings on diagnostic imaging of central nervous system

335

1944

1.86

21.77

9.5

8.4

0.92

0.79

mmol/l

0.22

275

1593

Non-Hodgkin lymphoma, all

353

2092

1.85

21.77

10.5

7.1

1.03

1.15

mmol/l

0.17

284

1698

Other and unspecified immunodeficiencies with predominantly antibody defects

106

398

3.15

21.69

18.6

10.4

0.72

0.98

mmol/l

0.23

333

Other encephalitis

213

1078

2.21

21.67

11.7

9.5

1.14

0.87

mmol/l

0.39

176

893

Wet age-related macular degeneration

1430

10690

1.35

21.57

6.4

6.2

1.02

1.09

mmol/l

0.24

1157

8697

Other mycoses, not elsewhere classified/unspecified

156

5.49

21.57

24.3

8.6

1.48

0.69

mmol/l

0.56

132

424

2612

1.72

21.57

5.9

6.3

1.77

1.14

mmol/l

3.13

357

2076

Hyperfunction of pituitary gland

285

1575

1.94

21.53

9.1

8.7

1.08

0.85

mmol/l

0.45

234

1285

Acute pharyngitis

799

5558

1.47

21.53

8.7

9.2

0.69

0.64

mmol/l

0.14

666

4577

Unspecified nephritic syndrome

185

896

2.36

21.50

8.3

8.9

0.65

0.91

mmol/l

0.41

155

753

Fissure and fistula of anal and rectal regions

1507

11716

1.32

21.42

8.3

7.6

0.91

0.92

mmol/l

0.03

1250

9668

322

3.60

21.41

7.4

7.1

2.55

0.95

mmol/l

5.19

262

Emotional disorders and disorders of social functioning with onset specific to childhood

200

949

2.16

21.40

10.4

10.6

0.35

0.02

mmol/l

0.52

162

738

Gastrojejunal ulcer

126

523

2.88

21.36

10.9

6.7

0.37

0.97

mmol/l

0.76

102

430

Impotence

469

3007

1.70

21.36

8.4

9.5

0.87

0.76

mmol/l

0.25

371

2487

Injury of nerves and spinal cord at neck level

195

969

2.31

21.31

11.5

9.2

2.04

0.92

mmol/l

3.08

166

806

Herpesviral [herpes simplex] infections

736

5134

1.50

21.30

7.6

7.9

1.19

0.94

mmol/l

0.97

594

4213

Other and unspecified disorders of adult personality and behaviour

138

4.95

21.24

6.8

11.0

0.49

0.88

mmol/l

0.33

118

Drug-induced osteoporosis

130

551

2.84

21.22

11.7

7.3

0.52

0.98

mmol/l

0.46

115

470

Chromophobe cell carcinoma of kidney

243

4.37

21.21

7.5

7.6

-0.25

1.34

mmol/l

3.29

208

Chronic nephritic syndrome

294

1668

1.94

21.18

13.0

8.8

-0.25

0.95

mmol/l

4.85

246

1371

Amyloidosis

191

941

2.30

21.18

8.4

7.1

0.86

1.14

mmol/l

0.40

157

746

Dislocation, sprain and strain of joints and ligaments at neck level

851

6079

1.45

21.17

7.1

8.5

1.07

0.75

mmol/l

1.69

697

4954

Viral haemorrhagic fevers, not elsewhere classified/unspecified

535

3521

1.62

21.15

7.3

8.9

1.15

0.93

mmol/l

0.80

420

2896

Colitis, primary sclerosing

111

430

2.98

21.13

15.7

11.4

-0.77

0.94

mmol/l

3.40

364

Generalized epilepsy

249

1330

2.01

21.01

7.7

9.6

0.99

0.77

mmol/l

0.35

203

1091

Mixed hyperlipidaemia

294

1667

1.93

21.00

11.0

7.9

0.78

0.98

mmol/l

0.34

251

1366

Chronic tubulo-interstitial nephritis

250

1343

2.02

20.96

6.7

6.9

-0.16

1.16

mmol/l

4.08

201

1122

Other general symptoms and signs

289

1596

1.90

20.96

11.0

8.2

1.45

0.66

mmol/l

2.58

246

1301

Mucosal proctocolitis

756

5311

1.48

20.89

9.2

8.5

0.34

0.83

mmol/l

2.43

629

4364

Algoneurodystrophy

208

1050

2.16

20.87

8.2

8.8

0.83

0.91

mmol/l

0.12

177

871

Diseases of appendix

4906

38197

1.17

20.86

8.3

8.2

0.85

0.88

mmol/l

0.21

4090

31572

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

331

1918

1.80

20.84

8.0

8.1

1.00

0.73

mmol/l

0.73

272

1545

Malignant neoplasm of prostate, including Hilmo

2164

10341

1.27

20.76

6.8

8.7

0.42

0.94

mmol/l

7.39

1768

8491

Other neurotic disorders

345

2054

1.82

20.74

7.1

8.1

0.83

0.93

mmol/l

0.15

292

1694

Polymyalgia rheumatica

1034

7716

1.41

20.69

6.8

6.6

1.26

1.03

mmol/l

1.16

890

6314

Appendicitis, broad definition

4860

37980

1.17

20.63

8.3

8.2

0.85

0.88

mmol/l

0.21

4051

31386

Disturbance of activity and attention

499

3123

1.60

20.62

9.1

9.5

0.62

0.28

mmol/l

1.13

378

2433

Other and unspecified hydrocephalus

162

759

2.46

20.61

10.5

8.3

1.70

1.08

mmol/l

1.66

137

628

Superficial injury of forearm

616

4176

1.54

20.54

7.6

8.3

0.73

0.82

mmol/l

0.20

515

3380

Arthropod-borne viral fevers and viral haemorrhagic fevers

649

4471

1.54

20.52

7.2

8.6

1.17

0.92

mmol/l

1.14

518

3677

Lesion of radial nerve

280

1577

1.94

20.51

10.0

9.0

1.67

1.00

mmol/l

1.86

242

1301

Hypersensitivity pneumonitis due to organic dust

147

667

2.59

20.43

8.8

8.2

0.97

0.94

mmol/l

0.03

121

559

Other specified congenital malformation syndromes affecting multiple systems

110

428

2.89

20.43

17.9

11.7

0.18

0.61

mmol/l

0.42

364

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2164

15225

1.25

20.43

6.6

7.4

0.92

0.94

mmol/l

0.10

1763

12591

Psoriasis

1878

15100

1.28

20.42

8.7

8.2

1.07

0.89

mmol/l

1.10

1603

12525

Thyrotoxicosis, other and/or unspecified

1235

9418

1.35

20.39

9.3

7.4

0.97

0.98

mmol/l

0.03

1017

7784

Multiple myeloma and malignant plasma cell neoplasms

393

2448

1.76

20.37

7.7

7.4

0.66

0.91

mmol/l

0.51

314

2006

Lyme disease

1438

18349

0.76

20.37

7.0

8.0

0.47

0.94

mmol/l

6.01

1265

15275

Lyme disease, including avohilmo

1438

18349

0.76

20.37

7.0

8.0

0.47

0.94

mmol/l

6.01

1265

15275

Other renal tubulo-interstitial diseases

160

739

2.39

20.35

11.1

6.7

0.10

1.25

mmol/l

2.51

133

607

Congenital malformations of the musculoskeletal system, not elsewhere classified

102

383

3.00

20.34

7.2

8.3

0.77

0.86

mmol/l

0.09

316

Mild mental retardation

168

792

2.34

20.33

9.6

10.5

2.61

0.50

mmol/l

5.90

139

666

Malignant neoplasm of breast, HER-negative

1085

7789

1.38

20.33

6.4

0.99

1.37

mmol/l

2.57

940

6439

Flat foot [pes planus] (acquired)

607

4118

1.55

20.31

7.0

8.5

1.43

0.96

mmol/l

2.98

505

3442

Internal derangement of knee

2402

19595

1.24

20.25

7.9

8.5

0.95

0.93

mmol/l

0.06

2011

16163

Disorders of vestibular function (Vertigo)

3326

27533

1.20

20.23

6.3

7.4

1.02

0.97

mmol/l

0.27

2759

22886

Congenital malformations of the respiratory system

146

659

2.55

20.22

15.0

9.6

1.58

0.75

mmol/l

2.50

133

557

Non-small cell lung cancer, squamous

373

2281

1.76

20.15

7.5

6.4

1.88

1.07

mmol/l

4.08

320

1814

Motor disorders, excluding more controls

218

3.53

20.14

29.7

13.9

-0.62

-0.09

mmol/l

0.47

185

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1065

4925

1.38

20.13

6.9

7.4

-0.11

0.52

mmol/l

5.24

794

3809

Pure hyperglyceridaemia

182

895

2.29

20.13

13.2

8.0

1.07

1.08

mmol/l

0.02

148

721

Pyoderma gangrenosum

265

3.67

20.05

9.6

9.9

0.14

1.00

mmol/l

1.07

220

Xerosis cutis

161

764

2.45

20.00

6.5

8.3

1.58

1.10

mmol/l

1.04

120

643

Assault by other specified means

283

3.42

19.99

13.3

12.6

1.06

1.18

mmol/l

0.11

230

Lichen simplex chronicus and prurigo

451

2896

1.67

19.97

9.2

7.7

0.81

0.96

mmol/l

0.31

365

2376

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1956

15827

1.27

19.95

7.9

8.4

1.11

0.87

mmol/l

2.15

1650

13077

Other peripheral vascular diseases

517

3410

1.60

19.95

6.4

7.3

0.96

0.97

mmol/l

0.01

427

2792

Late syphilis

128

553

2.75

19.94

10.6

9.0

1.18

0.93

mmol/l

0.25

116

464

Benign neoplasm of other and unspecified intrathoracic organs

110

445

3.02

19.93

10.9

7.8

0.87

0.78

mmol/l

0.08

372

Adenocarcinoma and papillary adenocarcinoma of stomach

231

1239

2.06

19.88

9.7

6.6

0.79

1.07

mmol/l

0.44

200

996

Inflammatory diseases of female pelvic organs

3397

19690

1.20

19.83

7.2

6.8

1.02

0.99

mmol/l

0.16

2791

16239

Other obstetric conditions, not elsewhere classified

1097

5119

1.37

19.83

6.9

7.4

-0.07

0.54

mmol/l

5.28

823

3974

Pleural plaque with presence of asbestos

616

4265

1.56

19.82

5.4

7.4

1.61

0.84

mmol/l

4.85

505

3416

Systemic atrophies primarily affecting the central nervous system

332

1990

1.83

19.81

5.8

7.7

3.07

0.91

mmol/l

16.48

284

1638

Diabetic retinopathy, strict definition

1357

9401

1.35

19.81

12.6

9.3

0.50

0.73

mmol/l

1.05

1110

7673

Congenital malformations of the respiratory system, including avohilmo

156

729

2.44

19.79

14.5

9.4

1.56

0.83

mmol/l

2.15

143

622

Cardiomyopathy in other diseases

186

4.36

19.78

6.1

4.8

0.58

1.05

mmol/l

0.33

150

Spirochaetal infections, other/unspecified, including avohilmo

1455

18469

0.77

19.75

7.0

8.0

0.48

0.94

mmol/l

5.71

1280

15381

Inflammatory disease of uterus

665

4595

1.50

19.74

6.9

7.0

0.61

0.81

mmol/l

0.70

549

3736

Nail disorders

545

3645

1.58

19.72

8.5

0.91

0.93

mmol/l

0.02

453

3003

Assault by blunt object

113

457

2.82

19.66

9.9

10.8

0.80

0.86

mmol/l

0.04

385

Other epidermal thickening

328

1956

1.82

19.60

7.9

8.9

1.28

0.88

mmol/l

1.27

255

1621

Diabetic maculopathy

998

7073

1.42

19.58

10.7

9.5

0.38

0.73

mmol/l

1.59

813

5757

Other spirochaetal diseases

1460

18503

0.77

19.55

7.0

8.0

0.49

0.94

mmol/l

5.62

1286

15402

Malignant neoplasm of prostate

2119

10202

1.27

19.54

6.7

8.7

0.42

0.93

mmol/l

7.04

1729

8374

Panniculitis affecting regions of neck and back

246

1347

1.98

19.49

9.2

8.5

1.12

1.04

mmol/l

0.12

198

1131

Hyperkinetic disorders

527

3379

1.56

19.49

9.0

10.1

0.62

0.25

mmol/l

1.29

402

2642

Brain mixed glioma

14.57

19.48

5.0

9.4

0.41

1.19

mmol/l

0.35

Viral infections of the central nervous system, including avohilmo

485

3172

1.62

19.47

7.7

8.5

0.94

0.91

mmol/l

0.06

411

2596

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

178

865

2.22

19.47

15.6

11.7

0.65

0.58

mmol/l

0.07

154

726

Sleep disorders

6091

37140

1.14

19.46

7.5

8.0

0.80

0.93

mmol/l

1.70

5120

30645

Autoimmune hepatitis, wide definition

311

1827

1.83

19.44

10.5

7.5

0.47

0.89

mmol/l

0.68

250

1524

Mixed disorders of conduct and emotions

107

416

2.75

19.36

10.3

10.6

0.18

0.02

mmol/l

0.15

329

Iridocyclitis

1453

11419

1.31

19.23

7.7

7.9

0.80

0.92

mmol/l

0.56

1173

9460

Other Crohn's disease

410

2585

1.68

19.17

8.4

8.5

0.01

0.89

mmol/l

3.55

339

2127

Other spirochaetal diseases, including avohilmo

1483

18709

0.77

19.11

6.9

8.0

0.50

0.93

mmol/l

5.38

1306

15577

Open wound of thorax

127

552

2.64

19.11

7.4

10.0

1.46

0.77

mmol/l

1.14

455

Unknown and unspecified causes of morbidity

404

2538

1.67

19.03

5.4

7.5

0.92

0.85

mmol/l

0.15

338

2099

Bronchitis, not specified as acute or chronic

536

3594

1.57

19.02

7.7

8.2

1.14

0.63

mmol/l

2.28

443

2917

Ingrowing nail

346

2102

1.76

19.01

7.5

9.2

0.56

0.89

mmol/l

0.69

292

1737

Complications following infusion, transfusion and therapeutic injection

125

542

2.66

19.00

10.6

6.8

1.29

0.93

mmol/l

0.45

111

448

Disorders of plasma-protein metabolism, not elsewhere classified

221

3.87

18.92

14.4

9.4

1.70

1.01

mmol/l

0.84

184

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

109

438

2.75

18.87

7.8

8.0

1.00

0.78

mmol/l

0.26

357

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

114

479

2.83

18.85

10.5

9.3

1.37

1.15

mmol/l

0.27

396

Personal history of certain other diseases

102

395

2.81

18.80

11.7

7.2

0.73

0.45

mmol/l

0.29

316

Superficial injury of ankle and foot

679

4761

1.48

18.80

9.0

8.3

0.85

0.76

mmol/l

0.23

555

3855

Nonhereditary hypogammaglobulinemia

358

3.11

18.79

15.0

10.7

0.50

1.02

mmol/l

0.43

305

Heterophoria

454

2943

1.62

18.74

8.8

8.4

1.25

0.87

mmol/l

1.83

373

2403

Hypoplasia of dental enamel

177

3.98

18.72

31.2

20.1

-1.12

-0.48

mmol/l

0.69

152

Complications of genitourinary prosthetic devices, implants and grafts

186

944

2.18

18.72

9.6

6.7

0.41

0.92

mmol/l

0.85

154

764

Arteriovenous malformation of cerebral vessels

103

415

2.98

18.66

13.0

9.9

1.02

0.84

mmol/l

0.22

354

Pregnancy hypertension

1886

13617

1.26

18.64

6.6

7.4

0.92

mmol/l

0.01

1533

11178

Late syphilis, including avohilmo

145

679

2.47

18.56

9.9

8.8

1.22

0.89

mmol/l

0.40

130

566

Myasthenia gravis

154

741

2.42

18.54

8.2

7.8

1.44

1.00

mmol/l

0.66

133

614

Encephalopathy

394

3.05

18.47

13.4

8.0

0.88

0.86

mmol/l

0.02

325

Somnolence

105

425

2.86

18.43

11.7

9.1

1.53

0.89

mmol/l

0.79

355

Salpingitis and oophoritis

955

7123

1.39

18.43

8.3

7.0

1.32

1.06

mmol/l

1.16

795

5985

3227

24830

1.20

18.40

6.5

7.0

0.80

1.02

mmol/l

2.59

2655

20464

Phakomatoses, not elsewhere classified

349

3.07

18.38

7.0

11.4

0.06

1.00

mmol/l

1.10

293

Cluster headache, strict, including avohilmo

294

1722

1.82

18.37

7.7

9.7

0.98

0.87

mmol/l

0.22

241

1426

Chronic rhinitis, nasopharyngitis and pharyngitis

1997

16322

1.25

18.36

8.7

8.1

0.84

0.85

mmol/l

0.03

1709

13535

Other specified/unspecified hearing loss

666

4713

1.49

18.35

7.3

7.5

0.89

0.92

mmol/l

0.07

580

3858

Cerebral palsy

106

427

2.76

18.35

8.8

12.6

0.61

0.64

mmol/l

0.03

356

Seropositive rheumatoid arthritis, strict definition

968

7261

1.39

18.35

8.4

7.7

1.15

0.97

mmol/l

0.64

833

6017

Personal history of malignant neoplasm

493

3273

1.58

18.33

7.8

6.6

0.39

1.12

mmol/l

5.57

441

2723

Cluster headache, wide,, including avohilmo

315

1883

1.78

18.29

7.4

9.4

1.11

0.89

mmol/l

0.54

256

1554

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

341

3.15

18.28

9.3

9.1

0.92

1.11

mmol/l

0.21

287

Benign neoplasm: Bronchus and lung

126

564

2.66

18.25

8.1

7.4

1.51

0.91

mmol/l

0.96

110

479

Amyloidosis, other/unspecified

159

776

2.34

18.24

8.0

7.5

0.65

1.10

mmol/l

0.66

129

622

Other surgical follow-up care

217

1164

2.01

18.24

9.8

7.6

0.21

0.84

mmol/l

1.39

179

950

Malignant neoplasm of gum, including Hilmo

379

3.08

18.22

15.4

6.4

1.29

1.37

mmol/l

0.09

321

Viral infections of the central nervous system

450

2942

1.62

18.17

7.5

8.4

1.03

0.92

mmol/l

0.24

382

2419

Coxibs

1904

8048

1.27

18.11

6.6

8.6

0.75

0.93

mmol/l

1.06

1538

6482

170

845

2.21

18.01

10.0

10.5

1.98

0.95

mmol/l

4.21

140

709

Emotional disorders starting during childhood or adolescence

184

916

2.08

17.97

10.9

11.6

0.20

0.04

mmol/l

0.20

148

710

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

109

451

2.70

17.94

9.3

10.1

0.44

0.69

mmol/l

0.24

383

Neovascular glaucoma

310

1870

1.80

17.93

7.5

0.37

0.96

mmol/l

1.31

244

1517

Benign neoplasm of urinary organs

361

2267

1.73

17.92

6.6

7.5

0.47

0.95

mmol/l

1.77

300

1868

Other disorders of binocular vision

333

3.01

17.92

4.7

8.7

1.85

0.99

mmol/l

1.39

272

Any prescribed medicine buy

8.61

17.91

5.6

7.1

-0.41

1.14

mmol/l

0.62

Monoplegia

132

603

2.53

17.90

6.2

7.7

0.20

1.03

mmol/l

1.46

112

505

Injuries to the wrist and hand

6997

41608

1.13

17.87

8.5

7.9

0.87

0.89

mmol/l

0.16

5812

34359

Acute laryngitis and tracheitis

558

3734

1.52

17.86

10.9

8.5

1.10

0.63

mmol/l

2.10

464

2998

Kela reimbursement Agammaglobulinemia (D80-84)

243

3.52

17.84

27.3

11.5

0.43

0.98

mmol/l

0.43

203

Aspergillosis, including avohilmo

373

3.11

17.82

9.7

7.5

1.57

0.72

mmol/l

1.16

311

Benign neoplasm: Kidney

280

1659

1.86

17.57

6.2

7.5

0.48

1.00

mmol/l

1.66

235

1384

Maze procedure for atrial fibrillation

213

4.33

17.55

20.1

7.7

-0.33

0.76

mmol/l

1.66

180

Other diseases of blood and blood-forming organs

486

3269

1.58

17.52

9.8

8.5

0.93

0.96

mmol/l

0.05

418

2701

Diseases of inner ear

3839

31914

1.17

17.50

6.6

7.5

1.02

0.97

mmol/l

0.33

3173

26526

Infarction of spleen

293

3.54

17.49

14.9

7.6

1.44

1.02

mmol/l

0.41

252

Acute generalized exanthematous pustulosis

305

1839

1.79

17.49

10.1

8.1

0.99

0.89

mmol/l

0.17

250

1514

Burns and corrosions of multiple and unspecified body regions

169

851

2.21

17.49

13.4

11.7

0.93

0.88

mmol/l

0.06

141

727

Complications peculiar to reattachment and amputation

261

3.56

17.49

10.0

6.4

0.77

0.94

mmol/l

0.13

214

Generalized skin eruption due to drugs and medicaments

270

1576

1.86

17.48

10.2

8.0

1.14

0.86

mmol/l

0.52

217

1294

Eosinophilic disease (BM)

102

414

2.76

17.48

9.9

6.5

1.13

0.17

mmol/l

1.51

335

Other specified/unspecified dorsopathies

235

1315

1.94

17.46

9.6

8.1

1.02

1.08

mmol/l

0.08

204

1093

Other meningitis

120

529

2.56

17.34

10.6

9.2

1.12

0.92

mmol/l

0.22

442

Toxic effect of alcohol

162

808

2.25

17.34

10.1

9.8

0.75

0.88

mmol/l

0.13

135

671

Acquired absence of organs, not elsewhere classified

113

491

2.70

17.33

10.1

7.8

0.42

0.87

mmol/l

0.66

408

Other disorders of electrolyte and fluid balance, not elsewhere classified

346

3.09

17.31

15.6

7.6

2.01

1.06

mmol/l

0.97

281

Benign neoplasm: Spinal meninges

109

471

2.82

17.30

4.6

6.6

0.59

1.04

mmol/l

0.58

401

Persistent delusional disorders

506

3434

1.56

17.28

8.7

7.9

1.86

0.88

mmol/l

6.17

432

2812

Gestational [pregnancy-induced] hypertension

1061

8061

1.34

17.24

6.3

7.4

0.99

0.78

mmol/l

1.04

847

6533

Meralgia paraesthetica

244

1391

1.91

17.22

7.0

9.4

1.20

0.95

mmol/l

0.45

214

1156

Diabetes insipidus

329

3.13

17.21

10.5

10.6

0.65

0.88

mmol/l

0.20

283

Papilloedema, unspecified

159

786

2.23

17.18

9.8

9.5

0.28

0.79

mmol/l

0.69

116

656

Hypothyroidism, strict autoimmune, 3 medication purchases required

5538

33014

1.14

17.17

7.4

7.5

1.00

0.88

mmol/l

1.44

4565

27125

106

449

2.75

17.08

8.8

1.33

0.93

mmol/l

0.48

377

Cardiomyopathies, Secondary/extrinsic

213

3.70

17.07

20.6

6.4

0.94

0.56

mmol/l

0.20

174

Urolithiasis

2308

19329

1.23

17.05

7.6

8.0

0.57

0.86

mmol/l

2.89

1931

15908

Keratitis

2300

19217

1.22

17.05

7.8

8.0

1.03

0.90

mmol/l

0.84

1895

15885

Abnormal findings on antenatal screening of mother

286

1678

1.76

17.04

4.2

7.7

1.37

0.23

mmol/l

6.97

175

1273

Meningitis

321

1972

1.74

17.04

9.5

9.1

1.14

0.95

mmol/l

0.42

275

1623

Paranoid personality disorder

133

617

2.41

17.02

7.6

9.9

1.64

0.81

mmol/l

1.45

114

514

Benign thyroid growths and nodules

2134

16452

1.23

17.00

6.4

7.0

1.25

1.05

mmol/l

1.79

1814

13681

Aspergillosis

365

3.07

16.91

9.8

7.3

1.57

0.71

mmol/l

1.15

305

Entropion and trichiasis of eyelid

669

4821

1.47

16.85

6.8

6.9

1.05

0.98

mmol/l

0.18

564

3887

Calculus of kidney and ureter

2117

17620

1.23

16.75

7.6

8.0

0.55

0.87

mmol/l

3.28

1773

14496

Other mycoses, not elsewhere classified/unspecified, including avohilmo

143

691

2.33

16.68

16.2

9.4

0.78

0.87

mmol/l

0.08

122

584

Benign neoplasm: Brain, infratentorial

208

3.82

16.65

7.7

11.1

0.46

0.86

mmol/l

0.35

178

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

215

3.86

16.63

10.6

8.1

1.28

1.20

mmol/l

0.06

184

Benign intracranial hypertension

212

3.44

16.63

10.3

12.1

0.10

0.59

mmol/l

0.37

167

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

226

1282

1.96

16.54

7.1

6.5

0.69

1.02

mmol/l

0.42

175

1052

Multiple myeloma

226

1282

1.96

16.54

7.1

6.5

0.69

1.02

mmol/l

0.42

175

1052

Glaucoma secondary to other eye disorders

311

1919

1.76

16.53

7.5

7.9

0.38

0.91

mmol/l

1.12

245

1574

1729

13192

1.26

16.52

5.8

6.3

1.07

1.06

mmol/l

0.03

1414

10785

Other inflammation of eyelid

933

7070

1.37

16.47

7.1

7.9

0.95

0.94

mmol/l

0.03

769

5841

Mouth breathing

2595

21972

1.21

16.42

8.0

8.8

1.04

0.84

mmol/l

2.14

2198

18318

Acquired haemolytic anaemia

194

1053

2.06

16.41

12.8

8.6

0.60

1.01

mmol/l

0.80

159

867

Hypotension due to drugs

143

705

2.38

16.39

10.5

7.2

1.41

1.08

mmol/l

0.44

120

582

Acute nasopharyngitis (common cold)

707

5087

1.43

16.37

8.2

9.4

0.88

0.85

mmol/l

0.08

573

4283

Insomnia

5882

36553

1.13

16.32

7.5

8.0

0.77

0.93

mmol/l

2.44

4938

30175

Secondary polycythaemia

190

1025

2.07

16.32

9.5

9.8

1.88

0.90

mmol/l

1.89

158

846

Dislocation, sprain and strain of joints and ligaments of thorax

238

1367

1.88

16.25

6.0

9.0

0.83

0.97

mmol/l

0.20

197

1129

Neuroendocrine tumor and carcinoma of pancreas

245

3.53

16.15

9.1

7.2

1.25

1.01

mmol/l

0.19

203

Anoxic brain damage

127

599

2.47

16.14

15.4

8.9

0.39

1.04

mmol/l

0.76

101

488

Schizotypal disorder

141

680

2.26

16.10

7.9

10.7

2.45

0.80

mmol/l

4.32

113

570

Other/unspecified synovitis and tenosynovitis

698

5075

1.43

16.01

7.9

8.0

0.92

0.97

mmol/l

0.13

571

4163

Acetic acid derivatives and related substances

1893

7989

1.25

15.96

6.8

8.6

0.69

0.94

mmol/l

1.70

1543

6432

Brain mixed glioma, helper endpoint

11.28

15.95

5.0

8.7

0.41

1.41

mmol/l

0.61

Crohn's disease NAS

380

2463

1.63

15.92

7.8

8.5

0.41

0.90

mmol/l

1.25

320

2024

Other or unspecified immunodeficiency

104

5.10

15.90

6.7

8.3

0.55

1.43

mmol/l

0.62

Glaucoma

4206

31430

1.16

15.89

6.6

7.4

0.96

0.98

mmol/l

0.08

3385

26135

Nummular dermatitis

591

4203

1.48

15.89

8.9

8.0

0.88

0.91

mmol/l

0.07

500

3450

Acute bronchiolitis

255

1334

1.80

15.85

11.5

10.7

0.89

0.27

mmol/l

1.39

214

1074

Pedestrian injured in transport accident

447

3008

1.57

15.85

8.6

8.4

0.95

0.98

mmol/l

0.05

379

2468

Striking against or struck by other objects

2035

16890

1.23

15.84

8.9

8.8

0.89

0.78

mmol/l

0.58

1728

13906

Polyarthritis, unspecified

255

1507

1.83

15.84

8.4

8.7

0.77

0.92

mmol/l

0.23

209

1243

Foreign body in alimentary tract

368

2383

1.65

15.80

9.8

8.8

1.26

0.86

mmol/l

1.14

317

1965

Colitis, primary sclerosing, strict definition

317

2.98

15.78

16.1

12.9

-0.62

0.99

mmol/l

3.06

265

Other specified/unspecified spondylopathies

194

1064

2.02

15.77

6.5

7.5

1.50

1.03

mmol/l

0.91

167

890

Cytomegaloviral pneumonitis

7.80

15.72

15.7

9.2

0.90

1.31

mmol/l

0.22

Dependent personality disorder

143

706

2.26

15.70

8.6

8.2

1.82

0.93

mmol/l

1.57

119

601

Arnold-Chiari syndrome

194

3.51

15.68

16.4

8.6

0.01

0.86

mmol/l

0.53

154

Tuberculosis, IBD comorbidity

496

3425

1.53

15.63

7.8

6.8

1.30

0.96

mmol/l

1.13

421

2780

Excessive, frequent and irregular menstruation

1990

8733

1.24

15.61

7.5

7.2

1.08

0.94

mmol/l

0.74

1607

7150

Third [oculomotor] nerve palsy

157

811

2.21

15.58

10.7

7.7

1.15

1.08

mmol/l

0.08

134

678

Thrombotic microangiopathy

222

3.60

15.58

12.4

9.6

0.26

0.84

mmol/l

0.57

185

Superficial injury of wrist and hand

1161

9095

1.31

15.57

8.9

8.5

0.92

0.78

mmol/l

0.62

965

7445

Syphilis

193

1061

2.01

15.54

9.7

10.2

0.87

0.94

mmol/l

0.08

172

895

Syphilis, including avohilmo

193

1061

2.01

15.54

9.7

10.2

0.87

0.94

mmol/l

0.08

172

895

Endometroid carcinoma of ovary

223

3.63

15.54

11.1

5.3

0.59

1.54

mmol/l

1.16

193

Other disorders of prostate

291

1803

1.77

15.47

5.6

8.2

0.94

0.70

mmol/l

0.51

244

1472

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

120

552

2.38

15.46

9.2

9.6

0.22

0.85

mmol/l

1.07

463

Injuries involving multiple body regions

246

1447

1.83

15.40

13.7

9.1

0.93

0.89

mmol/l

0.06

205

1191

Psoriatic and enteropathic arthropathies

684

4989

1.42

15.39

7.8

8.7

1.02

0.86

mmol/l

0.49

582

4120

Burns and corrosions

816

6119

1.38

15.36

9.6

8.9

1.10

0.84

mmol/l

1.08

675

5020

Other immunodeficiencies

346

2.86

15.33

8.6

9.3

0.98

0.75

mmol/l

0.20

289

Neuroendocrine tumor and carcinoma of small intestine

127

613

2.41

15.27

5.6

7.1

-0.14

1.13

mmol/l

2.21

108

505

Mental and behavioural disorders due to hallucinogens

124

4.35

15.26

5.4

13.3

0.70

0.51

mmol/l

0.11

105

Spondylopathies (FG)

751

5558

1.40

15.26

7.2

8.7

0.87

0.82

mmol/l

0.14

616

4537

Other acute viral hepatitis

420

2.66

15.25

16.8

11.9

1.72

0.85

mmol/l

1.49

355

Secondary parkinsonism+Parkinsonism in other disease

229

1338

1.90

15.24

5.7

8.4

2.05

0.97

mmol/l

2.83

189

1098

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

256

3.26

15.22

7.2

9.2

1.27

1.11

mmol/l

0.14

216

Atrioventricular septal defect

117

4.73

15.20

18.8

14.9

0.52

1.11

mmol/l

0.41

Benign paroxysmal vertigo

1988

16603

1.23

15.15

6.5

7.4

1.01

1.04

mmol/l

0.14

1671

13797

Other congenital malformations of nervous system

225

3.26

15.13

17.2

8.5

0.47

0.92

mmol/l

0.25

182

Oesophageal obstruction

273

1672

1.78

15.10

10.8

8.1

1.25

0.97

mmol/l

0.46

235

1371

Viral warts, including avohilmo

1234

9787

1.29

15.03

8.1

8.4

0.74

0.82

mmol/l

0.32

1034

8021

Cerebral oedema

6.67

15.02

17.5

7.8

1.32

0.98

mmol/l

0.20

Sequelae of injuries of upper limb

602

4325

1.45

15.02

8.9

8.6

1.20

0.92

mmol/l

1.12

499

3569

Ocular pain

494

3422

1.51

14.98

7.5

8.3

0.71

0.91

mmol/l

0.59

402

2805

Prurigo nodularis

194

1085

1.99

14.94

9.4

8.1

0.44

1.08

mmol/l

1.12

164

891

Impetigo

253

1505

1.78

14.93

7.9

9.2

1.24

0.72

mmol/l

1.48

214

1228

Open wound of shoulder and upper arm

148

753

2.17

14.90

9.1

8.9

0.73

0.77

mmol/l

0.04

120

624

Fistulae involving female genital tract

129

627

2.32

14.90

8.3

7.4

1.27

1.14

mmol/l

0.16

104

527

Chronic hepatitis, not elsewhere classified

230

1345

1.85

14.88

10.4

9.0

0.23

1.04

mmol/l

2.07

187

1123

Personal history of medical treatment

383

2.75

14.85

13.3

7.6

1.28

0.89

mmol/l

0.41

306

Secondary parkinsonism

224

1311

1.89

14.85

5.8

8.3

2.02

0.98

mmol/l

2.60

185

1083

Skin changes due to chronic exposure to nonionizing radiation

3036

23812

1.18

14.82

6.5

6.9

0.80

1.03

mmol/l

2.72

2496

19634

Glaucoma suspect

2578

22052

1.20

14.82

6.6

7.3

1.16

1.00

mmol/l

1.37

2060

18380

Metatarsalgia

564

4009

1.46

14.80

7.3

7.9

0.84

0.94

mmol/l

0.27

471

3317

Other ill-defined and unspecified causes of mortality

697

5173

1.42

14.70

6.2

7.2

2.22

0.93

mmol/l

15.83

522

4180

Other retinal artery occlusion

202

1154

1.96

14.70

7.9

7.5

0.58

1.04

mmol/l

0.71

166

933

Any dementia

3142

18835

1.18

14.68

5.1

6.7

1.31

0.95

mmol/l

4.84

2484

15536

Other congenital malformations of upper alimentary tract

282

3.20

14.65

6.1

10.3

1.60

0.79

mmol/l

1.22

245

Infective bursitis

227

1336

1.87

14.65

9.5

9.3

1.16

0.95

mmol/l

0.33

185

1099

Erectile dysfunction

621

4544

1.46

14.62

17.2

8.1

0.55

0.79

mmol/l

0.82

488

3703

Convalescence

317

2014

1.67

14.58

15.1

6.9

1.52

0.96

mmol/l

1.77

270

1650

Vascular dementia (mixed)

186

1041

2.01

14.53

6.2

6.3

1.51

1.13

mmol/l

0.49

148

836

Hypertrophic disorders of skin

311

1965

1.66

14.48

8.0

8.2

0.64

0.88

mmol/l

0.55

247

1607

Bell's palsy

729

5432

1.39

14.47

8.1

8.2

0.94

0.89

mmol/l

0.12

584

4456

Malignant neoplasm of adrenal gland, including Hilmo

235

3.30

14.45

7.1

9.3

0.42

1.12

mmol/l

0.63

202

Simple and mucopurulent chronic bronchitis

268

1641

1.74

14.42

6.7

7.7

1.42

0.55

mmol/l

2.88

224

1330

Divergent concomitant strabismus

429

2916

1.54

14.39

9.5

8.5

1.46

0.87

mmol/l

2.42

339

2388

Other congenital malformations, including avohilmo

661

4837

1.41

14.39

10.2

8.6

0.33

0.79

mmol/l

1.95

558

3948

Other ulcerative colitis

351

2292

1.62

14.36

8.6

8.5

0.81

0.85

mmol/l

0.06

266

1884

Benign neoplasm: Liver/bile ducts

175

953

2.00

14.33

9.0

8.1

0.45

0.85

mmol/l

0.75

151

789

Anankastic personality disorder

209

1193

1.86

14.32

7.2

10.0

1.01

0.74

mmol/l

0.51

171

975

Malignant melanoma

989

7707

1.33

14.29

6.9

7.5

0.74

1.11

mmol/l

2.24

832

6279

Systemic sclerosis (FG)

162

863

2.06

14.28

11.1

8.9

0.86

1.00

mmol/l

0.18

138

715

Psoriasis vulgaris

1182

9411

1.30

14.28

8.7

8.4

0.99

0.90

mmol/l

0.34

996

7776

Tuberculosis, wide, including avohilmo

514

3636

1.49

14.27

7.7

6.8

1.29

0.97

mmol/l

1.04

436

2943

Seborrhoeic keratosis

1740

14443

1.24

14.27

6.8

7.3

0.89

0.98

mmol/l

0.43

1439

11968

Other and unspecified psoriasis

461

3198

1.53

14.27

10.5

8.9

1.12

0.97

mmol/l

0.36

406

2639

Other disorders of binocular movement

139

699

2.16

14.27

7.7

9.1

0.95

0.78

mmol/l

0.22

104

577

Other and unspecified intracranial injuries

218

1272

1.86

14.27

8.2

1.02

0.92

mmol/l

0.11

182

1036

Unspecified contracted kidney

217

3.51

14.26

6.7

8.0

0.11

0.88

mmol/l

0.66

185

Other injuries of lower limb, level unspecified

374

2.76

14.23

7.9

10.0

0.10

1.03

mmol/l

1.27

312

Liposarcoma, including Hilmo

414

2.70

14.20

10.0

6.9

0.27

1.10

mmol/l

1.37

338

Other hearing loss

2121

17358

1.21

14.20

6.7

7.0

0.94

0.93

mmol/l

0.06

1757

14261

Other and unspecified urticaria

1067

8377

1.31

14.19

9.1

7.9

1.07

0.86

mmol/l

1.21

883

6871

Benign neoplasm: Liver

156

821

2.08

14.18

8.4

0.47

0.83

mmol/l

0.62

134

680

Congenital malformations of gallbladder, bile ducts and liver

337

2.84

14.18

15.0

9.3

-0.03

0.82

mmol/l

1.44

290

Specific developmental disorder of motor function

279

2.83

14.17

29.7

16.0

-0.62

-0.04

mmol/l

0.54

239

Necrosis of pulp, including avohilmo

3612

31318

1.16

14.16

8.6

8.4

0.92

0.85

mmol/l

0.52

2977

25984

Vascular dementia

753

5467

1.39

14.14

5.2

5.9

1.59

0.96

mmol/l

3.74

583

4381

Biological medication for rheuma

924

7123

1.33

14.12

9.1

8.7

0.79

0.80

mmol/l

0.03

780

5858

Burns classified according to extent of body surface involved

363

2.77

14.07

18.2

11.0

0.08

0.75

mmol/l

0.75

311

Seronegative rheumatoid arthritis

711

5301

1.39

14.07

8.0

7.7

1.16

0.98

mmol/l

0.59

607

4369

Nonpyogenic thrombosis of intracranial venous system

307

2.90

14.05

16.7

10.3

0.93

0.99

mmol/l

0.05

262

Tuberculosis, wide

507

3589

1.49

14.03

7.7

6.8

1.30

0.97

mmol/l

1.11

431

2906

Benign neoplasm of middle ear and respiratory system

537

3844

1.47

14.00

8.6

8.2

1.22

0.93

mmol/l

1.12

451

3151

Other and specified injuries of hip and thigh

173

950

2.01

14.00

6.2

7.8

1.41

0.93

mmol/l

1.00

143

782

Other disorders affecting eyelid function

398

2.72

14.00

8.0

7.4

1.97

0.87

mmol/l

2.76

333

Renal tubulo-interstitial disorders in diseases classified elsewhere

365

2.78

14.00

8.2

7.6

-0.24

1.07

mmol/l

1.13

311

Anterior Iridocyclitis

1235

9902

1.28

13.98

7.7

8.0

0.85

0.95

mmol/l

0.36

997

8181

Myelodysplastic syndrome, including Hilmo

230

1375

1.83

13.97

7.2

6.5

0.98

1.18

mmol/l

0.27

187

1113

Lactose intolerance, other/unspecified

158

835

2.03

13.96

12.6

8.5

0.71

1.02

mmol/l

0.39

130

678

Other enthesopathy of foot (+metatarsalgia)

595

4311

1.43

13.95

7.1

8.0

0.81

0.92

mmol/l

0.30

494

3570

Other diseases of gallbladder

313

2014

1.66

13.95

8.7

6.9

0.79

0.96

mmol/l

0.34

264

1657

Rash and other nonspecific skin eruption

595

4324

1.44

13.92

8.7

7.9

0.66

0.97

mmol/l

0.99

506

3544

IBD patients in KELA-register

1283

10318

1.27

13.90

8.5

8.6

0.47

0.83

mmol/l

2.53

1052

8493

Actinic keratosis

2953

23345

1.18

13.87

6.5

6.9

0.80

1.02

mmol/l

2.41

2428

19231

Hydrocele

857

6592

1.35

13.87

8.5

8.7

0.80

0.70

mmol/l

0.29

686

5415

Malignant melanoma, including Hilmo

1102

8735

1.30

13.86

6.8

7.4

0.70

1.12

mmol/l

2.98

924

7127

Exposure to other and unspecified forces of nature

225

3.33

13.81

15.2

9.1

0.10

0.69

mmol/l

0.53

188

Acute and subacute iridocyclitis

1166

9303

1.29

13.79

7.7

8.0

0.85

0.93

mmol/l

0.29

947

7690

Thyroiditis, ILD-related definition

622

4548

1.42

13.77

9.2

7.6

0.90

0.91

mmol/l

0.01

519

3738

Lactose intolerance

174

953

1.95

13.74

12.4

8.3

0.78

0.93

mmol/l

0.18

143

774

Malignant neoplasm of cervix uteri, including Hilmo

145

750

2.09

13.74

6.3

1.23

mmol/l

0.01

112

605

Delayed milestone in childhood

303

2.66

13.66

38.1

19.1

-0.61

-0.30

mmol/l

0.29

259

Use of rotigotine

102

474

2.54

13.63

5.5

7.9

1.71

0.88

mmol/l

1.51

402

Adenocarcinoma of pancreas

220

1309

1.83

13.59

7.9

7.1

0.58

1.08

mmol/l

1.46

197

1082

Convergence insufficiency and excess

357

2.63

13.58

5.9

7.9

1.21

0.84

mmol/l

0.39

289

Other factor of the environment

102

470

2.47

13.57

7.8

7.9

1.85

0.81

mmol/l

1.78

389

Contact with heat and hot substances

330

2155

1.62

13.54

8.2

9.4

1.01

0.85

mmol/l

0.31

272

1765

Acquired absence of limb

409

2.64

13.53

14.5

7.3

1.66

0.84

mmol/l

1.36

329

Infection due to other mycobacteria, including avohilmo

127

637

2.22

13.45

9.7

7.2

1.66

0.94

mmol/l

0.92

111

526

Retinal detachments and breaks

2547

21953

1.19

13.44

7.8

7.5

0.57

0.99

mmol/l

5.61

2124

18193

Chronic lymphocytic leukaemia, helper endpoint

225

1353

1.82

13.43

10.4

6.9

0.93

1.09

mmol/l

0.27

184

1110

Chronic lymphocytic leukaemia

225

1353

1.82

13.43

10.4

6.9

0.93

1.09

mmol/l

0.27

184

1110

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

225

1353

1.82

13.43

10.4

6.9

0.93

1.09

mmol/l

0.27

184

1110

Occupational exposure to risk-factors

247

1522

1.77

13.42

5.4

9.0

1.73

0.77

mmol/l

6.18

198

1251

Central retinal artery occlusion

194

1127

1.93

13.41

9.4

7.4

0.29

1.08

mmol/l

1.65

157

912

Other specified/unspecified soft tissue disorders

317

2059

1.63

13.40

7.7

7.4

1.41

1.09

mmol/l

0.89

263

1674

Other specified/unspecified necrotizing vasculopathies

118

582

2.33

13.39

8.0

8.3

0.82

0.90

mmol/l

0.08

481

Epileptic seizures related to alcohol

262

3.23

13.35

8.5

9.4

0.87

mmol/l

0.00

219

Enteropathic arthropathies

146

766

2.07

13.34

6.4

11.3

0.62

0.94

mmol/l

0.44

116

628

Other abnormal findings in urine

138

721

2.17

13.33

10.8

7.8

1.00

mmol/l

0.00

103

602

Malignant melanoma of skin, including Hilmo

906

7046

1.33

13.32

6.7

7.6

0.65

1.12

mmol/l

3.08

760

5756

Habit and impulse disorders

101

461

2.40

13.31

7.3

10.6

0.91

0.88

mmol/l

0.03

383

Anxious personality disorder

105

485

2.34

13.31

8.0

9.9

1.70

0.66

mmol/l

2.12

393

Other specified disorders of muscle

201

1169

1.86

13.29

12.6

9.0

1.05

1.09

mmol/l

0.05

161

965

Other specified disorders of kidney and ureter

228

1377

1.80

13.28

9.9

8.3

0.49

0.97

mmol/l

1.17

204

1139

Dislocation, sprain and strain of joints and ligaments of knee

3629

28893

1.15

13.25

7.7

8.3

0.93

0.83

mmol/l

0.99

3032

23869

Ehlers-Danlos syndrome

208

3.15

13.25

7.3

8.8

1.04

0.95

mmol/l

0.09

168

Normal-pressure hydrocephalus

377

2572

1.58

13.17

4.1

6.6

1.07

1.00

mmol/l

0.13

303

2106

Suppurative and unspecified otitis media

1828

13529

1.21

13.08

8.9

8.3

0.63

0.75

mmol/l

0.57

1453

10948

Primary biliary cholangitis (PBC)

152

818

2.04

13.07

13.8

6.7

-0.10

0.98

mmol/l

2.00

125

693

Isolated proteinuria

197

1148

1.87

13.07

9.0

8.5

-0.50

0.83

mmol/l

3.22

159

953

Pituitary-dependent Cushing's disease

107

4.79

13.07

11.3

8.1

0.27

1.32

mmol/l

1.20

Intentional self-harm by jumping from a high place

143

3.79

13.06

21.7

12.0

1.11

0.69

mmol/l

0.28

118

Other and unspecified injuries of abdomen, lower back and pelvis

110

527

2.31

13.05

8.4

9.8

0.76

0.86

mmol/l

0.11

431

Contusion of other and unspecified parts of foot

275

1729

1.67

13.05

8.1

9.1

0.74

0.81

mmol/l

0.14

217

1419

Restless leg syndrome

895

6971

1.33

13.04

7.2

7.8

0.86

1.00

mmol/l

0.51

769

5743

Other and unspecified vascular occlusions

690

5208

1.39

13.01

7.5

6.9

0.84

1.01

mmol/l

0.44

572

4228

Other diseases of peritoneum

288

1848

1.67

12.99

6.6

7.8

1.06

1.10

mmol/l

0.06

220

1508

Benign neoplasm of mouth and pharynx

699

5275

1.38

12.98

7.8

0.98

0.97

mmol/l

0.03

593

4315

Liposarcoma

307

2.91

12.86

10.4

7.1

0.20

0.99

mmol/l

1.09

252

Alzheimer’s disease (Atypical or mixed)

869

6695

1.34

12.79

4.0

5.7

1.38

1.04

mmol/l

1.66

653

5350

Early lumbar disc prolapse operation

488

3464

1.45

12.74

7.8

9.8

1.16

0.72

mmol/l

1.90

400

2853

Ill-defined and unknown causes of mortality

740

5660

1.37

12.72

6.1

7.2

2.17

0.95

mmol/l

15.22

558

4584

Viral agents as the cause of diseases classified to other chapters

150

811

2.03

12.72

11.8

9.7

0.55

0.81

mmol/l

0.35

132

672

Reactive arthropathies, FINNGEN

403

2776

1.52

12.69

8.9

8.8

0.70

0.85

mmol/l

0.33

332

2268

Otitis externa, unspecified

660

4942

1.38

12.67

7.1

8.2

0.68

0.82

mmol/l

0.45

533

4043

Other/unspecified disorders of vestibular function

293

1904

1.65

12.64

5.7

7.9

1.05

1.02

mmol/l

0.04

231

1575

Embedded teeth, including avohilmo

386

2623

1.52

12.63

8.2

8.8

0.95

0.63

mmol/l

0.84

304

2085

Isolated patent ductus arteriosus

240

2.95

12.60

16.9

17.2

-0.54

0.43

mmol/l

1.17

198

Otitis externa

1390

11415

1.25

12.56

7.3

8.1

0.83

0.88

mmol/l

0.17

1151

9400

Recurrent and persistent haematuria

314

2.79

12.53

7.9

9.4

0.50

0.91

mmol/l

0.28

259

Erosion of teeth , including avohilmo

1435

11807

1.24

12.50

10.6

8.2

0.96

0.78

mmol/l

1.00

1206

9673

Rare circulating lymphoid malignancy, including Hilmo

200

1184

1.83

12.50

8.7

8.6

1.04

0.90

mmol/l

0.21

154

974

Crohn's disease of large intestine

289

1866

1.63

12.45

9.6

8.6

0.10

0.88

mmol/l

2.31

242

1541

Gastrointestinal stromal tumor and sarcoma

108

532

2.36

12.44

7.5

6.9

0.08

1.08

mmol/l

1.91

447

Viral agents as the cause of diseases classified to other chapters, including avohilmo

165

924

1.94

12.44

12.3

9.5

0.46

0.87

mmol/l

0.70

143

762

Inflammatory bowel disease, strict (require KELA)

1283

10450

1.26

12.43

8.5

8.6

0.47

0.82

mmol/l

2.42

1052

8595

Accidental poisoning by and exposure to other gases and vapours

194

3.46

12.43

2.9

12.6

0.66

0.83

mmol/l

0.11

167

Myotonic disorders

254

2.97

12.42

9.4

8.9

1.69

0.99

mmol/l

0.68

216

IBD (strict) with PSC

282

2.81

12.41

15.1

10.3

-0.81

0.61

mmol/l

2.34

232

Peritonsillar abscess

1133

9101

1.27

12.41

8.7

8.6

1.01

0.72

mmol/l

2.10

938

7473

Burns and corrosions of external body surface, specified by site

632

4721

1.39

12.36

9.3

8.9

1.05

0.81

mmol/l

0.76

521

3871

Autonomic disorders

166

934

1.93

12.36

8.0

8.3

1.34

1.05

mmol/l

0.40

136

770

Injury of nerves and spinal cord at thorax level

183

3.50

12.36

14.8

8.4

1.61

1.01

mmol/l

0.48

156

Superficial injury of shoulder and upper arm

731

5580

1.35

12.31

5.8

7.9

0.90

0.89

mmol/l

0.01

615

4550

Disorders of brain, other and unspecified

367

2.62

12.31

10.1

8.8

1.25

1.01

mmol/l

0.21

302

Bruxism

107

516

2.25

12.31

6.8

10.5

1.04

0.87

mmol/l

0.22

426

Hypertrophic scar

279

1789

1.64

12.29

8.1

8.3

0.56

0.87

mmol/l

0.72

222

1458

Erectile dysfunction, exclusion

148

4.02

12.28

19.8

13.6

1.00

0.47

mmol/l

0.25

126

Systemic sclerosis

162

908

1.95

12.27

11.1

7.9

0.86

1.06

mmol/l

0.29

138

756

Sicca syndrome [Sjögren]

501

3619

1.45

12.27

7.8

7.2

0.96

1.00

mmol/l

0.08

419

2977

Osteonecrosis due to drugs

132

703

2.16

12.25

9.4

7.8

1.55

1.00

mmol/l

0.82

115

600

Allergic urticaria

440

3098

1.48

12.25

7.8

8.3

0.49

0.89

mmol/l

1.25

371

2529

Malignant neoplasm of ureter, including Hilmo

392

2.64

12.24

7.4

6.8

-0.88

1.16

mmol/l

3.47

324

Other and unspecified vasculitis limited to skin

174

1000

1.91

12.23

6.2

8.5

1.46

1.00

mmol/l

0.65

142

822

Carcinoma in situ of endometrium

192

3.53

12.20

3.7

6.4

1.24

1.45

mmol/l

0.27

168

Crohn's disease of small intestine

386

2659

1.52

12.16

8.2

8.4

0.33

0.85

mmol/l

1.58

316

2195

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

148

813

2.02

12.16

10.8

8.3

1.51

1.05

mmol/l

0.80

134

672

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

151

833

2.00

12.16

7.8

8.5

0.47

0.86

mmol/l

0.46

129

690

Other specified and unspecified disorders of eye and adnexa

242

1514

1.71

12.15

11.0

8.1

0.23

0.88

mmol/l

1.40

212

1239

Motor disorders

309

2.60

12.13

29.7

18.1

-0.62

-0.12

mmol/l

0.44

262

Drug-induced thyroiditis

5.05

12.13

16.9

6.4

0.62

0.52

mmol/l

0.05

Disorders of tooth development and eruption

886

5618

1.31

12.12

8.5

8.0

0.76

0.89

mmol/l

0.42

727

4560

Melanocytic naevi of trunk

727

5561

1.35

12.11

7.9

8.2

0.63

0.84

mmol/l

0.65

608

4540

Anorexia (incl.atypical)

261

1646

1.64

12.08

6.0

8.7

1.35

0.59

mmol/l

1.63

219

1305

Ehlers-Danlos syndrome, including avohilmo

253

2.80

12.06

8.4

8.2

1.34

1.15

mmol/l

0.16

205

Infection due to other mycobacteria

119

608

2.18

12.05

10.1

7.1

1.86

0.96

mmol/l

1.23

104

504

Other disorders of white blood cells

355

2423

1.55

12.05

9.9

8.6

0.90

0.88

mmol/l

0.03

292

1994

Fluid overload

113

4.44

12.05

9.8

11.3

1.20

1.28

mmol/l

0.03

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

360

2.66

12.04

12.8

6.1

0.97

1.37

mmol/l

0.72

298

Sixth [abducent] nerve palsy

244

1541

1.72

12.03

7.4

7.8

0.99

0.95

mmol/l

0.05

197

1275

Viral encephalitis, not elsewhere classified/unspecified

147

807

2.01

12.02

7.9

8.5

0.37

0.85

mmol/l

0.60

125

667

Bullous disorders

398

2782

1.52

12.01

6.6

7.5

0.74

0.95

mmol/l

0.42

325

2283

Frostbite

402

2.50

12.00

9.5

11.3

0.24

0.97

mmol/l

0.60

337

Malignant neoplasm of palate, including Hilmo

238

3.11

11.99

11.1

7.8

1.04

1.12

mmol/l

0.07

201

Schizoid personality disorder

123

636

2.14

11.99

5.8

10.4

2.13

0.67

mmol/l

3.00

108

534

Juvenile arthritis (FINNGEN)

199

1175

1.77

11.98

7.8

9.9

0.69

0.56

mmol/l

0.15

160

951

Pilonidal cyst

428

3006

1.47

11.98

10.6

9.4

0.78

0.77

mmol/l

0.01

368

2451

Vasculitis limited to skin, not elsewhere classified

190

1126

1.84

11.97

6.3

8.4

1.34

0.94

mmol/l

0.58

154

928

Pre-eclampsia or eclampsia

936

7379

1.30

11.96

6.5

7.4

0.75

0.91

mmol/l

0.59

768

6073

Pain associated with micturition

741

5695

1.35

11.96

6.5

7.6

1.13

0.93

mmol/l

0.75

611

4634

Implicit parasitic Sepsis

170

3.54

11.91

13.8

6.2

0.73

0.85

mmol/l

0.07

144

Lateral epicondylitis

744

5714

1.34

11.90

6.2

8.6

0.91

0.88

mmol/l

0.08

610

4740

Other and unspecified mononeuropathies, also in other diseases

204

1233

1.79

11.87

7.7

8.3

1.41

1.01

mmol/l

0.69

169

1006

Thyrotropin deficiency

351

2.57

11.86

4.5

9.2

0.62

0.79

mmol/l

0.21

300

Other juvenile arthritis

171

970

1.84

11.86

7.9

10.1

0.41

0.57

mmol/l

0.18

134

776

Malignant neoplasm of bone and articular cartilage of limbs

144

3.80

11.83

13.5

12.6

0.22

0.94

mmol/l

0.83

128

Parkinson's disease, including avohilmo

1160

9452

1.27

11.82

5.5

7.2

1.62

0.91

mmol/l

8.23

986

7728

Carcinoma in situ of other and unspecified genital organs

134

716

2.05

11.82

5.6

6.9

0.60

1.20

mmol/l

1.10

106

597

Degeneration of the brain due to alcohol

185

1101

1.87

11.80

11.0

9.9

0.68

0.79

mmol/l

0.11

153

914

Dermatopolymyositis (FG)

102

496

2.30

11.80

14.5

8.2

1.83

0.75

mmol/l

1.21

409

Systemic sclerosis, icd10

160

905

1.93

11.78

11.2

7.7

0.87

1.09

mmol/l

0.31

136

759

Implicit parasitic Sepsis, including avohilmo

198

3.25

11.78

13.0

6.0

0.75

mmol/l

0.00

169

Medical abortion

3340

15890

1.15

11.78

6.9

6.8

0.88

1.03

mmol/l

1.29

2760

13103

Fibrosis of liver

301

2.82

11.78

9.4

9.5

0.64

1.05

mmol/l

0.32

260

Congenital obstruction of the pelviureteric junction

274

2.84

11.74

7.4

10.2

-0.19

1.02

mmol/l

1.86

227

Malignant neoplasm of anus and anal canal, including Hilmo

102

500

2.32

11.73

10.8

6.7

0.62

1.21

mmol/l

1.12

418

Special screening examination for neoplasms

413

2906

1.48

11.70

8.0

8.3

0.54

0.69

mmol/l

0.35

348

2443

Degeneration of nervous system due to alcohol

185

1104

1.87

11.69

11.0

9.7

0.68

0.86

mmol/l

0.18

153

911

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

219

1304

1.70

11.69

17.7

10.4

-0.03

0.47

mmol/l

0.98

183

1042

Other and unspecified diseases of blood and blood-forming organs

190

1135

1.83

11.66

9.8

8.3

-0.09

0.98

mmol/l

2.68

171

936

Chondrosarcoma, including Hilmo

168

3.56

11.60

9.4

11.8

0.51

1.33

mmol/l

1.06

140

Pre-eclampsia

848

6633

1.31

11.55

6.4

7.4

0.64

0.87

mmol/l

1.00

690

5445

Dissection of cerebral arteries, nonruptured

252

2.91

11.54

9.9

8.2

1.06

mmol/l

0.01

219

Malignant melanoma of skin

748

5793

1.34

11.48

6.7

7.6

0.66

1.13

mmol/l

2.60

631

4720

Tuberculosis

421

2996

1.48

11.42

7.6

6.8

1.60

0.96

mmol/l

2.56

361

2416

Other abnormal findings of blood chemistry

309

2073

1.58

11.40

8.6

8.4

0.44

0.90

mmol/l

0.88

255

1700

Injury of eye and orbit

803

6265

1.32

11.39

8.6

1.08

0.81

mmol/l

1.07

654

5127

Melanocytic naevi

1809

15353

1.20

11.38

7.7

8.0

0.65

0.87

mmol/l

1.58

1480

12655

Non-small cell lung cancer, squamous, helper endpoint

373

2603

1.52

11.37

7.5

6.8

1.88

0.87

mmol/l

6.27

320

2084

Bacterial, viral and other infectious agents, including avohilmo

518

3807

1.41

11.33

11.2

9.1

0.30

0.91

mmol/l

2.54

432

3139

Disorders of purine and pyrimidine metabolism

234

3.09

11.32

10.7

8.1

0.79

0.90

mmol/l

0.06

197

Malignant neoplasm of tonsil and base of tongue, including Hilmo

175

1032

1.86

11.31

11.4

8.6

1.44

1.11

mmol/l

0.51

157

862

Ankylosing spondylitis

488

3552

1.43

11.28

7.5

8.7

0.87

0.85

mmol/l

0.04

405

2945

Herpesviral [herpes simplex] infections, including avohilmo

1363

11278

1.23

11.28

7.2

7.9

0.86

0.87

mmol/l

0.04

1125

9251

Other noninflammatory disorders of uterus, except cervix

1301

7126

1.25

11.27

5.7

7.0

1.34

1.13

mmol/l

1.19

1089

5988

Injury of blood vessels at abdomen, lower back and pelvis level

149

3.70

11.25

14.0

11.1

1.62

0.96

mmol/l

0.60

127

Acromegaly and pituitary gigantism

239

2.98

11.23

5.6

7.7

0.14

0.68

mmol/l

0.53

198

Bacterial, viral and other infectious agents

485

3534

1.43

11.22

11.2

9.2

0.38

0.91

mmol/l

1.90

407

2926

Unspecified maternal hypertension

227

2.82

11.20

5.9

9.7

0.21

0.72

mmol/l

0.43

167

Intussusception

143

793

1.96

11.18

7.6

7.9

1.83

1.19

mmol/l

1.18

106

657

Benign neoplasm: Other and unspecified parts of small intestine

130

709

2.07

11.13

9.8

7.0

1.07

1.02

mmol/l

0.05

112

594

Excessive vomiting in pregnancy

333

2258

1.52

11.13

5.2

7.5

0.84

0.79

mmol/l

0.09

263

1815

Malignant neoplasm, without specification of site, including Hilmo

315

2129

1.56

11.12

5.9

6.1

0.99

1.17

mmol/l

0.36

257

1720

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

397

2790

1.47

11.12

8.0

9.2

0.93

0.89

mmol/l

0.06

332

2293

Failure of sterile precautions during surgical operation

131

4.12

11.11

8.8

8.1

1.32

1.23

mmol/l

0.04

110

Collapsed vertebra, not elsewhere classified

341

2.63

11.10

11.0

6.6

1.53

1.31

mmol/l

0.14

284

Anorexia

451

2.29

11.09

5.6

9.5

1.38

0.85

mmol/l

0.49

379

Intermittent heterotropia

281

1842

1.59

11.08

12.2

9.3

1.13

0.66

mmol/l

1.07

228

1504

Muscle strain

202

1235

1.74

11.02

8.4

9.2

0.78

0.89

mmol/l

0.17

169

1012

Myositis

179

1068

1.82

10.97

11.6

9.3

0.98

1.06

mmol/l

0.08

155

887

Perforation of oesophagus

215

3.19

10.96

21.9

7.0

2.04

0.83

mmol/l

1.47

177

Recurrent dislocation of patella

208

1272

1.69

10.94

8.7

9.8

1.05

0.60

mmol/l

0.91

163

1006

Congenital malformations of great veins

4.57

10.92

17.1

12.2

0.14

-0.24

mmol/l

0.19

Other and unspecified injuries of shoulder and upper arm

211

1311

1.72

10.92

8.2

9.1

1.60

0.93

mmol/l

1.96

183

1083

Coarctation of the aorta

313

2.59

10.89

29.4

11.8

0.78

0.47

mmol/l

0.29

267

Pre-eclampsia or poor fetal growth

1219

9951

1.24

10.85

7.5

7.3

0.65

0.81

mmol/l

0.74

982

8051

Scabies

270

1774

1.60

10.84

11.5

9.6

1.32

0.77

mmol/l

1.63

230

1467

Achalasia of cardia

130

711

2.02

10.81

10.2

7.6

1.19

1.05

mmol/l

0.13

110

587

Leiomyosarcoma, including Hilmo

350

2.54

10.77

7.7

8.5

0.27

1.48

mmol/l

2.10

301

Diseases of tongue

388

2745

1.48

10.76

6.6

7.1

1.24

1.02

mmol/l

0.51

324

2211

Other disorders of iris and ciliary body

203

1260

1.74

10.76

7.0

7.9

0.34

0.99

mmol/l

1.42

173

1028

Ectropion of eyelid

316

2167

1.56

10.72

5.7

6.5

1.31

0.94

mmol/l

0.99

253

1740

Other specified/unspecified inflammatory spondylopathies

235

1495

1.64

10.71

7.1

8.9

1.09

0.91

mmol/l

0.35

199

1242

Sequelae of infectious and parasitic diseases

443

3209

1.44

10.69

8.2

7.7

1.62

0.94

mmol/l

2.71

382

2606

Visual impairment including blindness (binocular or monocular)

457

3334

1.43

10.68

8.0

7.2

0.63

1.07

mmol/l

1.33

372

2702

Selective deficiency of immunoglobulin G [IgG] subclasses

214

3.00

10.67

11.7

11.4

1.51

0.94

mmol/l

0.31

183

Campylobacter enteritis

180

1082

1.79

10.67

8.3

9.4

0.73

0.91

mmol/l

0.24

146

895

Chondrocostal junction syndrome [Tietze]

227

1443

1.67

10.66

6.6

8.0

0.67

1.01

mmol/l

0.60

190

1199

Reactive arthropathies

496

3660

1.40

10.59

9.1

8.6

0.67

0.93

mmol/l

0.78

413

3007

Congenital aortic valve stenosis

131

3.64

10.58

31.7

16.1

0.77

0.78

mmol/l

0.01

110

Disorders in reading

325

2.43

10.57

18.8

12.4

0.73

0.23

mmol/l

0.43

276

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

195

3.24

10.56

11.3

8.8

1.02

1.03

mmol/l

0.00

164

Sequelae of infectious and parasitic diseases, including avohilmo

454

3311

1.43

10.53

8.3

7.7

1.65

0.94

mmol/l

2.97

393

2690

Adalimumab

508

3761

1.39

10.51

8.4

8.9

0.59

0.80

mmol/l

0.61

422

3114

Hyperaldosteronism

198

1230

1.75

10.50

8.5

0.84

1.06

mmol/l

0.24

167

1014

Thyrotoxicosis with toxic multinodular goitre

391

2792

1.48

10.50

7.4

6.9

1.56

1.15

mmol/l

1.25

344

2300

Background retinopathy and retinal vascular changes

157

918

1.87

10.48

11.9

8.3

0.45

1.05

mmol/l

1.07

129

752

Accidental poisoning by and exposure to alcohol

111

578

2.08

10.45

11.7

9.1

1.52

0.71

mmol/l

1.38

472

Malignant neoplasm of renal pelvis

269

2.83

10.41

9.9

6.5

-0.99

1.05

mmol/l

2.60

219

Degenerative diseases of the nervous system

2856

18143

1.15

10.37

5.0

6.7

1.13

0.97

mmol/l

1.17

2233

14864

Femoral hernia

289

1954

1.57

10.37

8.8

7.5

0.90

1.02

mmol/l

0.18

241

1597

Colitis due to radiation

494

2.28

10.36

8.2

7.6

1.29

0.99

mmol/l

0.29

411

Other disorders starting during childhood or adolescence

186

1108

1.72

10.35

19.4

10.7

0.02

0.18

mmol/l

0.22

155

879

Monoarthritis, not elsewhere classified

253

1658

1.61

10.35

8.5

9.3

0.53

0.92

mmol/l

0.99

225

1361

Toxic liver disease

109

571

2.11

10.31

10.8

8.1

0.47

0.87

mmol/l

0.48

485

Beningn neoplasm: Meninges, unspecified

120

653

2.05

10.27

6.7

7.0

0.84

1.10

mmol/l

0.36

551

Glucosamine medication

3328

23705

1.14

10.26

6.6

7.1

1.15

1.01

mmol/l

1.25

2808

19649

Crystal arthropathies, rheuma endpoint

153

896

1.88

10.26

5.6

8.2

1.43

0.89

mmol/l

0.85

123

728

Lymphoid leukaemia

382

2733

1.48

10.25

10.2

8.1

1.06

0.84

mmol/l

0.58

302

2237

284

2.48

10.25

7.4

10.2

-0.68

0.17

mmol/l

0.86

227

Optic atrophy

128

710

1.99

10.22

10.0

9.8

0.45

0.91

mmol/l

0.56

107

587

Other specified and unspecified retinal disorders

249

1641

1.63

10.21

7.4

8.0

0.34

1.04

mmol/l

1.92

207

1357

Other and unspecified mononeuropathies of upper limb

185

1132

1.75

10.19

7.6

10.3

1.66

0.84

mmol/l

2.74

152

945

Ovarian dysfunction

271

1791

1.55

10.18

6.3

6.9

0.48

0.52

mmol/l

0.05

221

1385

Lifestyle-related condition

430

2.30

10.17

7.9

7.8

1.81

0.88

mmol/l

1.23

358

Nontoxic multinodular goitre

1202

9960

1.24

10.17

6.1

6.7

1.39

1.13

mmol/l

1.53

1014

8297

Other menopausal disorders

1025

7034

0.80

10.16

6.7

7.5

0.84

1.06

mmol/l

1.10

870

5933

Congenital deformities of feet

138

776

1.89

10.14

8.9

9.3

1.04

0.77

mmol/l

0.38

121

659

Benign neoplasm: Oesophagus

495

2.23

10.11

16.3

7.4

0.78

0.87

mmol/l

0.06

413

Lichen simplex chronicus

222

1426

1.66

10.11

8.9

8.1

0.97

0.95

mmol/l

0.03

171

1175

Parkinson's disease

1101

9075

1.25

10.11

5.4

7.2

1.68

0.92

mmol/l

9.07

935

7418

Disorders of vitreous body and globe

3596

30520

1.13

10.09

7.9

7.6

0.95

0.98

mmol/l

0.22

3073

25494

Corneal ulcer

1076

8813

1.25

10.09

7.5

8.1

0.90

0.88

mmol/l

0.06

890

7279

Mixed specific developmental disorders

388

2.21

10.08

19.6

15.7

-0.00

0.09

mmol/l

0.07

329

Other salmonella infections, including avohilmo

249

1635

1.60

10.08

7.7

8.2

0.56

1.00

mmol/l

1.02

203

1333

Blepharochalasis

1957

16924

1.18

10.04

6.6

7.3

1.23

1.01

mmol/l

1.90

1696

14083

Benign neoplasm: Rectosigmoid junction

295

2026

1.56

10.02

8.2

7.8

0.75

0.95

mmol/l

0.39

249

1685

Disseminated intravascular coagulation [defibrination syndrome]

106

4.10

10.00

21.1

8.1

-2.45

1.16

mmol/l

2.79

Open wound of neck

289

2.61

9.99

11.0

11.8

1.04

0.95

mmol/l

0.06

235

Wegener granulomatosis

115

623

2.06

9.98

11.5

8.3

0.48

0.93

mmol/l

0.60

518

Perichondritis of external ear

136

777

1.94

9.96

6.9

7.2

1.82

1.01

mmol/l

1.30

115

640

Thiamine deficiency

237

2.91

9.96

10.7

8.4

0.51

1.03

mmol/l

0.33

198

Malignant neoplasm of base of tongue, including Hilmo

350

2.49

9.95

12.2

8.1

1.76

1.18

mmol/l

0.48

293

Tumor necrosis factor alpha inhibitors

790

6254

1.29

9.95

9.1

8.7

0.71

0.80

mmol/l

0.23

664

5131

Hypermobility syndrome

221

1408

1.63

9.95

5.2

8.0

1.13

0.73

mmol/l

1.20

181

1131

Other crystal arthropathies

153

905

1.86

9.92

5.6

7.9

1.43

0.84

mmol/l

0.96

123

738

Inflammatory disorders of male genital organs, not elsewhere classified

110

591

2.08

9.80

10.4

11.7

1.00

0.78

mmol/l

0.20

490

Fourth [trochlear] nerve palsy

161

968

1.82

9.77

7.7

0.89

1.04

mmol/l

0.17

135

799

Crushed, pushed or stepped on by crowd or human stampede

365

2590

1.46

9.75

8.8

9.2

0.62

0.78

mmol/l

0.37

315

2108

Colonic or urogenital fistula

1655

14151

1.19

9.73

8.8

8.0

0.91

0.87

mmol/l

0.17

1374

11714

Other salmonella infections

218

1404

1.65

9.72

8.0

8.3

0.59

1.01

mmol/l

0.80

177

1155

Disorder of external ear, unspecified

224

1458

1.64

9.67

6.6

8.8

0.69

0.98

mmol/l

0.59

187

1203

Malignant neoplasm of nasal cavity and sinuses

264

2.71

9.65

7.4

7.2

0.88

1.07

mmol/l

0.13

227

SLE (Finngen)

196

1232

1.68

9.63

7.3

6.6

0.54

0.86

mmol/l

0.40

165

1029

Other keratitis

635

4923

1.33

9.62

8.5

8.1

0.95

0.87

mmol/l

0.18

526

4060

Single delivery by forceps and vacuum extractor

286

2504

0.67

9.62

5.8

9.3

-0.14

0.51

mmol/l

2.15

209

2008

Fitting and adjustment of external prosthetic device

131

3.75

9.62

12.8

6.1

1.54

1.23

mmol/l

0.24

115

Acute myeloid leukaemia and myelodysplastic syndromes

173

1063

1.76

9.61

7.6

6.3

1.07

1.10

mmol/l

0.03

142

861

Benign neoplasm: Pancreas

207

1334

1.69

9.59

7.1

7.3

0.74

0.95

mmol/l

0.39

179

1097

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

289

2.59

9.57

16.6

10.3

-1.08

0.88

mmol/l

2.21

242

Benign neoplasm of ovary

933

7579

1.26

9.57

6.9

6.7

1.04

1.14

mmol/l

0.35

780

6350

Congenital deformities of feet, including avohilmo

199

1254

1.67

9.56

9.3

9.8

0.89

0.85

mmol/l

0.05

177

1046

Benign neoplasm of other and unspecified sites

212

1368

1.66

9.52

7.8

8.7

1.36

0.94

mmol/l

0.96

174

1129

Benign lipomatous neoplasm

1857

16054

1.18

9.52

7.1

8.0

0.95

0.97

mmol/l

0.06

1540

13336

Scabies, including avohilmo

710

5576

1.30

9.51

8.9

8.7

0.82

0.73

mmol/l

0.27

596

4529

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

570

4379

1.35

9.51

8.3

8.0

1.12

0.97

mmol/l

0.43

473

3625

Burn and corrosion of trunk

186

1162

1.71

9.50

9.5

9.2

1.27

0.89

mmol/l

0.53

151

962

Benign neoplasm: Parotid gland

504

3809

1.38

9.50

10.0

8.1

1.05

0.99

mmol/l

0.12

426

3147

Atopic dermatitis, strict definition with reimbursement

1409

11400

1.20

9.49

7.8

8.4

0.61

0.70

mmol/l

0.38

1185

9211

Menorrhagia

1745

8300

1.19

9.48

7.1

7.2

1.25

0.99

mmol/l

1.78

1412

6858

Postmenopausal atrophic vaginitis

1089

7199

0.81

9.44

5.7

7.3

0.97

1.13

mmol/l

0.76

918

6062

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

273

2.64

9.40

6.7

7.6

0.33

1.16

mmol/l

0.63

231

Mild or no visual impairment, binocular

170

3.17

9.40

5.2

6.4

0.86

0.99

mmol/l

0.08

138

Other specified/unspecified bacterial intestinal infections

416

3057

1.42

9.39

8.8

8.2

0.77

0.99

mmol/l

0.53

338

2528

Atypical facial pain

296

2046

1.52

9.39

7.0

8.3

1.18

1.05

mmol/l

0.26

251

1687

Coeliac disease

654

5108

1.32

9.37

8.2

7.9

1.11

0.91

mmol/l

0.56

521

4200

Anuria and oliguria

294

2.60

9.37

9.5

8.8

0.49

1.01

mmol/l

0.44

245

Other disorders of patella

872

7035

1.27

9.34

6.7

8.9

0.85

0.86

mmol/l

0.02

717

5811

Haemorrhagic disorder due to circulating anticoagulants

122

693

1.98

9.31

10.8

7.4

0.77

1.11

mmol/l

0.31

104

558

Giant cell arteritis

301

2106

1.53

9.31

7.1

6.9

0.79

0.90

mmol/l

0.18

253

1734

Pyoderma

128

729

1.91

9.30

9.0

8.3

0.56

0.86

mmol/l

0.39

104

595

Disorders of refraction and accommodation

1497

12670

1.20

9.29

10.3

8.3

0.85

0.80

mmol/l

0.17

1252

10425

Dystonia

318

2234

1.49

9.28

6.1

8.5

1.38

0.91

mmol/l

1.46

267

1843

Pemphigoid

211

1378

1.66

9.24

5.4

6.8

0.45

1.03

mmol/l

1.07

164

1132

Other specified and unspecified disorders of eyelid

113

626

2.01

9.21

6.4

9.8

0.85

0.96

mmol/l

0.10

516

Acute nephritic syndrome

139

814

1.85

9.21

8.5

9.2

0.90

0.92

mmol/l

0.01

110

673

Injury of nerves at shoulder and upper arm level

413

2.25

9.18

8.6

0.54

0.66

mmol/l

0.12

347

Abnormal findings in nipple discharge synovial fluid wound secretions

101

537

2.07

9.17

8.9

9.2

-0.94

0.90

mmol/l

3.13

458

Other and unspecified aplastic anaemias

442

2.21

9.13

9.7

8.2

-0.11

1.15

mmol/l

1.47

371

Other and unspecified acquired haemolytic anaemias

396

2.31

9.13

12.4

9.4

1.16

0.88

mmol/l

0.27

338

Other abnormalities of plasma proteins

122

694

1.95

9.11

10.0

7.6

1.55

0.95

mmol/l

0.76

106

574

Other nutritional anaemias

408

2.27

9.10

6.9

7.8

0.96

1.20

mmol/l

0.16

337

Iron deficiency

130

738

1.84

9.10

8.3

8.7

1.63

0.47

mmol/l

2.81

584

Acute epiglottitis

104

559

2.03

9.10

9.3

8.3

1.18

0.84

mmol/l

0.38

465

Neurofibromatosis, type 2

5.51

9.08

8.0

8.3

0.42

1.66

mmol/l

0.58

Optic atrophy, wide definition

129

744

1.90

9.07

10.0

10.1

0.45

0.92

mmol/l

0.57

107

616

Other congenital malformations, not elsewhere classified

224

2.69

9.05

8.9

13.4

0.63

0.42

mmol/l

0.15

194

Psoriatic arthropathies

567

4370

1.34

9.04

8.0

8.8

1.10

0.94

mmol/l

0.44

489

3631

Malignant neoplasm of heart, mediastinum and pleura

108

594

2.03

9.02

9.9

8.2

1.51

1.00

mmol/l

0.73

485

Ganglion

1112

9232

1.23

9.01

7.2

8.1

0.96

0.87

mmol/l

0.34

911

7644

Inguinal or femoral hernia, bilateral

753

6038

1.29

9.01

7.7

7.9

0.84

0.82

mmol/l

0.03

623

4887

Other and unspecified epidermal thickening

169

1048

1.73

8.94

7.3

8.8

1.28

0.96

mmol/l

0.54

139

860

Inguinal hernia, bilateral

741

5938

1.29

8.93

7.7

8.0

0.83

0.84

mmol/l

0.01

613

4802

Other benign neoplasms of connective and other soft tissue

571

4421

1.34

8.90

7.1

7.9

0.95

0.92

mmol/l

0.06

476

3644

Bullous pemphigoid

174

1099

1.74

8.90

5.5

6.8

0.63

1.10

mmol/l

0.66

136

909

Synovial cyst of popliteal space [Baker]

451

3382

1.39

8.87

7.9

7.8

0.83

1.04

mmol/l

0.50

394

2774

Other/unspecified enthesopathies of lower limb, excluding foot

379

2757

1.42

8.87

6.4

8.2

0.65

0.90

mmol/l

0.62

305

2303

Pediculosis, acariasis and other infestations

344

2470

1.45

8.84

10.8

9.0

1.04

0.85

mmol/l

0.42

294

2040

Use of ropinirole

254

1742

1.57

8.83

5.4

8.3

1.98

0.96

mmol/l

4.72

216

1446

Drug-induced polyneuropathy

361

2.36

8.82

6.8

8.2

0.72

0.96

mmol/l

0.21

313

Tooth eruption problems

542

3998

1.33

8.81

10.5

9.1

0.56

0.40

mmol/l

0.41

426

3137

Exposure to excessive natural cold

470

2.15

8.80

9.2

9.5

0.64

1.05

mmol/l

0.27

390

Acne

390

2823

1.40

8.80

9.8

9.2

0.24

0.37

mmol/l

0.26

310

2209

Isolated proteinuria with specified morphological lesion

449

2.18

8.78

6.8

7.5

0.59

0.87

mmol/l

0.29

373

Palmar fascial fibromatosis [Dupuytren]

1048

8710

1.24

8.77

8.0

7.8

0.60

0.91

mmol/l

1.84

857

7116

Single spontaneous delivery

1682

10325

0.85

8.75

5.9

7.0

1.11

1.02

mmol/l

0.44

1389

8595

Respiratory tuberculosis, confirmed and not-confirmed

355

2575

1.45

8.75

8.1

7.0

1.33

0.98

mmol/l

0.93

303

2085

Respiratory tuberculosis

355

2575

1.45

8.75

8.1

7.0

1.33

0.98

mmol/l

0.93

303

2085

Pedestrian injured in collision with pedal cycle

192

1234

1.66

8.75

9.3

9.2

1.09

0.98

mmol/l

0.15

171

1020

Plantar fascial fibromatosis

539

4144

1.34

8.74

6.8

8.0

1.13

0.98

mmol/l

0.44

453

3409

Acne vulgaris

295

2044

1.47

8.73

10.1

9.2

0.45

0.34

mmol/l

0.16

227

1595

Benign neoplasm: salivary glands, exclude unknown (D119)

550

4258

1.34

8.73

9.8

8.0

1.04

0.97

mmol/l

0.15

461

3514

Malignant neoplasm of tonsil and base of tongue

146

883

1.80

8.72

10.9

8.6

1.29

1.12

mmol/l

0.25

130

737

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

345

2.41

8.66

9.3

6.6

-1.03

1.16

mmol/l

4.99

280

Neurofibromatosis, type 1

194

2.82

8.62

7.6

13.4

-0.40

0.89

mmol/l

1.45

160

Perineal laceration during delivery

319

3614

0.70

8.58

5.2

7.6

0.30

0.45

mmol/l

0.31

230

2832

Other superficial mycoses

137

812

1.80

8.56

8.4

10.5

0.60

0.75

mmol/l

0.19

119

684

Unspecified severe protein-energy malnutrition

4.69

8.50

14.2

7.6

0.46

1.29

mmol/l

0.26

Systemic sclerosis,strict definition

310

2.40

8.49

11.9

7.5

0.07

1.09

mmol/l

1.46

265

Other proliferative retinopathy

180

2.99

8.48

8.4

8.1

0.65

0.98

mmol/l

0.22

144

Postzoster neuralgia

129

763

1.87

8.47

6.6

6.8

2.42

1.08

mmol/l

3.52

112

630

Perforation of tympanic membrane

585

4574

1.32

8.47

9.0

7.6

0.92

0.91

mmol/l

0.01

471

3765

Congenital deformities of hip

432

2.09

8.46

8.9

10.2

-0.06

0.48

mmol/l

0.63

354

Ulcerative colitis (strict) with PSC

232

2.61

8.46

15.6

9.9

-0.54

0.78

mmol/l

2.33

193

Ankylosing hyperostosis [Forestier]

100

547

2.03

8.46

5.6

8.4

1.56

1.12

mmol/l

0.57

460

Disorders of vitreous body

3465

29823

1.12

8.46

8.0

7.6

0.92

0.99

mmol/l

0.51

2971

24922

Malignant neoplasm of larynx, including Hilmo

145

882

1.78

8.44

10.0

7.2

1.92

1.00

mmol/l

1.45

120

719

Hepatomegaly and splenomegaly, not elsewhere classified

337

2.32

8.44

15.2

8.7

0.12

0.52

mmol/l

0.30

296

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

400

2.22

8.41

7.4

7.0

0.73

1.20

mmol/l

0.39

332

Common variable immunodeficiency

191

2.83

8.41

7.2

10.9

-0.17

1.04

mmol/l

0.89

160

Other and unspecified disorders of white blood cells

252

1733

1.54

8.41

9.8

8.6

0.78

0.95

mmol/l

0.23

212

1424

Mucinous and mucinous cystic tumor of rectum

194

2.94

8.40

9.7

8.2

1.22

1.06

mmol/l

0.10

168

Autoimmune hyperthyroidism

316

2252

1.45

8.39

7.2

7.1

0.92

0.93

mmol/l

0.02

255

1860

Pedal cyclist injured in transport accident

1268

10736

1.20

8.39

8.0

8.3

1.05

0.84

mmol/l

1.13

1056

8802

Otalgia

460

3483

1.36

8.38

7.9

8.1

0.81

0.90

mmol/l

0.19

379

2875

CR(E)ST syndrome

103

569

1.98

8.36

9.9

8.0

0.59

1.23

mmol/l

0.96

478

Vascular dementia (subcortical)

269

1882

1.52

8.36

5.4

6.3

1.49

1.04

mmol/l

1.02

221

1508

Malignant neoplasm of other and ill-defined sites, including Hilmo

114

650

1.91

8.35

7.2

6.0

0.82

1.15

mmol/l

0.35

101

532

All dysplastic lesions of the vulva

222

1484

1.57

8.34

7.5

7.3

0.66

1.18

mmol/l

1.16

187

1216

Acquired pure red cell aplasia [erythroblastopenia]

146

3.21

8.34

10.3

7.3

0.01

0.70

mmol/l

0.41

127

Other and/or unspecified nontoxic goitre

478

3651

1.36

8.31

6.4

7.0

0.90

1.08

mmol/l

0.50

412

3018

Sequelae of other and unspecified effects of external causes

199

2.80

8.30

11.8

11.1

0.34

0.95

mmol/l

0.46

163

Achilles tendinitis

593

4652

1.31

8.30

8.1

8.6

1.31

0.81

mmol/l

2.60

515

3852

Polymyositis

308

2.41

8.29

19.1

7.7

1.92

0.98

mmol/l

0.75

257

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

854

6979

1.25

8.25

8.3

8.7

0.68

0.83

mmol/l

0.51

708

5728

Dermatopolymyositis

103

573

1.98

8.22

14.4

7.6

1.83

0.89

mmol/l

1.00

483

Other and unspecified mental retardation

478

2.03

8.20

11.5

16.1

0.96

0.33

mmol/l

0.74

411

Injury of muscle and tendon at wrist and hand level

814

6636

1.26

8.20

8.3

8.9

0.81

0.86

mmol/l

0.12

671

5490

Radial styloid tenosynovitis [de Quervain]

282

1977

1.48

8.19

7.0

8.7

0.99

0.90

mmol/l

0.15

238

1642

Other benign neoplasms of skin

2428

21595

1.14

8.18

7.0

7.4

1.05

0.94

mmol/l

0.71

2003

17860

Aortic stenosis, including avohilmo

4.20

8.18

21.6

22.2

1.18

1.50

mmol/l

0.15

Leiomyosarcoma

285

2.47

8.11

7.9

9.1

0.29

1.54

mmol/l

2.36

245

Premature rupture of membranes

468

4375

0.75

8.10

7.4

7.9

0.70

0.63

mmol/l

0.16

345

3500

conjunctival haemorrhage

502

3884

1.35

8.09

9.2

7.5

1.19

0.99

mmol/l

0.54

419

3204

Femoral hernia, unilateral

182

1181

1.65

8.08

7.3

8.1

1.00

1.05

mmol/l

0.05

149

960

Inguinal hernia, unilateral

182

1181

1.65

8.08

7.3

8.1

1.00

1.05

mmol/l

0.05

149

960

Inguinal of femoral hernia, unilateral

182

1181

1.65

8.08

7.3

8.1

1.00

1.05

mmol/l

0.05

149

960

Purulent endophthalmitis

287

2.49

8.08

5.9

6.4

1.20

1.15

mmol/l

0.02

237

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

400

2981

1.38

8.07

6.5

7.4

0.83

0.97

mmol/l

0.31

331

2457

Tetraplegia

306

2.41

8.07

13.5

10.2

2.34

0.90

mmol/l

1.58

257

Chronic laryngitis and laryngotracheitis

855

7019

1.25

8.06

8.2

7.9

1.10

0.89

mmol/l

0.82

726

5815

Bacterial meningitis

206

1373

1.59

8.01

9.7

1.02

0.97

mmol/l

0.07

179

1131

Medial epicondylitis

212

1417

1.57

8.00

6.0

9.9

0.88

1.04

mmol/l

0.23

184

1183

Cachexia

203

2.75

7.99

9.9

6.5

0.79

0.77

mmol/l

0.01

166

Deviated nasal septum

2131

18807

1.15

7.99

8.4

8.6

0.92

0.81

mmol/l

0.71

1789

15648

Acute drug-induced interstitial lung disorder

357

2.32

7.98

9.1

7.4

1.24

0.88

mmol/l

0.33

302

Pedal cyclist injured in other and unspecified transport accidents

635

5049

1.29

7.97

8.0

8.3

0.93

0.83

mmol/l

0.27

542

4149

Generalized epilepsy, mode (most common among epilepsy diagnosis)

154

956

1.69

7.97

7.2

10.1

1.18

0.78

mmol/l

0.49

127

790

Benign neoplasm: Cranial nerves

189

1242

1.63

7.97

7.6

8.0

0.60

0.95

mmol/l

0.54

143

1039

Acute lymphadenitis

289

2048

1.46

7.95

8.6

9.0

0.61

0.83

mmol/l

0.44

238

1661

Carcinoma in situ of rectum

107

614

1.96

7.94

7.7

8.6

0.31

0.84

mmol/l

0.67

507

Diabetes mellitus in pregnancy

1093

5779

1.21

7.93

6.8

8.1

0.27

0.60

mmol/l

1.81

829

4626

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

121

714

1.85

7.91

6.2

6.1

1.20

1.17

mmol/l

0.03

106

589

Alcohol induced polyneuropathy

462

2.11

7.89

12.1

9.2

1.33

0.73

mmol/l

0.60

389

Convergent concomitant strabismus

267

1867

1.48

7.87

11.7

9.3

1.01

0.84

mmol/l

0.28

210

1537

Injury of cranial nerves

223

2.63

7.86

7.6

7.9

0.20

0.86

mmol/l

0.55

188

Exposure to uncontrolled fire in building or structure

281

2.43

7.86

12.1

10.2

1.69

0.71

mmol/l

1.00

240

Parkinson's disease, strict definition

1007

8444

1.23

7.84

5.3

7.1

1.70

0.92

mmol/l

8.69

858

6895

Residual foreign body in soft tissue

289

2057

1.46

7.84

7.7

9.4

0.75

0.88

mmol/l

0.25

246

1691

Chylothorax

4.10

7.82

12.7

9.5

1.63

1.00

mmol/l

0.29

Bursitis of shoulder

159

1007

1.68

7.77

6.1

9.0

1.18

0.99

mmol/l

0.31

137

834

Chronic myeloid leukaemia, including Hilmo

343

2.26

7.75

8.9

6.6

0.96

1.10

mmol/l

0.09

286

Hyphaema and other vascular disorders of iris and ciliary body

150

942

1.72

7.75

7.7

7.6

0.12

1.07

mmol/l

1.93

131

771

Allergic purpura

169

1084

1.65

7.75

7.3

9.2

0.57

0.91

mmol/l

0.52

140

905

Idiopathic thrombocytopenic purpura

187

1231

1.61

7.74

9.3

8.2

0.31

0.93

mmol/l

1.22

155

1009

Atlantoaxial subluxation

231

2.58

7.74

4.2

9.2

1.17

1.29

mmol/l

0.05

197

Systemic lupus erythematosus

196

1300

1.59

7.73

7.3

8.1

0.54

0.98

mmol/l

0.60

165

1079

Benign neoplasm: Heart

155

3.20

7.72

13.7

7.7

1.27

mmol/l

0.00

126

Infections with a predominantly sexual mode of transmission

1360

11613

1.18

7.72

9.1

8.0

0.59

0.76

mmol/l

0.85

1143

9409

Effects of foreign body entering through natural orifice

1431

12330

1.18

7.71

8.5

8.8

1.03

0.82

mmol/l

1.40

1203

10188

Other and unspecified erythematous conditions

201

1345

1.58

7.71

8.3

8.0

1.18

1.02

mmol/l

0.22

168

1117

Carcinoma in situ of oral cavity, oesophagus and stomach

254

2.57

7.70

6.5

0.31

1.11

mmol/l

0.94

210

Sequelae of other accidents

109

629

1.88

7.68

10.4

7.3

1.79

1.02

mmol/l

0.85

514

Other and unspecified primary disorders of muscles

271

2.44

7.67

8.1

10.7

1.17

1.11

mmol/l

0.03

237

Disorders of phosphorus metabolism and phosphatases

164

2.91

7.65

10.3

7.7

0.51

0.60

mmol/l

0.06

143

Atopic dermatitis, strict definition

1323

11053

1.19

7.64

7.9

8.8

0.52

0.70

mmol/l

0.85

1115

8933

Benign neoplasm of major salivary glands

609

4859

1.30

7.64

9.4

7.9

1.14

0.98

mmol/l

0.44

508

3992

Use of donepezil

1183

13210

0.83

7.63

3.9

6.1

1.24

1.05

mmol/l

0.93

909

10694

Unspecified threat to breathing

316

2.27

7.62

11.9

10.3

0.68

0.96

mmol/l

0.26

263

Rheumatic fever incl heart disease

200

1341

1.58

7.61

10.7

7.1

0.93

1.09

mmol/l

0.23

159

1080

Contact with other hot fluids

167

1072

1.64

7.60

6.4

9.9

0.78

0.79

mmol/l

0.01

136

900

Use of levodopa decarboxylase inhibitor

988

8297

1.23

7.60

5.3

7.1

1.70

0.92

mmol/l

8.29

847

6762

Nosocomial condition (hospital)

241

2.57

7.59

9.3

6.7

1.83

0.96

mmol/l

0.99

196

Other erythematous conditions

220

1505

1.54

7.57

8.1

7.9

1.18

0.96

mmol/l

0.33

182

1245

Caught, crushed, jammed or pinched in or between objects

294

2115

1.45

7.54

9.6

9.7

1.20

0.86

mmol/l

0.92

240

1759

Syndrome of inappropriate secretion of antidiuretic hormone

257

2.56

7.53

8.8

6.7

1.31

1.16

mmol/l

0.09

207

Complications of labour and delivery

2436

15193

0.88

7.53

7.1

7.4

0.92

1.00

mmol/l

0.42

1986

12688

Malignant neoplasm of cervix uteri

482

1.97

7.51

6.7

5.8

1.27

1.15

mmol/l

0.12

388

Sexual assault by bodily force

4.82

7.50

8.5

7.9

0.51

0.79

mmol/l

0.10

Scar conditions and fibrosis of skin

216

1469

1.54

7.49

9.5

8.1

0.77

0.91

mmol/l

0.23

173

1208

Other bacterial agents as the cause of diseases classified to other chapters

396

2.14

7.49

12.0

8.6

0.69

0.89

mmol/l

0.15

330

Burn and corrosion of other internal organs

3.67

7.48

10.3

14.0

2.90

0.52

mmol/l

1.85

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

243

2.55

7.46

18.9

10.7

-1.16

0.84

mmol/l

1.74

206

Secondary malignant neoplasm of respiratory and digestive organs

130

798

1.78

7.42

5.5

6.6

1.82

1.02

mmol/l

1.63

102

663

Drug-induced obesity

259

2.38

7.41

11.9

9.6

1.59

0.84

mmol/l

0.61

215

Sleep disorders, other/unspecified

174

1131

1.60

7.39

8.9

10.2

0.47

0.76

mmol/l

0.40

152

931

Polypectomy (DHB20)

416

3178

1.36

7.39

7.4

8.8

1.17

0.81

mmol/l

1.19

330

2617

Ulcerative enterocolitis

171

1113

1.62

7.36

10.1

8.6

-0.27

0.83

mmol/l

2.25

134

927

Disorders of optic nerve, not elsewhere classified

144

908

1.72

7.36

8.5

8.2

0.79

0.99

mmol/l

0.20

117

752

Necrobiosis lipoidica, not elsewhere classified

154

2.86

7.34

8.5

11.5

0.67

0.54

mmol/l

0.07

125

Other female pelvic inflammatory diseases

777

6370

1.25

7.34

7.2

6.8

1.18

1.04

mmol/l

0.49

620

5327

Malignant neoplasm of oropharynx, including Hilmo

139

869

1.73

7.33

12.1

8.4

1.18

1.13

mmol/l

0.07

126

724

Nontoxic goitre/thyroid nodule

1749

15355

1.16

7.32

6.1

7.0

1.22

1.07

mmol/l

0.85

1473

12807

Other and unspecified follicular disorders

238

1661

1.50

7.31

8.0

9.5

0.76

0.89

mmol/l

0.19

195

1378

HSIL lesion of the vulva

106

615

1.86

7.29

6.7

6.4

-0.19

1.10

mmol/l

2.22

513

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

103

593

1.88

7.29

6.5

10.3

1.62

0.82

mmol/l

1.63

497

Disorders of acoustic nerve

182

1212

1.61

7.27

7.6

8.0

0.75

0.93

mmol/l

0.25

138

1009

Marginal zone B-cell lymphoma, including Hilmo

115

688

1.83

7.25

6.1

7.2

0.64

1.23

mmol/l

0.93

573

Other/unspecified reactive arthropathies

362

2712

1.39

7.25

9.2

8.6

0.70

0.94

mmol/l

0.56

301

2222

Spontaneous rupture of synovium and tendon

504

3952

1.32

7.25

7.5

8.3

1.18

0.98

mmol/l

0.54

428

3242

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1566

13631

1.16

7.24

8.0

8.6

0.96

0.79

mmol/l

1.02

1288

11233

Maternal care for other conditions predominantly related to pregnancy

726

5746

1.25

7.24

8.3

7.8

0.53

0.63

mmol/l

0.31

573

4641

Other and unspecified glaucoma

483

3779

1.33

7.23

8.3

6.8

0.48

1.06

mmol/l

2.47

401

3105

Pneumoconiosis due to asbestos and other mineral fibres

163

1064

1.66

7.23

6.6

1.65

0.94

mmol/l

1.38

133

846

Cystic disease of liver

252

2.45

7.20

13.6

7.3

-0.11

1.00

mmol/l

2.10

220

Hypothyroidism due to medicaments and other exogenous substances

473

2.01

7.20

8.7

7.3

0.27

1.14

mmol/l

1.16

397

Pigmented purpuric dermatosis

431

2.07

7.19

5.6

7.3

1.54

0.83

mmol/l

1.25

361

Traumatic ischaemia of muscle

531

1.94

7.18

13.6

9.3

1.52

0.91

mmol/l

0.80

444

Mantle cell lymphoma, including Hilmo

106

623

1.88

7.18

10.1

6.6

1.14

1.03

mmol/l

0.09

509

Anomalies of pupillary function

119

714

1.77

7.17

9.0

9.7

1.26

0.88

mmol/l

0.55

101

597

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

182

2.74

7.17

14.0

11.3

0.88

1.26

mmol/l

0.26

159

Seborrhoeic dermatitis

612

4919

1.28

7.15

7.8

1.27

0.92

mmol/l

1.47

503

4027

Toxic effect of corrosive substances

163

2.80

7.14

7.3

11.2

0.96

0.71

mmol/l

0.22

140

Other bursitis of knee

101

584

1.88

7.13

6.7

8.9

0.58

0.99

mmol/l

0.46

493

Other noninflammatory disorders of vulva and perineum

472

3666

1.32

7.11

7.5

7.2

0.72

0.89

mmol/l

0.49

394

3044

Hodgkin lymphoma, hilmo

166

1085

1.62

7.11

9.7

9.0

1.23

0.85

mmol/l

0.78

139

899

Myeloproliferative diseases

525

4157

1.31

7.10

8.2

7.5

0.93

0.99

mmol/l

0.10

427

3425

Sequelae of burns, corrosions and frostbite

177

2.77

7.10

10.4

12.0

0.71

0.94

mmol/l

0.15

151

Moderate mental retardation

194

2.61

7.08

7.8

14.4

2.86

0.90

mmol/l

3.36

162

Malignant neoplasm of vulva, including Hilmo

504

1.95

7.07

8.0

5.2

0.76

1.51

mmol/l

0.91

425

Nonspecific lymphadenitis

301

2196

1.42

7.07

7.7

8.9

1.19

0.91

mmol/l

0.66

240

1813

Diseases of external ear

2265

20249

1.13

7.05

7.1

7.9

0.84

0.89

mmol/l

0.24

1888

16740

Other and unspecified medical devices associated with adverse incidents

231

2.57

7.03

10.8

8.5

0.17

0.86

mmol/l

0.83

200

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

943

7911

1.22

7.02

8.6

8.7

0.61

0.83

mmol/l

0.96

781

6515

Disorders of conjunctiva

5251

37718

1.09

7.02

8.1

7.9

0.87

0.90

mmol/l

0.24

4414

31094

Juvenile rheumatoid arthirtis

542

1.86

7.01

9.4

11.6

1.15

1.01

mmol/l

0.10

442

Polyarteritis nodosa and related conditions

512

1.93

7.01

6.9

9.2

0.94

0.82

mmol/l

0.09

425

Temporal arteritis

253

1812

1.48

6.99

7.4

6.7

0.82

0.96

mmol/l

0.25

212

1491

Injury of muscle and tendon at shoulder and upper arm level

2433

21869

1.13

6.98

7.2

8.4

0.97

0.86

mmol/l

0.89

2029

18231

Hereditary hypogammaglobulinemia

113

3.27

6.97

9.5

13.4

0.58

1.09

mmol/l

0.19

Contact with sharp object, undetermined intent

139

875

1.68

6.95

11.7

10.7

0.29

0.70

mmol/l

0.64

122

744

Cystic fibrosis

4.14

6.95

8.7

9.8

0.96

0.14

mmol/l

0.43

Lumbosacral plexus disorders

114

3.31

6.94

4.7

7.8

1.24

1.00

mmol/l

0.12

Superficial injuries involving multiple body regions

152

979

1.64

6.90

10.4

9.2

0.84

0.94

mmol/l

0.10

125

810

Ulcerative colitis (strict definition, require KELA)

872

7277

1.22

6.89

8.4

8.6

0.67

0.82

mmol/l

0.57

721

5980

L04AC Interleukin inhibitors

331

2462

1.39

6.89

9.2

9.3

0.80

0.93

mmol/l

0.27

288

2034

Disorder of pancreatic internal secretion, other and/or unspecified

263

2.36

6.88

7.5

10.0

0.92

0.76

mmol/l

0.09

227

Malignant neoplasm of other and unspecified parts of mouth

252

2.45

6.88

12.4

6.5

0.63

1.32

mmol/l

1.10

213

Crohn disease (strict definition, require KELA, min 2 HDR)

308

2266

1.40

6.85

9.6

8.9

0.14

0.87

mmol/l

2.34

252

1862

Certain zoonotic bacterial diseases, including avohilmo

184

1241

1.57

6.84

7.4

8.3

1.35

0.94

mmol/l

0.91

142

1026

Microscopic polyangiitis

267

2.42

6.84

6.5

11.1

-0.08

1.07

mmol/l

1.30

232

Dementia due to Parkinsons disease, excluding more controls

159

1042

1.63

6.81

4.3

6.4

1.75

0.74

mmol/l

3.52

133

845

Seronegative juvenile rheumatoid arthritis

388

2.01

6.81

10.6

10.5

-0.05

0.72

mmol/l

0.64

317

Haemolytic-uraemic syndrome

4.09

6.80

30.8

10.9

0.53

0.78

mmol/l

0.10

Pulmonary eosinophilia, not elsewhere classified

498

1.96

6.80

6.5

7.8

1.55

1.02

mmol/l

0.51

423

Malignant neoplasm of base of tongue

233

2.48

6.78

11.4

8.4

1.31

1.16

mmol/l

0.11

196

Unspecified/other endometriosis

355

2607

1.36

6.77

5.0

7.7

0.68

0.71

mmol/l

0.05

277

2109

Pectus excavatum

3.25

6.76

5.6

17.9

2.01

0.64

mmol/l

0.85

Other disorders of penis

637

5174

1.27

6.76

9.6

0.68

0.71

mmol/l

0.05

531

4297

Astigmatism

326

2425

1.39

6.73

14.6

8.8

0.85

0.75

mmol/l

0.20

290

1977

Chronic Coagulation defects

120

734

1.73

6.70

10.9

9.3

0.98

0.91

mmol/l

0.07

100

605

Erythema multiforme

141

903

1.66

6.67

7.1

8.0

1.64

0.99

mmol/l

1.14

116

750

Crohn disease (strict definition, require KELA)

312

2311

1.39

6.66

9.5

8.9

0.14

0.87

mmol/l

2.41

255

1898

Hyperhidrosis

141

895

1.64

6.64

5.9

7.9

0.56

0.64

mmol/l

0.10

117

742

Other bursitis of elbow

409

2.07

6.63

8.7

7.0

1.66

0.89

mmol/l

0.60

333

Dental pulpitis, including avohilmo

5640

33624

1.08

6.63

8.1

8.5

0.84

0.85

mmol/l

0.04

4647

27901

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

521

1.89

6.62

10.3

7.3

0.99

1.09

mmol/l

0.11

428

Recurrent dislocation and subluxation of joint

317

2353

1.38

6.61

8.0

9.2

0.97

0.94

mmol/l

0.06

265

1932

Unspecified visual impairment (binocular)

581

1.84

6.60

8.9

10.3

0.42

1.14

mmol/l

0.76

492

Chondrosarcoma

112

3.29

6.57

8.8

9.0

0.34

1.32

mmol/l

0.97

Giant cell arteritis with polymyalgia rheumatica

253

1833

1.46

6.57

7.4

6.8

0.82

1.02

mmol/l

0.39

212

1514

Other rupture of muscle

207

2.47

6.57

7.8

8.5

1.57

1.05

mmol/l

0.43

170

Tuberculosis of other organs

144

934

1.66

6.57

6.5

7.9

0.99

1.20

mmol/l

0.24

122

757

Malignant neoplasm of larynx

113

691

1.77

6.56

11.2

7.2

2.12

0.99

mmol/l

1.66

567

Nonsuppurative otitis media

1061

7821

1.19

6.56

10.2

8.2

0.66

0.70

mmol/l

0.10

861

6247

Tuberculosis of other organs, strict, including avohilmo

162

1078

1.61

6.54

6.4

7.5

0.93

1.13

mmol/l

0.25

137

870

Dementia

3268

20408

1.11

6.54

5.2

6.9

1.27

0.94

mmol/l

4.34

2600

16924

Contusion of toe(s) without damage to nail

131

823

1.67

6.53

8.5

8.9

0.76

0.81

mmol/l

0.04

110

681

Listeriosis, including avohilmo

191

2.62

6.53

21.7

7.0

0.67

1.18

mmol/l

0.32

167

Myopia

591

4764

1.26

6.53

11.6

8.3

0.84

0.72

mmol/l

0.33

488

3880

Other abnormal immunological findings in serum

109

657

1.76

6.48

11.2

8.7

0.60

0.74

mmol/l

0.11

552

Drug-induced tremor

278

2.31

6.48

5.2

8.1

1.55

0.92

mmol/l

0.57

242

Myeloid leukaemia

181

1236

1.56

6.47

9.6

8.3

1.21

1.03

mmol/l

0.23

146

1014

Molar incisor enamel hypoplasia

128

760

1.66

6.46

25.5

12.8

-0.87

0.11

mmol/l

1.82

108

617

Macular pucker

1102

9478

1.19

6.45

7.5

7.4

0.82

1.02

mmol/l

0.96

926

7861

Hyperkinetic disorders (excl. ADHD)

403

1.94

6.45

7.2

12.4

0.52

0.34

mmol/l

0.17

343

Hordeolum and other deep inflammation of eyelid

328

2466

1.38

6.43

8.3

9.0

0.62

0.82

mmol/l

0.43

282

2031

Other and unspecified types of non-Hodgkin lymphoma, hilmo

277

2042

1.43

6.43

8.6

7.5

1.08

0.93

mmol/l

0.19

226

1670

Other disorders of the genitourinary system

741

6149

1.24

6.43

7.9

6.9

0.59

1.12

mmol/l

2.63

613

5132

Tuberculosis of other organs, strict

159

1058

1.60

6.42

6.5

7.5

0.96

1.13

mmol/l

0.20

135

853

Congenital deformities of hip, including avohilmo

505

1.85

6.41

8.7

10.0

-0.05

0.50

mmol/l

0.69

416

Disorders of synovium and tendon in diseases classified elsewhere

139

897

1.65

6.40

6.9

9.5

1.03

1.07

mmol/l

0.05

110

734

Malignant neoplasm of meninges, including Hilmo

137

2.96

6.40

6.9

6.3

2.01

1.85

mmol/l

0.11

121

Endometriosis

1652

8421

1.15

6.39

6.2

7.2

0.94

0.97

mmol/l

0.10

1330

6923

Horner syndrome

484

1.92

6.39

8.8

9.6

1.07

0.92

mmol/l

0.12

416

Malignant neoplasm of vulva

383

2.05

6.37

7.5

4.9

0.68

1.48

mmol/l

0.81

320

Disorders of orbit

239

1714

1.45

6.36

7.9

8.7

1.17

0.99

mmol/l

0.31

194

1422

Atrophic disorders of skin

844

7082

1.22

6.36

6.9

7.4

0.98

1.02

mmol/l

0.12

699

5938

Other and unspecified injuries of ankle and foot

205

1425

1.49

6.36

8.1

8.8

0.82

0.88

mmol/l

0.10

176

1175

Pediculosis, acariasis and other infestations, including avohilmo

838

7020

1.21

6.32

8.6

0.83

0.77

mmol/l

0.17

707

5727

Pectus excavatum, including avohilmo

117

2.92

6.31

5.2

16.4

2.02

0.55

mmol/l

1.05

Hypersplenism

169

2.72

6.30

10.4

0.98

1.25

mmol/l

0.15

144

Pleural plaque without asbestos

269

1987

1.44

6.29

7.5

6.8

1.67

0.91

mmol/l

1.73

232

1622

Other osteochondrodysplasias, including avohilmo

404

1.99

6.29

8.4

9.5

1.15

0.98

mmol/l

0.16

350

Other injuries of upper limb, level unspecified

463

1.92

6.28

12.3

9.4

0.96

0.68

mmol/l

0.33

387

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

257

1872

1.43

6.28

6.3

9.1

1.28

0.97

mmol/l

0.67

209

1552

Malignant neoplasm of accessory sinuses, including Hilmo

162

2.71

6.28

8.3

7.5

0.93

1.26

mmol/l

0.15

138

Certolizumab pegol

481

1.86

6.25

11.2

8.9

0.08

0.72

mmol/l

0.72

399

Combined immunodeficiencies

385

2.03

6.23

11.0

9.2

1.67

0.77

mmol/l

1.20

321

Other abnormal uterine and vaginal bleeding

1217

7541

1.18

6.22

6.6

7.0

1.25

1.05

mmol/l

0.97

1012

6272

Delivery

1735

10340

0.87

6.22

6.3

7.0

1.05

1.02

mmol/l

0.14

1433

8606

Hallux rigidus

818

6870

1.22

6.20

7.3

8.0

0.87

1.07

mmol/l

0.79

690

5711

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

470

1.89

6.20

11.6

10.6

1.46

0.81

mmol/l

0.76

388

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

184

2.66

6.20

10.9

7.3

1.07

1.10

mmol/l

0.02

148

Anti-inflammatory and antirheumatic products, non-steroids

1841

8187

1.14

6.19

8.0

8.8

0.80

0.90

mmol/l

0.51

1502

6610

Certain conditions originating in the perinatal period

276

1788

1.40

6.18

14.0

11.3

-0.15

0.36

mmol/l

1.02

224

1415

Toxic effect of other gases, fumes and vapours

194

2.50

6.18

7.7

13.6

1.47

1.00

mmol/l

0.30

162

Congenital musculoskeletal deformities of head, face, spine and chest

319

2.09

6.18

5.8

10.9

1.42

0.46

mmol/l

1.12

267

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

466

1.91

6.16

11.7

8.3

0.48

0.89

mmol/l

0.35

382

Iliotibial band syndrome

341

2.05

6.16

9.0

8.1

1.11

0.89

mmol/l

0.19

292

Injury of muscle and tendon at forearm level

114

708

1.72

6.15

8.1

10.7

0.50

0.83

mmol/l

0.39

601

Pustular psoriasis

261

1913

1.42

6.14

7.0

8.6

1.17

1.02

mmol/l

0.23

226

1589

Propionic acid derivatives

1839

8185

1.14

6.11

7.8

8.8

0.82

0.90

mmol/l

0.37

1500

6608

Personality and behavioural disorders due to brain disease, damage and dysfunction

595

1.80

6.11

9.7

2.54

0.83

mmol/l

3.72

501

Carrier of infectious disease

134

864

1.64

6.10

8.5

8.6

0.40

0.83

mmol/l

0.68

115

710

Female infertility, associated with anovulation

234

1669

1.43

6.09

7.4

7.6

1.09

0.32

mmol/l

2.37

170

1290

Preterm labour and delivery

1093

9390

1.18

6.08

7.0

7.6

1.14

0.98

mmol/l

0.71

880

7812

Deficiency of other B group vitamins

132

852

1.65

6.07

9.7

7.6

0.51

1.03

mmol/l

0.60

114

695

Unspecified protein-energy malnutrition

251

2.33

6.07

11.6

9.0

1.31

1.19

mmol/l

0.06

200

Injury of nerves at wrist and hand level

212

1503

1.47

6.05

10.0

9.9

0.58

0.93

mmol/l

0.71

183

1250

Contact with sharp glass

189

1308

1.50

6.05

11.0

10.2

0.64

0.77

mmol/l

0.17

169

1089

Temporomandibular joint disorders, including avohilmo

2237

19490

1.12

6.05

6.2

7.9

0.98

0.82

mmol/l

1.26

1800

16011

Panniculitis, unspecified

374

2.01

6.04

7.2

8.9

1.27

1.28

mmol/l

0.01

310

Fenamates

887

5092

1.21

6.01

6.5

8.7

0.83

0.99

mmol/l

0.54

732

4149

Histrionic personality disorder

172

2.62

6.00

4.1

7.6

1.65

1.05

mmol/l

0.54

145

Mucinous and mucinous cystic tumor, including Hilmo

203

2.42

5.99

8.9

5.5

0.79

1.72

mmol/l

0.88

175

Blindness, monocular

392

2.00

5.97

7.8

8.6

0.59

1.17

mmol/l

0.62

333

Wide developmental disorders, excluding more controls

544

1.75

5.97

6.1

10.4

0.74

-0.11

mmol/l

1.23

438

Bitten or struck by other mammals

550

4452

1.26

5.94

10.6

8.3

0.71

0.80

mmol/l

0.23

461

3633

Other and unspecified iridocyclitis

268

1983

1.41

5.94

7.1

8.7

0.49

0.88

mmol/l

0.80

208

1637

Bicipital tendinitis

285

2132

1.39

5.91

7.3

9.1

0.75

0.94

mmol/l

0.39

243

1766

Other lack of coordination

110

687

1.72

5.88

5.0

9.3

0.89

1.03

mmol/l

0.15

571

Disorders of globe

165

1127

1.55

5.88

6.1

7.3

1.69

1.05

mmol/l

0.95

128

923

SLE, ICD10

178

1229

1.52

5.88

6.8

7.9

0.36

1.07

mmol/l

1.07

149

1020

SLE, strict definition

178

1229

1.52

5.88

6.8

7.9

0.36

1.07

mmol/l

1.07

149

1020

Etanercept

320

2429

1.36

5.87

10.9

9.1

1.00

0.87

mmol/l

0.23

270

2006

Torticollis

484

1.84

5.87

7.6

9.7

0.77

0.89

mmol/l

0.08

407

Conjunctivitis

4547

34008

1.08

5.86

8.0

7.9

0.82

0.92

mmol/l

0.90

3813

28058

Primary ovarian failure

453

1.85

5.86

10.0

7.6

0.38

0.92

mmol/l

0.50

361

Other facial nerve disorders

162

1100

1.55

5.85

5.5

9.5

1.17

0.92

mmol/l

0.33

119

909

Lumbosacral root disorders, not elsewhere classified

460

1.90

5.84

5.6

8.1

1.55

1.02

mmol/l

0.58

382

Postprocedural disorders of ear and mastoid process, not elsewhere classified

376

2.05

5.84

7.0

7.3

2.74

0.99

mmol/l

3.19

312

Prepatellar bursitis

279

2086

1.39

5.84

7.3

9.5

0.39

0.87

mmol/l

1.23

235

1714

Excessive attrition of teeth

3573

32602

1.09

5.81

7.9

8.3

0.88

0.85

mmol/l

0.15

2971

27000

Defects in the complement system

212

2.35

5.81

10.2

9.0

1.62

0.83

mmol/l

0.72

171

Injury of blood vessels at hip and thigh level

152

2.83

5.80

15.5

7.4

1.57

0.86

mmol/l

0.66

129

Peptic ulcer

380

1.99

5.80

8.0

6.6

0.35

1.05

mmol/l

0.68

316

Migraine without aura, drug-induced

306

2.07

5.79

5.0

9.9

1.44

1.04

mmol/l

0.30

257

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

327

2494

1.35

5.79

9.3

8.7

0.13

0.87

mmol/l

2.51

265

2043

Other acquired deformities of musculoskeletal system and connective tissue

259

1917

1.41

5.78

10.3

8.8

1.45

0.92

mmol/l

1.79

212

1595

Other osteochondrodysplasias

266

2.18

5.77

9.5

10.8

1.40

1.06

mmol/l

0.27

231

Contact with other hot metals

581

1.77

5.77

9.6

10.0

1.42

0.76

mmol/l

0.76

495

Vasomotor and allergic rhinitis

1974

17289

1.13

5.76

7.7

8.3

0.85

0.77

mmol/l

0.47

1613

14222

Dementia in other diseases classified elsewhere

305

2319

1.37

5.76

6.0

7.0

1.26

0.94

mmol/l

0.57

251

1894

Atypical mycobacterium lung infection

486

1.87

5.73

8.7

7.9

2.79

0.97

mmol/l

3.31

401

Cholesteatoma of external ear

349

2.07

5.71

5.5

8.2

1.92

0.78

mmol/l

1.36

292

Mesothelioma, including Hilmo

579

1.79

5.71

8.4

6.7

1.77

1.00

mmol/l

1.30

476

Use of antiglaucoma preparations and miotics

516

4188

1.27

5.71

6.9

6.3

0.58

1.07

mmol/l

1.90

413

3417

Respiratory tuberculosis, confirmed

121

779

1.66

5.70

8.8

7.5

1.12

1.03

mmol/l

0.09

106

628

Essential (haemorrhagic) thrombocythaemia

210

1506

1.46

5.68

7.5

7.0

0.65

1.09

mmol/l

0.72

171

1241

Pustulosis palmaris et plantaris

232

1691

1.43

5.68

6.9

8.7

1.21

1.05

mmol/l

0.22

199

1404

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

221

1601

1.45

5.67

6.6

7.3

1.22

0.98

mmol/l

0.33

180

1317

Chondropathies

790

6663

1.21

5.67

7.3

8.5

0.74

0.87

mmol/l

0.42

660

5477

Nasal polyp

1197

10443

1.17

5.66

7.2

8.2

1.09

0.80

mmol/l

1.91

964

8629

Pedestrian injured in collision with car, pick-up truck or van

144

962

1.58

5.66

8.5

7.6

0.27

1.02

mmol/l

1.08

114

796

Haemangioma and lymphangioma, any site

495

3994

1.27

5.66

6.6

8.1

0.89

mmol/l

0.00

404

3295

Respiratory tuberculosis, bacteriologically and histologically confirmed

124

804

1.64

5.65

8.7

7.4

1.13

1.01

mmol/l

0.13

109

650

Urethritis and urethral syndrome

123

793

1.64

5.64

6.9

9.2

1.40

0.84

mmol/l

0.81

113

657

Other chondrocalcinosis

102

638

1.76

5.63

3.8

8.4

1.48

1.05

mmol/l

0.44

532

Other drug-induced secondary parkinsonism

446

1.92

5.62

5.4

10.1

2.67

0.96

mmol/l

1.99

377

Mantle cell lymphoma

424

1.95

5.62

9.8

6.9

1.07

1.10

mmol/l

0.02

347

Hyposplenism

4.15

5.62

20.4

16.7

-0.19

0.58

mmol/l

0.25

Benign neoplasm: Peripheral nerves and autonomic nervous system

104

649

1.73

5.61

9.3

9.6

1.25

0.96

mmol/l

0.35

542

Melanocytic naevi, other sites/unspecified

450

3595

1.29

5.61

7.4

8.5

0.75

0.86

mmol/l

0.25

361

2965

Exposure to ignition or melting of other clothing and apparel

105

3.22

5.60

11.5

7.9

2.13

0.81

mmol/l

0.77

Polyhydramnios

165

1126

1.51

5.58

6.2

7.1

1.03

0.47

mmol/l

1.22

117

885

Abscess of mediastinum

3.70

5.58

45.9

7.6

0.52

1.26

mmol/l

0.33

Fitting and adjustment of other devices

1941

18996

0.89

5.57

5.9

6.8

1.27

0.91

mmol/l

3.86

1507

15683

Superficial injury of neck

598

1.72

5.56

8.0

9.6

1.36

0.73

mmol/l

1.04

483

Disorders of adrenal gland, other and/or unspecified

191

2.44

5.56

11.6

7.5

1.21

1.14

mmol/l

0.04

156

Exposure to other and unspecified animate mechanical forces

151

1018

1.54

5.56

8.2

9.4

1.00

0.80

mmol/l

0.25

130

852

Arthropathy in ulcerative colitis

443

1.87

5.55

7.4

10.5

0.81

0.88

mmol/l

0.06

370

Chromosomal abnormalities, not elsewhere classified

566

1.74

5.54

17.3

12.6

0.59

0.56

mmol/l

0.03

465

Hypoplasia of dental enamel , including avohilmo

119

727

1.62

5.54

21.7

13.3

-0.85

0.04

mmol/l

1.44

100

592

Other disorders of bone density and structure

131

859

1.60

5.54

6.6

9.0

0.71

0.91

mmol/l

0.27

106

716

Disorders of aromatic amino-acid metabolism

3.18

5.53

3.6

6.9

0.81

0.86

mmol/l

0.02

Supervision of normal pregnancy

495

3514

0.79

5.52

5.4

8.7

0.42

0.71

mmol/l

1.16

393

2867

Presbycusis

1031

8815

1.18

5.52

5.5

6.2

0.96

0.99

mmol/l

0.10

827

7140

Diseases of middle ear and mastoid

3207

24066

1.10

5.51

8.5

8.0

0.72

0.83

mmol/l

0.76

2573

19702

Special screening examination for infectious and parasitic diseases

972

6056

1.18

5.50

10.1

8.4

-0.26

0.64

mmol/l

9.37

864

4998

Personal history of allergy to drugs, medicaments and biological substances

355

1.96

5.50

8.3

1.44

1.00

mmol/l

0.31

294

Dislocation, sprain and strain of joints and ligaments of head

188

1324

1.47

5.50

7.9

9.0

1.18

0.77

mmol/l

0.92

156

1088

Mixed connective tissue disease

102

635

1.71

5.48

6.6

8.4

0.55

0.99

mmol/l

0.47

528

Hypermetropia

370

2891

1.31

5.47

7.3

8.3

0.85

0.83

mmol/l

0.02

300

2359

Other/unspecified soft tissue disorders related to use, overuse and pressure

161

1106

1.52

5.47

8.3

9.6

0.93

0.99

mmol/l

0.06

136

926

Other injuries of spine and trunk, level unspecified

344

2.01

5.47

12.2

7.6

0.90

0.97

mmol/l

0.04

292

Burns and corrosions of multiple body regions

322

2.04

5.46

10.6

10.0

1.73

0.60

mmol/l

1.79

280

Unspecified renal colic

219

2.32

5.46

7.6

7.5

0.94

0.88

mmol/l

0.04

178

271

2019

1.36

5.46

9.6

7.3

-0.48

0.42

mmol/l

2.96

234

1548

Embolism and thrombosis of abdominal aorta

3.56

5.46

15.0

5.8

1.58

1.02

mmol/l

0.23

Hyperprolactinaemia

145

972

1.55

5.45

9.4

1.38

0.79

mmol/l

1.27

121

786

Von Willebrand disease

341

1.97

5.44

5.6

7.8

0.89

1.07

mmol/l

0.12

287

Malignant neoplasm of nasal cavity and middle ear

187

2.46

5.43

6.8

7.8

0.81

1.02

mmol/l

0.10

163

264

2.11

5.42

6.7

10.4

1.00

0.81

mmol/l

0.12

212

Nonalcoholic steatohepatitis

323

2.03

5.42

8.8

10.3

0.49

0.92

mmol/l

0.32

271

Urethral stricture

383

3027

1.31

5.41

7.1

8.4

0.77

0.91

mmol/l

0.29

312

2474

Traction detachment of retina

332

2.03

5.39

11.1

8.8

-0.46

1.00

mmol/l

1.57

275

Other hereditary haemolytic anaemias

213

2.31

5.38

7.0

8.9

0.87

0.79

mmol/l

0.04

180

Hypogonadotropic hypogonadism

171

1194

1.50

5.38

7.0

11.0

1.33

0.83

mmol/l

1.12

148

1010

Injury of nerves at forearm level

470

1.83

5.38

7.7

9.3

0.42

0.65

mmol/l

0.17

386

Listeriosis

188

2.44

5.36

21.0

6.6

1.25

1.11

mmol/l

0.08

164

Other/unspecified enthesopathies, not elsewhere classified

477

3858

1.27

5.36

6.8

8.0

0.61

1.01

mmol/l

1.46

390

3146

Congenital iodine-deficiency syndrome/hypothyroidism

163

1131

1.51

5.32

8.3

6.3

1.38

1.10

mmol/l

0.37

132

925

Other or unspecified common variable immunodeficiency

106

2.98

5.32

7.7

12.7

-0.61

1.35

mmol/l

1.33

Cerebral arteritis

3.30

5.32

5.8

6.8

-0.30

0.91

mmol/l

1.02

Lichen planus

771

6543

1.21

5.31

7.0

7.7

1.03

1.01

mmol/l

0.05

619

5415

Atopic conjunctivitis

216

1570

1.42

5.30

6.0

9.2

1.49

0.73

mmol/l

2.26

179

1284

Malignant neoplasm of oropharynx

109

699

1.68

5.30

10.7

8.8

1.28

1.14

mmol/l

0.18

587

Polycythaemia vera

203

1469

1.45

5.30

7.9

7.3

0.70

1.05

mmol/l

0.46

159

1215

Respiratory tuberculosis, confirmed, including avohilmo

122

801

1.62

5.29

8.8

7.4

1.16

1.01

mmol/l

0.16

107

646

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

174

1220

1.48

5.28

7.7

8.9

0.93

0.90

mmol/l

0.04

151

1011

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

359

1.92

5.27

5.6

10.5

1.46

0.47

mmol/l

1.25

301

Other bursitis of hip

129

857

1.59

5.27

7.6

6.7

0.84

1.21

mmol/l

0.54

115

707

Other and unspecified diseases of spleen

150

2.61

5.26

10.6

8.3

0.60

1.17

mmol/l

0.46

126

Cardiovascular devices associated with adverse incidents

5.11

5.25

26.0

8.9

0.91

0.82

mmol/l

0.03

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

132

2.77

5.25

6.3

13.8

0.22

0.81

mmol/l

0.42

114

Haemangioma, any site

464

3753

1.27

5.24

6.7

8.1

0.94

0.87

mmol/l

0.13

379

3093

Tuberous sclerosis 1

4.15

5.23

7.6

11.9

0.14

1.71

mmol/l

0.92

Special screening examination for other diseases and disorders

608

5037

1.23

5.23

9.7

7.3

1.08

0.69

mmol/l

1.93

474

4203

Cysts of oral region, not elsewhere classified

334

2602

1.33

5.22

8.5

9.1

0.69

0.86

mmol/l

0.37

281

2171

Effects of heat and light

307

2.06

5.22

10.6

9.0

0.70

1.01

mmol/l

0.18

254

Inflammatory diseases of prostate (prostatitis)

859

7372

1.19

5.22

7.5

9.1

1.11

0.71

mmol/l

2.78

702

6151

Pyogenic granuloma

102

643

1.68

5.21

6.2

8.3

1.25

0.92

mmol/l

0.31

537

Malignant neoplasm of ureter

121

2.90

5.19

9.1

6.5

-1.79

1.24

mmol/l

2.62

103

Restrictive cardiomyopathy

153

2.67

5.19

24.1

8.8

0.65

0.97

mmol/l

0.13

131

Torsion of ovary, ovarian pedicle and fallopian tube

616

1.67

5.19

4.7

7.4

0.70

0.98

mmol/l

0.37

505

Muscular dystrophy

293

2.07

5.18

4.5

10.9

1.11

0.71

mmol/l

0.27

259

Burn and corrosion of hip and lower limb, except ankle and foot

132

883

1.57

5.18

15.6

9.6

1.10

0.84

mmol/l

0.38

111

732

Other disorders of pigmentation

262

1978

1.38

5.17

6.2

7.8

1.16

0.94

mmol/l

0.54

211

1638

Other primary thrombocytopenia

132

2.70

5.17

7.5

12.6

0.22

1.30

mmol/l

0.49

110

Myelodysplastic syndrome

587

1.74

5.16

7.7

5.8

0.92

1.14

mmol/l

0.18

477

Alzheimer’s disease (undefined)

404

0.28

5.14

1.6

4.5

4.17

1.32

mmol/l

—

304

Secondary malignant neoplasm of other and unspecified sites

125

834

1.61

5.13

5.7

7.1

2.26

1.10

mmol/l

2.75

693

Traumatic cerebral oedema

3.12

5.11

13.0

6.4

1.18

0.16

mmol/l

0.48

Inflammatory disorders of breast

262

1971

1.36

5.10

7.6

7.1

0.93

0.82

mmol/l

0.19

209

1583

Abscess of external ear

485

1.79

5.09

7.9

9.3

0.55

0.86

mmol/l

0.22

405

Benign neoplasm: Other and unspecified parts of mouth

200

1455

1.44

5.09

7.7

8.2

1.19

1.03

mmol/l

0.23

169

1210

Rheumatic valve diseases

141

962

1.55

5.09

10.7

6.3

0.80

1.03

mmol/l

0.26

111

773

Thyroiditis

353

2774

1.31

5.08

8.1

7.6

1.27

0.99

mmol/l

0.75

298

2274

Folate deficiency anaemia

451

1.84

5.07

9.9

8.7

1.52

1.05

mmol/l

0.26

373

Other specified and unspecified strabismus

395

1.87

5.07

7.8

8.1

1.48

0.65

mmol/l

0.95

331

Cardiomyopathy due to drugs and other external agents

3.36

5.06

4.6

8.0

1.63

1.29

mmol/l

0.16

Use of levodopa decarbox-comt-inhibitor

222

1651

1.42

5.05

4.2

7.5

1.69

0.89

mmol/l

3.07

192

1342

Superficial frostbite

246

2.16

5.04

9.0

11.4

0.49

0.95

mmol/l

0.25

203

Sequelae of other and unspecified infectious and parasitic diseases

269

2042

1.36

5.04

9.2

8.9

0.95

mmol/l

0.01

226

1680

Injury of nerves at lower leg level

360

1.93

5.04

14.7

8.2

0.17

1.09

mmol/l

0.81

299

Ankylosing spondylitis, ICD10

459

3725

1.26

5.02

7.7

8.9

0.90

0.89

mmol/l

0.02

382

3063

Other and unspecified bullous disorders

421

1.86

5.02

7.4

7.9

0.94

0.95

mmol/l

0.01

357

UC patients in KELA-register (code 208), prior to 1994

252

1904

1.38

5.02

10.2

8.6

0.49

0.98

mmol/l

1.03

204

1576

Juvenile cataract

121

2.71

5.00

6.3

14.7

0.07

1.10

mmol/l

0.95

Eosinophilia

102

653

1.67

4.99

9.9

9.3

1.13

1.07

mmol/l

0.05

538

Guillain-Barre syndrome

103

661

1.67

4.99

14.5

8.0

1.59

0.77

mmol/l

1.30

551

Granulomatous disorders of skin and subcutaneous tissue

138

938

1.54

4.99

8.1

1.22

0.94

mmol/l

0.38

116

774

Other degenerative diseases of the basal ganglia

140

967

1.56

4.97

6.6

7.9

1.60

0.91

mmol/l

1.16

127

802

Malignant neoplasm of gallbladder, including Hilmo

284

2.08

4.97

6.8

7.0

0.88

1.35

mmol/l

0.52

235

Alzheimer disease

2486

16263

1.11

4.96

4.4

6.4

1.22

0.98

mmol/l

1.98

1928

13259

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

271

2065

1.35

4.95

9.4

8.9

0.99

0.96

mmol/l

0.04

228

1698

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

4.00

4.95

47.9

10.7

0.89

1.21

mmol/l

0.08

Other/unspecified postprocedural disorders of ear and mastoid process

138

2.77

4.93

8.5

8.3

2.48

0.48

mmol/l

2.51

116

Injury of muscle and tendon at hip and thigh level

560

4648

1.23

4.92

8.9

8.7

0.76

0.87

mmol/l

0.31

474

3838

Fibrosarcoma, including Hilmo

328

1.98

4.90

5.1

7.5

0.77

1.29

mmol/l

0.55

280

Orthopaedic devices associated with adverse incidents

891

0.51

4.90

4.9

7.1

1.08

1.05

mmol/l

0.02

750

Other and unspecified disorders of binocular movement

180

2.34

4.90

9.5

11.3

0.14

0.73

mmol/l

0.42

151

Otorrhagia

315

2.02

4.90

11.2

8.3

0.87

mmol/l

0.00

263

Tongue abnormality

354

2806

1.31

4.88

6.4

7.8

1.31

1.03

mmol/l

0.68

297

2318

Chronic myeloid leukaemia

189

2.35

4.86

9.2

6.9

0.29

1.18

mmol/l

0.46

158

Foreign body or object entering through skin

328

2571

1.31

4.86

9.9

9.2

0.65

0.81

mmol/l

0.30

285

2128

Malignant neoplasm of tonsil, including Hilmo

110

722

1.63

4.86

10.8

8.5

1.15

1.20

mmol/l

0.05

101

602

Retinal detachment with retinal break

822

7075

1.19

4.83

7.9

7.8

0.50

0.97

mmol/l

2.79

685

5795

Frostbite with tissue necrosis

112

2.82

4.82

13.4

14.6

-0.62

0.78

mmol/l

0.46

Motorcycle rider injured in noncollision transport accidents

149

1034

1.50

4.82

8.1

11.1

0.75

0.69

mmol/l

0.07

120

875

Open wound of wrist and hand

2715

24128

1.10

4.80

9.1

8.6

0.69

0.80

mmol/l

0.77

2264

19939

Carcinoma in situ of skin of other and unspecified parts of face

606

5100

1.23

4.79

6.3

6.1

0.26

1.03

mmol/l

4.30

512

4118

Haemophagocytic lymphohistiocytosis

4.05

4.78

7.4

17.7

-0.13

1.03

mmol/l

0.64

Lagophthalmos

560

1.72

4.77

10.3

6.7

1.80

0.93

mmol/l

1.66

468

Hypersensitivity angiitis

212

2.27

4.76

11.6

10.2

-0.42

1.01

mmol/l

1.12

179

Contact with hot air and gases

245

2.13

4.75

10.4

7.7

0.35

0.91

mmol/l

0.44

210

Other dermatomyositis

170

2.39

4.75

11.1

8.3

2.72

0.75

mmol/l

1.15

139

All dysplastic lesions of the cervix uteri, vagina or vulva

1120

9578

1.15

4.74

7.4

7.2

0.83

0.79

mmol/l

0.12

901

7758

Contusion of ankle

193

1405

1.42

4.73

10.1

8.8

1.37

0.92

mmol/l

0.80

164

1160

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

752

6431

1.19

4.73

7.2

8.2

0.92

0.95

mmol/l

0.08

624

5302

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

236

1783

1.38

4.72

9.2

8.9

1.11

0.96

mmol/l

0.26

196

1470

Sequelae of inflammatory diseases of the central nervous system

107

2.84

4.71

3.8

8.4

0.88

0.87

mmol/l

0.00

Exposure to other and unspecified man-made environmental factors

102

659

1.63

4.71

7.1

10.2

0.37

0.82

mmol/l

0.62

552

Benign neoplasm: Skin of eyelid, including canthus

931

8100

1.17

4.70

7.1

7.4

1.04

1.00

mmol/l

0.13

773

6687

Thyrotoxicosis with diffuse goitre

688

5834

1.20

4.70

7.6

0.97

mmol/l

0.01

562

4826

Other congenital malformations of intestine

295

1.99

4.70

10.4

12.2

0.20

0.72

mmol/l

0.41

257

Melanocytic naevi of upper limb, including shoulder

130

886

1.54

4.70

8.3

8.5

0.43

0.93

mmol/l

0.64

106

729

Myeloproliferative diseases (CML excluded)

456

3737

1.26

4.69

8.1

7.4

0.93

0.98

mmol/l

0.09

374

3079

Other acute skin changes due to ultraviolet radiation

198

1457

1.42

4.69

6.5

8.1

0.74

1.01

mmol/l

0.37

162

1199

Prolonged pregnancy

313

3415

0.77

4.67

5.2

8.1

0.22

0.47

mmol/l

0.53

237

2698

Erythema nodosum

155

1093

1.48

4.67

7.3

7.6

1.09

1.05

mmol/l

0.05

138

906

Dementia, including avohilmo

3469

21998

1.09

4.66

5.3

7.1

1.25

0.96

mmol/l

3.73

2773

18264

Henoch-Schönlein purpura nephritis (HSPN)

126

2.64

4.65

7.7

13.9

-1.25

0.87

mmol/l

1.09

100

Malignant neoplasm, without specification of site

202

1493

1.41

4.65

5.6

6.1

0.98

1.14

mmol/l

0.23

163

1208

Oligomenorrhoea

141

972

1.49

4.65

6.9

7.9

0.15

0.92

mmol/l

1.42

117

789

Other and unspecified haemorrhagic conditions

608

1.66

4.64

10.5

7.8

0.30

0.83

mmol/l

0.37

508

Pedal cyclist injured in noncollision transport accidents

594

4983

1.22

4.63

9.2

8.6

1.05

0.85

mmol/l

0.58

499

4083

Ulcerative ileocolitis

192

1405

1.41

4.61

7.6

9.0

-0.19

0.91

mmol/l

2.67

155

1157

Malignant neoplasm of tonsil

627

1.66

4.61

11.0

8.6

1.29

1.20

mmol/l

0.11

524

Other superficial mycoses, including avohilmo

505

4170

1.23

4.61

7.6

8.5

0.80

0.73

mmol/l

0.18

424

3383

Chronic hepatitis NAS

485

1.75

4.61

11.8

8.8

-0.24

1.00

mmol/l

1.16

406

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

343

1.93

4.60

8.3

7.0

2.27

1.17

mmol/l

1.18

276

Drug-induced Cushing's syndrome

4.41

4.60

11.9

6.1

0.14

1.70

mmol/l

0.94

Sequelae of tuberculosis

119

803

1.57

4.59

6.7

6.1

2.88

1.13

mmol/l

3.83

106

639

Viral meningitis, including avohilmo

170

1219

1.44

4.59

8.5

9.9

0.51

0.83

mmol/l

0.45

142

1009

Osteomalacia

261

2.04

4.58

5.5

9.8

0.48

0.68

mmol/l

0.08

226

Pneumonia due to Haemophilus influenzae

120

2.63

4.58

9.9

5.3

4.02

0.42

mmol/l

2.80

100

Polycystic ovarian syndrome

165

1170

1.44

4.58

5.1

6.6

0.71

0.14

mmol/l

1.33

122

880

Mucinous and mucinous cystic tumor

139

2.49

4.57

11.3

5.3

0.76

1.37

mmol/l

0.43

120

Biological medicines for asthma

110

728

1.58

4.55

6.7

9.4

1.30

0.76

mmol/l

0.98

611

Sequelae of tuberculosis, including avohilmo

121

821

1.56

4.55

7.0

6.1

2.85

1.14

mmol/l

3.78

108

653

Demyelinating diseases of the central nervous system

374

2998

1.27

4.54

8.9

8.8

1.11

0.87

mmol/l

0.57

301

2456

Otitis media, unspecified

462

3479

1.24

4.54

11.0

9.2

0.89

0.68

mmol/l

0.50

370

2774

Other deformities of toe(s)

196

1447

1.41

4.52

5.9

8.8

0.71

0.97

mmol/l

0.42

160

1199

HSIL lesion of the cervix uteri, vagina or vulva

728

6211

1.19

4.52

7.5

7.2

0.75

0.74

mmol/l

0.04

578

4987

Infections with a predominantly sexual mode of transmission, including avohilmo

1738

14344

1.12

4.52

8.5

8.3

0.52

0.75

mmol/l

1.63

1441

11611

Macular hole

378

3057

1.28

4.50

6.2

7.1

0.79

0.99

mmol/l

0.44

324

2526

Calcific tendinitis of shoulder

296

2315

1.32

4.49

6.7

9.0

1.23

0.94

mmol/l

0.88

243

1930

Fasciculation

395

1.81

4.49

6.8

9.4

1.84

0.61

mmol/l

1.64

332

Acute myeloid leukaemia, helper endpoint

536

1.70

4.48

7.9

6.9

1.32

1.25

mmol/l

0.06

441

Acute myeloid leukaemia, including Hilmo

536

1.70

4.48

7.9

6.9

1.32

1.25

mmol/l

0.06

441

Acute myeloid leukaemia

536

1.70

4.48

7.9

6.9

1.32

1.25

mmol/l

0.06

441

Medullary cystic kidney disease, nephronophthisis

3.83

4.48

8.3

6.7

-3.23

1.60

mmol/l

3.34

Carcinoma in situ of skin of upper limb, including shoulder

189

1402

1.43

4.48

9.0

6.6

0.18

0.92

mmol/l

1.54

158

1142

Drug-induced systemic lupus erythematosus

222

2.14

4.47

9.4

6.6

-0.41

1.04

mmol/l

0.90

188

Benign neoplasm: Other/unspecified site

623

1.64

4.46

6.5

7.9

1.54

1.00

mmol/l

0.74

525

Disease of hard tissues of teeth, NOS

3541

17232

1.08

4.46

7.6

7.5

0.85

0.98

mmol/l

1.24

3011

14113

Multiple delivery

217

2873

0.74

4.46

7.6

8.3

0.56

0.80

mmol/l

0.38

184

2371

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

3.05

4.45

6.1

15.2

-1.76

0.95

mmol/l

1.25

Benign neoplasm: Tongue

166

1200

1.45

4.45

9.0

7.9

0.73

0.96

mmol/l

0.28

144

1001

Spasmodic torticollis

169

1222

1.44

4.45

5.4

7.9

1.35

0.99

mmol/l

0.60

138

1007

Eclampsia

3.56

4.44

10.4

7.3

0.46

1.47

mmol/l

0.64

Myositis ossificans

2.86

4.43

7.1

14.7

2.54

1.04

mmol/l

1.00

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

233

2.17

4.42

7.6

7.5

0.95

1.20

mmol/l

0.19

197

Systemic lupus erythematosus, unspecified

150

1063

1.47

4.42

7.1

8.2

0.52

1.02

mmol/l

0.57

122

885

Isolated growth hormone deficiency

153

2.33

4.41

11.3

18.7

-0.58

0.12

mmol/l

0.45

131

Additional codes for the location of defect, injury or illness

323

2564

1.30

4.41

8.2

8.9

1.15

0.92

mmol/l

0.51

266

2111

Dermatographic urticaria

307

2416

1.30

4.39

7.7

8.3

1.02

0.88

mmol/l

0.29

247

1983

Other autoimmune haemolytic anaemias

557

1.69

4.39

7.9

8.3

0.53

0.87

mmol/l

0.31

480

Carcinoma in situ of skin of trunk

236

1813

1.37

4.37

7.1

6.8

0.23

0.92

mmol/l

1.80

204

1476

Effects of other external causes

133

921

1.50

4.36

7.2

10.3

0.69

0.75

mmol/l

0.07

109

759

Hyperchylomicronaemia

3.25

4.34

10.7

4.8

2.04

1.08

mmol/l

0.50

Contact with other and unspecified heat and hot substances

246

2.05

4.32

9.0

9.2

1.41

0.75

mmol/l

0.50

209

Malignant neoplasm of testis, including Hilmo

641

1.61

4.32

9.6

10.8

0.74

0.96

mmol/l

0.31

524

Oral leukoplakia, including avohilmo

166

1207

1.44

4.31

7.3

9.3

1.49

1.00

mmol/l

0.91

127

1009

Sacrococcygeal disorders, not elsewhere classified

145

1024

1.47

4.30

8.8

8.2

1.23

0.98

mmol/l

0.38

122

863

Shoulder region

605

1.64

4.30

8.7

8.5

0.71

0.84

mmol/l

0.12

507

Golimumab

159

1141

1.44

4.30

9.8

9.9

0.52

0.85

mmol/l

0.41

135

947

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

746

6410

1.18

4.28

6.5

6.9

0.99

0.81

mmol/l

0.69

613

5205

Lesion of sciatic nerve

267

2083

1.33

4.28

6.2

6.6

1.07

0.99

mmol/l

0.11

219

1694

Injury of muscle and tendon at lower leg level

870

7586

1.17

4.26

8.4

8.6

1.08

0.85

mmol/l

1.17

747

6263

Porphyria cutanea tarda

5.38

4.26

7.0

5.4

1.80

0.64

mmol/l

—

Malignant neoplasm of testis

548

1.66

4.25

10.5

11.4

0.76

1.11

mmol/l

0.48

452

Other inflammation of eyelid, including avohilmo

2425

22325

1.09

4.25

7.5

8.1

0.68

0.85

mmol/l

1.41

2006

18355

570

4821

1.21

4.25

12.9

8.3

0.09

0.87

mmol/l

2.30

445

3958

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

142

999

1.46

4.24

10.1

11.5

0.15

0.65

mmol/l

0.92

118

820

Marginal zone B-cell lymphoma

413

1.79

4.23

5.9

7.0

0.60

1.18

mmol/l

0.61

345

Benign neoplasm of eye and adnexa

623

5306

1.20

4.23

7.8

7.6

0.88

0.97

mmol/l

0.21

511

4357

Retinal haemorrhage

163

1187

1.44

4.22

11.9

7.5

0.86

1.13

mmol/l

0.43

136

960

Delivery, wide proxy

1480

8740

0.89

4.20

6.3

6.7

0.93

1.06

mmol/l

0.59

1200

7230

Crohn disease (strict definition, all UC cases excluded)

242

1860

1.34

4.20

10.4

8.6

0.05

0.84

mmol/l

1.94

200

1542

Other disorders of optic disc

497

1.69

4.17

9.2

10.1

0.74

0.88

mmol/l

0.11

425

Spinal osteochondrosis

374

1.80

4.15

7.6

10.4

1.26

0.83

mmol/l

0.54

321

Ulcer of vagina/vulva

130

907

1.49

4.14

7.9

6.6

0.83

0.93

mmol/l

0.12

104

755

L01XX Other antineoplastic agents

365

2969

1.27

4.14

8.4

7.5

0.52

1.02

mmol/l

1.30

295

2450

Ulcerative proctitis

301

2384

1.30

4.14

7.9

8.6

0.72

0.92

mmol/l

0.38

252

1955

Other disorders of cornea

554

4678

1.21

4.14

7.7

7.8

1.18

0.98

mmol/l

0.59

460

3873

Postmenopausal bleeding

1536

7233

1.13

4.12

6.5

7.2

1.22

1.13

mmol/l

0.37

1299

6092

Viral infections of central nervous system, not elsewhere classified/unspecified

375

1.80

4.12

6.9

9.3

1.82

0.80

mmol/l

1.76

316

L02BA Anti-estrogens

835

7275

1.17

4.11

5.6

7.0

0.67

1.13

mmol/l

3.13

720

6091

Autoimmune hepatitis

308

1.89

4.11

9.9

7.3

0.72

0.87

mmol/l

0.09

267

Spinal instabilities

138

977

1.47

4.10

7.0

10.0

1.07

1.15

mmol/l

0.09

117

831

Other and unspecified corneal deformities and disorders

178

1318

1.41

4.09

7.5

8.2

1.14

0.95

mmol/l

0.25

144

1105

Disorders of puberty, all

312

1.83

4.07

10.1

13.5

0.10

0.24

mmol/l

0.07

263

Other specified/unspecified deforming dorsopathies

537

1.64

4.07

10.3

9.0

1.70

1.11

mmol/l

0.99

443

Medicines for HER+ breast cancer

1989

16954

1.10

4.06

5.7

6.8

1.03

1.16

mmol/l

0.87

1720

14232

Retinal breaks without detachment

743

8559

0.85

4.05

7.9

8.2

0.58

0.98

mmol/l

2.41

637

7105

Other and unspecified injuries of wrist and hand

192

1437

1.38

4.04

7.5

8.9

0.65

0.87

mmol/l

0.32

161

1187

Amblyopia ex anopsia

188

1402

1.38

4.04

9.9

8.8

0.18

0.85

mmol/l

1.30

152

1168

Herpesviral keratitis and keratoconjunctivitis

247

1922

1.33

4.03

7.2

8.2

1.55

0.98

mmol/l

1.52

202

1589

Malignant neoplasm of oropharynx, including Hilmo

219

2.13

4.03

17.2

7.3

1.08

1.23

mmol/l

0.12

182

Sickle-cell disorders

2.79

4.02

8.7

7.0

-0.55

1.01

mmol/l

0.66

Exophthalmic conditions

402

1.77

4.02

9.3

9.4

1.56

0.94

mmol/l

0.71

339

Gonococcal infection

163

1192

1.42

4.01

7.9

9.2

0.83

1.05

mmol/l

0.35

139

1012

Respiratory tuberculosis, not confirmed, including avohilmo

249

1942

1.33

4.01

7.5

7.1

1.45

1.00

mmol/l

0.99

209

1572

Kwashiorkor

3.53

4.00

4.0

6.9

3.72

0.89

mmol/l

—

Polycystic ovarian syndrome, broad definition

313

2489

1.27

3.99

6.9

6.8

0.90

0.30

mmol/l

2.08

227

1893

Enteropathogenic Escherichia coli infection

136

2.46

3.99

10.9

8.0

0.93

0.85

mmol/l

0.03

116

Mesothelioma

468

1.72

3.99

8.2

6.8

1.88

1.01

mmol/l

1.31

389

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

225

1726

1.34

3.98

6.0

9.4

1.03

0.96

mmol/l

0.09

177

1429

Malignant neoplasm of hypopharynx, including Hilmo

284

1.95

3.98

10.7

6.8

1.83

0.95

mmol/l

0.98

230

Viral meningitis

161

1175

1.42

3.98

8.5

10.0

0.63

0.87

mmol/l

0.28

134

973

Benign neoplasm: Pharynx, unspecified

313

1.88

3.96

9.6

7.9

1.88

0.78

mmol/l

1.32

267

Carcinoma in situ of skin of scalp and neck

205

1570

1.38

3.96

8.2

6.9

-0.14

0.96

mmol/l

3.24

179

1270

Gonococcal infection, including avohilmo

172

1272

1.40

3.94

8.0

9.3

0.79

1.06

mmol/l

0.45

145

1080

Sacroiliitis, not elsewhere classified

180

1335

1.38

3.94

7.2

9.1

0.95

0.79

mmol/l

0.23

148

1102

Pedestrian injured in other and unspecified transport accidents

450

1.71

3.94

6.6

7.4

1.87

0.96

mmol/l

1.16

369

Acute appendicitis, with complications

1116

9944

1.14

3.93

9.2

8.1

0.82

0.90

mmol/l

0.26

934

8178

Acute lymphocytic leukaemia, including Hilmo

154

2.23

3.92

17.9

15.1

0.65

0.56

mmol/l

0.04

130

Acute lymphocytic leukaemia, helper endpoint

154

2.23

3.92

17.9

15.1

0.65

0.56

mmol/l

0.04

130

Acute lymphocytic leukaemia

154

2.23

3.92

17.9

15.1

0.65

0.56

mmol/l

0.04

130

Infections of genitourinary tract in pregnancy

366

2978

1.25

3.91

6.4

7.6

0.77

0.85

mmol/l

0.13

286

2417

Osteomyelitis of vertebra

124

2.51

3.90

10.1

7.4

-0.04

1.13

mmol/l

0.44

108

Placental disorders

188

2.07

3.88

8.0

7.1

-1.03

0.41

mmol/l

1.06

145

Abnormality of white blood cells, not elsewhere classified

330

1.83

3.87

11.6

10.2

0.59

0.91

mmol/l

0.18

280

Pain and other conditions associated with female genital organs and menstrual cycle

837

6100

1.16

3.87

7.9

0.53

0.75

mmol/l

0.86

648

4998

Unspecified chronic bronchitis

189

1423

1.37

3.86

9.7

7.5

1.70

0.64

mmol/l

3.37

153

1141

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

174

2.10

3.86

6.2

5.3

1.04

0.31

mmol/l

0.38

135

Nystagmus and other irregular eye movements

483

1.66

3.85

8.7

11.6

0.81

0.87

mmol/l

0.04

407

Other lesions of median nerve

163

1206

1.41

3.84

5.8

7.1

1.01

1.00

mmol/l

0.01

132

989

Benign neoplasm: Central nervous system, other parts/unspecified

145

2.37

3.84

6.4

14.0

0.82

1.07

mmol/l

0.15

123

Aphakia

578

1.60

3.84

8.8

8.0

-0.15

0.94

mmol/l

0.99

476

Disorders of other and unspecified cranial nerves

185

2.15

3.83

10.5

10.6

1.78

0.60

mmol/l

0.81

148

Senility

396

1.72

3.82

3.7

4.8

0.28

1.08

mmol/l

0.69

319

Exclusion endpoint for supernumerary teeth

298

1.83

3.81

13.7

12.8

1.10

0.42

mmol/l

0.44

250

Migraine with aura, drug-induced

330

1.81

3.81

10.5

7.8

1.49

1.18

mmol/l

0.33

272

Respiratory tuberculosis, not confirmed

245

1921

1.32

3.81

7.6

7.1

1.46

0.99

mmol/l

1.06

207

1554

Use of rasagiline

165

1230

1.42

3.81

3.8

7.6

1.98

0.97

mmol/l

2.73

139

1013

Other and unspecified acute skin changes due to ultraviolet radiation

152

1115

1.43

3.80

6.3

8.0

0.41

1.08

mmol/l

1.00

121

919

Localized skin eruption due to drugs and medicaments

439

1.70

3.80

7.4

7.7

1.75

0.97

mmol/l

1.02

383

Female infertility, tubal origin

190

1430

1.36

3.80

5.6

8.7

0.61

0.76

mmol/l

0.20

160

1199

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

348

1.81

3.79

7.2

9.0

1.39

0.88

mmol/l

0.38

290

Alzheimer’s disease (undefined), excluding more controls

330

0.34

3.77

1.6

4.2

4.17

1.04

mmol/l

—

257

Biliary cirrhosis, NAS

148

2.41

3.76

7.6

6.8

-1.03

1.10

mmol/l

1.62

130

Ectopic pregnancy

704

6094

1.17

3.76

6.4

7.2

0.95

0.93

mmol/l

0.05

584

5079

Other and unspecified disorders of psychological development

211

1.97

3.75

22.1

14.4

1.11

0.38

mmol/l

0.61

179

Patent foramen ovale

110

761

1.51

3.75

13.3

11.5

0.45

0.63

mmol/l

0.20

651

Other localized connective tissue disorders

105

721

1.53

3.75

11.4

8.4

-0.05

1.03

mmol/l

1.60

605

Uterine polyps

1466

7732

1.12

3.75

6.9

7.2

0.84

1.06

mmol/l

1.19

1233

6463

Other bullous disorders

155

1142

1.42

3.75

8.3

8.6

1.39

1.02

mmol/l

0.72

135

953

Varus deformity, not elsewhere classified

370

1.75

3.74

9.4

7.2

1.53

1.11

mmol/l

0.47

307

Congenital malformations of genital organs

335

2695

1.25

3.74

9.9

8.7

0.55

0.67

mmol/l

0.20

274

2175

Other and unspecified trigeminal disorders

559

1.60

3.73

7.8

7.4

0.66

1.01

mmol/l

0.33

466

Non-seminoma of testis, including Hilmo

158

2.19

3.72

9.5

16.0

0.45

0.97

mmol/l

0.45

134

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

352

1.81

3.71

8.7

7.0

0.82

1.20

mmol/l

0.41

292

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

512

1.63

3.70

5.9

8.3

1.43

0.88

mmol/l

0.73

426

Other congenital malformations of intestine, including avohilmo

403

1.72

3.70

9.4

11.0

0.35

0.82

mmol/l

0.45

350

Carcinoma in situ of skin of lip

142

2.42

3.70

6.4

6.0

0.93

1.32

mmol/l

0.13

115

Malignant neoplasm of parotid gland, including Hilmo

389

1.74

3.68

6.2

6.9

0.78

1.26

mmol/l

0.39

324

Leukaemia of unspecified cell type

374

1.76

3.68

10.4

9.4

1.14

0.80

mmol/l

0.37

309

Other abnormal auditory perceptions

395

1.72

3.68

5.5

7.9

1.45

0.87

mmol/l

0.72

329

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

377

3115

1.24

3.67

7.1

8.8

1.16

0.89

mmol/l

0.81

317

2569

Corneal scars and opacities

164

1224

1.40

3.66

8.0

8.3

1.26

1.04

mmol/l

0.28

139

1013

Fibrosarcoma

276

1.90

3.66

5.5

6.9

0.64

1.27

mmol/l

0.63

236

Disorders of myoneural junction and muscle in diseases classified elsewhere

306

1.85

3.66

6.9

7.5

1.16

1.02

mmol/l

0.08

261

Protein-energy malnutrition of moderate and mild degree

383

1.75

3.64

15.0

7.4

1.78

0.90

mmol/l

1.01

320

Alzheimer’s disease (Early onset)

164

2180

0.73

3.63

7.3

6.6

1.28

1.16

mmol/l

0.16

131

1764

Secondary systemic amyloidosis

115

2.52

3.63

9.1

5.6

1.23

0.99

mmol/l

0.07

100

Contact with other sharp object(s)

310

2504

1.26

3.62

10.6

9.3

0.41

0.77

mmol/l

0.81

260

2066

Congenital malformations of oesophagus, including avohilmo

226

2.01

3.62

10.4

10.6

0.82

1.26

mmol/l

0.33

194

Other contact dermatitis

397

3292

1.23

3.61

8.2

7.6

0.98

0.92

mmol/l

0.09

323

2684

Intercostal neuropathy

307

1.84

3.61

6.3

10.1

1.39

0.82

mmol/l

0.60

260

Certain zoonotic bacterial diseases

107

745

1.51

3.61

6.6

8.8

1.82

0.86

mmol/l

1.87

620

Other infective otitis externa

328

2675

1.26

3.59

9.2

8.6

0.57

0.88

mmol/l

0.73

278

2192

Factitial dermatitis

183

2.11

3.58

12.8

6.7

2.44

0.60

mmol/l

1.65

152

Pterygium

104

1474

0.68

3.57

7.3

8.0

1.32

0.86

mmol/l

0.82

1203

Cutaneous lupus erythematosus

130

938

1.45

3.57

6.6

7.4

0.55

1.05

mmol/l

0.59

111

778

Other disorders of conjunctiva

857

7573

1.15

3.56

9.0

7.6

1.14

0.97

mmol/l

0.67

726

6211

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1458

9435

0.90

3.56

6.5

8.0

0.88

mmol/l

0.01

1152

7754

Malignant immunoproliferative diseases

483

1.67

3.54

9.6

9.0

1.01

0.91

mmol/l

0.08

401

Endometriosis diagnosis and infertility diagnosis occurring together

368

3028

1.23

3.54

5.5

7.5

0.47

0.79

mmol/l

1.11

271

2453

Acquired clawhand, clubhand, clawfoot and clubfoot

169

2.13

3.53

8.8

12.7

2.22

1.33

mmol/l

0.57

140

LSIL lesion of the vulva

128

920

1.44

3.53

7.7

7.5

1.28

1.11

mmol/l

0.22

111

758

Hypertrichosis

506

1.59

3.53

8.6

7.5

0.78

0.68

mmol/l

0.09

412

Labour and delivery complicated by fetal stress [distress]

539

4119

0.84

3.50

5.3

7.7

-0.12

0.53

mmol/l

3.65

389

3227

Malignant neoplasm of eye and adnexa, including Hilmo

643

1.54

3.49

8.1

7.2

0.84

1.19

mmol/l

0.28

527

Vertical strabismus

178

1353

1.36

3.48

8.7

8.2

0.74

0.93

mmol/l

0.28

148

1128

Nonsuppurative otitis media, including avohilmo

1478

11607

1.11

3.48

8.8

8.3

0.59

0.77

mmol/l

1.01

1215

9402

Other congenital malformations of urinary system

163

2.14

3.48

16.8

9.6

-1.06

0.62

mmol/l

1.86

133

Benign neoplasm: Anus and anal canal

171

1297

1.38

3.47

6.4

7.0

0.36

1.00

mmol/l

1.05

147

1062

Immunodeficiency associated with other major defects

2.67

3.47

13.4

11.4

1.79

1.26

mmol/l

0.22

Other haemoglobinopathies

2.87

3.47

4.7

10.2

1.47

0.79

mmol/l

0.23

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

266

2082

1.28

3.46

8.5

10.2

0.28

0.56

mmol/l

0.64

210

1677

Haemorrhage in early pregnancy

1086

9438

1.13

3.46

5.5

7.6

1.12

0.88

mmol/l

1.41

868

7814

Ulcer of oesophagus, drug-induced

209

2.05

3.45

7.2

6.5

2.38

0.87

mmol/l

1.96

175

Severe mental retardation

2.84

3.45

10.3

19.3

1.72

0.30

mmol/l

0.55

Narcolepsy and cataplexy

191

2.02

3.45

3.4

7.9

0.76

0.70

mmol/l

0.04

161

Noninflammatory disorders of female genital tract

1902

8748

1.10

3.43

6.6

7.2

0.86

0.93

mmol/l

0.33

1527

7165

Hip and thigh

112

2.51

3.42

9.3

6.7

1.91

1.58

mmol/l

0.15

Benign neoplasm: Appendix

453

1.66

3.42

8.2

7.6

0.62

1.14

mmol/l

0.48

383

Disorders of iron metabolism

546

1.57

3.41

9.9

9.8

0.80

0.94

mmol/l

0.12

450

Viral conjunctivitis

100

692

1.50

3.41

6.4

9.8

1.41

0.80

mmol/l

0.86

571

Motorcycle rider injured in other and unspecified transport accidents

262

2093

1.28

3.41

12.3

10.2

1.06

0.75

mmol/l

0.80

218

1749

Benign neoplasm: Skin of lower limb, including hip

150

1117

1.40

3.40

8.5

8.8

1.23

1.08

mmol/l

0.24

120

935

Other corneal oedema

392

1.72

3.40

5.4

6.8

0.73

1.18

mmol/l

0.50

330

Long labour

661

6447

0.86

3.40

7.9

7.7

0.52

0.73

mmol/l

0.79

520

5231

Renal agenesis and other reduction defects of kidney

151

2.19

3.40

5.2

12.4

0.29

0.82

mmol/l

0.18

129

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

3.36

10.9

6.9

0.13

0.91

mmol/l

—

Other and unspecified rosacea

471

3999

1.20

3.36

7.1

7.9

0.87

0.90

mmol/l

0.04

365

3292

Suppurative otitis media, unspecified

121

869

1.44

3.36

6.1

7.9

1.23

1.01

mmol/l

0.21

711

Contact with and exposure to communicable diseases

997

11106

0.89

3.35

8.5

8.6

0.96

0.61

mmol/l

2.73

796

8942

Hypersomnia

486

1.60

3.31

11.1

10.4

1.66

0.91

mmol/l

1.01

405

therapeutic use

179

1377

1.35

3.29

9.3

7.2

0.68

0.88

mmol/l

0.35

153

1141

Alcohol abuse counselling and surveillance

626

1.53

3.28

9.3

10.7

1.06

0.82

mmol/l

0.24

533

Calcific tendinitis

346

1.73

3.27

5.0

9.6

1.36

0.83

mmol/l

0.46

286

Hypertrophy of breast in women and men

898

7987

1.14

3.27

7.4

7.9

1.08

0.93

mmol/l

0.53

743

6628

Short stature, not elsewhere classified

395

1.62

3.27

16.0

19.2

-1.45

-0.16

mmol/l

1.65

333

Contracture of joint

472

1.61

3.27

8.7

8.2

0.74

1.06

mmol/l

0.36

383

Posteruptive colour changes of dental hard tissues

2.49

3.26

7.5

9.0

0.69

1.00

mmol/l

0.15

False labour

990

5465

1.13

3.26

5.2

8.3

0.80

0.68

mmol/l

0.49

737

4407

Clubfoot

276

1.80

3.25

11.8

11.0

1.27

0.83

mmol/l

0.26

234

Other/unspecified crystal arthropathies

296

1.83

3.24

9.3

6.6

0.71

0.88

mmol/l

0.11

250

Malignant neoplasm of other and unspecified urinary organs

142

2.27

3.24

12.7

7.2

-1.91

1.41

mmol/l

3.13

120

Abscess of Bartholin gland

105

739

1.46

3.24

7.9

7.1

-0.12

1.00

mmol/l

1.87

604

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, including Hilmo

2.56

3.24

16.1

8.1

1.37

1.31

mmol/l

0.02

Lesion of femoral nerve

263

1.84

3.24

5.7

9.9

1.13

1.16

mmol/l

0.03

228

Other disorders of Eustachian tube

160

1213

1.37

3.22

9.1

8.4

0.87

0.98

mmol/l

0.13

132

1017

Arthropathic psoriasis

592

5137

1.17

3.22

8.2

8.5

1.02

0.91

mmol/l

0.26

516

4224

Other disorders of peripheral nervous system

273

1.84

3.21

13.3

8.6

1.36

0.87

mmol/l

0.37

228

Crushing injury of wrist and hand

673

1.51

3.20

11.4

9.1

0.71

0.78

mmol/l

0.07

566

Congenital malformations of uterus and cervix

454

1.59

3.20

13.8

8.3

0.40

0.74

mmol/l

0.24

363

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

176

1357

1.35

3.20

5.9

6.9

1.35

1.10

mmol/l

0.35

143

1108

Conductive hearing loss, unspecified

442

3753

1.20

3.19

8.6

8.3

1.21

0.94

mmol/l

0.65

370

3105

Hereditary deficiency of other clotting factors

263

1.81

3.18

17.8

10.7

1.35

1.03

mmol/l

0.26

217

Pseudomembranous colitis

287

1.79

3.18

6.2

7.0

-0.39

1.04

mmol/l

0.69

240

Inhalation and ingestion of other objects causing obstruction of respiratory tract

205

1.95

3.18

12.8

13.5

1.20

1.36

mmol/l

0.10

171

Psoriatic arthropathies, ICD10

544

4699

1.18

3.16

8.0

8.7

1.03

0.92

mmol/l

0.26

468

3872

Macular cyst

203

1601

1.32

3.16

7.6

0.59

1.00

mmol/l

0.85

175

1325

Other benign neoplasm of uterus: Other parts/unspecified

146

1921

0.73

3.16

5.5

5.2

1.16

1.28

mmol/l

0.13

123

1579

Pregnancy with abortive outcome

3278

16039

1.07

3.15

6.9

6.8

0.98

1.03

mmol/l

0.26

2699

13214

Autism spe, excluding more controls

398

1.61

3.14

6.0

8.8

0.93

0.07

mmol/l

0.86

317

Acute mastoiditis

272

1.80

3.14

11.1

9.1

0.73

1.11

mmol/l

0.39

225

Foreign body in ear

689

1.48

3.13

13.1

10.0

0.87

0.79

mmol/l

0.07

582

Other and unspecified injuries of thorax

690

1.48

3.12

9.9

9.7

1.39

0.96

mmol/l

0.59

566

Scleritis and episcleritis

293

2399

1.25

3.11

7.2

8.5

0.78

0.88

mmol/l

0.15

244

1975

Kela-code for behavioural disturbances in mental retardation

337

1.73

3.11

5.8

10.5

4.00

0.92

mmol/l

4.58

288

Arthropathy in Crohn disease

335

1.71

3.09

6.1

9.4

0.36

0.72

mmol/l

0.27

282

Acute poliomyelitis

529

1.57

3.09

5.3

6.8

1.32

1.07

mmol/l

0.19

448

Other and unspecified injuries of forearm

236

1.84

3.07

13.3

11.2

0.93

0.71

mmol/l

0.09

193

Alcoholic cardiomyopathy

247

1.88

3.06

24.5

9.0

1.29

0.72

mmol/l

0.22

204

Spinal enthesopathy

154

1165

1.36

3.06

4.3

5.2

1.30

1.20

mmol/l

0.10

125

929

Drug-induced gout

203

1.99

3.06

10.8

7.0

1.30

1.05

mmol/l

0.10

165

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

172

2.04

3.06

7.2

10.4

1.10

1.24

mmol/l

0.06

151

Foreign body entering into or through eye or natural orifice

415

3519

1.20

3.06

8.2

9.1

0.81

0.85

mmol/l

0.07

352

2900

Chronic conjunctivitis

150

1136

1.37

3.05

7.4

9.0

1.01

0.87

mmol/l

0.21

125

938

Placenta praevia

146

1095

1.36

3.05

7.9

7.3

0.24

0.65

mmol/l

0.76

117

864

Struck by thrown, projected or falling objec

266

2163

1.26

3.04

7.6

9.1

1.21

0.82

mmol/l

1.27

213

1796

Carcinoma in situ of skin

546

4746

1.18

3.03

7.1

6.9

0.36

1.01

mmol/l

3.81

454

3883

Disorders of copper metabolism

4.38

3.03

7.3

7.9

-0.89

0.01

mmol/l

—

Degenerative conditions of globe

202

1.95

3.02

3.5

6.6

2.29

1.07

mmol/l

1.13

166

Acute poliomyelitis, including avohilmo

532

1.56

3.01

5.3

6.7

1.32

1.04

mmol/l

0.22

451

Sequelae of poliomyelitis

365

1.70

3.01

6.1

7.0

1.98

0.93

mmol/l

1.34

303

Allergic rhinitis

1382

12463

1.10

3.01

7.6

8.6

0.79

0.74

mmol/l

0.20

1135

10176

Adenocarcinomas of cervix

116

2.25

3.01

4.9

5.2

0.83

1.05

mmol/l

0.15

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

277

1.79

3.01

7.1

6.5

1.93

0.98

mmol/l

0.68

234

Follow-up care involving plastic surgery

170

1311

1.33

3.00

5.5

6.9

0.75

0.95

mmol/l

0.26

149

1071

Ulcerative colitis (strict definition, all Crohn cases excluded)

696

6134

1.15

3.00

8.1

8.5

0.66

0.84

mmol/l

0.61

573

5037

Benign neoplasm: Brain, unspecified

225

1.88

2.99

9.5

9.8

1.73

0.89

mmol/l

0.98

191

Routine general health check-up of defined subpopulation

494

1.54

2.98

8.1

7.3

1.15

0.69

mmol/l

0.49

412

Other demyelinating diseases of the central nervous system

151

1146

1.35

2.98

13.5

9.7

1.08

0.76

mmol/l

0.48

118

933

Unspecified drowning and submersion

3.80

2.97

2.1

23.0

0.54

1.33

mmol/l

—

Malignant neoplasm of gallbladder

196

1.96

2.97

5.4

6.3

0.82

1.45

mmol/l

0.53

163

Esophageal diverticulum (pouch), including avohilmo

162

2.13

2.97

6.5

11.5

0.44

1.33

mmol/l

0.68

140

Carcinoma in situ of vulva

293

1.75

2.96

7.1

6.9

-0.59

1.12

mmol/l

2.09

255

Other psoriatic arthropathies

526

4560

1.17

2.94

7.7

8.7

1.01

0.91

mmol/l

0.22

450

3760

Polyp of the female genital tract

1523

7902

1.10

2.93

6.5

7.2

0.99

1.06

mmol/l

0.24

1263

6583

Generalized epilepsy, strict definition

646

1.47

2.93

8.1

11.2

1.26

0.65

mmol/l

0.59

540

Fall on and from ladder

464

3996

1.19

2.92

9.3

8.7

0.83

0.85

mmol/l

0.04

392

3293

Female genital prolapse

1511

7697

1.10

2.92

5.5

7.2

1.15

1.10

mmol/l

0.19

1235

6436

Muscle wasting and atrophy, not elsewhere classified

258

1.82

2.91

9.6

9.4

1.71

0.83

mmol/l

0.80

217

Procedures for purposes other than remedying health state

103

740

1.44

2.90

5.0

6.7

0.79

0.94

mmol/l

0.12

613

Contusion of toe(s) with damage to nail

364

1.64

2.90

9.8

9.5

-0.10

0.86

mmol/l

1.14

307

Impacted cerumen

553

6328

0.86

2.90

7.7

7.5

0.70

0.93

mmol/l

0.90

471

5176

Burn and corrosion, body region unspecified

220

1.88

2.88

10.7

8.7

1.08

0.88

mmol/l

0.13

179

Benign neoplasm: Orbit, unspecified

243

1.83

2.88

7.5

10.5

0.75

1.00

mmol/l

0.14

207

Lichen planus, including avohilmo

1102

10010

1.12

2.86

7.0

7.8

0.95

0.99

mmol/l

0.14

890

8326

Transient synovitis

211

1.85

2.85

8.7

12.7

0.48

0.71

mmol/l

0.22

176

Hirsutism in women

435

1.56

2.85

9.1

6.8

0.75

0.59

mmol/l

0.16

352

Other and unspecified hypertrophic disorders of skin

220

1.85

2.84

8.2

9.5

1.34

0.87

mmol/l

0.44

178

Organ-limited amyloidosis

207

1.91

2.83

9.9

6.8

1.04

1.30

mmol/l

0.15

165

Chronic suppurative otitis media

335

2809

1.22

2.82

8.5

8.0

0.85

0.95

mmol/l

0.15

272

2282

Other adrenocortical overactivity

147

2.03

2.80

7.4

8.6

0.05

0.53

mmol/l

0.27

120

Calculus of lower urinary tract

332

2794

1.22

2.80

7.8

8.3

0.73

0.88

mmol/l

0.28

277

2260

Pregnancy examination and test

451

2383

1.18

2.79

7.1

8.4

0.58

0.69

mmol/l

0.24

334

1898

Vascular dementia (other)

348

1.68

2.79

7.7

6.0

0.92

1.16

mmol/l

0.22

282

Other and unspecified disorders of skin and subcutaneous tissue

225

2772

0.79

2.78

6.7

7.8

0.85

0.94

mmol/l

0.12

194

2282

Other and unspecified pemphigoid

412

1.62

2.78

4.6

6.6

0.93

1.06

mmol/l

0.11

341

Type 1 diabetes, wide definition, subgroup 2

582

0.56

2.78

10.8

6.3

-0.22

1.21

mmol/l

0.87

469

Patellar tendinitis

480

1.53

2.76

6.0

11.0

0.73

0.79

mmol/l

0.06

408

Other specified/unspecified disorders of tympanic membrane

150

2.07

2.76

7.6

8.2

1.32

0.98

mmol/l

0.34

128

Epiphora

126

949

1.38

2.75

5.6

7.9

1.32

0.97

mmol/l

0.46

105

790

Injury of blood vessels of thorax

136

2.13

2.74

9.7

12.3

1.51

1.71

mmol/l

0.15

115

Tarsal tunnel syndrome

355

1.64

2.73

5.8

7.5

0.63

1.05

mmol/l

0.43

302

Other congenital malformations of limb(s)

162

1.94

2.73

27.5

9.5

-0.75

0.75

mmol/l

1.40

134

Other congenital malformations of tongue, mouth and pharynx

311

1.66

2.73

15.8

12.5

-0.29

0.24

mmol/l

0.30

254

Idiopathic urticaria

673

1.44

2.72

8.1

9.1

0.51

0.83

mmol/l

0.39

552

Other infestations, including avohilmo

783

0.62

2.72

4.9

8.7

1.65

1.03

mmol/l

0.58

657

Mature T/NK-cell lymphomas, hilmo

595

1.49

2.72

9.4

8.9

-0.27

0.87

mmol/l

1.26

498

Alzheimer disease, including avohilmo

2755

17967

1.07

2.71

4.5

6.5

1.13

1.00

mmol/l

0.90

2162

14736

Other, unspecified and serous retinal detachments

187

1489

1.30

2.70

8.2

8.1

0.55

0.87

mmol/l

0.63

161

1221

Hereditary retinal dystrophy

552

1.50

2.70

5.5

8.6

1.27

1.01

mmol/l

0.26

463

Carcinoma in situ of skin of lower limb, including hip

146

1132

1.35

2.68

8.9

6.5

0.79

1.14

mmol/l

0.49

125

931

Congenital malformations of eye, ear, face and neck

259

2127

1.24

2.68

10.7

9.3

0.99

0.75

mmol/l

0.48

206

1727

Disorder of the sleep-wake schedule

550

1.49

2.68

4.4

11.6

1.65

0.61

mmol/l

1.76

465

Dermatopolymyositis, unspecified

203

1.88

2.68

8.1

8.3

1.78

1.08

mmol/l

0.31

173

Caries of enamel

5638

38422

0.95

2.66

8.9

8.1

0.53

0.95

mmol/l

13.76

4817

31826

Burn and corrosion of shoulder and upper limb, except wrist and hand

106

780

1.41

2.66

9.8

10.3

0.92

0.80

mmol/l

0.10

648

Spirochaetal infections, other/unspecified

368

4309

0.84

2.66

8.1

8.3

0.56

1.01

mmol/l

1.63

323

3576

Degenerative macular diseases

753

6743

1.14

2.65

6.6

6.8

0.86

1.07

mmol/l

0.79

621

5508

Other and unspecified nail disorders

122

919

1.38

2.65

11.8

9.5

1.31

0.96

mmol/l

0.44

767

Postviral fatigue syndrome

171

1.89

2.64

8.4

11.7

1.47

0.88

mmol/l

0.36

144

Motor- or nonmotor-vehicle accident in traffic area

217

1.81

2.64

8.0

12.6

0.80

0.84

mmol/l

0.02

181

Contact with machinery

644

5714

1.15

2.64

7.6

9.2

0.77

0.86

mmol/l

0.27

508

4736

Other disorders of skin and subcutaneous tissue related to radiation

2.78

2.64

2.6

5.4

2.74

1.82

mmol/l

—

Acne conglobata

136

2.04

2.64

8.0

16.8

-0.39

0.74

mmol/l

0.41

112

Other congenital malformations of skin

177

1399

1.30

2.64

10.5

9.5

0.38

0.81

mmol/l

0.68

146

1150

Disturbances of smell and taste

214

1732

1.27

2.63

7.0

8.6

1.46

0.94

mmol/l

1.06

175

1444

Other bursal cyst

639

1.46

2.63

4.6

8.0

2.16

0.96

mmol/l

2.28

530

Abnormal findings in cerebrospinal fluid

2.32

2.62

6.1

9.6

0.92

1.03

mmol/l

0.04

Carcinoma in situ, bladder

246

2033

1.25

2.60

6.8

7.8

0.25

0.88

mmol/l

1.82

201

1653

Other inflammation of vagina/vulva

135

1030

1.34

2.59

6.9

7.0

0.31

0.94

mmol/l

1.11

111

831

Alopecia areata

116

868

1.38

2.58

8.8

10.0

0.98

0.97

mmol/l

0.01

103

726

Benign neoplasm of bone and articular cartilage

405

3481

1.18

2.58

8.6

1.02

0.93

mmol/l

0.20

346

2861

Sequelae of poliomyelitis, including avohilmo

437

1.58

2.58

6.0

6.6

2.05

1.00

mmol/l

1.43

358

Occlusion and stenosis of arteries, not leading to stroke

583

1.47

2.57

10.2

5.8

1.01

1.28

mmol/l

0.22

467

Phlebitis and thrombophlebitis of unspecified site, drug-induced

4.75

2.56

9.6

5.9

0.23

2.09

mmol/l

—

Other nonthrombocytopenic purpura

403

1.59

2.56

4.3

9.5

0.94

0.98

mmol/l

0.03

340

Use of anticholinesterases

2300

18859

0.93

2.55

4.1

6.5

1.22

0.98

mmol/l

2.02

1800

15450

N06DA Anticholinesterases

2300

18859

0.93

2.55

4.1

6.5

1.22

0.98

mmol/l

2.02

1800

15450

Follicular adenocarcinoma of thyroid gland, including Hilmo

353

1.61

2.55

5.3

7.1

0.74

1.22

mmol/l

0.52

293

Congenital malformation of optic disc

3.34

2.55

60.8

7.4

-0.09

1.44

mmol/l

0.67

Other osteochondropathies

334

2830

1.20

2.54

7.9

9.1

1.15

0.84

mmol/l

0.81

283

2340

Renal agenesis and other reduction defects of kidney, including avohilmo

183

1.89

2.54

5.0

11.4

0.37

0.86

mmol/l

0.17

152

Dislocation, sprain and strain of joints and ligaments of elbow

281

2342

1.22

2.54

7.4

8.9

0.84

0.87

mmol/l

0.05

233

1917

Disorders of breast

2423

20044

1.07

2.53

7.1

6.8

0.95

1.05

mmol/l

0.62

2030

16580

Benign neoplasm: Skin of trunk

216

1759

1.26

2.53

6.9

8.7

0.84

1.01

mmol/l

0.25

177

1457

Other congenital malformations of ear

241

1.71

2.52

9.2

12.5

1.16

0.31

mmol/l

0.83

192

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

397

1.59

2.51

7.8

9.5

0.44

1.01

mmol/l

0.46

335

Foreign body in respiratory tract

248

2048

1.24

2.51

8.5

9.2

1.44

0.91

mmol/l

1.61

208

1699

Osteitis due to dental implant

341

1.64

2.51

11.0

9.1

0.64

1.08

mmol/l

0.32

290

Testicular hypofunction

194

1564

1.28

2.51

11.0

11.1

0.81

0.78

mmol/l

0.03

173

1305

Cellulitis of external ear

419

1.55

2.50

7.4

9.3

1.22

0.84

mmol/l

0.46

350

Hypertrophy of tongue papillae

536

1.49

2.50

8.7

8.9

0.79

0.88

mmol/l

0.06

455

Fibrothorax

2.46

2.49

18.6

5.8

1.52

0.43

mmol/l

0.24

Other disorders of choroid

630

1.45

2.49

7.7

7.2

0.92

0.98

mmol/l

0.05

511

Increased muscle tone

253

1.73

2.48

8.0

11.6

0.96

0.85

mmol/l

0.06

213

Disorders of porphyrin and bilirubin metabolism

355

1.59

2.47

9.3

11.6

0.68

0.80

mmol/l

0.09

297

Other and unspecified disorders of refraction

4.28

2.46

3.8

11.3

1.54

0.39

mmol/l

—

Blepharospasm

382

1.59

2.46

4.9

9.2

0.65

0.92

mmol/l

0.18

323

Varicella [chickenpox]

209

1700

1.26

2.45

12.8

10.9

0.25

0.77

mmol/l

0.91

165

1430

Thyrotoxicosis factitia

113

2.16

2.45

5.4

7.5

0.27

1.26

mmol/l

0.79

Disorders of puberty

274

1.65

2.45

9.2

14.4

-0.21

0.11

mmol/l

0.14

233

Benign neoplasm: Connective and other soft tissue of head, face and neck

639

1.44

2.45

5.9

8.7

0.58

0.92

mmol/l

0.39

524

Benign neoplasm: Bladder

416

1.56

2.43

6.8

7.3

0.39

0.91

mmol/l

0.62

349

Other specified and unspecified disorders of conjunctiva

407

1.56

2.43

14.2

8.1

1.08

0.87

mmol/l

0.16

339

Mandibular prognathia

445

1.51

2.43

7.3

10.8

0.72

0.50

mmol/l

0.21

376

HSIL lesion of the vagina

438

1.52

2.43

7.5

1.35

1.13

mmol/l

0.14

374

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

417

1.52

2.42

13.5

11.8

-0.13

0.31

mmol/l

0.30

349

Tularaemia

515

1.49

2.41

5.6

9.5

2.20

0.76

mmol/l

2.93

435

Victim of lightning

3.70

2.41

12.8

13.2

1.12

0.77

mmol/l

—

Male infertility

195

1576

1.26

2.40

9.3

10.7

0.75

0.86

mmol/l

0.19

163

1321

Family history of other conditions

372

1.55

2.40

15.3

8.2

0.90

0.81

mmol/l

0.07

299

Juvenile osteochondrosis

127

974

1.33

2.39

9.3

10.7

0.42

0.66

mmol/l

0.28

104

804

Postpartum care and examination

384

2058

1.18

2.39

6.2

8.2

0.66

0.65

mmol/l

0.00

275

1615

Unspecified parasitic disease, including avohilmo

304

1.65

2.38

5.5

7.8

-0.02

0.88

mmol/l

0.77

262

Tick-borne viral encephalitis, including avohilmo

203

1.80

2.35

13.6

7.9

1.45

1.02

mmol/l

0.30

175

Unspecified parasitic disease

297

1.65

2.35

5.6

7.8

0.05

0.89

mmol/l

0.67

257

Other peripheral vertigo

515

4544

1.15

2.35

5.9

7.6

0.90

1.06

mmol/l

0.39

421

3743

Disorders of eyelid in diseases classified elsewhere

161

1281

1.29

2.34

6.7

8.6

1.00

0.98

mmol/l

0.02

131

1048

Carcinoma in situ of other and unspecified sites

261

2194

1.23

2.34

6.7

7.6

0.31

0.89

mmol/l

1.69

212

1776

Contact with other specified venomous animals

234

1.73

2.34

10.4

10.3

1.45

0.86

mmol/l

0.48

196

Other and unspecified mononeuropathies of lower limb

143

1123

1.31

2.33

9.0

8.3

1.47

1.04

mmol/l

0.76

126

932

Tinnitus

1380

12790

1.09

2.33

7.9

8.1

0.88

0.90

mmol/l

0.08

1180

10685

Testicular dysfunction

215

1768

1.25

2.33

10.6

10.9

0.75

0.81

mmol/l

0.06

193

1486

Ulcerative rectosigmoiditis

392

3391

1.17

2.33

9.2

8.2

0.89

mmol/l

0.00

325

2790

Scleritis

451

1.50

2.32

7.6

8.0

0.41

0.93

mmol/l

0.62

385

Circumscribed brain atrophy

134

1048

1.33

2.32

7.5

7.2

1.05

0.95

mmol/l

0.09

112

864

Episcleritis

242

2011

1.23

2.32

7.3

8.5

0.92

0.93

mmol/l

0.01

197

1663

HSIL lesion of the cervix uteri

601

5340

1.13

2.31

7.8

7.3

0.81

0.67

mmol/l

0.36

477

4261

Benign neoplasm: Conjunctiva

171

1375

1.28

2.30

7.3

8.4

0.52

0.98

mmol/l

0.72

145

1135

Carcinoma in situ of vagina

181

1.83

2.30

8.5

7.9

0.45

1.39

mmol/l

0.86

156

Severe visual impairment, binocular

221

1.76

2.28

6.4

8.8

-0.08

1.31

mmol/l

0.73

175

Vascular dementia (undefined)

258

2142

1.22

2.28

4.1

5.8

2.03

1.09

mmol/l

3.01

187

1700

Other prurigo

446

1.51

2.28

10.3

6.6

1.41

1.09

mmol/l

0.27

371

Disorders of male genital organs in diseases classified elsewhere

260

1.69

2.27

9.9

14.3

1.47

0.65

mmol/l

1.10

211

Unspecified organic or symptomatic mental disorder

138

1.98

2.27

7.0

8.0

2.49

0.48

mmol/l

1.55

106

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

422

3683

1.17

2.27

6.1

8.3

0.79

0.98

mmol/l

0.40

347

3043

Desensitization to allergens

111

1452

0.75

2.26

8.8

9.7

0.29

0.61

mmol/l

0.60

1182

Chronic suppurative otitis media, including avohilmo

389

3375

1.17

2.25

8.4

8.5

0.83

0.87

mmol/l

0.07

316

2759

Other congenital malformations of skull and face bones

2.27

2.25

9.2

25.3

-0.18

0.99

mmol/l

0.57

Congenital hydrocephalus

109

2.08

2.24

8.2

12.8

0.34

1.18

mmol/l

0.27

Anogenital herpesviral [herpes simplex] infection

232

1924

1.22

2.23

10.3

8.7

0.43

0.66

mmol/l

0.48

194

1558

Assault by hanging, strangulation and suffocation

2.55

2.22

9.7

7.0

-0.48

-0.01

mmol/l

0.13

Supervision of high-risk pregnancy

646

3459

1.13

2.22

6.4

8.7

0.59

0.75

mmol/l

0.49

506

2833

Torsion of testis

537

1.44

2.22

12.0

12.9

0.82

mmol/l

0.00

450

Other vitreous opacities

226

1880

1.23

2.21

6.4

7.9

1.46

0.94

mmol/l

1.90

198

1524

Other complications of labour and delivery, not elsewhere classified

221

2368

0.82

2.21

4.8

7.4

0.02

0.28

mmol/l

0.46

164

1796

Poor fetal growth

342

2932

1.18

2.21

10.1

7.5

0.16

0.43

mmol/l

0.61

260

2267

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

2.33

2.21

6.1

7.8

0.03

0.76

mmol/l

0.33

Endometriosis ASRM stages 1,2

662

5938

1.12

2.20

5.9

7.2

0.83

0.90

mmol/l

0.20

516

4873

431

1.47

2.20

16.6

17.8

-0.74

-0.32

mmol/l

0.42

351

Chronic iridocyclitis

242

2025

1.22

2.19

6.8

8.6

1.09

0.98

mmol/l

0.18

185

1675

Stenosis and insufficiency of lacrimal passages

504

4461

1.15

2.19

5.5

7.4

1.32

1.03

mmol/l

0.86

400

3672

Open bite

174

1403

1.26

2.19

15.4

9.8

0.67

0.60

mmol/l

0.08

137

1139

Other and unspecified injuries of neck

245

1.67

2.19

4.5

7.9

0.98

0.75

mmol/l

0.15

202

Congenital lens malformations

139

1.92

2.18

10.9

8.6

0.12

1.00

mmol/l

0.47

117

Absence of one kidney

2.23

2.17

7.1

16.5

0.29

0.74

mmol/l

0.10

Open wounds involving multiple body regions

140

1.94

2.17

19.3

12.4

0.28

1.09

mmol/l

0.45

119

Flatulence and related conditions

342

1.56

2.17

9.3

7.8

0.98

0.63

mmol/l

0.20

287

Frontotemporal dementia, wide, incl. Pick's disease

305

1.62

2.16

9.7

7.2

0.97

0.73

mmol/l

0.09

256

Thyroiditis, unspecified

508

1.45

2.16

7.3

6.7

1.69

1.09

mmol/l

0.86

415

Antenatal screening

579

3647

0.88

2.16

5.6

8.7

0.39

0.72

mmol/l

1.28

456

2975

Atypical virus infections of central nervous system

352

1.56

2.16

5.4

8.3

0.94

1.05

mmol/l

0.05

303

Toxic effect of contact with venomous animals

200

1646

1.24

2.16

7.7

9.4

0.62

0.85

mmol/l

0.34

169

1367

Malignant neoplasm of eye and adnexa

328

1.58

2.16

5.3

8.0

0.55

1.25

mmol/l

0.54

272

6-mercaptopurine

131

1024

1.30

2.16

6.4

9.0

0.34

0.58

mmol/l

0.31

110

851

Crushing injury of head

2.57

2.16

5.6

14.8

2.46

0.88

mmol/l

—

Autoimmune thyroiditis

601

1.41

2.15

7.4

8.4

1.41

1.04

mmol/l

0.30

498

Prolapse and hernia of ovary and fallopian tube

221

1823

1.23

2.15

4.5

5.1

1.26

1.23

mmol/l

0.04

179

1496

Cleft lip, lip and palate or palate

399

1.50

2.14

11.6

10.8

0.97

0.79

mmol/l

0.12

330

Crossbite

254

1962

1.21

2.14

14.6

10.2

0.79

0.52

mmol/l

0.62

211

1621

Iridocyclitis in diseases classified elsewhere

101

768

1.36

2.13

8.1

8.7

1.29

0.97

mmol/l

0.37

640

Other and unspecified disorders of autonomic nervous system

133

1.94

2.13

9.5

11.8

1.38

1.22

mmol/l

0.12

111

Burn and corrosion of wrist and hand

169

1367

1.26

2.13

6.7

10.1

0.90

0.78

mmol/l

0.14

138

1141

Other specified/unspecified nutritional deficiencies

240

1.68

2.13

10.5

6.9

1.69

0.95

mmol/l

0.73

196

Burn and corrosion of ankle and foot

554

1.43

2.12

9.3

9.7

1.35

0.84

mmol/l

0.56

470

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

149

1.90

2.11

4.2

8.2

1.29

1.08

mmol/l

0.11

125

Frontotemporal dementia

267

1.67

2.11

10.5

7.3

0.76

0.75

mmol/l

0.00

223

Symptoms and signs involving appearance and behaviour

264

1.63

2.10

4.2

7.3

0.46

0.57

mmol/l

0.04

220

Tularaemia, including avohilmo

101

770

1.36

2.10

6.4

9.9

1.86

0.97

mmol/l

1.98

644

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

110

851

1.35

2.10

7.7

7.6

0.40

1.14

mmol/l

1.11

695

Other disorders originating in the perinatal period

232

1.66

2.08

10.8

19.2

-0.39

-0.17

mmol/l

0.11

198

Mixed conductive and sensorineural hearing loss

721

6538

1.12

2.08

7.1

7.4

1.34

0.92

mmol/l

2.28

583

5389

Inflammation of lacrimal passages (acute and unspecified)

658

1.38

2.07

7.6

7.1

0.59

1.18

mmol/l

0.64

541

Benign neoplasm: Connective and other soft tissue, unspecified

455

1.47

2.07

6.2

7.7

-0.08

0.92

mmol/l

0.77

389

380

1.49

2.07

15.6

17.4

-0.79

-0.41

mmol/l

0.34

308

Inhalation and ingestion of food causing obstruction of respiratory tract

414

1.50

2.07

13.9

8.8

2.42

0.85

mmol/l

2.56

345

Other disorders following mastoidectomy

182

1.82

2.07

6.3

7.0

3.97

0.80

mmol/l

3.29

149

Tibial collateral bursitis [Pellegrini-Stieda]

396

1.50

2.07

8.4

7.1

0.99

1.26

mmol/l

0.18

336

Varicella [chickenpox], including avohilmo

230

1924

1.22

2.06

12.1

10.7

0.32

0.72

mmol/l

0.70

181

1615

Benign neoplasm: Hypopharynx

181

1.80

2.06

12.2

9.1

1.34

0.59

mmol/l

0.50

155

Melanocytic naevi of lower limb, including hip

211

1755

1.23

2.06

7.0

9.1

0.52

0.92

mmol/l

0.88

172

1455

Burns and corrosions confined to eye and internal organs

122

955

1.31

2.06

8.4

10.2

1.66

0.87

mmol/l

1.57

101

801

Dislocation of lens

687

1.38

2.05

9.6

7.4

1.28

0.75

mmol/l

0.71

560

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

760

6895

1.11

2.05

8.6

8.1

0.40

0.69

mmol/l

1.21

620

5550

Carcinoma in situ of breast, intraductal

406

3565

1.16

2.02

6.6

7.0

0.89

1.18

mmol/l

0.85

347

2990

Oral lichen planus

142

1138

1.29

2.02

8.7

8.5

0.53

1.05

mmol/l

1.22

121

957

Peroneal tendinitis

548

1.41

2.02

9.8

9.3

0.63

1.13

mmol/l

0.48

470

Allergic colitis

469

1.44

2.02

17.1

12.2

0.45

0.12

mmol/l

0.29

381

Malignant neoplasm of other and ill-defined digestive organs

358

1.54

2.02

4.8

6.2

1.56

1.15

mmol/l

0.34

291

Colorectal neuroendocrine tumor and carcinoma

499

1.44

2.01

7.3

7.0

0.93

1.19

mmol/l

0.35

417

Acne, including avohilmo

731

5353

1.11

2.00

9.6

8.6

0.31

0.39

mmol/l

0.19

575

4189

Use of selegiline

266

2272

1.20

1.99

4.2

7.2

1.83

0.87

mmol/l

4.72

225

1860

Benign neoplasm: Nasopharynx

351

1.53

1.99

9.0

8.3

1.45

1.02

mmol/l

0.38

299

Carcinoma in situ of other/unspecified male genital organs

4.82

1.98

4.3

8.2

-1.48

0.30

mmol/l

—

Atypical virus infections of central nervous system, including avohilmo

359

1.52

1.98

5.4

8.2

0.94

1.03

mmol/l

0.05

307

Chalazion

571

5125

1.13

1.97

7.0

8.3

1.04

0.90

mmol/l

0.42

460

4215

Meckel's diverticulum

238

1.66

1.97

6.5

10.9

0.38

0.82

mmol/l

0.21

201

Contracture of muscle

152

1.84

1.97

4.9

6.3

0.78

1.13

mmol/l

0.18

129

Burn and corrosion of head and neck

105

813

1.33

1.96

8.6

11.1

1.31

0.70

mmol/l

0.90

684

Amoebiasis

175

1.76

1.95

12.8

12.1

-1.47

1.10

mmol/l

0.97

155

Pemphigus

271

1.61

1.95

7.8

6.3

0.24

0.96

mmol/l

0.28

230

Family history of other specific disorders

358

1.50

1.94

8.8

7.8

1.62

0.78

mmol/l

1.15

286

Seminoma of testis

270

1.59

1.94

10.4

10.8

0.62

1.19

mmol/l

0.55

226

Nail dystrophy

239

1.65

1.94

11.3

10.7

1.99

0.91

mmol/l

0.85

206

Congenital cataract

130

1.89

1.93

9.5

8.6

-0.07

0.99

mmol/l

0.53

109

Varicose veins of other sites

331

2878

1.17

1.92

7.0

9.0

0.91

0.92

mmol/l

0.01

280

2396

Choroidal detachment

110

2.04

1.92

3.2

6.2

0.29

0.94

mmol/l

0.23

Other congenital malformations of kidney

131

1.89

1.91

12.3

9.8

0.49

1.19

mmol/l

0.27

110

Other specified/unspecified disorders of bone/cartilage

136

1092

1.28

1.90

10.4

8.6

0.64

0.84

mmol/l

0.22

119

915

Cerebral amyloid angiopathy

250

1.65

1.90

8.2

7.7

1.33

0.88

mmol/l

0.34

211

Benign neoplasm: Ill-defined sites within the digestive system

249

1.64

1.90

4.4

9.4

0.91

1.28

mmol/l

0.24

212

Optic neuritis

164

1341

1.25

1.90

6.5

8.9

0.60

0.87

mmol/l

0.43

125

1099

Graves ophthalmopathy, strict

101

782

1.33

1.89

8.2

7.5

1.16

1.12

mmol/l

0.03

660

Androgenic alopecia

296

1.55

1.89

12.1

6.8

0.24

0.97

mmol/l

0.41

246

Mental and behavioural disorders of puerperium, not classified elsewhere

222

1.63

1.88

6.2

6.6

1.04

0.83

mmol/l

0.09

179

Multifocal fibrosclerosis

266

1.61

1.88

8.8

6.3

2.12

0.97

mmol/l

1.11

223

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

2.18

1.88

5.1

9.6

2.31

0.66

mmol/l

1.25

Effects of other deprivation

2.17

1.88

2.6

9.1

0.01

1.42

mmol/l

—

Family history of certain disabilities and chronic diseases leading to disablement

172

1414

1.23

1.86

9.0

7.3

0.63

0.82

mmol/l

0.30

132

1136

Other articular cartilage disorders

123

980

1.29

1.86

6.0

9.9

1.28

0.96

mmol/l

0.36

103

809

Ankle and foot

306

1.54

1.85

9.0

6.8

1.85

0.90

mmol/l

1.04

257

Recurrent cholesteatoma of postmastoidectomy cavity

126

1.93

1.85

8.2

8.3

1.50

1.11

mmol/l

0.20

106

Striae atrophicae

313

1.52

1.85

9.4

8.7

0.09

0.82

mmol/l

0.69

260

Vulvovaginal ulceration/inflammation in other diseases

237

2009

1.19

1.85

6.9

7.0

0.75

0.78

mmol/l

0.07

197

1620

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

161

1321

1.25

1.84

8.3

10.0

0.75

1.00

mmol/l

0.44

134

1109

Melanocytic naevi of scalp and neck

113

891

1.30

1.84

8.2

8.5

0.10

0.87

mmol/l

1.57

734

Allergic conjunctivitis

2993

27507

1.05

1.84

7.9

7.7

0.72

0.94

mmol/l

2.40

2524

22699

Melanocytic naevi of other and unspecified parts of face

274

2357

1.18

1.84

6.6

8.2

0.76

0.89

mmol/l

0.20

214

1925

Chorioretinal inflammation

142

1151

1.27

1.84

11.0

8.3

0.73

1.01

mmol/l

0.37

110

940

Cleft palate

232

1.61

1.83

9.0

13.4

1.84

0.60

mmol/l

1.33

189

Childhood allergy (age < 16)

367

2644

1.15

1.83

10.0

9.9

-0.04

-0.08

mmol/l

0.07

299

1981

Endometriosis of pelvic peritoneum

643

5294

1.11

1.83

5.8

8.0

0.81

0.85

mmol/l

0.08

499

4419

Cleft hard palate NOS

1.99

1.83

6.8

17.3

0.89

0.86

mmol/l

0.01

Tick-borne viral encephalitis

172

1.74

1.81

8.2

2.01

0.91

mmol/l

0.95

149

Postpartum haemorrhage

716

6480

0.91

1.80

6.6

7.9

-0.11

0.73

mmol/l

7.72

550

5245

Benign neoplasm: Larynx

173

1438

1.24

1.79

7.7

8.9

1.30

0.91

mmol/l

0.69

144

1183

All dysplastic lesions of the cervix uteri

883

7996

1.09

1.79

7.4

7.3

0.78

0.73

mmol/l

0.15

706

6418

Hereditary ataxia

529

1.40

1.78

5.0

9.4

0.70

0.93

mmol/l

0.19

441

Absence of one kidney, including avohilmo

112

1.94

1.78

6.5

15.0

0.44

0.90

mmol/l

0.12

Lichen ruber planus, wide definition including periferal and oral lichen planus

1273

11907

1.08

1.77

7.0

7.8

0.91

1.01

mmol/l

0.41

1034

9937

Cerebral atherosclerosis

633

1.36

1.77

9.3

6.3

1.24

1.03

mmol/l

0.23

514

Other and unspecified acne

374

1.46

1.76

9.0

10.5

0.63

0.68

mmol/l

0.03

311

Endometriosis of intestine

340

1.47

1.76

8.6

8.1

0.77

0.80

mmol/l

0.02

273

Glaucoma, exfoliation

678

6192

1.11

1.76

5.3

6.2

1.11

1.05

mmol/l

0.15

520

5042

Pedal cyclist injured in collision with pedestrian or animal

278

1.56

1.75

8.1

8.3

1.51

0.83

mmol/l

0.65

235

Malignant neoplasm of parotid gland

336

1.50

1.75

6.4

6.9

0.77

1.23

mmol/l

0.30

279

Lesion of plantar nerve

297

2585

1.17

1.74

5.1

7.4

0.87

1.05

mmol/l

0.30

253

2147

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

211

1.61

1.74

5.6

13.9

0.37

0.55

mmol/l

0.06

171

Tic and related disorders

242

1.56

1.74

8.9

9.4

0.72

0.54

mmol/l

0.13

203

Livedoid vasculitis

167

1.76

1.74

8.6

10.4

0.39

0.85

mmol/l

0.22

143

Injury of muscle and tendon at ankle and foot level

115

916

1.29

1.74

6.3

9.9

0.86

mmol/l

0.00

760

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

190

1.69

1.73

7.0

7.6

0.07

1.02

mmol/l

0.85

166

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2857

26159

1.05

1.72

8.0

7.7

0.69

0.94

mmol/l

2.82

2417

21586

Cholera, including avohilmo

2.22

1.72

19.1

10.5

0.63

0.01

mmol/l

—

MS-disease / Multiple Sclerosis

281

2434

1.17

1.72

6.3

8.6

1.23

0.85

mmol/l

0.86

227

1987

Other otitis externa (chronic)

339

2981

1.16

1.71

7.9

8.7

0.96

0.87

mmol/l

0.16

269

2446

Benign neoplasm: Pineal gland

2.42

1.71

9.5

7.2

1.02

1.41

mmol/l

0.17

Major anomalies of jaw size

110

873

1.29

1.71

7.9

10.7

1.58

0.74

mmol/l

1.03

738

Malignant neoplasm of penis, including Hilmo

264

1.57

1.70

8.8

7.4

-0.06

0.88

mmol/l

0.62

212

Congenital malformations of lung

2.12

1.70

5.6

15.3

0.33

1.12

mmol/l

0.45

Other infective spondylopathies

2.11

1.70

15.6

7.9

2.96

0.85

mmol/l

1.16

Other papulosquamous disorders

430

1.43

1.70

10.8

7.6

0.38

1.07

mmol/l

0.54

361

Other chromosome abnormalities, not elsewhere classified

113

1.87

1.69

20.3

23.6

-0.00

0.61

mmol/l

0.35

100

Explosion of other materials

114

1.90

1.69

5.0

8.9

-0.36

0.86

mmol/l

1.03

Other benign neoplasms of uterus

208

2439

0.84

1.69

5.4

5.6

1.39

1.26

mmol/l

0.19

173

2015

Other melanin hyperpigmentation

122

986

1.28

1.68

6.9

7.2

1.39

1.02

mmol/l

0.61

819

Triptan medication for migraine, single purchase ok

3776

26563

0.96

1.67

7.5

8.4

0.80

0.91

mmol/l

1.11

3116

22130

Migraine, single triptan purchase ok & required. ICD-code if available is included

3776

26563

0.96

1.67

7.5

8.4

0.80

0.91

mmol/l

1.11

3116

22130

Reiter disease

224

1.61

1.67

5.0

9.0

-0.12

0.74

mmol/l

0.52

189

Outcome of delivery

373

2594

0.88

1.66

6.8

8.6

-0.53

0.74

mmol/l

9.67

322

2080

Benign neoplasm: Skin of upper limb, including shoulder

101

799

1.30

1.66

9.3

8.6

0.74

0.95

mmol/l

0.25

662

Other endocrine disorders

195

1576

1.20

1.65

9.9

10.9

0.09

0.59

mmol/l

0.85

164

1302

Carcinoma in situ of oral cavity and pharynx

2.30

1.64

13.1

8.7

-0.30

0.98

mmol/l

0.72

Benign neoplasm: Skin of other and unspecified parts of face

577

5248

1.11

1.64

6.5

7.4

1.13

1.01

mmol/l

0.33

469

4279

Periodontal disease, other/unspecified

130

1059

1.26

1.64

8.9

8.1

1.11

1.00

mmol/l

0.14

103

874

Benign neoplasm: Skin of scalp and neck

129

1051

1.26

1.63

7.1

8.6

1.02

0.99

mmol/l

0.03

104

862

Secondary sideroblastic anaemia

108

1.92

1.63

8.0

7.5

1.94

1.52

mmol/l

0.10

Disorders of lacrimal system and orbit in diseases classified elsewhere

110

880

1.28

1.63

7.9

7.2

1.19

1.05

mmol/l

0.15

740

Mental and behavioural disorders associated with the puerperium

231

1.56

1.63

6.2

9.2

1.04

0.78

mmol/l

0.11

182

Other and unspecified degenerative diseases of nervous system

167

1401

1.23

1.62

5.9

7.6

1.16

0.89

mmol/l

0.34

137

1144

Complications of the puerperium, not elsewhere classified

118

948

1.26

1.62

8.6

7.7

0.04

0.77

mmol/l

1.09

747

Follicular lymphoma, hilmo

238

2056

1.18

1.62

6.6

7.8

1.55

0.92

mmol/l

1.68

201

1699

Ankylosing spondylitis, strict definition

180

1514

1.21

1.61

9.2

10.4

1.02

0.81

mmol/l

0.33

150

1256

Adrenogenital disorders

162

1.71

1.61

9.9

6.1

0.41

0.72

mmol/l

0.17

128

ILD medications: acetylcysteine

282

1.51

1.61

10.8

5.2

1.77

1.03

mmol/l

0.47

225

Short stature starting before birth

2.03

1.61

26.5

15.0

0.17

-0.34

mmol/l

0.13

Benign lipomatous neoplasm of other sites/unspecified

471

4246

1.13

1.61

6.8

7.4

0.63

1.05

mmol/l

1.66

397

3488

Glycosuria

2.38

1.60

8.5

6.8

4.80

1.37

mmol/l

—

Benign neoplasm: Choroid

360

3198

1.15

1.60

7.9

7.6

0.91

1.01

mmol/l

0.21

290

2638

Venous complications and haemorrhoids in pregnancy

347

1.44

1.60

5.8

8.9

0.32

0.73

mmol/l

0.44

263

Glaucoma secondary to eye inflammation

334

1.47

1.59

6.4

10.0

1.06

1.00

mmol/l

0.04

279

Noonan syndrome

2.89

1.59

17.7

8.8

1.44

-0.97

mmol/l

—

Small cell lung cancer, including Hilmo

134

1100

1.25

1.58

5.6

6.4

1.73

1.11

mmol/l

0.78

107

887

Small cell lung cancer

134

1100

1.25

1.58

5.6

6.4

1.73

1.11

mmol/l

0.78

107

887

Adenomyosis (Endometriosis of uterus)

638

5826

1.10

1.58

6.3

7.1

0.85

1.05

mmol/l

0.58

519

4912

Carcinoma in situ of skin of ear and external auricular canal

105

845

1.29

1.57

6.7

6.8

0.26

0.89

mmol/l

1.23

683

Malignant neoplasm of lip, including Hilmo

472

1.39

1.57

10.8

5.9

0.57

1.21

mmol/l

0.51

389

Benign neoplasm: Retina

195

1.63

1.57

5.8

7.5

0.50

0.89

mmol/l

0.15

166

Follicular adenocarcinoma of thyroid gland

219

1.59

1.56

3.3

6.7

0.98

1.18

mmol/l

0.15

183

Guttate psoriasis

497

1.37

1.56

6.4

9.1

0.66

0.95

mmol/l

0.18

414

Benign neoplasm: Skin of ear and external auricular canal

215

1848

1.19

1.55

6.3

7.4

1.03

0.89

mmol/l

0.19

181

1497

Spermatocele

467

4220

1.12

1.55

6.8

9.0

1.01

0.75

mmol/l

0.86

382

3468

Cyst of Bartholin Gland

145

1200

1.23

1.55

5.2

7.3

0.94

1.04

mmol/l

0.17

115

985

Rapidly progressive nephritic syndrome

2.01

1.55

28.9

7.6

-0.11

0.77

mmol/l

—

Failed attempted abortion

234

1.53

1.54

4.1

8.1

-0.66

0.42

mmol/l

0.58

176

Disorders of sphingolipid metabolism and other lipid storage disorders

102

1.88

1.54

5.8

14.6

2.19

1.30

mmol/l

0.28

Impacted maxillary canine

219

1.56

1.53

17.4

14.4

1.30

0.33

mmol/l

0.72

193

Sexual dysfunction

701

1.30

1.52

10.1

11.6

0.81

0.84

mmol/l

0.03

586

Acute inflammation of orbit

204

1.59

1.52

11.0

8.4

-0.00

0.84

mmol/l

0.62

171

Other hypersecretion of intestinal hormones

3.38

1.51

22.3

10.8

-1.33

2.63

mmol/l

—

Graves ophthalmopathy

109

880

1.27

1.51

8.0

7.3

1.18

1.04

mmol/l

0.14

741

Lymphangioma, anys site

245

1.53

1.51

7.3

11.2

0.35

0.59

mmol/l

0.13

201

Crowding of teeth, including avohilmo

265

1907

1.16

1.51

10.3

0.41

0.29

mmol/l

0.21

204

1504

Dentofacial anomalies [including malocclusion]

3562

28893

0.96

1.51

6.9

8.4

0.94

0.88

mmol/l

0.55

2880

23998

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

420

1.38

1.50

8.4

7.7

0.89

0.75

mmol/l

0.14

322

Other abortion

220

1.55

1.50

8.3

6.9

1.88

0.60

mmol/l

1.53

178

Myopathy due to other toxic agents

3.27

1.50

12.0

8.8

5.23

1.02

mmol/l

—

Benign leiomyoma with endometriosis

642

6986

0.91

1.49

6.5

6.6

0.94

1.14

mmol/l

0.66

532

5857

Glaucoma-related operations

333

2962

1.15

1.49

6.7

6.8

0.72

0.97

mmol/l

0.59

269

2431

Disorder of thyroid, unspecified

502

1.36

1.48

16.9

6.4

1.28

1.25

mmol/l

0.02

416

Tooth agenesis EXCLUDE clefts and syndromes

108

868

1.26

1.48

15.2

10.5

0.81

0.37

mmol/l

0.65

711

Other disorders of male genital organs

201

1725

1.19

1.47

7.5

10.0

0.96

0.73

mmol/l

0.42

172

1429

Carcinoid syndrome

427

1.40

1.47

6.3

9.6

0.38

1.03

mmol/l

0.50

361

Vitiligo

381

1.41

1.47

6.5

9.5

-0.16

0.88

mmol/l

0.69

320

Benign neoplasm: Other parts of oropharynx

357

1.43

1.46

8.3

9.9

0.55

0.83

mmol/l

0.20

313

Other acquired deformities of ankle and foot

289

1.48

1.46

4.2

7.9

1.21

1.16

mmol/l

0.04

241

Other specified and unspecified disorders of lens

384

1.42

1.45

6.3

6.8

0.91

0.98

mmol/l

0.05

317

Benign neoplasm: Long bones of lower limb

140

1165

1.23

1.45

10.3

1.17

0.92

mmol/l

0.44

116

970

Seminoma of testis, including Hilmo

323

1.45

11.2

11.6

0.48

1.25

mmol/l

0.89

271

Pseudopolyposis of colon

1.89

1.45

11.9

9.8

2.73

1.07

mmol/l

1.55

Small plaque parapsoriasis

121

1.81

1.44

2.8

7.0

2.19

1.03

mmol/l

0.59

102

Bicornuate uterus

134

1.70

1.44

4.0

7.6

0.59

1.25

mmol/l

0.38

110

Conjunctivitis (acute, non atopic), including avohilmo

6644

39043

1.03

1.44

7.7

8.1

0.82

0.91

mmol/l

1.15

5611

32167

Toxoplasmosis

183

1.61

1.44

6.2

8.8

0.13

0.96

mmol/l

0.65

150

Postinflammatory hyperpigmentation

2.27

1.43

10.7

8.2

-2.35

0.24

mmol/l

1.71

Autism

527

1.33

1.43

6.9

10.4

1.01

0.30

mmol/l

0.72

436

Pervasive developmental disorders excl. Autism + Asperger

268

1.47

1.42

5.8

14.5

0.42

0.28

mmol/l

0.09

223

Open bite that required surgery (Lefort1 or BSSO)

198

1.56

1.42

2.8

11.2

1.69

0.83

mmol/l

0.46

163

Lichen sclerosus et atrophicus

558

5107

1.10

1.41

5.7

7.3

1.12

1.07

mmol/l

0.10

466

4278

Labour and delivery complicated by umbilical cord complications

169

1432

1.20

1.41

6.4

7.4

1.31

0.82

mmol/l

1.06

130

1175

Other disorders of thyroid

524

1.34

1.41

16.5

6.8

1.25

1.19

mmol/l

0.04

436

Chronic myeloproliferative disease

660

1.31

1.40

8.6

8.3

0.30

1.02

mmol/l

0.69

542

Chronic mastoiditis

140

1175

1.22

1.38

9.6

7.9

1.23

1.03

mmol/l

0.26

118

963

Xanthelasma of eyelid

327

1.44

1.38

6.8

7.6

0.30

1.05

mmol/l

0.66

273

Selective deficiency of immunoglobulin A [IgA]y

129

1.72

1.38

6.9

12.5

0.86

1.19

mmol/l

0.11

107

Rosacea

616

5670

1.10

1.37

7.4

8.0

0.88

0.90

mmol/l

0.04

484

4673

Hereditary angioödema type 1

2.63

1.37

5.0

8.0

2.00

1.08

mmol/l

—

Hypertrophy of breast

693

6408

1.09

1.36

7.4

1.08

0.98

mmol/l

0.27

580

5332

Other congenital malformations of peripheral vascular system

412

1.37

1.36

21.3

10.2

0.87

0.78

mmol/l

0.05

350

Other congenital malformations of female genitalia

152

1.62

1.35

8.5

7.9

1.56

0.80

mmol/l

0.39

122

Hypothyroidism, autoimmune, DX-based

114

1.76

1.35

6.7

8.5

0.42

1.21

mmol/l

0.40

Subclinical iodine-deficiency hypothyroidism

2.16

1.35

5.3

7.2

0.27

1.78

mmol/l

1.58

Congenital malformations of lung, including avohilmo

1.91

1.35

5.6

14.3

0.33

1.06

mmol/l

0.43

L02BG Aromatase inhibitors

1590

14928

1.06

1.35

5.8

6.8

1.08

1.17

mmol/l

0.40

1382

12570

Use of apomorphine

2.65

1.35

18.4

8.1

-0.16

1.68

mmol/l

—

Osteopathy after poliomyelitis

2.88

1.34

1.7

4.0

-0.58

1.26

mmol/l

—

Other appendicitis

401

3624

1.12

1.34

9.5

8.1

0.82

0.95

mmol/l

0.26

336

2982

Sequelae of transport accidents

187

1.58

1.33

13.5

10.5

3.63

0.92

mmol/l

3.05

154

Crushing injury of ankle and foot

139

1.69

1.33

7.6

7.5

2.21

0.64

mmol/l

1.60

114

Other disorders of amniotic fluid and membranes

314

3403

0.89

1.33

7.0

8.1

0.59

0.53

mmol/l

0.10

230

2707

Raynaud syndrome

404

3653

1.12

1.33

5.9

8.3

0.97

0.86

mmol/l

0.26

335

2998

Pedal cyclist injured in collision with motor vehicle

137

1149

1.21

1.33

6.6

9.1

1.32

0.87

mmol/l

1.06

110

959

Valgus deformity, not elsewhere classified

244

1.49

1.33

4.7

11.1

-0.11

1.30

mmol/l

1.36

200

Glaucoma secondary to eye trauma

288

1.47

1.33

7.7

7.9

0.98

0.92

mmol/l

0.03

240

Congenital absence of the vagina

3.01

1.32

13.8

12.3

4.52

1.31

mmol/l

—

Nondiabetic hypoglycaemic coma

123

1.73

1.32

8.1

12.7

2.29

1.32

mmol/l

0.30

101

Other combined immunodeficiencies

2.29

1.32

2.9

5.4

0.73

1.21

mmol/l

—

Toxoplasmosis, including avohilmo

187

1.57

1.32

6.2

8.7

0.14

0.90

mmol/l

0.59

154

Wilms' tumor, including Hilmo

229

1.52

1.32

6.6

6.3

-0.12

1.05

mmol/l

0.67

189

Other and unspecified disease of Bartholin gland

125

1042

1.23

1.32

7.5

7.3

0.99

1.11

mmol/l

0.13

108

869

Whooping cough

130

1.67

1.31

13.3

7.7

-0.35

0.70

mmol/l

0.68

109

Chronic diseases of tonsils and adenoids

4270

27761

0.97

1.31

7.8

8.5

0.93

0.83

mmol/l

1.01

3541

23053

Pityriasis rosea

228

1.50

1.30

10.0

10.6

0.68

0.89

mmol/l

0.09

188

Measles

312

1.42

1.30

5.2

12.1

0.56

1.07

mmol/l

0.36

256

Spontaneous abortion

1767

12412

0.95

1.30

6.5

7.3

1.00

0.95

mmol/l

0.22

1418

10288

Severe visual impairment, monocular

435

1.36

1.30

4.6

6.5

0.76

1.22

mmol/l

0.42

366

Exposure to electric transmission lines

2.42

1.30

8.4

11.0

2.22

-0.09

mmol/l

—

Ménière disease

505

4629

1.10

1.29

5.0

7.5

1.15

1.03

mmol/l

0.26

411

3810

Other predominantly sexually transmitted diseases, not elsewhere classified

627

5788

1.09

1.29

9.6

8.2

0.40

0.73

mmol/l

1.25

517

4691

Anogenital herpesviral [herpes simplex] infection, including avohilmo

386

3484

1.12

1.29

9.4

8.5

0.34

0.67

mmol/l

1.10

323

2778

Inflammation of lacrimal passages (chronic)

666

1.29

1.28

5.8

7.5

0.89

1.08

mmol/l

0.14

542

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

292

2604

1.14

1.28

6.4

6.8

0.83

1.15

mmol/l

0.82

231

2165

Respiratory tuberculosis, clinically confirmed

542

1.32

1.27

12.2

7.7

1.72

1.09

mmol/l

0.63

436

Other bursitis, not elsewhere classified

367

1.38

1.26

4.9

7.9

0.53

1.12

mmol/l

0.82

302

LSIL lesion of the cervix uteri, vagina or vulva

487

4453

1.10

1.26

7.6

7.2

0.87

0.81

mmol/l

0.12

400

3609

Moderate visual impairment, monocular

182

1.57

1.25

15.6

7.4

-0.18

1.05

mmol/l

0.73

157

Psoriatic arthropathies, strict definition

0.00

1.24

0.0

9.4

—

-0.11

—

Endometriosis of fallopian tube

231

1.48

1.24

7.5

10.1

0.59

0.94

mmol/l

0.23

189

Edwards' syndrome and Patau's syndrome

2.55

1.24

21.7

7.8

1.22

1.85

mmol/l

—

Wide developmental disorders

769

1.24

6.1

13.1

0.74

0.15

mmol/l

0.75

634

Pregnancy, childbirth and the puerperium

1374

7563

0.94

1.23

5.8

6.4

0.90

1.07

mmol/l

0.77

1135

6215

Obstructed labour due to malposition and malpresentation of fetus

629

6292

0.92

1.23

6.1

8.1

0.75

mmol/l

0.01

501

5098

Otosclerosis

310

3450

0.89

1.23

8.2

7.8

0.95

1.00

mmol/l

0.08

259

2849

Disorders of visual cortex

2.95

1.22

6.2

14.9

-1.56

1.13

mmol/l

—

Reduction defects of upper limb

1.94

1.22

8.2

10.9

-0.63

1.83

mmol/l

1.09

Traumatic amputation of wrist and hand

233

2058

1.15

1.22

7.8

9.4

1.28

0.82

mmol/l

1.34

192

1705

Other conjunctival vascular disorders and cysts

115

961

1.23

1.21

6.6

8.2

0.55

0.99

mmol/l

0.57

802

Exfoliative dermatitis

467

1.33

1.21

9.6

7.4

1.31

0.84

mmol/l

0.31

381

Abnormalities of forces of labour

273

3065

0.88

1.21

7.7

7.6

0.45

0.83

mmol/l

1.22

231

2543

Chorioretinal scars

143

1.64

1.21

14.5

8.3

0.41

0.96

mmol/l

0.34

119

Measles, including avohilmo

317

1.39

1.20

5.2

12.0

0.56

1.06

mmol/l

0.35

260

Other and unspecified papulosquamous disorders

242

1.47

1.20

11.4

6.9

-0.56

1.08

mmol/l

1.41

203

Use of teriflunomide

248

0.59

1.20

3.4

9.6

-0.20

0.86

mmol/l

—

200

Benign neoplasm: Skin of lip

548

1.30

1.19

6.5

7.2

0.88

1.10

mmol/l

0.15

459

Chondromalacia

1019

0.80

1.18

5.9

9.1

-0.06

0.84

mmol/l

1.43

856

Chronic myringitis

193

1.53

1.17

5.4

12.8

2.16

0.99

mmol/l

0.75

167

Viral conjunctivitis, including avohilmo

159

1369

1.18

1.16

7.1

8.7

1.30

0.84

mmol/l

0.81

132

1135

Other and unspecified neuropathies

169

1.57

1.16

9.0

7.9

1.94

1.08

mmol/l

0.27

142

Parapsoriasis

720

1.25

1.15

9.4

8.3

0.96

0.93

mmol/l

0.03

598

Benign neoplasm: other/unspecified salivary gland

139

1189

1.20

1.15

6.9

7.7

1.51

1.08

mmol/l

0.56

113

984

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

234

1.44

1.14

8.0

7.8

0.06

0.96

mmol/l

0.89

187

Other noninflammatory disorders of vagina

341

3087

1.12

1.14

6.5

7.3

1.10

0.95

mmol/l

0.28

270

2583

Occupant of special vehicle mainly used on industrial premises injured in transport accident

195

1.52

1.14

6.5

8.2

1.99

0.57

mmol/l

0.81

164

Labyrinthitis

121

1.67

1.13

3.8

6.0

0.76

0.95

mmol/l

0.15

101

Rhinophyma

325

1.40

1.12

5.2

8.3

1.51

0.90

mmol/l

0.53

266

Unspecified lump in breast

717

6705

1.08

1.12

7.6

6.9

0.78

1.08

mmol/l

1.33

622

5612

Other acute disseminated demyelination

270

1.41

1.12

6.7

7.9

0.77

0.93

mmol/l

0.09

220

Changes in corneal membranes

146

1.60

1.11

4.4

6.9

2.11

1.24

mmol/l

0.61

124

Other diseases of appendix

446

1.32

1.11

15.1

7.4

0.79

1.09

mmol/l

0.28

374

Maxillary retrognathism

466

0.72

1.11

14.1

10.7

0.97

0.73

mmol/l

0.11

388

Respiratory and cardiovascular disorders specific to the perinatal period

411

1.30

1.10

20.6

19.4

-0.89

-0.31

mmol/l

0.62

335

Hereditary motor and sensory neuropathy

306

1.39

1.10

8.1

8.3

2.36

1.02

mmol/l

0.87

265

Vasomotor rhinitis (mode)

352

3201

1.11

1.10

6.3

8.2

1.13

0.93

mmol/l

0.50

277

2640

Use of glatiramer acetate

409

1.32

1.10

6.6

9.9

0.80

0.88

mmol/l

0.05

332

Failed induction of labour

152

1309

1.17

1.09

4.6

7.6

-0.11

0.25

mmol/l

0.56

114

1004

Premature separation of placenta [abruptio placentae]

579

1.26

1.08

4.4

7.8

0.78

0.79

mmol/l

0.01

465

Complications associated with artificial fertilization

331

1.35

1.08

4.2

8.3

0.15

0.54

mmol/l

0.20

254

Primary angle-closure glaucoma

241

2156

1.14

1.06

6.0

7.3

0.97

1.01

mmol/l

0.04

194

1782

Deep bite that required surgery

342

1.35

1.06

3.9

11.0

1.03

0.88

mmol/l

0.09

285

Unspecified abortion

177

1549

1.16

1.06

7.1

7.4

0.84

1.02

mmol/l

0.25

142

1293

Amoebiasis, including avohilmo

265

1.40

1.05

11.3

10.5

-1.18

1.13

mmol/l

1.21

232

Ankyloglossia

323

1.35

1.05

17.4

13.4

-0.64

0.05

mmol/l

0.43

265

Dementia due to Parkinson's disease

159

1392

1.17

1.02

4.3

6.9

1.75

1.02

mmol/l

2.27

133

1116

Dermatitis herpetiformis

705

1.24

1.01

8.8

8.0

1.81

1.02

mmol/l

1.57

590

Unspecific neurodegenerative disorder

3047

20235

1.04

1.01

4.7

6.8

1.19

0.98

mmol/l

1.89

2401

16711

Trichomoniasis, including avohilmo

338

1.35

1.00

7.2

8.4

0.96

1.18

mmol/l

0.16

293

Donors of organs and tissues

398

1.31

1.00

14.2

7.9

0.49

0.68

mmol/l

0.21

326

Sweet's syndrome

2.00

1.00

15.3

6.9

1.74

0.73

mmol/l

—

All dysplastic lesions of the vagina

106

898

1.20

0.99

7.5

0.92

1.18

mmol/l

0.25

741

Early syphilis

463

1.29

0.99

8.2

11.1

0.35

0.98

mmol/l

0.65

399

Other disorders of kidney and ureter in diseases classified elsewhere

2.48

0.99

5.2

6.6

0.68

1.09

mmol/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

235

1.42

0.98

12.3

7.5

0.14

0.99

mmol/l

0.37

194

Eccrine sweat disorders

102

1.68

0.98

1.9

8.4

-0.43

0.72

mmol/l

0.27

Onycholysis

226

1.42

0.98

7.3

9.9

2.06

0.76

mmol/l

1.44

196

Other and unspecified spinal muscular atrophies

340

1.34

0.98

6.9

9.2

2.58

0.97

mmol/l

2.14

279

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

279

1.38

0.97

5.1

8.4

0.32

1.02

mmol/l

0.85

236

Foreign body in genitourinary tract

322

1.34

0.96

4.7

8.7

1.19

0.87

mmol/l

0.20

271

Febrile neutrophilic dermatosis [Sweet]

1.96

0.95

15.3

6.4

1.74

0.68

mmol/l

—

Enteritis due to Yersinia enterocolitica

185

1.46

0.95

7.0

8.2

1.39

0.87

mmol/l

0.36

152

Acute otitis externa, noninfective

665

1.23

0.94

8.6

7.7

1.61

0.82

mmol/l

0.88

558

Malignant neoplasm of nasopharynx, including Hilmo

186

1.47

0.94

11.3

7.7

0.84

1.26

mmol/l

0.14

158

Benign neoplasm: Tonsil

494

1.27

0.93

5.6

8.1

0.26

1.03

mmol/l

0.99

431

Granuloma annulare

520

1.26

0.93

8.6

7.5

1.63

0.81

mmol/l

0.93

439

L02BX Other hormone antagonists and related agents

318

3463

0.90

0.92

5.6

7.9

0.63

0.79

mmol/l

0.27

253

2820

Loose body in joint

113

971

1.19

0.92

9.0

10.4

0.94

0.84

mmol/l

0.11

793

Gluteal tendinitis

186

1654

1.14

0.91

6.5

7.7

1.05

0.95

mmol/l

0.15

153

1392

Separation of retinal layers (serosa)

213

1913

1.13

0.91

9.0

0.73

1.01

mmol/l

0.60

185

1594

Hand

187

1.45

0.90

6.9

11.0

1.26

0.87

mmol/l

0.25

158

Felty syndrome

222

1.41

0.90

10.1

6.6

0.31

1.12

mmol/l

0.65

187

Exposure to other specified electric current

748

0.80

0.90

17.2

10.5

0.93

0.83

mmol/l

0.05

623

Night blindness

2.16

0.90

14.8

11.6

-1.85

1.87

mmol/l

—

Reduction defects of upper limb, including avohilmo

1.68

0.89

15.8

11.7

-0.21

1.54

mmol/l

0.71

Use of rivastigmine

1045

9945

1.06

0.89

4.0

6.1

1.21

1.07

mmol/l

0.54

827

8053

Exposure to excessive heat of man-made origin

381

1.30

0.89

12.0

9.4

1.16

0.98

mmol/l

0.12

319

Crushing injury of hip and thigh

2.12

0.89

10.5

5.2

-1.92

0.23

mmol/l

—

Injury of nerves at ankle and foot level

239

1.38

0.89

12.3

8.4

2.69

0.73

mmol/l

1.40

200

Cervical root disorders

257

1.37

0.89

6.2

9.5

1.17

0.75

mmol/l

0.36

225

Use of galantamine

434

4664

0.92

0.89

3.7

5.8

1.28

1.01

mmol/l

0.78

337

3753

Early syphilis, including avohilmo

497

1.26

0.89

8.2

10.7

0.33

0.91

mmol/l

0.63

423

Congenital absence, atresia and stenosis of small intestine

2.07

0.88

32.5

16.4

0.40

0.63

mmol/l

—

Progressive external ophthalmoplegia

2.10

0.87

6.0

9.8

2.67

1.21

mmol/l

—

Other sexually transmitted chlamydial diseases

134

1534

0.87

10.5

9.4

-0.41

0.53

mmol/l

1.93

111

1197

Acute necrotizing ulcerative gingivitis, including avohilmo

1.86

0.87

8.8

21.5

2.21

1.26

mmol/l

—

Carcinoma in situ of cervix uteri

303

2771

1.10

0.87

6.4

7.4

0.74

0.68

mmol/l

0.11

233

2187

Mental and behavioural disorders due to cocaine

1.84

0.86

11.4

20.3

1.00

1.06

mmol/l

—

Benign neoplasm: Bone and articular cartilage, unspecified

258

1.36

0.86

10.4

10.8

0.94

1.34

mmol/l

0.26

214

Postpartum haemorrhage due to anatomy

208

2315

0.89

0.86

6.0

6.8

-0.47

0.36

mmol/l

2.04

149

1752

Psoriasis (vulgaris), strict definition

154

1362

1.15

0.85

9.4

10.1

0.36

0.98

mmol/l

1.05

127

1146

Graves disease, strict definition

413

3834

1.08

0.85

6.5

8.0

0.80

0.92

mmol/l

0.24

338

3139

Melanoma of uvea

438

1.27

0.85

7.6

9.4

1.05

0.97

mmol/l

0.04

368

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

2.04

0.84

4.8

10.0

1.53

0.27

mmol/l

—

Supernumerary ureter

1.79

0.84

15.0

6.7

0.85

1.39

mmol/l

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

347

1.29

0.83

4.3

7.2

1.81

0.93

mmol/l

1.04

285

Monocytic leukaemia

175

1.46

0.83

5.4

7.1

1.79

1.12

mmol/l

0.30

147

Crystalline deposits in vitreous body

440

1.27

0.83

5.4

7.2

1.26

1.00

mmol/l

0.29

370

Sclerosis of liver

2.51

0.82

13.8

6.4

-1.16

1.25

mmol/l

—

Meretoja disease

149

1.49

0.82

7.0

7.8

1.08

1.09

mmol/l

0.01

129

Other endophthalmitis

226

1.38

0.82

9.3

6.1

0.33

1.02

mmol/l

0.32

185

Other forms of systemic lupus erythematosus

269

1.34

0.82

12.9

7.0

-0.14

1.15

mmol/l

0.76

230

Injury of blood vessels at wrist and hand level

279

1.34

0.81

11.6

11.2

1.57

1.08

mmol/l

0.41

234

Adhesive middle ear disease

539

1.23

0.81

5.1

8.5

1.23

0.97

mmol/l

0.24

447

Whooping cough, including avohilmo

402

1.26

0.81

8.8

7.9

-0.76

0.67

mmol/l

1.71

324

Infectious mononucleosis

249

2268

1.10

0.80

8.9

9.1

0.57

0.56

mmol/l

0.02

198

1801

Infectious mononucleosis, including avohilmo

249

2268

1.10

0.80

8.9

9.1

0.57

0.56

mmol/l

0.02

198

1801

Otorrhoea

108

1.57

0.79

17.7

9.3

-1.30

0.91

mmol/l

0.82

Syndactyly

1.79

0.79

58.6

12.1

-0.37

0.87

mmol/l

—

Helminthiases

633

1.21

0.79

10.3

8.4

0.44

0.89

mmol/l

0.41

533

Alpha thalassaemia

1.99

0.78

3.6

9.5

0.70

1.94

mmol/l

—

Endocrine disorders, other/unspecified

688

0.81

0.76

6.5

7.7

1.22

0.91

mmol/l

0.18

574

Palatinal maxillary operation

124

1.48

0.76

13.3

19.5

-1.41

-0.13

mmol/l

0.55

100

Contraceptive management

1791

12936

0.96

0.76

8.2

9.3

0.73

0.91

mmol/l

1.42

1476

10820

Impacted maxillary molar

154

1371

1.13

0.76

6.6

8.7

-0.46

0.26

mmol/l

1.36

113

1046

Relapsing fevers

1.68

0.75

7.7

21.9

1.30

1.18

mmol/l

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

638

1.21

0.75

5.0

6.6

0.85

1.22

mmol/l

0.39

526

Anisometropia and aniseikonia

110

1254

0.87

0.74

11.1

8.0

0.26

0.80

mmol/l

0.77

1042

Other diseases caused by chlamydiae, including avohilmo

398

1.25

0.74

9.7

9.0

0.46

1.09

mmol/l

0.43

326

Crushing injury of forearm

1.65

0.74

35.4

9.2

1.31

0.15

mmol/l

—

Other maternal disorders predominantly related to pregnancy

2350

14279

1.03

0.74

6.8

7.6

0.95

0.94

mmol/l

0.02

1884

11904

Aggressive periodontitis

108

946

1.16

0.73

11.0

8.8

0.48

0.96

mmol/l

0.40

797

Sequelae of hyperalimentation

1.64

0.73

7.3

5.8

0.57

1.38

mmol/l

—

Neuroendocrine tumor and carcinoma of stomach

187

1.39

0.73

5.0

6.9

-0.08

1.20

mmol/l

0.90

154

Scissor bite

584

1.20

0.73

11.2

12.9

0.63

0.14

mmol/l

0.71

488

Corrosions classified according to extent of body surface involved

1.78

0.72

3.6

8.7

2.44

1.47

mmol/l

—

Other rickettsioses, including avohilmo

2.06

0.72

12.2

11.4

-1.44

1.97

mmol/l

—

Asymptomatic human immunodeficiency virus [HIV] infection status

205

1.36

0.71

15.1

16.8

-0.03

0.92

mmol/l

0.49

170

Need for immunization against other single infectious diseases

1.73

0.70

24.3

8.2

0.41

1.08

mmol/l

—

Other congenital malformations of face and neck

104

911

1.16

0.69

8.4

10.3

1.17

0.76

mmol/l

0.44

759

Tonsillectomy and adenotomy

2385

17041

0.97

0.69

7.8

8.9

0.73

0.75

mmol/l

0.12

1931

13897

Vascular dementia (multiple infarctions)

604

1.19

0.69

5.4

6.2

1.43

1.00

mmol/l

0.28

466

Postdysenteric arthropathy

349

0.76

0.68

5.0

10.7

0.31

0.71

mmol/l

0.30

300

Primary open-angle glaucoma

2091

19569

1.03

0.68

6.3

6.9

0.96

1.01

mmol/l

0.25

1659

16161

Osteochondrosis of ankle, juvenile

128

1.44

0.68

5.1

16.0

1.51

0.69

mmol/l

0.66

101

Benign neoplasm: Short bones of lower limb

350

1.26

0.67

6.2

10.6

1.11

0.82

mmol/l

0.25

298

Other specific arthropathies, wide

774

1.17

0.67

6.6

9.9

0.86

0.87

mmol/l

0.00

637

Postpartum hemorraghe, parous women as controls

716

6284

0.95

0.67

6.6

7.1

-0.11

0.73

mmol/l

7.74

550

5006

Abrasion of teeth

1844

18983

0.97

0.67

7.4

8.0

1.00

0.94

mmol/l

0.29

1542

15847

Abnormality of red blood cells

208

1.34

0.66

7.3

8.6

1.10

1.12

mmol/l

0.01

181

Benign neoplasm: Connective and other soft tissue of thorax

182

1.37

0.66

7.1

7.6

1.10

0.96

mmol/l

0.11

153

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

415

1.23

0.65

6.2

9.2

1.39

0.90

mmol/l

0.58

349

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

850

1.15

0.65

8.0

8.7

1.10

0.98

mmol/l

0.14

703

Synovial hypertrophy, not elsewhere classified

279

1.28

0.65

9.3

11.4

0.55

1.06

mmol/l

0.31

221

Complications following abortion and ectopic and molar pregnancy

139

1249

1.13

0.65

7.4

7.3

1.05

1.16

mmol/l

0.13

116

1058

Embedded and impacted teeth

920

7159

1.05

0.64

8.1

8.8

0.61

0.51

mmol/l

0.37

717

5689

Congenital ovarian cysts

124

1105

1.13

0.64

7.9

7.5

0.13

0.88

mmol/l

1.11

104

887

Benign neoplasm: Lip

104

920

1.15

0.64

6.3

7.1

1.35

1.09

mmol/l

0.30

753

Other sexually transmitted chlamydial diseases, including avohilmo

230

2499

0.92

0.64

8.9

8.7

-0.37

0.43

mmol/l

2.18

182

1915

Drug-induced headache, not elsewhere classified

174

1.36

0.63

14.2

6.3

-0.31

1.27

mmol/l

1.32

142

Ovarian hyperstimulation (induction)

334

1.24

0.62

4.4

7.8

0.03

0.58

mmol/l

0.27

244

Localized scleroderma [morphea]

519

1.20

0.62

10.1

8.0

-0.09

1.01

mmol/l

1.14

436

Exposure to high-pressure jet

0.00

0.62

0.0

9.2

—

0.27

—

Other noninflammatory disorders of cervix uteri

195

2124

0.91

0.62

5.6

7.4

0.84

1.12

mmol/l

0.41

162

1803

Choroidal haemorrhage and rupture

150

1.40

0.60

4.5

6.9

0.92

0.74

mmol/l

0.08

117

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

623

1.17

0.60

15.9

12.4

-0.20

0.96

mmol/l

1.70

522

Puerperal sepsis

505

4792

1.06

0.60

7.9

7.5

1.05

mmol/l

0.00

435

4029

Malignant neoplasm of lip

347

1.24

0.60

9.2

6.3

-0.49

1.29

mmol/l

1.46

283

Endometriosis of ovary

717

6459

1.05

0.60

7.0

7.5

0.98

0.96

mmol/l

0.04

583

5409

Carcinoma in situ of bronchus and lung

1.63

0.59

11.4

10.8

2.23

1.36

mmol/l

—

Alzheimer’s disease (Late onset)

1656

13249

1.03

0.59

4.1

6.1

1.08

1.04

mmol/l

0.13

1295

10738

Keratoconus

103

917

1.14

0.58

8.7

9.1

2.10

0.85

mmol/l

3.06

783

Presence of other devices

1407

14261

0.97

0.58

6.7

6.4

1.23

0.99

mmol/l

1.61

1105

11671

Asymmetry of jaw

366

1.22

0.57

5.1

12.1

0.46

0.91

mmol/l

0.31

309

Melanocytic naevi of ear and external auricular canal

213

1.30

0.57

6.9

7.2

1.44

0.64

mmol/l

0.43

180

Pollen allergy

658

6203

1.05

0.57

7.7

9.1

0.53

0.63

mmol/l

0.36

557

5017

Complications following myocardial infarction

294

1.25

0.57

11.2

6.9

0.19

0.95

mmol/l

0.56

239

Allergic contact dermatitis due to drugs in contact with skin

834

1.14

0.57

8.3

7.8

1.08

1.02

mmol/l

0.05

690

Undefined dementia

661

6366

0.95

0.56

4.6

5.4

1.73

1.02

mmol/l

4.61

508

5019

Benign neoplasm: Vulva

759

1.15

0.56

5.4

6.9

1.26

1.15

mmol/l

0.10

634

Hypospadias with an incomplete glans penis

1.53

0.56

13.9

10.0

1.49

0.83

mmol/l

—

Perioral dermatitis, drug-induced

1.63

0.56

15.2

4.7

1.55

1.44

mmol/l

—

Disorders of olfactory nerve

1.63

0.56

6.0

8.3

-1.32

1.72

mmol/l

—

Cleft lip and palate

169

1.33

0.55

9.0

13.0

1.52

0.77

mmol/l

0.38

139

Eustachian salpingitis and obstruction

280

2617

1.08

0.55

9.1

8.9

0.82

0.87

mmol/l

0.08

244

2162

Benign neoplasm: Short bones of upper limb

535

1.18

0.55

4.9

8.6

0.86

0.99

mmol/l

0.12

452

Acquired keratosis [keratoderma] palmaris et plantaris

170

1.34

0.55

20.4

8.6

1.34

0.77

mmol/l

0.40

149

Nontoxic single thyroid nodule

290

3091

0.93

0.54

5.4

7.4

0.90

1.03

mmol/l

0.28

232

2542

Autism spe

544

1.17

0.54

6.0

11.3

0.93

0.32

mmol/l

0.55

447

Human immunodeficiency virus [HIV] disease resulting in other conditions

622

1.16

0.53

16.0

12.5

-0.24

0.96

mmol/l

1.75

521

Helminthiases, including avohilmo

148

1353

1.10

0.52

10.1

9.0

0.09

0.72

mmol/l

1.13

129

1107

Medical treatment for female infertility

583

5523

1.05

0.52

6.1

7.4

0.53

0.56

mmol/l

0.06

442

4361

Bullous keratopathy

363

1.21

0.52

4.4

6.2

1.36

mmol/l

0.00

303

Oral lichen planus and hypothyroidism or thyroxine medication

737

1.14

0.51

6.0

7.7

0.81

1.23

mmol/l

0.61

621

Anomalies of dental arch relationship, including avohilmo

805

7012

1.04

0.51

7.8

8.7

0.94

0.69

mmol/l

1.29

660

5693

Postprocedural disorders of eye and adnexa, not elsewhere classified

155

1.35

0.51

5.4

6.7

-1.45

0.97

mmol/l

1.20

134

Defect, injury or illness of neck

208

1.28

0.50

9.2

8.8

1.68

0.93

mmol/l

0.50

175

Erysipeloid, including avohilmo

173

1.32

0.50

3.2

6.1

0.19

1.18

mmol/l

0.83

144

Antepartum haemorrhage, not elsewhere classified

228

2126

1.08

0.50

9.7

8.1

0.72

0.59

mmol/l

0.20

185

1691

Endometriosis ASRM stages 3,4

937

9065

1.04

0.49

6.6

6.7

1.10

0.98

mmol/l

0.47

753

7511

Congenital malformations of ovaries, fallopian tubes and broad ligaments

165

1521

1.09

0.49

7.5

7.4

0.61

0.81

mmol/l

0.23

140

1237

Abnormal findings on diagnostic imaging of breast

523

1.16

0.49

9.2

6.5

1.78

1.21

mmol/l

0.55

451

Other diseases caused by chlamydiae

318

1.21

0.49

11.0

9.6

0.99

1.10

mmol/l

0.05

264

LSIL lesion of the cervix uteri

349

3303

1.06

0.49

7.4

7.3

0.75

0.76

mmol/l

0.02

283

2652

Unspecified human immunodeficiency virus [HIV] disease

366

1.20

0.47

14.7

13.8

-1.06

1.03

mmol/l

2.26

315

Human immunodeficiency virus [HIV] disease, including avohilmo

704

1.14

0.47

18.1

11.7

0.07

0.97

mmol/l

1.23

587

Deformity of finger(s)

247

1.25

0.47

6.0

8.6

0.22

1.23

mmol/l

1.06

203

Benign mammary dysplasia

657

6326

1.04

0.47

6.6

6.7

1.15

mmol/l

0.00

540

5298

Vestibular neuronitis

447

4271

1.05

0.46

7.2

8.0

1.17

0.97

mmol/l

0.51

375

3510

Postpartum hemorraghe, all women as controls

716

7240

0.96

0.46

6.6

7.4

-0.11

0.67

mmol/l

6.81

550

5757

Tic and related disorders

311

1.20

0.46

8.9

11.5

0.72

0.64

mmol/l

0.05

255

Other hypertrophic osteoarthropathy

1.72

0.45

3.8

4.7

-1.12

1.68

mmol/l

—

Villonodular synovitis (pigmented)

257

1.23

0.45

5.4

12.1

1.32

1.24

mmol/l

0.03

210

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1987

14929

0.98

0.44

6.8

7.3

0.88

0.94

mmol/l

0.30

1609

12267

Noise effects on inner ear

219

2056

1.08

0.44

7.6

9.4

1.26

0.76

mmol/l

0.92

171

1699

Retinoschisis and retinal cysts

122

1120

1.10

0.44

5.0

7.9

0.37

0.96

mmol/l

1.28

919

Other benign neoplasm of uterus: Corpus uteri

314

1.20

0.43

5.2

6.4

1.93

1.10

mmol/l

0.90

269

Dementia in Alzheimer disease

1150

9875

0.97

0.43

3.8

6.1

1.43

0.98

mmol/l

3.55

872

8018

Contact with nonpowered hand tool

199

1863

1.08

0.43

10.7

9.5

0.79

0.82

mmol/l

0.04

168

1553

Carcinoma in situ of cervix uteri, endocervix

286

1.20

0.42

7.9

9.1

0.14

0.68

mmol/l

0.32

227

Other congenital malformations of male genital organs, including avohilmo

222

1.24

0.42

9.3

16.1

-0.22

0.51

mmol/l

0.69

186

Acne keloid

1.38

0.42

10.1

7.2

2.56

1.35

mmol/l

—

Other disorders of carbohydrate metabolism

132

1.32

0.42

6.1

11.1

0.68

1.35

mmol/l

0.54

109

Use of cabergoline

436

1.16

0.42

6.3

8.8

0.71

0.85

mmol/l

0.11

359

Bilateral sagittal split ramus osteotomy operation

109

996

1.10

0.42

3.4

9.6

1.30

0.85

mmol/l

0.60

806

Benign neoplasm of breast

508

4882

1.05

0.42

7.2

6.7

1.15

1.07

mmol/l

0.21

437

4070

Galactorrhea

250

1.22

0.41

5.2

6.9

1.89

0.90

mmol/l

1.00

202

Traumatic amputation of hip and thigh

1.44

0.41

8.1

6.8

2.77

1.19

mmol/l

—

Other specific arthropathies

1.44

0.41

2.9

11.3

-2.42

1.22

mmol/l

—

Premenstrual syndrome

325

1.18

0.40

7.5

8.5

0.95

0.71

mmol/l

0.17

256

Other recurrent vertebral subluxation

1.44

0.39

8.0

8.5

1.60

0.58

mmol/l

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

152

1.29

0.39

5.6

8.0

1.83

1.08

mmol/l

0.40

125

Vertigo of central origin

704

0.88

0.39

8.1

6.7

1.61

1.05

mmol/l

0.58

580

Benign neoplasm of other and unspecified female genital organs

174

1629

1.08

0.39

6.1

6.5

1.57

1.19

mmol/l

0.63

150

1350

Subacute thyroiditis

148

1378

1.08

0.38

7.1

7.9

1.06

1.03

mmol/l

0.03

125

1136

Diseases caused by chlamydiae, including avohilmo

355

1.17

0.38

10.3

9.6

-0.34

1.02

mmol/l

1.41

285

Complications predominantly related to the puerperium

914

8890

1.03

0.38

7.8

7.3

0.70

0.80

mmol/l

0.37

760

7244

Relapsing fevers, including avohilmo

1.32

0.38

7.7

18.9

1.30

0.86

mmol/l

—

Yaws

1.52

0.38

3.2

6.9

1.38

0.76

mmol/l

—

Pathological resorption of teeth

160

1497

1.08

0.37

14.3

8.9

0.65

0.91

mmol/l

0.49

136

1242

Osteolysis

1.46

0.37

5.7

6.9

2.38

0.77

mmol/l

—

Rare circulating lymphoid malignancy

255

1.20

0.37

8.6

9.1

1.85

1.40

mmol/l

0.19

216

Diaper [napkin] dermatitis

1.44

0.36

8.7

15.9

1.00

-0.28

mmol/l

—

Other congenital malformations of male genital organs

190

1.23

0.36

10.0

16.6

-0.36

0.47

mmol/l

0.68

163

Erosion and ectropion of cervix uteri

105

1137

0.92

0.36

5.6

7.4

0.53

1.14

mmol/l

0.67

950

Human immunodeficiency virus [HIV] disease

691

1.11

0.35

18.3

11.8

-0.05

0.99

mmol/l

1.52

578

Filariasis, including avohilmo

1.44

0.34

39.1

8.7

1.54

1.62

mmol/l

—

Filariasis

1.44

0.34

39.1

8.7

1.54

1.62

mmol/l

—

Hereditary corneal dystrophies

171

1613

1.07

0.33

7.8

7.4

0.77

1.01

mmol/l

0.39

150

1349

Melanoma in situ of other and unspecified parts of face

642

0.89

0.33

9.7

7.5

0.56

1.12

mmol/l

0.52

536

Small cell lung cancer, helper endpoint

134

1254

1.08

0.33

5.6

7.1

1.73

1.01

mmol/l

0.98

107

1019

Dislocations, sprains and strains involving multiple body regions

1.40

0.33

9.9

19.9

0.21

0.26

mmol/l

—

Congenital myopathies

1.41

0.33

3.7

20.7

1.60

1.63

mmol/l

—

Melanocytic naevi of lip

296

1.17

0.32

4.8

8.9

1.70

1.03

mmol/l

0.60

252

General hospital and personal-use devices associated with adverse incidents

1.34

0.32

4.7

16.8

0.64

0.67

mmol/l

—

Tic disorders

296

1.16

0.31

9.6

10.7

0.60

0.62

mmol/l

0.01

247

LeFortI or BSSO operation

129

1208

1.07

0.31

3.7

9.7

1.16

0.87

mmol/l

0.37

985

Carcinoma in situ of breast, other/unspecified

555

0.89

0.30

5.2

6.4

1.69

1.42

mmol/l

0.21

473

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

393

1.13

0.29

14.5

13.6

-1.05

1.08

mmol/l

2.43

337

Syndactyly, including avohilmo

1.30

0.29

44.3

9.0

0.44

1.05

mmol/l

0.30

Diseases caused by chlamydiae

270

1.16

0.29

12.4

10.4

0.10

1.02

mmol/l

0.64

220

Persons encountering health services in circumstances related to reproduction

2929

19388

1.01

0.28

9.8

9.3

0.74

0.90

mmol/l

1.55

2485

16231

Melanoma in situ

220

2297

0.95

0.27

7.8

7.6

0.86

0.97

mmol/l

0.19

190

1877

Disorder of carbohydrate metabolism, other/unspecified

1.31

0.27

2.4

13.7

0.92

1.20

mmol/l

—

Impacted teeth

578

5094

0.97

0.26

8.5

8.9

0.44

0.41

mmol/l

0.05

451

3998

Congenital malformations of nose, including avohilmo

1.28

0.26

20.0

10.7

2.04

1.19

mmol/l

—

Mandibular retrognathia

208

1984

1.05

0.26

7.1

10.0

1.20

0.74

mmol/l

1.03

162

1642

Other and unspecified disorders of pigmentation

245

1.16

0.26

5.8

9.4

0.06

0.93

mmol/l

0.63

202

Corneal degeneration

735

1.08

0.25

8.4

7.7

1.44

1.05

mmol/l

0.44

622

Use of dimethyl fumarate

170

1.19

0.25

12.8

8.4

1.02

0.73

mmol/l

0.13

133

Universal erythroderma, KELA reimbursement

581

1.10

0.25

10.0

8.0

1.32

0.77

mmol/l

0.40

490

Cervical polyps

420

4079

1.03

0.25

7.0

7.6

1.24

0.99

mmol/l

0.71

353

3467

Congenital malformations of breast

360

1.12

0.24

7.6

6.8

1.02

0.98

mmol/l

0.02

292

Rubella [German measles]

159

1517

1.05

0.24

14.0

11.0

0.98

0.61

mmol/l

0.74

135

1298

Nontoxic diffuse goitre

135

1282

1.06

0.24

6.6

6.7

1.15

1.06

mmol/l

0.10

117

1065

Visual disturbances in diseases classified elsewhere

0.00

0.24

0.0

7.1

—

2.44

—

Carcinoma in situ of skin, other sites/unspecified

806

1.08

0.24

7.3

6.9

1.12

1.09

mmol/l

0.02

666

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

101

951

1.07

0.24

8.4

7.9

1.44

1.04

mmol/l

0.45

789

Deep endometriosis

357

3462

1.03

0.23

6.1

6.5

1.29

0.99

mmol/l

0.85

276

2835

FESS (DNB20)

542

5554

0.97

0.23

6.1

8.7

1.19

0.86

mmol/l

1.57

430

4578

Anthrax

0.00

0.23

0.0

9.5

—

2.75

—

Mandibular hypoplasia

172

1.18

0.23

10.4

8.7

0.50

1.16

mmol/l

0.33

142

Inflammatory disease of cervix uteri

242

2509

0.96

0.22

6.2

6.4

1.40

1.14

mmol/l

0.54

204

2070

Other protozoal diseases, not elsewhere classified/unspecified

0.00

0.22

0.0

70.5

—

2.48

—

Rubella [German measles], including avohilmo

159

1521

1.05

0.22

14.0

11.0

0.98

0.61

mmol/l

0.73

135

1302

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

1.21

0.22

2.2

27.7

-0.30

1.70

mmol/l

—

Mandibular retrognathia AND surgery (BSSO)

749

1.07

0.22

3.4

10.3

1.60

0.85

mmol/l

0.88

610

Contact with venomous snakes and lizards

392

1.11

0.22

4.8

10.5

-0.01

0.92

mmol/l

0.65

333

Cicatricial alopecia [scarring hair loss]

325

1.12

0.22

9.5

10.1

-0.67

0.95

mmol/l

0.88

278

Other and unspecified parapsoriasis

219

0.85

0.22

21.4

7.1

0.97

0.93

mmol/l

0.02

183

Anthrax, including avohilmo

0.00

0.22

0.0

8.4

—

2.53

—

Female infertility

1083

6381

1.02

0.22

6.5

7.9

0.62

0.84

mmol/l

1.08

866

5262

Benign neoplasm: Parathyroid gland

460

1.10

0.22

3.1

7.2

0.87

1.08

mmol/l

0.15

391

Hair colour and hair shaft abnormalities

183

1.17

0.21

4.6

8.7

1.82

0.82

mmol/l

0.63

163

Carcinoma in situ of breast

112

0.79

0.21

5.6

6.2

-0.29

1.36

mmol/l

—

Other congenital malformations of skin, including avohilmo

323

3137

1.03

0.21

8.4

8.6

0.31

0.84

mmol/l

1.38

270

2570

Benign neoplasm of male genital organs

107

1016

1.06

0.21

7.1

9.6

1.12

0.71

mmol/l

0.52

832

Excessive earwax

4150

37295

1.01

0.20

6.9

7.9

0.86

0.94

mmol/l

0.70

3474

30985

Maternal care for cervical incompetence

123

1290

0.95

0.20

7.1

7.0

0.93

1.00

mmol/l

0.06

1068

Melanoma in situ of upper limb, including shoulder

337

1.11

0.20

11.4

8.9

2.15

0.72

mmol/l

1.11

282

Congenital malformations of larynx

1.25

0.20

40.1

13.0

0.47

0.74

mmol/l

0.15

Mumps

971

0.94

0.19

7.8

9.1

0.55

0.91

mmol/l

0.53

807

Primary open-angle glaucoma, strict

1665

16418

1.01

0.19

6.3

6.9

0.95

1.03

mmol/l

0.38

1320

13578

Enterobiasis, including avohilmo

529

0.92

0.19

8.3

10.7

-0.37

0.50

mmol/l

0.75

425

Peripheral retinal degeneration

126

1317

0.95

0.19

5.3

7.9

1.53

0.99

mmol/l

1.12

110

1078

Dermatitis due to ingested food

693

1.07

0.19

21.4

13.6

-0.08

-0.07

mmol/l

0.00

552

Cholesteatoma of middle ear

251

2436

1.03

0.18

8.1

7.8

1.14

0.94

mmol/l

0.37

199

1999

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

237

2445

0.97

0.18

10.1

7.5

0.52

0.83

mmol/l

0.61

195

1990

Leiomyoma of uterus

3115

17324

1.01

0.18

6.7

6.9

1.00

1.14

mmol/l

1.20

2619

14392

Acrodermatitis chronica atrophicans

1.22

0.17

7.1

8.2

1.16

1.78

mmol/l

—

Normotensive glaucoma

489

4794

1.02

0.17

6.8

6.9

0.93

1.09

mmol/l

0.40

384

3981

Other and unspecified disorders of vitreous body

2537

25005

0.99

0.17

7.3

7.7

1.00

0.99

mmol/l

0.04

2184

20927

Use of interferon beta-1a

602

1.07

0.17

7.7

10.0

0.76

0.75

mmol/l

0.01

492

Retained placenta and membranes, without haemorrhage

420

4289

0.98

0.16

6.3

7.1

0.88

0.93

mmol/l

0.10

340

3563

Other mosquito-borne viral fevers, including avohilmo

235

1.12

0.16

5.3

8.3

1.85

0.85

mmol/l

1.30

200

Maternal care for other known or suspected fetal problems

615

3925

0.98

0.16

6.6

8.2

-0.12

0.57

mmol/l

4.81

478

3104

Other specified disorders of external ear

195

1891

1.04

0.16

6.5

8.7

0.66

0.85

mmol/l

0.29

161

1546

Benign neoplasm: Female genital organ, unspecified

119

0.82

0.16

10.4

5.9

2.76

1.06

mmol/l

—

107

Benign neoplasm: Skin, unspecified

177

1713

1.04

0.16

7.4

8.1

0.81

0.97

mmol/l

0.29

147

1411

Mumps, including avohilmo

994

0.95

0.16

7.6

9.1

0.50

0.89

mmol/l

0.62

825

Feeding problems of newborn

1.10

0.15

12.1

23.2

0.33

-0.03

mmol/l

—

Single delivery by caesarean section

554

3216

0.98

0.15

7.3

9.1

-0.04

0.58

mmol/l

2.72

430

2618

Maternal care for known or suspected malpresentation of fetus

470

3414

0.98

0.15

6.8

8.0

0.27

0.52

mmol/l

0.74

348

2690

Palindromic rheumatism

388

0.92

0.14

9.2

8.6

1.10

0.92

mmol/l

0.12

320

Moderate visual impairment, binocular

145

1402

1.04

0.14

6.9

6.7

0.74

1.17

mmol/l

0.56

119

1146

Benign neoplasm of thyroid gland

138

1333

1.04

0.14

7.9

7.2

1.11

1.09

mmol/l

0.03

123

1112

Melanoma in situ of trunk

756

0.95

0.14

8.1

8.0

0.72

0.86

mmol/l

0.15

622

Contact with lifting and transmission devices, not elsewhere classified

734

1.06

0.14

9.2

11.1

1.40

0.70

mmol/l

1.17

606

Endometriosis of rectovaginal septum and vagina

314

3072

1.02

0.14

6.3

6.9

1.37

1.02

mmol/l

0.96

246

2564

Use of memantine

1943

15507

1.01

0.14

4.1

6.2

1.33

0.98

mmol/l

3.32

1497

12613

Use of other anti-dementia drugs

1943

15507

1.01

0.14

4.1

6.2

1.33

0.98

mmol/l

3.32

1497

12613

Burn and corrosion confined to eye and adnexa

827

0.95

0.14

6.4

10.2

1.18

0.81

mmol/l

0.46

698

Habitual aborter

383

1.07

0.13

4.2

7.7

-0.67

0.35

mmol/l

0.64

298

Congenital malformations of breast, including avohilmo

393

1.07

0.13

7.7

7.0

1.08

0.97

mmol/l

0.06

319

Other protozoal intestinal diseases

458

0.93

0.13

5.6

10.0

0.27

0.97

mmol/l

0.65

389

Deep bite

419

3613

1.02

0.13

7.6

9.7

0.86

0.71

mmol/l

0.43

350

2961

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

169

1643

1.03

0.12

10.7

7.7

0.08

0.67

mmol/l

1.34

135

1296

Drowning and submersion while in natural water

220

1.11

0.12

3.1

11.1

-0.28

0.67

mmol/l

0.54

187

Gestational diabetes (for exclusion)

1105

7520

1.01

0.12

6.7

7.8

0.36

0.64

mmol/l

1.51

854

5989

Venous complications and haemorrhoids in the puerperium

323

0.92

0.12

5.3

7.3

1.48

1.15

mmol/l

0.14

274

Dyshidrosis [pompholyx]

487

0.94

0.12

5.2

7.0

0.05

0.60

mmol/l

0.21

397

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

275

1.08

0.12

10.2

21.2

-1.00

-0.47

mmol/l

0.28

229

Other obstructed labour

250

2448

1.02

0.11

6.9

7.3

1.04

0.84

mmol/l

0.38

213

2019

L02BB Anti-androgens

558

5652

0.99

0.11

5.4

7.5

0.43

0.79

mmol/l

1.07

423

4552

Unspecified urinary incontinence

424

4177

1.02

0.11

9.7

6.9

0.87

1.13

mmol/l

0.63

368

3430

Alzheimer’s disease (Early onset), excluding more controls

164

1586

0.97

0.11

7.3

6.0

1.28

0.79

mmol/l

0.93

131

1254

Postpartum haemorrhage due to retained placenta

328

3223

1.02

0.11

7.1

7.0

-0.56

0.68

mmol/l

7.44

249

2547

Overjet

584

0.95

0.11

11.6

11.8

0.09

0.28

mmol/l

0.18

480

LSIL lesion of the vagina

475

1.06

0.11

7.9

7.5

0.12

1.04

mmol/l

0.98

397

Internuclear ophthalmoplegia

125

1.13

0.10

14.3

8.8

1.56

0.57

mmol/l

0.65

106

Multiple gestation

250

2452

1.02

0.10

7.7

7.9

0.57

0.66

mmol/l

0.12

205

1978

Atopic dermatitis

2975

23556

1.01

0.10

8.0

8.3

0.67

0.84

mmol/l

1.56

2507

19378

Disorders of sexual preference

1.17

0.10

11.7

14.8

1.46

0.75

mmol/l

—

Other abnormal products of conception

985

6518

0.99

0.10

6.1

7.7

0.61

0.73

mmol/l

0.45

773

5243

Maternal care for known or suspected fetal abnormality and damage

403

3460

0.99

0.09

7.1

8.3

0.11

0.54

mmol/l

1.39

321

2746

Oral lichen planus, including avohilmo , including avohilmo

318

3132

1.02

0.09

6.5

8.1

0.60

1.06

mmol/l

2.01

266

2614

Dysplasia of cervi uteri

905

6306

1.01

0.09

6.9

7.7

0.80

0.86

mmol/l

0.18

730

5194

Other fusion of spine

1.12

0.09

13.7

7.8

-0.07

1.66

mmol/l

—

Polyp of middle ear

0.76

0.08

8.0

9.6

3.36

1.73

mmol/l

—

Twin gestation

239

2350

1.02

0.08

8.0

7.9

0.55

0.65

mmol/l

0.12

195

1894

Benign neoplasm: Vagina

450

1.05

0.08

5.6

6.0

1.61

1.26

mmol/l

0.26

380

Benign neoplasm: Uterine tubes and ligaments

256

0.93

0.08

5.3

6.6

1.69

1.35

mmol/l

0.09

220

Telogen effluvium

0.83

0.08

6.5

15.5

0.30

1.25

mmol/l

—

Allergic contact dermatitis

538

5433

0.99

0.08

7.3

7.6

0.79

0.90

mmol/l

0.23

433

4438

Maternal care for known or suspected abnormality of pelvic organs

765

5202

0.99

0.07

6.4

7.9

0.02

0.71

mmol/l

5.16

588

4205

Presbyopia

334

3302

1.01

0.07

8.4

8.7

0.89

0.92

mmol/l

0.06

286

2755

Triptan medication for migraine, min. 3 purchases

2452

18385

1.00

0.07

7.2

8.2

0.72

0.86

mmol/l

1.24

1998

15117

Female infertility, cervical, vaginal, other or unspecified origin

973

6256

0.99

0.06

6.6

8.0

0.55

0.84

mmol/l

1.59

782

5168

Maternal care for known or suspected disproportion

102

1041

0.98

0.05

5.0

8.0

0.50

0.79

mmol/l

0.41

825

Sudden idiopathic hearing loss

523

5191

1.01

0.05

8.8

7.9

1.03

0.91

mmol/l

0.24

437

4290

Use of fingolimod

181

0.94

0.05

3.1

7.7

-0.06

0.52

mmol/l

—

145

Use of entacapone

367

1.04

0.05

5.0

7.0

2.17

1.34

mmol/l

0.62

307

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

288

1.04

0.04

3.3

13.2

1.02

0.53

mmol/l

0.40

243

Benign neoplasm: Prostate

362

0.96

0.04

4.4

7.5

0.46

0.80

mmol/l

0.21

297

conjunctival degenerations and deposits

904

1.02

0.04

8.9

7.6

1.47

0.94

mmol/l

0.99

753

Intrahepatic Cholestasis of Pregnancy (ICP)

169

1710

0.99

0.04

10.7

7.7

0.08

0.67

mmol/l

1.33

135

1360

Use of amantadine

666

1.02

0.04

4.4

7.3

0.25

1.12

mmol/l

0.77

553

Infections of breast associated with childbirth

855

0.98

0.04

7.9

7.5

0.97

0.81

mmol/l

0.20

683

Ethmoidectomy

578

5808

0.99

0.03

6.4

8.7

1.15

0.86

mmol/l

1.30

460

4789

Bus occupant injured in other and unspecified transport accidents

250

1.04

0.03

11.3

7.5

-0.43

0.88

mmol/l

1.34

209

Perioral dermatitis

693

0.98

0.03

11.0

9.0

1.52

0.89

mmol/l

0.54

575

Obstructed labour due to maternal pelvic abnormality

581

5836

1.00

0.03

7.5

7.3

0.89

1.08

mmol/l

0.57

476

4911

Alzheimer’s disease, strict definition

1740

14008

1.00

0.03

4.3

6.2

1.10

1.03

mmol/l

0.26

1366

11372

Unattended death

420

0.97

0.03

4.5

7.1

1.51

0.97

mmol/l

0.37

346

Foreign body on external eye

713

7107

1.00

0.02

7.5

9.4

0.75

0.82

mmol/l

0.25

595

5904

Other obstetric trauma

130

1313

0.99

0.02

8.1

7.5

0.28

0.54

mmol/l

0.38

106

1037

Benign neoplasm: Rectum/anal canal icd-9

361

1.03

0.02

5.2

6.0

1.80

1.42

mmol/l

0.37

289

Distal bite

894

1.01

0.01

10.2

11.7

0.37

0.30

mmol/l

0.07

726

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

178

1770

1.01

0.01

5.1

7.4

1.59

1.04

mmol/l

1.51

145

1487

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

237

2380

1.00

0.01

10.1

7.3

0.52

0.82

mmol/l

0.58

195

1933

Unspecified dementia

658

5893

1.00

0.01

4.6

5.9

1.70

0.95

mmol/l

5.12

506

4715

Melanocytic naevi of eyelid, including canthus

354

1.02

0.00

8.6

8.9

1.65

1.06

mmol/l

0.52

305

Other disorders of breast

527

5263

1.00

0.00

6.9

7.1

0.85

0.99

mmol/l

0.35

456

4366

Transient global amnesia

479

4796

1.00

0.00

5.7

7.4

1.20

1.00

mmol/l

0.61

405

3994

Other puerperal infections

176

1765

1.00

0.00

7.4

7.5

-0.21

0.41

mmol/l

1.97

147

1371

Other protozoal intestinal diseases, including avohilmo

694

0.99

0.00

6.5

9.1

0.68

0.90

mmol/l

0.18

572

Benign neoplasm: Eye, unspecified

174

0.97

0.00

7.4

5.6

0.35

0.67

mmol/l

0.12

146

Mesial bite

231

1.00

0.00

10.6

13.7

0.51

0.74

mmol/l

0.19

197

Other and unspecified postprocedural disorders of eye and adnexa

118

1.02

0.00

3.8

7.5

-2.72

1.01

mmol/l

—

Congenital malformations of anterior segment of eye

283

0.99

0.00

8.3

10.1

1.43

0.77

mmol/l

0.41

239

Personal history of allergy to analgesic agent

184

0.98

0.00

4.6

8.6

1.31

0.86

mmol/l

0.22

154

Foreign body granuloma of skin and subcutaneous tissue

138

1.02

0.00

8.6

5.9

2.25

0.88

mmol/l

—

113

Use of metixene

0.00

0.0

2.2

—

-0.16

—

Exposure to noise

1.00

-0.00

2.0

7.9

2.14

0.44

mmol/l

—

Oesophagitis, drug-induced

1.00

-0.00

18.0

7.0

-0.43

0.69

mmol/l

—

Huntington disease

1.00

-0.00

7.8

8.1

3.26

2.02

mmol/l

—

Disorders of zinc metabolism

0.00

-0.00

0.0

15.7

—

2.63

—

Intrauterine hypoxia

0.00

-0.00

0.0

8.5

—

0.08

—

Other congenital infectious and parasitic diseases

0.00

-0.00

0.0

12.2

—

2.90

—

Neuropathic heredofamilial amyloidosis

0.00

-0.00

0.0

7.6

—

0.71

—

Toxic effect of noxious substances eaten as seafood

0.00

-0.00

0.0

15.1

—

1.94

—

Ototoxic hearing loss, drug-induced

0.00

-0.00

0.0

16.0

—

-3.04

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Base excess in Arterial blood by calculation

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS